Update tot 28-05-2020
1. COVID-19, Australia: Epidemiology Report 14 (Reporting week to 23:59 AEST 3 May 2020). Communicable diseases intelligence (2018). 2020;44.
2. COVID-19, Australia: Epidemiology Report 15 (Reporting week to 23:59 AEST 10 May 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.43.
3. Erratum: COVID-19, Australia: Epidemiology Report 14 (Reporting week to 23:59 AEST 3 May 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.44.
4. Metformin and COVID-19: A novel deal of an Old Drug. A.A ELA, Abdalla M. Journal of Medical Virology. 2020.
5. The mutual effects of COVID-19 and obesity. Abbas AM, Fathy SK, Fawzy AT, Salem AS, Shawky MS. Obesity Medicine. 2020;19.
6. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review. Aboughdir M, Kirwin T, Abdul Khader A, Wang B. Viruses. 2020;12(5).
7. Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients. Abrishami A, Samavat S, Behnam B, Arab-Ahmadi M, Nafar M, Sanei Taheri M. European Urology. 2020.
8. COVID-19 and lung cancer: risks, mechanisms and treatment interactions. Addeo A, Obeid M, Friedlaender A. J Immunother Cancer. 2020;8(1). http://dx.doi.org/10.1136/jitc-2020-000892.
9. 5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection. Ahmad SI. Med Hypotheses. 2020;142:109754. http://dx.doi.org/10.1016/j.mehy.2020.109754.
10. The accuracy of “Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data”. Ahmadi A, Kheiril S, Mohammadian-Hafshejani A, Raeisi H, Mosavi M, Sharifi H. International Journal of Infectious Diseases. 2020;95:319-20.
11. Pharmacological options in treating SARS-CoV-2 infection/COVID-19. Ákos F, István L, Marianna J, Mariann B, Tamás V, György K, et al. Orvosi Hetilap. 2020;161(17):685-8.
12. Turkish Cardiology Association Consensus Report: COVID-19 Pandemic and Cardiovascular Diseases (May 13, 2020). Aktoz M, Altay H, Aslanger E, Atalar E, Atar İ, Aytekin V, et al. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2020;48:1-87.
13. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Kidney international. 2020. http://dx.doi.org/10.1016/j.kint.2020.04.030.
14. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Albini A, Di Guardo G, Noonan DM, Lombardo M. Internal and emergency medicine. 2020. http://dx.doi.org/10.1007/s11739-020-02364-6.
15. Guidelines for dental care provision during the COVID-19 pandemic. Alharbi A, Alharbi S, Alqaidi S. Saudi Dental Journal. 2020;32(4):181-6.
16. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: A rapid systematic review and meta-analysis. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. PLoS ONE. 2020;15(5).
17. Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide? Al-Tawfiq JA, Leonardi R, Fasoli G, Rigamonti D. Travel Medicine and Infectious Disease. 2020.
18. Molecular mechanisms for thrombosis risk in black people: a role in excess mortality from Covid-19. Amasamy R, Milne KM, Stoneham SM, Chevassut TJ. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16869.
19. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Amawi H, Abu Deiab GI, Aa AA, Dua K, Tambuwala MM. Therapeutic delivery. 2020;11(4):245-68. http://dx.doi.org/10.4155/tde-2020-0035. Epub 2020 May 12.
20. Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection. Ameratunga R, Lehnert K, Leung E, Comoletti D, Snell R, Woon ST, et al. The New Zealand medical journal. 2020;133(1515):112-8.
21. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control? Amimo F, Lambert B, Magit A. Tropical medicine and health. 2020;48:32. http://dx.doi.org/10.1186/s41182-020-00219-6. eCollection 2020.
22. Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic. Anders HJ, Bruchfeld A, Fernandez Juarez GM, Floege J, Goumenos D, Turkmen K, et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2020. http://dx.doi.org/10.1093/ndt/gfaa112.
23. Chilblains in children in the setting of COVID-19 pandemic. Andina D, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, et al. Pediatric dermatology. 2020.
24. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Angelo Vaira L, Hopkins C, Salzano G, Petrocelli M, Melis A, Cucurullo M, et al. Head & neck. 2020. http://dx.doi.org/10.1002/hed.26269.
25. Does communicable diseases (including COVID-19) may increase global poverty risk? A cloud on the horizon. Anser MK, Yousaf Z, Khan MA, Nassani AA, Alotaibi SM, Qazi Abro MM, et al. Environmental Research. 2020;187.
26. COVID-19: a novel coronavirus and a novel challenge for critical care. Arabi YM, Murthy S, Webb S. Intensive Care Medicine. 2020;46(5):833-6.
27. Mapping the incidence of the COVID-19 hotspot in Iran – Implications for Travellers. Arab-Mazar Z, Sah R, Rabaan AA, Dhama K, Rodriguez-Morales AJ. Travel Medicine and Infectious Disease. 2020;34.
28. Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. JAMA - Journal of the American Medical Association. 2020;323(16):1612-4.
29. Anticipating the “Second Wave” of Health Care Strain in the COVID-19 Pandemic. Argulian E. JACC: Case Reports. 2020;2(5):845-6.
30. Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients. Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, et al. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16852.
31. Insights from immuno-oncology: The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. Ascierto PA, Fox B, Urba W, Anderson AC, Atkins MB, Borden EC, et al. Journal for ImmunoTherapy of Cancer. 2020;8(1).
32. Management of patients with COPD during the COVID-19 pandemic. Attaway A. Cleveland Clinic journal of medicine. 2020.
33. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL, et al. The FEBS journal. 2020. http://dx.doi.org/10.1111/febs.15375.
34. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California. Azar KMJ, Shen Z, Romanelli RJ, Lockhart SH, Smits K, Robinson S, et al. Health affairs (Project Hope). 2020:101377hlthaff202000598. http://dx.doi.org/10.1377/hlthaff.2020.00598.
35. Telehealth for High-Risk Pregnancies in the Setting of the COVID-19 Pandemic. Aziz A, Zork N, Aubey JJ, Baptiste CD, D'Alton ME, Emeruwa UN, et al. American journal of perinatology. 2020.
36. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, et al. Allergy. 2020.
37. A Chinese case of coronavirus disease 2019 (COVID-19) did not show infectivity during the incubation period: Based on an epidemiological survey. Bae JM. Journal of Preventive Medicine and Public Health. 2020;53(2):67-9.
38. Author response: Coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. Bae JM. Journal of Preventive Medicine and Public Health. 2020;53(2):71.
39. What dentists need to know about COVID-19. Baghizadeh Fini M. Oral Oncology. 2020;105.
40. Covid-19 management: It's inappropriate to make judgments in hindsight that rely on information not available at the outset. Bamji AN. The BMJ. 2020;369.
41. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Banerjee A, Pasea L, Harris S, Gonzalez-Izquierdo A, Torralbo A, Shallcross L, et al. Lancet (London, England). 2020.
42. ‘Age and ageism in COVID-19’: Elderly mental health-care vulnerabilities and needs. Banerjee D. Asian Journal of Psychiatry. 2020;51.
43. COVID-19 Worries and Behavior Changes in Older and Younger Men and Women. Barber SJ, Kim H. The journals of gerontology Series B, Psychological sciences and social sciences. 2020. http://dx.doi.org/10.1093/geronb/gbaa068.
44. Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice. Barra S, Guarnieri A, di Monale EBMB, Marcenaro M, Tornari E, Belgioia L, et al. La Radiologia medica. 2020. http://dx.doi.org/10.1007/s11547-020-01216-9.
45. Covid-19 and infection in health-care workers: An emerging problem. Barranco R, Ventura F. The Medico-legal journal. 2020:25817220923694. http://dx.doi.org/10.1177/0025817220923694.
46. A Proposed Plan for Prenatal Care to Minimize Risks of COVID-19 to Patients and Providers: Focus on Hypertensive Disorders of Pregnancy. Barton JR, Saade GR, Sibai BM. American journal of perinatology. 2020.
47. COVID-19: Infection prevention and control guidance for all ultrasound practitioners. Basseal JM, Campbell Westerway S, McAuley T. Australasian Journal of Ultrasound in Medicine. 2020.
48. Covid-19 and co-morbidities: a role for Dipeptidyl Peptidase 4 (DPP4) in disease severity? Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD. Journal of diabetes. 2020.
49. Non-communicable disease management in vulnerable patients during Covid-19. Basu S. Indian journal of medical ethics. 2020(2):103-5.
50. Precision Physical Distancing for COVID-19: An Important Tool in Unlocking the Lockdown. Bausch DG. The American journal of tropical medicine and hygiene. 2020. http://dx.doi.org/10.4269/ajtmh.20-0359.
51. No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes. Beato-Víbora PI. Diabetes technology & therapeutics. 2020.
52. SARS-CoV-2/COVID-19: Evidence-Based Recommendations on Diagnosis and Therapy. Bein B, Bachmann M, Huggett S, Wegermann P. Geburtshilfe und Frauenheilkunde. 2020;80(5):491-8. http://dx.doi.org/10.1055/a-1156-3991. Epub 2020 May 18.
53. Acute limb ischemia in patients with COVID-19 pneumonia. Bellosta R, Luzzani L, Natalini G, Pegorer MA, Attisani L, Cossu LG, et al. Journal of Vascular Surgery. 2020.
54. Role of duties related to COVID-19 suspected, probable and confirmed fatality cases. Bence FC, Dávid P, Gergely B, Gábor D, Gergő S, Csaba B, et al. Orvosi Hetilap. 2020;161(17):713-22.
55. COVID-19 and MS disease-modifying therapies. Berger JR, Brandstadter R, Bar-Or A. Neurology(R) neuroimmunology & neuroinflammation. 2020;7(4). http://dx.doi.org/10.1212/NXI.0000000000000761. Print 2020 Jul.
56. COVID19: potential cardiovascular issues in pediatric patients. Bertoncelli D, Guidarini M, Della Greca A, Ratti C, Falcinella F, Iovane B, et al. Acta bio-medica : Atenei Parmensis. 2020;91(2):177-83. http://dx.doi.org/10.23750/abm.v91i2.9655.
57. Need for integrated surveillance at human-animal interface for rapid detection & response to emerging coronavirus infections using one health approach. Bhatia R. Indian Journal of Medical Research, Supplement. 2020;151(2):132-5.
58. Consensus statement-suggested recommendations for acute stroke management during the COVID-19 pandemic: Expert group on behalf of the indian stroke association. Bhatia R, Sylaja PN, Padma Srivastava MV, Khurana D, Pandian JD, Suri V, et al. Annals of Indian Academy of Neurology. 2020;23(7):15-23.
59. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count. Bi X, Su Z, Yan H, Du J, Wang J, Chen L, et al. Platelets. 2020:1-6.
60. Discovery of intervention effect of Chinese herbal formulas on COVID-19 pulmonary fibrosis treated by VEGFR and FGFR inhibitors. Bian YQ, Ma J, Ren Y, Zhang YL, Qiao YJ. Zhongguo Zhongyao Zazhi. 2020;45(7):1481-7.
61. Clinical Presentation of COVID19 in Dementia Patients. Bianchetti A, Rozzini R, Guerini F, Boffelli S, Ranieri P, Minelli G, et al. Journal of Nutrition, Health and Aging. 2020.
62. [Managing cardiac patients post-COVID-19 pandemic: a proposal by the ANMCO Veneto Region]. Bilato C, Roncon L, Anselmi M, Valle R, Perrone C, Mecenero A, et al. Giornale italiano di cardiologia (2006). 2020;21(6):408-16. http://dx.doi.org/10.1714/3359.33322.
63. Cancer at the time of the COVID-19 hurricane. Blandino G. Journal of Experimental and Clinical Cancer Research. 2020;39(1).
64. Pandemic Recovery Using a Covid-Minimal Cancer Surgery Pathway. Boffa DJ, Judson BL, Billingsley KG, Galetta D, Fontanez P, Odermatt C, et al. The Annals of thoracic surgery. 2020. http://dx.doi.org/10.1016/j.athoracsur.2020.05.003.
65. COVID-19-associated immune thrombocytopenia. Bomhof G, Mutsaers P, Leebeek FWG, Te Boekhorst PAW, Hofland J, Croles FN, et al. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16850.
66. Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy. Borghesi A, Zigliani A, Golemi S, Carapella N, Maculotti P, Farina D, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.05.021.
67. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research. Bostanciklioglu M, Temiz E. Current neurovascular research. 2020. http://dx.doi.org/10.2174/1567202617666200522220509.
68. Not a perfect storm - Covid-19 and the importance of language. Brandt AM, Botelho A. New England Journal of Medicine. 2020;382(16):1493-5.
69. Global Access to Handwashing: Implications for COVID-19 Control in Low-Income Countries. Brauer M, Zhao JT, Bennitt FB, Stanaway JD. Environmental health perspectives. 2020;128(5):57005. http://dx.doi.org/10.1289/EHP7200. Epub 2020 May 15.
70. Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry. Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, et al. Gastroenterology. 2020. http://dx.doi.org/10.1053/j.gastro.2020.05.032.
71. Neurologic complications of COVID-19. Bridwell R, Long B, Gottlieb M. The American journal of emergency medicine. 2020. http://dx.doi.org/10.1016/j.ajem.2020.05.024.
72. Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington. Buckner FS, McCulloch DJ, Atluri V, Blain M, McGuffin SA, Nalla AK, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa632.
73. Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich Cohort. Burian E, Jungmann F, Kaissis GA, Lohofer FK, Spinner CD, Lahmer T, et al. Journal of clinical medicine. 2020;9(5). http://dx.doi.org/10.3390/jcm9051514.
74. Eco-epidemiological assessment of the COVID-19 epidemic in China, January-February 2020. Byass P. Global health action. 2020;13(1):1760490.
75. Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy. Cafarotti S. Journal of Thoracic Oncology. 2020.
76. ACE2 and prognosis of COVID-19. Insights from Bartter's and Gitelman's syndromes patients. Calò LA, Davis PA, Rigato M, Sgarabotto L. Journal of medical virology. 2020.
77. COVID-19: immunopathology and its implications for therapy. Cao X. Nature Reviews Immunology. 2020;20(5):269-70.
78. Collateral Crises of Gun Preparation and the COVID-19 Pandemic: An Infodemiology Study. Caputi TL, Ayers JW, Dredze M, Suplina N, Burd-Sharps S. JMIR public health and surveillance. 2020. http://dx.doi.org/10.2196/19369.
79. COVID-19 pandemic. What should PRM specialists do? A clinician's perspective. Carda S, Invernizzi M, Bavikatte G, Bensmail D, Bianchi F, Deltombe T, et al. European journal of physical and rehabilitation medicine. 2020. http://dx.doi.org/10.23736/S1973-9087.20.06317-0.
80. Liver injury in critically ill patients with COVID-19: A case series. Cardoso FS, Pereira R, Germano N. Critical Care. 2020;24(1).
81. Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico. Carrillo-Vega MF, Salinas-Escudero G, Garcia-Peña C, Gutierrez-Robledo LM, Parra-Rodriguez L. medRxiv. 2020:2020.05.11.20098145.
82. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature. Cattaruzza MS, Zaga V, Gallus S, D'Argenio P, Gorini G. Acta bio-medica : Atenei Parmensis. 2020;91(2):106-12. http://dx.doi.org/10.23750/abm.v91i2.9698.
83. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy. Cecconi M, Piovani D, Brunetta E, Aghemo A, Greco M, Ciccarelli M, et al. Journal of clinical medicine. 2020;9(5). http://dx.doi.org/10.3390/jcm9051548.
84. Coronavirus: a clinical update of Covid-19. Cespedes MDS, Souza J. Revista da Associacao Medica Brasileira (1992). 2020;66(2):116-23. http://dx.doi.org/10.1590/1806-9282.66.2.116.
85. Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: A pan-cancer analysis. Chai P, Yu J, Ge S, Jia R, Fan X. Journal of Hematology and Oncology. 2020;13(1).
86. Monitoring respiratory infections in covid-19 epidemics. Chan KH, Lee PW, Chan CY, Lam KBH, Ho PL. The BMJ. 2020;369.
87. The 2019 novel coronavirus disease (Covid-19) pandemic: A review of the current evidence. Chatterjee P, Nagi N, Agarwal A, Das B, Banerjee S, Sarkar S, et al. Indian Journal of Medical Research, Supplement. 2020;151(2):147-59.
88. Containing COVID-19 Among 627,386 Persons in Contact With the Diamond Princess Cruise Ship Passengers Who Disembarked in Taiwan: Big Data Analytics. Chen CM, Jyan HW, Chien SC, Jen HH, Hsu CY, Lee PC, et al. Journal of medical Internet research. 2020;22(5):e19540.
89. Clinical and immunological features of severe and moderate coronavirus disease 2019. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Journal of Clinical Investigation. 2020;130(5):2620-9.
90. Simplified immune-dysregulation index: a novel marker predicts 28-day mortality of intensive care patients with COVID-19. Chen H, Wang J, Su N, Bao X, Li Y, Jin J. Intensive Care Med. 2020. http://dx.doi.org/10.1007/s00134-020-06114-2.
91. Imported COVID-19 cases pose new challenges for China. Chen L, Cai J, Lin Q, Xiang B, Ren T. Journal of Infection. 2020;80(6):e43-e4.
92. How related is SARS-CoV-2 to other coronaviruses? Chen N, Li X, Li S, Xiao Y, Ye M, Yan X, et al. Veterinary Record. 2020;186(15):496.
93. Risk Factors of Coronavirus Disease 2019 Patients Progressing to Sepsis. Chen Q-H, Shao J, Fu P, Yu J-Q, Wu S-H, Zheng R-Q. Available at SSRN 3576956. 2020.
94. COVID-19 in Africa: care and protection for frontline healthcare workers. Chersich MF, Gray G, Fairlie L, Eichbaum Q, Mayhew S, Allwood B, et al. Globalization and health. 2020;16(1):46. http://dx.doi.org/10.1186/s12992-020-00574-3.
95. COVID-19 and the role of chronic inflammation in patients with obesity. Chiappetta S, Sharma AM, Bottino V, Stier C. International Journal of Obesity. 2020.
96. QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin. Chorin E, Wadhwani L, Magnani S, Dai M, Shulman E, Nadeau-Routhier C, et al. Heart rhythm. 2020.
97. A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19. Chowdhury MDS, Rathod J, Gernsheimer J. Academic Emergency Medicine. 2020.
98. The predictive capacity of air travel patterns during the global spread of the covid-19 pandemic: Risk, uncertainty and randomness. Christidis P, Christodoulou A. International Journal of Environmental Research and Public Health. 2020;17(10).
99. More data are required for incubation period, infectivity, and quarantine duration for COVID-19. Cimolai N. Travel Medicine and Infectious Disease. 2020.
100. Intravenous Thrombolysis for Stroke in a COVID-19 Positive Filipino Patient, a Case Report. Co COC, Yu JRT, Laxamana LC, David-Ona DIA. Journal of Clinical Neuroscience. 2020.
101. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Colafrancesco S, Alessandri C, Conti F, Priori R. Autoimmunity reviews. 2020:102573.
102. The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins? Cole SA, Laviada-Molina HA, Serres-Perales JM, Rodriguez-Ayala E, Bastarrachea RA. Pathogens. 2020;9(5). http://dx.doi.org/10.3390/pathogens9050389.
103. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children. Condie LO. Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence. 2020:1-20.
104. Critical Illness in Patients with COVID-19: Mounting an Effective Clinical and Research Response. Cook DJ, Marshall JC, Fowler RA. JAMA - Journal of the American Medical Association. 2020;323(16):1559-60.
105. Diabetes and COVID-19-the meeting of two pandemics: what are the concerns? Coppell KJ, Hall RM, Downie M, Fraser SK, Garrett M, Jefferies CA, et al. The New Zealand medical journal. 2020;133(1514):85-7.
106. EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic. Costa-Frossard L, Moreno-Torres I, Meca-Lallana V, García-Domínguez JM. Revista de Neurologia. 2020;70(9):329-40.
107. New Zealand eliminates COVID-19. Cousins S. Lancet (London, England). 2020;395(10235):1474.
108. A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage. Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L, et al. The Journal of infectious diseases. 2020;221(11):1775-81. http://dx.doi.org/10.1093/infdis/jiaa113.
109. Coronavirus Disease 2019: In-Home Isolation Room Construction. Culp WC. A and A Practice. 2020.
110. Repositioning PARP inhibitors for SARS-CoV-2 infection (COVID-19); a new multi-pronged therapy for ARDS? Curtin N, Banyai K, Thaventhiran J, Le Quesne J, Helyes Z, Bai P. British journal of pharmacology. 2020. http://dx.doi.org/10.1111/bph.15137.
111. Biologics increase the risk of SARS- CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration. Damiani G, Pacifico A, Bragazzi NL, Malagoli P. Dermatologic Therapy. 2020.
112. The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues. Darbani B. International journal of environmental research and public health. 2020;17(10). http://dx.doi.org/10.3390/ijerph17103433.
113. Natural experiment concept to accelerate the Re-purposing of existing therapeutics for Covid-19. Daughton CG. Global epidemiology. 2020:100026. http://dx.doi.org/10.1016/j.gloepi.2020.100026.
114. ACR Statement on Safe Resumption of Routine Radiology Care During the Coronavirus Disease 2019 (COVID-19) Pandemic. Davenport MS, Bruno MA, Iyer RS, Johnson AM, Herrera R, Nicola GN, et al. Journal of the American College of Radiology : JACR. 2020. http://dx.doi.org/10.1016/j.jacr.2020.05.001.
115. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. de Abajo FJ, Rodriguez-Martin S, Lerma V, Mejia-Abril G, Aguilar M, Garcia-Luque A, et al. Lancet. 2020. http://dx.doi.org/10.1016/S0140-6736(20)31030-8.
116. Are patients with Down syndrome vulnerable to life-threatening COVID-19? De Cauwer H, Spaepen A. Acta neurologica Belgica. 2020. http://dx.doi.org/10.1007/s13760-020-01373-8.
117. COVID-19: In the Eye of the Cytokine Storm. de la Rica R, Borges M, Gonzalez-Freire M. 2020.
118. Clozapine is strongly associated with the risk of pneumonia and inflammation. de Leon J, Ruan CJ, Verdoux H, Wang C. General psychiatry. 2020;33(2):e100183. http://dx.doi.org/10.1136/gpsych-2019-100183. eCollection 2020.
119. The EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) initiative: background and protocol for the international SARS-CoV-2 infections registry. De Luca D, Rava L, Nadel S, Tissieres P, Gawronski O, Perkins E, et al. Eur J Pediatr. 2020. http://dx.doi.org/10.1007/s00431-020-03690-9.
120. Novel Coronavirus disease (COVID-19) in newborns and infants: What we know so far. De Rose DU, Piersigilli F, Ronchetti MP, Santisi A, Bersani I, Dotta A, et al. Italian Journal of Pediatrics. 2020;46(1).
121. Is COVID-19 a New Hematologic Disease? Debuc B, Smadja DM. Stem cell reviews and reports. 2020:1-5.
122. North American COVID-19 ST-segment elevation myocardial infarction (NACMI) registry: Rationale, design, and implications. Dehghani P, Davidson LJ, Grines CL, Nayak K, Saw J, Kaul P, et al. Am Heart J. 2020. http://dx.doi.org/10.1016/j.ahj.2020.05.006.
123. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection. Delgado-Roche L, Mesta F. Archives of Medical Research. 2020.
124. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Demelo-Rodríguez P, Cervilla-Muñoz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Macías M, Toledo-Samaniego N, et al. Thrombosis Research. 2020;192:23-6.
125. Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis. Devasenapathy N, Ye Z, Loeb M, Fang F, Najafabadi BT, Xiao Y, et al. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2020. http://dx.doi.org/10.1503/cmaj.200642.
126. COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Di Fiore F, Bouché O, Lepage C, Sefrioui D, Gangloff A, Schwarz L, et al. Digestive and Liver Disease. 2020.
127. Clotting factors in COVID-19: Epidemiological association and prognostic values in different clinical presentations in an Italian cohort. Di Micco P, Russo V, Carannante N, Imparato M, Rodolfi S, Cardillo G, et al. Journal of Clinical Medicine. 2020;9(5).
128. A rationale for targeting the P2X7 receptor in Coronavirus disease 19 (Covid-19). Di Virgilio F, Tang Y, Sarti AC, Rossato M. British journal of pharmacology. 2020. http://dx.doi.org/10.1111/bph.15138.
129. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Front Immunol. 2020;11:827. http://dx.doi.org/10.3389/fimmu.2020.00827. eCollection 2020.
130. Wearable Sensing and Telehealth Technology with Potential Applications in the Coronavirus Pandemic. Ding X, Clifton D, Ji N, Lovell NH, Bonato P, Chen W, et al. IEEE Reviews in Biomedical Engineering. 2020.
131. Treatment guidance for lung cancer patients during the COVID-19 pandemic. Dingemans AC, Soo RA, Jazieh AR, Rice SJ, Kim YT, Teo LL, et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020. http://dx.doi.org/10.1016/j.jtho.2020.05.001.
132. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19). Dixon DL, Van Tassell BW, Vecchie A, Bonaventura A, Talasaz AH, Kakavand H, et al. Journal of cardiovascular pharmacology. 2020;75(5):359-67. http://dx.doi.org/10.1097/FJC.0000000000000836.
133. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Bmj. 2020;369:m1985. http://dx.doi.org/10.1136/bmj.m1985.
134. In vivo antiviral effects of U18666A against type I feline infectious peritonitis virus. Doki T, Tarusawa T, Hohdatsu T, Takano T. Pathogens. 2020;9(1).
135. COVID-19 In Spain: Transplantation In The Midst Of The Pandemic. Domínguez-Gil B, Coll E, Fernández-Ruiz M, Corral E, del Río F, Zaragoza R, et al. American Journal of Transplantation. 2020.
136. Covid-19: Collateral damage of lockdown in India. Dore B. The BMJ. 2020;369.
137. Dengue fever and severe dengue in Barbados, 2008–2016. Douglas KO, Dutta SK, Martina B, Anfasa F, Alafia Samuels T, St. Hilaire GM. Tropical Medicine and Infectious Disease. 2020;5(2).
138. YouTube as a source of medical information on the novel coronavirus 2019 disease (COVID-19) pandemic. D'Souza RS, D'Souza S, Strand N, Anderson A, Vogt MNP, Olatoye O. Global public health. 2020:1-8.
139. Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV- 2: A prospective cohort study. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al. European Respiratory Journal. 2020;55(5).
140. Mathematical Modeling of Interaction between Innate and Adaptive Immune Responses in COVID-19 and Implications for Viral Pathogenesis. Du SQ, Yuan W. Journal of Medical Virology. 2020.
141. COVID-19 – the role of mass gatherings. Ebrahim SH, Memish ZA. Travel Medicine and Infectious Disease. 2020;34.
142. New coronavirus outbreak. Economou A. Current Pharmaceutical Analysis. 2020;16(4):335-6.
143. Using X-ray Images and Deep Learning for Automated Detection of Coronavirus Disease. Elasnaoui K, Chawki Y. Journal of biomolecular structure & dynamics. 2020:1-22.
144. Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking. Engin AB, Engin ED, Engin A. Environmental toxicology and pharmacology. 2020;78:103411. http://dx.doi.org/10.1016/j.etap.2020.103411.
145. Emerging cardiological issues during the COVID-19 pandemic. Everaert B, Muylle J, Twicker TB. European journal of clinical investigation. 2020:e13270. http://dx.doi.org/10.1111/eci.13270.
146. Early Short Course Corticosteroids in Hospitalized Patients with COVID-19. Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa601.
147. Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients. Faggiano P, Bonelli A, Paris S, Milesi G, Bisegna S, Bernardi N, et al. International Journal of Cardiology. 2020.
148. ProgNet: Covid-19 prognosis using recurrent and convolutional neural networks. Fakhfakh M, Bouaziz B, Gargouri F, Chaari L. medRxiv. 2020.
149. Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored. Fan H, Zhang L, Huang B, Zhu M, Zhou Y, Zhang H, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.05.024.
150. Role of the chronic air pollution levels in the Covid-19 outbreak risk in Italy. Fattorini D, Regoli F. Environmental Pollution. 2020;264.
151. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring. Favaloro EJ, Lippi G. Seminars in Thrombosis and Hemostasis. 2020;46(3):379-82.
152. COVID-19: Updated Data and its Relation to the Cardiovascular System. Ferrari F. Arquivos brasileiros de cardiologia. 2020.
153. It's not over until it's over: the chameleonic behavior of COVID-19 over a six-day period. Fichera G, Stramare R, De Conti G, Motta R, Giraudo C. La Radiologia medica. 2020;125(5):514-6.
154. As a potential treatment of COVID-19: Montelukast. Fidan C, Aydoğdu A. Medical Hypotheses. 2020;142.
155. Clinical implications and economic effects of the corona virus pandemic on gynaecology, obstetrics and reproductive medicine in Germany-learning from Italy. Findeklee S, Morinello E. Minerva ginecologica. 2020.
156. The role of passive immunization in the age of SARS-CoV-2: an update. Fischer JC, Zänker K, van Griensven M, Schneider M, Kindgen-Milles D, Knoefel WT, et al. European journal of medical research. 2020;25(1):16.
157. Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill? Floyd CN, Wierzbicki AS. Current opinion in cardiology. 2020.
158. Ph+ Acute Lymphoblastic Leukaemia in Italy During the Covid-19 Pandemic. A Campus ALL Study. Foà R, Bonifacio M, Chiaretti S, Curti A, Candoni A, Fava C, et al. British Journal of Haematology. 2020.
159. Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. Foerch C, Friedauer L, Bauer B, Wolf T, Adam EH. Multiple Sclerosis and Related Disorders. 2020;42.
160. COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice. Fox NS, Melka S. American journal of perinatology. 2020. http://dx.doi.org/10.1055/s-0040-1712529.
161. Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic. Fratino L, Procopio G, Di Maio M, Cinieri S, Leo S, Beretta G. Frontiers in Oncology. 2020;10.
162. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale. Frontera J, Mainali S, Fink EL, Robertson CL, Schober M, Ziai W, et al. Neurocrit Care. 2020. http://dx.doi.org/10.1007/s12028-020-00995-3.
163. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Fu J, Kong J, Wang W, Wu M, Yao L, Wang Z, et al. Thrombosis Research. 2020;192:3-8.
164. COVID-19: A Lesson in Humility and an Opportunity for Sagacity and Hope. Fuster V, Varieur Turco J. Journal of the American College of Cardiology. 2020;75(20):2625-6.
165. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández Nieto D, Rodríguez-Villa Lario A, et al. British Journal of Dermatology. 2020.
166. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Ganyani T, Kremer C, Chen D, Torneri A, Faes C, Wallinga J, et al. Eurosurveillance. 2020;25(17).
167. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020. Garazzino S, Montagnani C, Donà D, Meini A, Felici E, Vergine G, et al. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25(18).
168. [Epidemiological Aspects, Clinic And Control Mechanisms Of Sars-Cov-2pandemic: Situation In Spain]. Garcia-Alamino JM. Enfermeria clinica. 2020. http://dx.doi.org/10.1016/j.enfcli.2020.05.001.
169. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism. Garcia-Olivé I, Sintes H, Radua J, Capa JA, Rosell A. Respiratory medicine. 2020:106023.
170. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North – supports vitamin D as a factor determining severity. Authors' reply. Garg M, Al-Ani A, Mitchell H, Hendy P, Christensen B. Alimentary Pharmacology and Therapeutics. 2020.
171. Clinical utility of cardiac troponin measurement in COVID-19 infection. Gaze DC. Annals of clinical biochemistry. 2020;57(3):202-5. http://dx.doi.org/10.1177/0004563220921888. Epub 2020 Apr 27.
172. Are Type 1 Interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19? Gemcioglu E, Davutoglu M, Ozdemir EE, Erden A. Multiple sclerosis and related disorders. 2020:102196. http://dx.doi.org/10.1016/j.msard.2020.102196.
173. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. Int J Mol Sci. 2020;21(10). http://dx.doi.org/10.3390/ijms21103474.
174. Proposal of a timing strategy for cholesteatoma surgery during the COVID-19 pandemic. George M, Alexander A, Mathew J, Iyer A, Waterval J, Simon C, et al. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2020. http://dx.doi.org/10.1007/s00405-020-06037-0.
175. News from the front: Estimation of excess mortality and life expectancy in the major epicenters of the COVID-19 pandemic in Italy. Ghislandi S, Muttarak R, Sauerberg M, Scotti B. medRxiv. 2020:2020.04.29.20084335.
176. Impact of complete lockdown on total infection and death rates: A hierarchical cluster analysis. Ghosal S, Bhattacharyya R, Majumder M. Diabetes & metabolic syndrome. 2020. http://dx.doi.org/10.1016/j.dsx.2020.05.026.
177. Development and Implementation of a Clinician-facing Prognostic Communication Tool for Patients with COVID-19 and Critical Illness. Gibbon LM, GrayBuck KE, Buck LI, Huang KN, Penumarthy NL, Wu S, et al. Journal of pain and symptom management. 2020. http://dx.doi.org/10.1016/j.jpainsymman.2020.05.005.
178. Case fatality rate in patients with COVID-19 infection and its relationship with length of follow up. Giorgi Rossi P, Broccoli S, Angelini P. Journal of Clinical Virology. 2020;128.
179. Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France. Giraud-Gatineau A, Colson P, Jimeno MT, Zandotti C, Ninove L, Boschi C, et al. International Journal of Infectious Diseases. 2020;96:154-6.
180. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment. Gisondi P, Zaza G, Del Giglio M, Rossi M, Iacono V, Girolomoni G. Journal of the American Academy of Dermatology. 2020.
181. COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain. Goicoechea M, Sanchez Camara LA, Macias N, Munoz de Morales A, Gonzalez Rojas A, Bascunana A, et al. Kidney international. 2020. http://dx.doi.org/10.1016/j.kint.2020.04.031.
182. Recommendations for trauma and emergency general surgery practice during COVID-19 pandemic. Gök AFK, Eryılmaz M, Özmen MM, Alimoğlu O, Ertekin C, Kurtoğlu MH. Ulusal Travma ve Acil Cerrahi Dergisi. 2020;26(3):335-42.
183. Covid‑19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak (Review). Goumenou M, Sarigiannis D, Tsatsakis A, Anesti O, Docea AO, Petrakis D, et al. Molecular Medicine Reports. 2020;22(1):20-32.
184. The confounded crude case-fatality rates for COVID-19 hide more than they reveal - a comparison of age-specific and age-adjusted rates between six countries. Green MS, Peer V, Nitzan D. medRxiv. 2020:2020.05.09.20096503.
185. Safety netting; best practice in the face of uncertainty. Greenhalgh S, Finucane LM, Mercer C, Selfe J. Musculoskeletal Science and Practice. 2020;48.
186. Compassionate Use of Remdesivir for Patients with Severe Covid-19. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. The New England journal of medicine. 2020.
187. p38 MAPK inhibition: A promising therapeutic approach for COVID-19. Grimes JM, Grimes KV. Journal of molecular and cellular cardiology. 2020;144:63-5. http://dx.doi.org/10.1016/j.yjmcc.2020.05.007.
188. Professionally responsible counseling about birth location during the COVID-19 pandemic. Grünebaum A, McCullough LB, Bornstein E, Klein R, Dudenhausen JW, Chervenak FA. Journal of perinatal medicine. 2020.
189. Clinical characteristics of coronavirus disease 2019 in China. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. New England Journal of Medicine. 2020;382(18):1708-20.
190. Diabetes and COVID-19: evidence, current status and unanswered research questions. Gupta R, Hussain A, Misra A. European journal of clinical nutrition. 2020.
191. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. Cardiovascular research. 2020.
192. COVID-19 in children: More than meets the eye. Hagmann SHF. Travel Medicine and Infectious Disease. 2020;34.
193. Development and validation of the COVID-19 severity index (CSI): a prognostic tool for early respiratory decompensation. Haimovich A, Ravindra NG, Stoytchev S, Young HP, Wilson FP, van Dijk D, et al. medRxiv. 2020:2020.05.07.20094573.
194. Rapid worsening in Parkinson's disease may hide COVID-19 infection. Hainque E, Grabli D. Parkinsonism & related disorders. 2020. http://dx.doi.org/10.1016/j.parkreldis.2020.05.008.
195. Lifestyle Risk Factors for Cardiovascular Disease in Relation to COVID-19 Hospitalization: A Community-Based Cohort Study of 387,109 Adults in UK. Hamer M, Kivimaki M, Gale CR, Batty GD. medRxiv. 2020:2020.05.09.20096438.
196. CT morphology of COVID-19: Case report and review of literature. Hamer OW, Salzberger B, Gebauer J, Stroszczynski C, Pfeifer M. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren. 2020;192(5):386-90.
197. Etoposide-based therapy for severe forms of COVID-19. Hamizi K, Aouidane S, Belaaloui G. Medical Hypotheses. 2020;142.
198. Coronavirus Disease 2019 (COVID-19): Prevention and Control in the Radiology Department. Hamm R. Radiologic technology. 2020;91(5):485-8.
199. Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report. Hammami MB, Garibaldi B, Shah P, Liu G, Jain T, Chen PH, et al. American Journal of Transplantation. 2020.
200. What Should I Do? Hanto DW. Annals of surgery. 2020.
201. Coronavirus disease 2019 (COVID-19): A literature review. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Journal of Infection and Public Health. 2020;13(5):667-73.
202. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives. Harenberg J, Favaloro E. Clinical chemistry and laboratory medicine. 2020.
203. [COVID-19: care at home or in hospital? Considerations in primary care]. Harskamp RE, de Meij MA, Cals JWL, Reesink HJ, Geersing GJ. Nederlands tijdschrift voor geneeskunde. 2020;164.
204. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Härter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, et al. Infection. 2020.
205. Should Extremely Premature Babies Get Ventilators During the COVID-19 Crisis? Haward MF, Janvier A, Moore GP, Laventhal N, Fry JT, Lantos J. The American journal of bioethics : AJOB. 2020:1-7.
206. A comparative study of techniques used for the diagnosis of effusive feline infectious peritonitis. Hellemans A, Acar DD, Stroobants VJE, Theuns S, Desmarets LMB, Nauwynck HJ. Vlaams Diergeneeskundig Tijdschrift. 2020;89(1):28-33.
207. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. Intensive care medicine. 2020.
208. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series. Heman-Ackah SM, Su YS, Spadola M, Petrov D, Chen HI, Schuster J, et al. Neurosurgery. 2020. http://dx.doi.org/10.1093/neuros/nyaa198.
209. Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19): A simplified summary. Hendaus MA. Journal of biomolecular structure & dynamics. 2020:1-10.
210. Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19. Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, et al. The Journal of allergy and clinical immunology. 2020. http://dx.doi.org/10.1016/j.jaci.2020.05.008.
211. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design. Herst CV, Burkholz S, Sidney J, Sette A, Harris PE, Massey S, et al. Vaccine. 2020. http://dx.doi.org/10.1016/j.vaccine.2020.04.034.
212. Beyond Deaths per Person: Three CoViD-19 Mortality Indicators for Temporal and International Comparisons. Heuveline P, Tzen M. medRxiv. 2020:2020.04.29.20085506.
213. Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight. Higham A, Singh D. Obesity (Silver Spring, Md). 2020. http://dx.doi.org/10.1002/oby.22907.
214. Clinical features and outcomes of 98 patients hospitalized with sars-cov-2 infection in daegu, south korea: A brief descriptive study. Hong KS, Lee KH, Chung JH, Shin KC, Choi EY, Jin HJ, et al. Yonsei Medical Journal. 2020;61(5):431-7.
215. Early recovery following new onset anosmia during the COVID-19 pandemic - An observational cohort study. Hopkins C, Surda P, Whitehead E, Kumar BN. Journal of Otolaryngology - Head and Neck Surgery. 2020;49(1).
216. Managing COVID-19 in Low- and Middle-Income Countries. Hopman J, Allegranzi B, Mehtar S. JAMA - Journal of the American Medical Association. 2020;323(16):1549-50.
217. Clot in Transit on Transesophageal Echocardiography in a Prone Patient with COVID-19 Acute Respiratory Distress Syndrome. Horowitz JM, Yuriditsky E, Henderson IJ, Stachel MW, Kwok B, Saric M. CASE (Philadelphia, Pa). 2020. http://dx.doi.org/10.1016/j.case.2020.05.007.
218. Using IL-2R/lymphocyte for predicting the clinical progression of patients with COVID-19. Hou H, Zhang B, Huang H, Luo Y, Wu S, Tang G, et al. Clinical and experimental immunology. 2020.
219. A highly pathogenic GI-19 lineage infectious bronchitis virus originated from multiple recombination events with broad tissue tropism. Hou Y, Zhang L, Ren M, Han Z, Sun J, Zhao Y, et al. Virus Research. 2020;285.
220. Computed tomography manifestations in super early stage 2019 novel coronavirus pneumonia. Hu S, Li Z, Chen X, Liang CH. Acta radiologica (Stockholm, Sweden : 1987). 2020:284185120924806. http://dx.doi.org/10.1177/0284185120924806.
221. Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. Huang J, Cheng A, Kumar R, Fang Y, Chen G, Zhu Y, et al. Journal of medical virology. 2020.
222. Obesity hypoventilation syndrome and severe COVID-19. Huang JF, Wang XB, Zheng KI, Liu WY, Chen JJ, George J, et al. Metabolism: Clinical and Experimental. 2020;108.
223. Dialectical behavior therapy-based psychological intervention for woman in late pregnancy and early postpartum suffering from COVID-19: a case report. Huang JW, Zhou XY, Lu SJ, Xu Y, Hu JB, Huang ML, et al. Journal of Zhejiang University Science B. 2020;21(5):394-9. http://dx.doi.org/10.1631/jzus.B2010012. Epub 2020 Apr 1.
224. Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam. Hughes DA. British journal of pharmacology. 2020. http://dx.doi.org/10.1111/bph.15101.
225. Analysis of Codon Usage and Nucleotide Bias in Middle East Respiratory Syndrome Coronavirus Genes. Hussain S, Shinu P, Islam MM, Chohan MS, Rasool ST. Evolutionary Bioinformatics. 2020;16.
226. Possible factors associated with low case fatality rate of covid-19 in Kurdistan Region, Iraq. Hussein NR. Journal of Kermanshah University of Medical Sciences. 2020;24(1).
227. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2. Ingraham NE, Boulware D, Sparks MA, Schacker T, Benson B, Sparks JA, et al. Critical Care. 2020;24(1).
228. Covid-19: A Dynamic Analysis of Fatality Risk in Italy. Iosa M, Paolucci S, Morone G. Frontiers in Medicine. 2020;7.
229. COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases. Ippolito E, Fiore M, Greco C, D'Angelillo RM, Ramella S. Radiotherapy and Oncology. 2020;148:201-2.
230. SARS-CoV-2 Impact on Elective Orthopaedic Surgery: Implications for Post-Pandemic Recovery. Jain A, Jain P, Aggarwal S. The Journal of bone and joint surgery American volume. 2020.
231. QT prolongation, torsades de pointes and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review. Jankelson L, Karam G, Becker ML, Chinitz LA, Tsai MC. Heart Rhythm. 2020. http://dx.doi.org/10.1016/j.hrthm.2020.05.008.
232. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study. Javanian M, Bayani M, Shokri M, Sadeghi-Haddad-Zavareh M, Babazadeh A, Yeganeh B, et al. Romanian journal of internal medicine = Revue roumaine de medecine interne. 2020.
233. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. Ji HL, Zhao R, Matalon S, Matthay MA. Physiological reviews. 2020;100(3):1065-75.
234. A predictive model for disease progression in non-severe illness patients with Corona Virus Disease 2019. Ji M, Yuan L, Shen W, Lv J, Li Y, Chen J, et al. The European respiratory journal. 2020. http://dx.doi.org/10.1183/13993003.01234-2020.
235. Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan, China. Ji M, Yuan L, Shen W, Lv J, Li Y, Li M, et al. Epidemiology and infection. 2020;148:e94. http://dx.doi.org/10.1017/S0950268820000977.
236. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Journal of General Internal Medicine. 2020;35(5):1545-9.
237. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19. Jiang M, Guo Y, Luo Q, Huang Z, Zhao R, Liu S, et al. The Journal of infectious diseases. 2020.
238. COVID-19 Dynamic Computed Tomography (CT) Performance and Observation of Some Laboratory Indicators. Jiang X, Yin Z, Wang T, Zhai N, Lu F, Zhan C, et al. Medical science monitor : international medical journal of experimental and clinical research. 2020;26:e924403.
239. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Jimenez-Cauhe J, Ortega-Quijano D, Carretero-Barrio I, Suarez-Valle A, Saceda-Corralo D, Moreno-Garcia Del Real C, et al. Clinical and experimental dermatology. 2020.
240. Oral Chemotherapy for Treatment of Lung Cancer. Jonna S, Reuss JE, Kim C, Liu SV. Frontiers in Oncology. 2020;10.
241. Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study. Jung SY, Choi JC, You SH, Kim WY. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa624.
242. THE MENTAL HEALTH OF THOSE WHOSE RIGHTS HAVE BEEN TAKEN AWAY: AN ESSAY ON THE MENTAL HEALTH OF INDIGENOUS PEOPLES IN THE FACE OF THE 2019 CORONAVIRUS (2019-NCOV) OUTBREAK. Júnior JG, Moreira MM, Pinheiro WR, de Amorim LM, Lima CKT, da Silva CGL, et al. Psychiatry research. 2020:113094.
243. Interventions for treatment of COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING Project). Juul S, Nielsen N, Bentzer P, Veroniki AA, Thabane L, Linder A, et al. Systematic reviews. 2020;9(1):108.
244. Cardiovascular manifestations and treatment considerations in covid-19. Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, et al. Heart. 2020.
245. COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution. Kansal NK. Journal of the American Academy of Dermatology. 2020;82(6):e213.
246. 'Scientific Strabismus' or Two Related Pandemics: COVID-19 & Vitamin D Deficiency. Kara M, Ekiz T, Ricci V, Kara Ö, Chang KV, Özçakar L. The British journal of nutrition. 2020:1-20.
247. Increase in Covid-19 Cases and Case Fatality and Case Recovery Rates in Europe: A Cross Temporal Meta-Analysis. Karadag E. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.26035.
248. Tracking the impact of interventions against covid-19 in absence of extensive testing active surveillance for sari is urgently needed. Karthikeyan G. Indian Journal of Medical Research, Supplement. 2020;151(2):114-5.
249. Use of SARS-CoV-2 infected deceased organ donors: Should we always "just say no?". Kates OS, Fisher CE, Rakita RM, Reyes JD, Limaye AP. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020.
250. Clinical course of 2019 novel coronavirus disease (COVID-19) in individuals present during the outbreak on the Diamond Princess cruise ship. Kato H, Shimizu H, Shibue Y, Hosoda T, Iwabuchi K, Nagamine K, et al. Journal of Infection and Chemotherapy. 2020.
251. The SARS-CoV-2 epidemic in Zimbabwe: Quo vadis? Katsidzira L, Gwaunza L, Hakim JG. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
252. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Katulanda P, Dissanayake HA, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Yogendranathan N, et al. Diabetologia. 2020.
253. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report. Kaya Y, Kara S, Akinci C, Kocaman AS. Journal of the Neurological Sciences. 2020;413.
254. Artificial intelligence approach fighting COVID-19 with repurposing drugs. Ke YY, Peng TT, Yeh TK, Huang WZ, Chang SE, Wu SH, et al. Biomedical journal. 2020. http://dx.doi.org/10.1016/j.bj.2020.05.001.
255. Nursing homes and the elderly regarding the COVID-19 pandemic: situation report from Hungary. Kemenesi G, Kornya L, Toth GE, Kurucz K, Zeghbib S, Somogyi BA, et al. GeroScience. 2020:1-7. http://dx.doi.org/10.1007/s11357-020-00195-z.
256. Forensic Psychiatry and Covid-19: Accelerating Transformation in Forensic Psychiatry. Kennedy HG, Mohan D, Davoren M. Irish journal of psychological medicine. 2020:1-26. http://dx.doi.org/10.1017/ipm.2020.58.
257. The role of biomarkers in diagnosis of COVID-19 - A systematic review. Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. Life sciences. 2020:117788.
258. Coronavirus Disease 2019 in Heart Transplant Recipients in Southeastern Michigan - Case Series. Ketcham SW, Adie SK, Malliett A, Abdul-Aziz AA, Bitar A, Grafton G, et al. Journal of cardiac failure. 2020. http://dx.doi.org/10.1016/j.cardfail.2020.05.008.
259. Estimating and forecasting COVID-19 attack rates and mortality. Ketcheson DI, Ombao HC, Moraga P, Ballal T, Duarte CM. medRxiv. 2020:2020.05.11.20097972.
260. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis. Khan M, Khan MN, Mustagir MG, Rana J, Islam MS, Kabir MI. medRxiv. 2020:2020.05.08.20095968.
261. Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: Biology and therapeutic options. Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, et al. Journal of Clinical Microbiology. 2020;58(5).
262. Social Vulnerability and Racial Inequality in COVID-19 Deaths in Chicago. Kim SJ, Bostwick W. Health education & behavior : the official publication of the Society for Public Health Education. 2020:1090198120929677. http://dx.doi.org/10.1177/1090198120929677.
263. Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50. Klang E, Kassim G, Soffer S, Freeman R, Levin MA, Reich DL. Obesity (Silver Spring, Md). 2020. http://dx.doi.org/10.1002/oby.22913.
264. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection. Klimke A, Hefner G, Will B, Voss U. Medical hypotheses. 2020;142:109783.
265. [Dealing with COVID-19-associated coagulopathy]. Klok FA, den Exter PL, Huisman MV, Eikenboom J. Nederlands tijdschrift voor geneeskunde. 2020;164.
266. Coronavirus disease 2019 (COVID-19): Protecting hospitals from the invisible. Klompas M. Annals of internal medicine. 2020;172(9):619-20.
267. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection. Kong W, Zhang J, Xu Y, Li L, Li Q, Yang L, et al. Metabolism: Clinical and Experimental. 2020;108.
268. Nanoscale nights of COVID-19. Kostarelos K. Nature Nanotechnology. 2020;15(5):343-4.
269. COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic? Kotfis K, Williams Roberson S, Wilson J, Pun B, Ely EW, Jezowska I, et al. Anaesthesiology intensive therapy. 2020. http://dx.doi.org/10.5114/ait.2020.95164.
270. Covid-19, mers and sars with concomitant liver injury—systematic review of the existing literature. Kukla M, Skonieczna-żydecka K, Kotfis K, Maciejewska D, Łoniewski I, Lara LF, et al. Journal of Clinical Medicine. 2020;9(5).
271. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, et al. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):535-45.
272. A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment. Kumar M, Taki K, Gahlot R, Sharma A, Dhangar K. Science of the Total Environment. 2020;734.
273. Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic. Kumar S, Chmura S, Robinson C, Lin SH, Gadgeel SM, Donington J, et al. Journal of Thoracic Oncology. 2020.
274. Withanone and Caffeic Acid Phenethyl Ester are Predicted to Interact with Main Protease (M(pro)) of SARS-CoV-2 and Inhibit its Activity. Kumar V, Dhanjal JK, Kaul SC, Wadhwa R, Sundar D. J Biomol Struct Dyn. 2020:1-17. http://dx.doi.org/10.1080/07391102.2020.1772108.
275. Cardiovascular comorbidities, cardiac injury and prognosis of COVID-19 in New York City. Kuno T, Takahashi M, Obata R, Maeda T. Am Heart J. 2020. http://dx.doi.org/10.1016/j.ahj.2020.05.005.
276. Deaths in healthcare workers due to COVID-19: the need for robust data and analysis. Kursumovic E, Lennane S, Cook TM. Anaesthesia. 2020.
277. Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries. Kwok KO, Lai F, Wei WI, Wong SYS, Tang JWT. Journal of Infection. 2020;80(6):e32-e3.
278. COVID-19: lessons from the Italian reproductive medical experience. La Marca A, Niederberger C, Pellicer A, Nelson SM. Fertility and Sterility. 2020;113(5):920-2.
279. The dark cloud with a silver lining: Assessing the impact of the SARS COVID-19 pandemic on the global environment. Lal P, Kumar A, Kumar S, Kumari S, Saikia P, Dayanandan A, et al. Science of the Total Environment. 2020;732.
280. COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ). Lal S, Hayward CS, De Pasquale C, Kaye D, Javorsky G, Bergin P, et al. Heart Lung Circ. 2020. http://dx.doi.org/10.1016/j.hlc.2020.04.005.
281. [Cardiovascular disease in times of COVID-19]. Lamelas P, Botto F, Pedernera G, Alves De Lima A, Costabel JP, Belardi J. Medicina (B Aires). 2020;80(3):248-52.
282. Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019. Latif F, Farr MA, Clerkin KJ, Habal MV, Takeda K, Naka Y, et al. JAMA cardiology. 2020.
283. COVID-19 and obesity: links and risks. Lavie CJ, Sanchis-Gomar F, Henry BM, Lippi G. Expert review of endocrinology & metabolism. 2020:1-2. http://dx.doi.org/10.1080/17446651.2020.1767589.
284. Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia. Le Berre A, Marteau V, Emmerich J, Zins M. Diagnostic and Interventional Imaging. 2020;101(5):321-2.
285. Virus detections among patients with severe acute respiratory illness, Northern Vietnam. Le YH, Nguyen KC, Coleman KK, Nguyen TT, Than ST, Phan HH, et al. PLoS ONE. 2020;15(5).
286. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, et al. Hepatology (Baltimore, Md). 2020.
287. Author's reply – Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. Lei S, Jiang F, Xia ZY, Xia Z. EClinicalMedicine. 2020;22.
288. Arterial hypertension and the risk of severity and mortality of COVID-19. Leiva Sisnieguez CE, Espeche WG, Salazar MR. The European respiratory journal. 2020.
289. Clinical characteristics of COVID-19 in children: are they similar to those of SARS? Leung C. Pediatr Pulmonol. 2020. http://dx.doi.org/10.1002/ppul.24855.
290. Is the HScore useful in COVID-19? Leverenz DL, Tarrant TK. The Lancet. 2020;395(10236):e83.
291. Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. Lewnard JA, Liu VX, Jackson ML, Schmidt MA, Jewell BL, Flores JP, et al. Bmj. 2020;369:m1923. http://dx.doi.org/10.1136/bmj.m1923.
292. Thoughts and suggestions on analysis of death cases report during COVID-19 epidemic. Li B, Yan YM, Li ZY, Chen TF, Guo YH, Hu J, et al. Zhongguo Zhongyao Zazhi. 2020;45(7):1531-5.
293. A close-up on COVID-19 and cardiovascular diseases. Li G, Hu R, Gu X. Nutrition, Metabolism and Cardiovascular Diseases. 2020.
294. Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China. Li H, Wang S, Zhong F, Bao W, Li Y, Liu L, et al. Frontiers in medicine. 2020;7:190. http://dx.doi.org/10.3389/fmed.2020.00190. eCollection 2020.
295. Involvement of the Nervous System in SARS-CoV-2 Infection. Li H, Xue Q, Xu X. Neurotoxicity Research. 2020.
296. Clinical and pathological investigation of severe COVID-19 patients. Li S, Jiang L, Li X, Lin F, Wang Y, Li B, et al. JCI insight. 2020. http://dx.doi.org/10.1172/jci.insight.138070.
297. Organ function support in patients with coronavirus disease 2019: Tongji experience. Li Y, He F, Zhou N, Wei J, Ding Z, Wang L, et al. Frontiers of medicine. 2020;14(2):232-48.
298. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. Liang W, Liang H, Ou L, Chen B, Chen A, Li C, et al. JAMA internal medicine. 2020.
299. SARS-COV-2 infection in children and newborns: a systematic review. Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A, Nocerino A, et al. Eur J Pediatr. 2020. http://dx.doi.org/10.1007/s00431-020-03684-7.
300. Covid-19 in the State of Ceara: behaviors and beliefs in the arrival of the pandemic. Lima DLF, Dias AA, Rabelo RS, Cruz IDD, Costa SC, Nigri FMN, et al. Ciencia & saude coletiva. 2020;25(5):1575-86. http://dx.doi.org/10.1590/1413-81232020255.07192020. Epub 2020 May 8.
301. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Lippi G, Favaloro EJ. Thrombosis and Haemostasis. 2020;120(5):876-7.
302. Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19). Lippi G, Wong J, Henry BM. World Journal of Emergency Medicine. 2020;11(3):193-4.
303. COVID-19 in Older People: A Rapid Clinical Review. Lithander FE, Neumann S, Tenison E, Lloyd K, Welsh TJ, Rodrigues JCL, et al. Age and Ageing. 2020.
304. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Liu F, Zhang Q, Huang C, Shi C, Wang L, Shi N, et al. Theranostics. 2020;10(12):5613-22.
305. The management of coronavirus disease 2019 (COVID-19). Liu J, Liu S. Journal of Medical Virology. 2020.
306. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. J Transl Med. 2020;18(1):206. http://dx.doi.org/10.1186/s12967-020-02374-0.
307. Analysis of imported cases of covid-19 in taiwan: A nationwide study. Liu JY, Chen TJ, Hwang SJ. International Journal of Environmental Research and Public Health. 2020;17(9).
308. Ultrasound on the Frontlines of COVID-19: Report from an International Webinar. Liu RB, Tayal VS, Panebianco NL, Tung-Chen Y, Nagdev A, Shah S, et al. Academic Emergency Medicine. 2020.
309. Comparison of the Characteristics and Outcomes of Coronavirus Disease 2019 in Different Types of Family Infections in Taiwan. Liu SF, Kuo NY, Kuo HC. Journal of clinical medicine. 2020;9(5). http://dx.doi.org/10.3390/jcm9051527.
310. Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia. Liu Z, Jin C, Wu CC, Liang T, Zhao H, Wang Y, et al. Korean journal of radiology. 2020;21(6):736-45. http://dx.doi.org/10.3348/kjr.2020.0171.
311. At the center of the COVID-19 pandemic: Lessons learned for otolaryngology-head and neck surgery in China. Liu Z, Zhang L. International Forum of Allergy and Rhinology. 2020;10(5):584-6.
312. Clinical Characteristics of 46 Pregnant Women with a SARS-CoV-2 Infection in Washington State. Lokken EM, Walker CL, Delaney S, Kachikis A, Kretzer NM, Erickson A, et al. Am J Obstet Gynecol. 2020. http://dx.doi.org/10.1016/j.ajog.2020.05.031.
313. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Lopes RD, Macedo AVS, de Barros ESPGM, Moll-Bernardes RJ, Feldman A, D'Andréa Saba Arruda G, et al. American heart journal. 2020.
314. Dynamic changes in routine blood parameters of a severe COVID-19 case. Lu G, Wang J. Clinica Chimica Acta. 2020;508:98-102.
315. SARS-CoV-2 infection in children. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. New England Journal of Medicine. 2020;382(17):1663-5.
316. Children are unlikely to be the main drivers of the COVID-19 pandemic - a systematic review. Ludvigsson JF. Acta paediatrica (Oslo, Norway : 1992). 2020. http://dx.doi.org/10.1111/apa.15371.
317. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers. Luo J, Rizvi H, Egger JV, Preeshagul IR, Wolchok JD, Hellmann MD. Cancer discovery. 2020.
318. Prognostic value of C-reactive protein in patients with COVID-19. Luo X, Zhou W, Yan X, Guo T, Wang B, Xia H, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa641.
319. Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus. Luo Y, Yuan X, Xue Y, Mao L, Lin Q, Tang G, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
320. Using a diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus. Luo Y, Yuan X, Xue Y, Mao L, Lin Q, Tang G, et al. International Journal of Infectious Diseases. 2020;95:436-40.
321. Reflection on lower rates of COVID-19 in children: does childhood immunizations offer unexpected protection? Lyu J, Miao T, Dong J, Cao R, Li Y, Chen Q. Med Hypotheses. 2020:109842. http://dx.doi.org/10.1016/j.mehy.2020.109842.
322. A single-center, retrospective study of COVID-19 features in children: A descriptive investigation. Ma H, Hu J, Tian J, Zhou X, Li H, Laws MT, et al. BMC Medicine. 2020;18(1).
323. Minimal Access Gardening: Laparoscopic techniques during COVID-19 lockdown. Ma K. Journal of minimally invasive gynecology. 2020. http://dx.doi.org/10.1016/j.jmig.2020.05.004.
324. Relation between BCG coverage rate and COVID-19 infection worldwide. Macedo A, Febra C. Medical Hypotheses. 2020;142.
325. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Mackey K, King VJ, Gurley S, Kiefer M, Liederbauer E, Vela K, et al. Annals of internal medicine. 2020. http://dx.doi.org/10.7326/M20-1515.
326. Need of the Hour- COVID-19 for Cardiologists. Maddury J, Paramjyothi GK. Indian Journal of Cardiovascular Disease in Women - WINCARS. 2020;5(1):04-7.
327. Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach. Mahanta S, Chowdhury P, Gogoi N, Goswami N, Borah D, Kumar R, et al. Journal of biomolecular structure & dynamics. 2020:1-15.
328. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. Mahevas M, Tran VT, Roumier M, Chabrol A, Paule R, Guillaud C, et al. Bmj. 2020;369:m1844. http://dx.doi.org/10.1136/bmj.m1844.
329. Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates. Manning JT, Fink B. Early human development. 2020:105074. http://dx.doi.org/10.1016/j.earlhumdev.2020.105074.
330. Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Mansur J. Alimentary pharmacology & therapeutics. 2020.
331. Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear. Mantica G, Riccardi N, Terrone C, Gratarola A. Public Health. 2020;183:40-1.
332. Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications. Manto M, Dupre N, Hadjivassiliou M, Louis ED, Mitoma H, Molinari M, et al. Cerebellum (London, England). 2020.
333. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, et al. The Lancet Gastroenterology and Hepatology. 2020.
334. The COVID-19 Pandemic: Consideration for Brain Infection. Mao XY, Jin WL. Neuroscience. 2020;437:130-1.
335. Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers. Mareev YV, Mareev VY. Kardiologiia. 2020;60(4):4-9.
336. Diabetes and metabolic syndrome as risk factors for COVID-19. Marhl M, Grubelnik V, Magdič M, Markovič R. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):671-7.
337. [COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)]. Marin-Jimenez I, Zabana Y, Rodriguez-Lago I, Marin L, Acosta MB, Esteve M. Gastroenterologia y hepatologia. 2020. http://dx.doi.org/10.1016/j.gastrohep.2020.05.003.
338. Colorectal cancer care in the age of coronavirus: Strategies to reduce risk and maintain benefit. Marshall JL, Yarden RI, Weinberg BA. Colorectal Cancer. 2020;9(1).
339. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Martin Gimenez VM, Inserra F, Tajer CD, Mariani J, Ferder L, Reiter RJ, et al. Life sciences. 2020;254:117808. http://dx.doi.org/10.1016/j.lfs.2020.117808.
340. Pulmonary embolism in a young pregnant woman with COVID-19. Martinelli I, Ferrazzi E, Ciavarella A, Erra R, Iurlaro E, Ossola M, et al. Thrombosis Research. 2020;191:36-7.
341. Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence. Mason KE, McHale P, Pennington A, Maudsley G, Day J, Barr B. medRxiv. 2020:2020.05.06.20093351.
342. Pathogenesis of COVID-19 from a cell biology perspective. Mason RJ. European Respiratory Journal. 2020;55(4).
343. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures. Matricardi PM, Dal Negro RW, Nisini R. Pediatric Allergy and Immunology. 2020.
344. Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic. Matsuo K, Novatt H, Matsuzaki S, Hom MS, Castaneda AV, Licon E, et al. Gynecologic oncology. 2020. http://dx.doi.org/10.1016/j.ygyno.2020.05.019.
345. Impact of COVID-19 on the cardiovascular system: A review. Matsushita K, Marchandot B, Jesel L, Ohlmann P, Morel O. Journal of Clinical Medicine. 2020;9(5).
346. Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management. Matucci-Cerinic M, Bruni C, Allanore Y, Clementi M, Dagna L, Damjanov NS, et al. Ann Rheum Dis. 2020;79(6):724-6. http://dx.doi.org/10.1136/annrheumdis-2020-217407. Epub 2020 Apr 29.
347. Supporting adults bereaved through COVID-19: a rapid review of the impact of previous pandemics on grief and bereavement. Mayland CR, Harding AJ, Preston N, Payne S. Journal of pain and symptom management. 2020. http://dx.doi.org/10.1016/j.jpainsymman.2020.05.012.
348. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C. The Lancet Rheumatology. 2020.
349. Tracheostomy in the COVID-19 era: global and multidisciplinary guidance. McGrath BA, Brenner MJ, Warrillow SJ, Pandian V, Arora A, Cameron TS, et al. The Lancet Respiratory medicine. 2020. http://dx.doi.org/10.1016/S2213-2600(20)30230-7.
350. Employing Drug Delivery Strategies to Create Safe and Effective Pharmaceuticals for COVID-19. McHugh KJ. Bioengineering and Translational Medicine. 2020.
351. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy. Means C. Metabolism: Clinical and Experimental. 2020;108.
352. Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, et al. Histopathology. 2020.
353. A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates. Meyerowitz-Katz G, Merone L. medRxiv. 2020.
354. Assessing Differential Impacts of COVID-19 on Black Communities. Millett GA, Jones AT, Benkeser D, Baral S, Mercer L, Beyrer C, et al. Annals of epidemiology. 2020. http://dx.doi.org/10.1016/j.annepidem.2020.05.003.
355. A focus on CORONA VIRUS (COVID-19). Mitra S, Mitra JC. International Journal of Research in Pharmaceutical Sciences. 2020;11:23-30.
356. Serum amyloid A is a predictor for prognosis of COVID-19. Mo XN, Su ZQ, Lei CL, Chen DF, Peng H, Chen RC, et al. Respirology. 2020.
357. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron LM, Pagliaro P, et al. GeroScience. 2020. http://dx.doi.org/10.1007/s11357-020-00198-w.
358. How deadly is COVID-19? A rigorous analysis of excess mortality and age-dependent fatality rates in Italy. Modi C, Boehm V, Ferraro S, Stein G, Seljak U. medRxiv. 2020:2020.04.15.20067074.
359. COVID-19 in Post-Operative Patients: Imaging Findings. Moliere S, Veillon F. Surgical infections. 2020.
360. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Molina JM, Delaugerre C, Le Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, et al. Medecine et Maladies Infectieuses. 2020;50(4):384.
361. Managing COVID-19 Iinfection in pediatric patients. Mon EY, Mandelia Y. Cleveland Clinic journal of medicine. 2020.
362. The impact of biosensing in a pandemic outbreak: COVID-19. Morales-Narváez E, Dincer C. Biosensors and Bioelectronics. 2020;163.
363. Invasive aspergillosis in COVID-19: A review study and recommendations for diagnostic approaches. Mortezaee V, Saraee SAS, Ghazanfari M, Khozani MA, Maleki M, Hedayati MT. Journal of Mazandaran University of Medical Sciences. 2020;30(184):169-78.
364. End-of-life care in patients with a highly transmissible respiratory virus: implications for COVID-19. Mottiar M, Hendin A, Fischer L, Roze des Ordons A, Hartwick M. Canadian Journal of Anesthesia. 2020.
365. Analysis of Maternal Coronavirus Infections and Neonates Born to Mothers with 2019-nCoV; a Systematic Review. Muhidin S, Behboodi Moghadam Z, Vizheh M. Archives of academic emergency medicine. 2020;8(1):e49.
366. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Munster VJ, Feldmann F, Williamson BN, van Doremalen N, Pérez-Pérez L, Schulz J, et al. Nature. 2020.
367. β-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects — Implications for coronavirus disease (COVID-19) immunotherapies. Murphy EJ, Masterson C, Rezoagli E, O'Toole D, Major I, Stack GD, et al. Science of the Total Environment. 2020;732.
368. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis. Mustafa NM, L AS. Journal of Clinical Virology. 2020;128.
369. Has COVID-19 played an unexpected “stroke” on the chain of survival? Naccarato M, Scali I, Olivo S, Ajčević M, Buoite Stella A, Furlanis G, et al. Journal of the Neurological Sciences. 2020;414.
370. The ocular surface and the coronavirus disease 2019: Does a dual ‘ocular route’ exist? Napoli PE, Nioi M, D’aloja E, Fossarello M. Journal of Clinical Medicine. 2020;9(5).
371. Coronavirus disease (COVID-19): Rheumatological Prospects/Relevance. Nasonov EL. Nauchno-Prakticheskaya Revmatologiya. 2020;58(2):123-30.
372. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Nepogodiev D, Bhangu A. The British journal of surgery. 2020.
373. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Neri P, Pichi F. International Ophthalmology. 2020;40(5):1057-60.
374. Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group. Nguyen NP, Vinh-Hung V, Baumert B, Zamagni A, Arenas M, Motta M, et al. Cancers. 2020;12(5). http://dx.doi.org/10.3390/cancers12051287.
375. Acute Myocardial Injury at Hospital Admission is Associated with All-cause Mortality in COVID-19. Ni W, Yang X, Liu J, Bao J, Li R, Xu Y, et al. Journal of the American College of Cardiology. 2020.
376. Remdesivir for COVID-19: challenges of underpowered studies. Norrie JD. The Lancet. 2020;395(10236):1525-7.
377. The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises. Nott D. The Lancet. 2020;395(10236):1532-3.
378. Clinical characteristics and short-term outcomes of coronavirus disease 2019: retrospective, single-center experience of designated hospital in Poland. Nowak B, Szymanski P, Pankowski I, Szarowska A, Zycinska K, Rogowski W, et al. Polish archives of internal medicine. 2020. http://dx.doi.org/10.20452/pamw.15361.
379. Response to SARS-CoV-2 Pandemic in a Non-COVID-19 Designated Latin-American Neurosurgery Department. Nunez-Velasco S, Mercado-Pimentel R, Ochoa-Plascencia M, Rodriguez-Arias R, Lopez-Espinoza G, Gonzalez-Gonzalez ME, et al. World Neurosurg. 2020. http://dx.doi.org/10.1016/j.wneu.2020.05.019.
380. SnapShot: COVID-19. Oberfeld B, Achanta A, Carpenter K, Chen P, Gilette NM, Langat P, et al. Cell. 2020;181(4):954-.e1.
381. Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic. Obi AT, Barnes GD, Wakefield TW, Brown S, Eliason JL, Arndt E, et al. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2020.
382. The Covid-19 pandemic in Denmark: Big lessons from a small country. Olagnier D, Mogensen TH. Cytokine & growth factor reviews. 2020.
383. Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it! Omarini C, Maur M, Luppi G, Narni F, Luppi M, Dominici M, et al. European Journal of Cancer. 2020;133:29-32.
384. COVID-19 and gastrointestinal endoscopy: Importance of reducing SARS-CoV-2 infection risks of medical workers and preserving personal protective equipment resources. Onoyama T, Isomoto H. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 2020.
385. Early SARS-CoV-2 outbreak detection by sewage-based epidemiology. Orive G, Lertxundi U, Barcelo D. Science of the Total Environment. 2020;732.
386. The COVID-19 Pandemic and its Impact on Substance Use: Implications for Prevention and Treatment. Ornell F, Moura HF, Scherer JN, Pechansky F, Kessler F, von Diemen L. Psychiatry research. 2020:113096.
387. COVID-19 in adults: test menu for hospital blood science laboratories. O'Shea PM, Lee GR, Griffin TP, Tormey V, Hayat A, Costelloe SJ, et al. Irish journal of medical science. 2020. http://dx.doi.org/10.1007/s11845-020-02252-0.
388. SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps and Opportunities. Osuchowski MF, Aletti F, Cavaillon JM, Flohe SB, Giamarellos-Bourboulis EJ, Huber-Lang M, et al. Shock (Augusta, Ga). 2020. http://dx.doi.org/10.1097/SHK.0000000000001565.
389. The impact of preoperative screening system on head and neck cancer surgery during the COVID-19 pandemic: Recommendations from the nationwide survey in Japan. Ota I, Asada Y. Auris, nasus, larynx. 2020. http://dx.doi.org/10.1016/j.anl.2020.05.006.
390. Coronavirus (COVID-19): Patient experience-Administrative services on the frontline during crisis. Overton J, Denton K, Frumovitz M, Lewis C, Christensen S, Bezerra J, et al. Head & neck. 2020. http://dx.doi.org/10.1002/hed.26259.
391. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis. Oyelade T, Alqahtani J, Canciani G. Tropical medicine and infectious disease. 2020;5(2). http://dx.doi.org/10.3390/tropicalmed5020080.
392. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Metabolism: clinical and experimental. 2020;108:154262. http://dx.doi.org/10.1016/j.metabol.2020.154262.
393. Study on transmission dynamic of 15 clusters of coronavirus disease 2019 cases in Ningbo. Pan XX, Chen Y, Wang AH, Wang JM, Ye LX, Gu SH, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41:E066.
394. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets. Park SJ, Yu KM, Kim YI, Kim SM, Kim EH, Kim SG, et al. mBio. 2020;11(3). http://dx.doi.org/10.1128/mBio.01114-20.
395. SARS2 modifies spastic paraplegia type 4 age at onset. Parodi L, Lejeune F, Barbier M, Brice A, Stevanin G, Durr A. European Journal of Human Genetics. 2019;27:1486.
396. Patients with COVID-19: are current isolation guidelines effective enough? Patel KP, Patel PA, Vunnam SR, Jain R, Vunnam RR. Public Health. 2020;183:38-9.
397. Treating Leukemia in the Time of COVID-19. Paul S, Rausch CR, Jain N, Kadia T, Ravandi F, DiNardo CD, et al. Acta haematologica. 2020:1-13.
398. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Journal of Thrombosis and Thrombolysis. 2020.
399. Social isolation during the COVID-19 pandemic can increase physical inactivity and the global burden of cardiovascular disease. Pecanha T, Goessler KF, Roschel H, Gualano B. American journal of physiology Heart and circulatory physiology. 2020;318(6):H1441-h6. http://dx.doi.org/10.1152/ajpheart.00268.2020. Epub 2020 May 15.
400. COVID-19 managed with early non-invasive ventilation and a bundle pharmacotherapy: A case report. Peng M, Ren D, Liu XY, Li JX, Chen RL, Yu BJ, et al. World journal of clinical cases. 2020;8(9):1705-12. http://dx.doi.org/10.12998/wjcc.v8.i9.1705.
401. NEWS can predict deterioration of patients with COVID-19. Peng X, Subbe CP, Zhang L, Luo Z, Peng L. Resuscitation. 2020;152:26-7.
402. Clinical course of Coronavirus Disease-2019 (COVID-19) in pregnancy. Pereira A, Cruz-Melguizo S, Adrien M, Fuentes L, Marin E, Perez-Medina T. Acta Obstet Gynecol Scand. 2020. http://dx.doi.org/10.1111/aogs.13921.
403. Diabetes and COVID-19 : Disease-Management-People. Peric S, Stulnig TM. Wiener klinische Wochenschrift. 2020. http://dx.doi.org/10.1007/s00508-020-01672-3.
404. Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE). Peron JPS, Nakaya H. Clinics (Sao Paulo, Brazil). 2020;75:e1912. http://dx.doi.org/10.6061/clinics/2020/e1912. Epub 2020 May 15.
405. Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review). Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. Molecular Medicine Reports. 2020;22(1):9-19.
406. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. Bmj. 2020;369:m1966. http://dx.doi.org/10.1136/bmj.m1966.
407. Social Capital in the Response to COVID-19. Pitas N, Ehmer C. American journal of health promotion : AJHP. 2020:890117120924531.
408. Sudden death due to acute pulmonary embolism in a young woman with COVID-19. Polat V, Bostancı Gİ. Journal of Thrombosis and Thrombolysis. 2020.
409. Covid-19 deaths: Are we sure it is pneumonia? please, autopsy, autopsy, autopsy! Pomara C, Volti GL, Cappello F. Journal of Clinical Medicine. 2020;9(5).
410. Sodium status and kidney involvement during COVID-19 infection. Post A, Dullaart RPF, Bakker SJL. Virus Res. 2020:198034. http://dx.doi.org/10.1016/j.virusres.2020.198034.
411. OPEN TRACHEOSTOMY FOR COVID19 POSITIVE PATIENTS: A METHOD TO MINIMIZE AEROSOLIZATION AND REDUCE RISK OF EXPOSURE. Prabhakaran K, Malcom R, Choi J, Chudner A, Moscatello A, Panzica P, et al. The journal of trauma and acute care surgery. 2020.
412. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Pranata R, Huang I, Lukito AA, Raharjo SB. Postgraduate medical journal. 2020. http://dx.doi.org/10.1136/postgradmedj-2020-137884.
413. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression. Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2020;21(2):1470320320926899. http://dx.doi.org/10.1177/1470320320926899.
414. The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy. Preskorn SH. Journal of psychiatric practice. 2020;26(3):219-27. http://dx.doi.org/10.1097/PRA.0000000000000475.
415. Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment. Prete M, Favoino E, Catacchio G, Racanelli V, Perosa F. International Journal of Molecular Sciences. 2020;21(9).
416. Ten key points that vascular doctors learned very quickly about COVID-19. Priollet P, Yannoutsos A, Mourad JJ. JMV-Journal de Medecine Vasculaire. 2020;45(3):105-6.
417. Influenza virus like particles (VLPs): Opportunities for H7N9 vaccine development. Pushko P, Tretyakova I. Viruses. 2020;12(5).
418. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study. Qi X, Liu Y, Wang J, Fallowfield J, Wang J, Li X, et al. Gut. 2020. http://dx.doi.org/10.1136/gutjnl-2020-321666.
419. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China. Qi X, Wang J, Li X, Wang Z, Liu Y, Yang H, et al. Hepatology international. 2020. http://dx.doi.org/10.1007/s12072-020-10051-z.
420. Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China. Qi Z, Yu Y. Current topics in medicinal chemistry. 2020.
421. Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China. Qiu C, Deng Z, Xiao Q, Shu Y, Deng Y, Wang H, et al. Journal of Medical Virology. 2020.
422. Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit. Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Agostini A, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020. http://dx.doi.org/10.1111/jdv.16586.
423. Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care. Quartuccio L, Sonaglia A, McGonagle D, Fabris M, Peghin M, Pecori D, et al. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2020:104444. http://dx.doi.org/10.1016/j.jcv.2020.104444.
424. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? Quiros Roldan E, Biasiotto G, Magro P, Zanella I. Pharmacological research. 2020;158.
425. A dynamic modeling tool for estimating healthcare demand from the COVID19 epidemic and evaluating population-wide interventions. Rainisch G, Undurraga EA, Chowell G. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.05.043.
426. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. Rajendran K, Narayanasamy K, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A. Journal of Medical Virology. 2020.
427. Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic. Raker EJ, Zacher M, Lowe SR. Proc Natl Acad Sci U S A. 2020. http://dx.doi.org/10.1073/pnas.2006706117.
428. Medical certification of cause of death for COVID-19. Rao C. Bulletin of the World Health Organization. 2020;98(5):298-A.
429. A surgeon's role in fighting a medical pandemic: Experiences from the unit at the epicentre of COVID-19 in Singapore - A cohort perspective. Rasappan K, Oh JYL, Ding BTK, Mohd Fadhil MF, Lee KT. International journal of surgery (London, England). 2020;79:31-5. http://dx.doi.org/10.1016/j.ijsu.2020.05.033.
430. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M, Di Costanzo D, et al. Andrology. 2020. http://dx.doi.org/10.1111/andr.12821.
431. Critical Care Management of Patients with COVID-19: Early Experience in Thailand. Ratanarat R, Sivakorn C, Viarasilpa T, Schultz MJ. The American journal of tropical medicine and hygiene. 2020. http://dx.doi.org/10.4269/ajtmh.20-0442.
432. Cardiovascular Disease Prevention and Implications of COVID-19: An Evolving Case Study in the Crescent City. Razavi AC, Kelly TN, He J, Fernandez C, Whelton PK, Krousel-Wood M, et al. Journal of the American Heart Association. 2020:e016997. http://dx.doi.org/10.1161/JAHA.120.016997.
433. Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study. Regina J, Papadimitriou-Olivgeris M, Burger R, Filippidis P, Tschopp J, Desgranges F, et al. medRxiv. 2020:2020.05.11.20097741.
434. Current Scenario of COVID-19 in Pediatric Age Group and Physiology of Immune and Thymus response. Rehman S, Majeed T, Azam Ansari M, Ali U, Sabit H, Al-Suhaimi EA. Saudi journal of biological sciences. 2020. http://dx.doi.org/10.1016/j.sjbs.2020.05.024.
435. Non-evidenced based treatment: An unintended cause of morbidity and mortality related to COVID-19. Reihani H, Ghassemi M, Mazer-Amirshahi M, Aljohani B, Pourmand A. The American journal of emergency medicine. 2020.
436. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients. Remy KE, Lin JC, Verhoef PA. Critical Care. 2020;24(1).
437. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19. Ren H, Yang Y, Wang F, Yan Y, Shi X, Dong K, et al. Cardiovascular diabetology. 2020;19(1):58.
438. Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirusxs. Renieris G, Katrini K, Damoulari C, Akinosoglou K, Psarrakis C, Kyriakopoulou M, et al. Shock (Augusta, Ga). 2020. http://dx.doi.org/10.1097/SHK.0000000000001562.
439. Is the COVID-19 pandemic masking the deadlier Lassa fever epidemic in Nigeria? Reuben RC, Danladi MMA, Pennap GR. Journal of Clinical Virology. 2020;128.
440. Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Authors' reply. Rhodes JM, Subramanian S, Laird E, Anne Kenny R. Alimentary pharmacology & therapeutics. 2020.
441. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y, et al. The Lancet Global health. 2020.
442. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. Rogers CJ, Harman RJ, Bunnell BA, Schreiber MA, Xiang C, Wang FS, et al. J Transl Med. 2020;18(1):203. http://dx.doi.org/10.1186/s12967-020-02380-2.
443. Convalescent plasma in Covid-19: Possible mechanisms of action. Rojas M, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y, Camacho B, Gallo JE, et al. Autoimmunity Reviews. 2020.
444. Coronavirus disease 2019 infection and the cardiovascular system. Romeo F, Calcaterra G, Barilla F, Mehta JL. Journal of Cardiovascular Medicine. 2020;21(6):403-5.
445. Association of Treatment with Hydroxychloroquine or Azithromycin with In-Hospital Mortality in Patients with COVID-19 in New York State. Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, et al. JAMA - Journal of the American Medical Association. 2020.
446. COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults. Ross SB, Wilson MG, Papillon-Ferland L, Elsayed S, Wu PE, Battu K, et al. Journal of the American Geriatrics Society. 2020. http://dx.doi.org/10.1111/jgs.16623.
447. Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic. Rowland B, Kunadian V. Heart. 2020. http://dx.doi.org/10.1136/heartjnl-2020-317011.
448. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Ruan Q, Yang K, Wang W, Jiang L, Song J. Intensive Care Medicine. 2020;46(5):846-8.
449. Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity. Ruocco G, Feola M, Palazzuoli A. International Journal of Infectious Diseases. 2020;95:373-5.
450. Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic. Ryan JJ, Melendres-Groves L, Zamanian RT, Oudiz RJ, Chakinala M, Rosenzweig EB, et al. Pulmonary circulation. 2020;10(2):2045894020920153. http://dx.doi.org/10.1177/2045894020920153. eCollection 2020 Apr-Jun.
451. Is COVID Evolution Due to Occurrence of Pulmonary Vascular Thrombosis? Saba L, Sverzellati N. Journal of thoracic imaging. 2020.
452. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with Multiple Sclerosis during the early COVID-19 epidemic in Iran. Safavi F, Nourbakhsh B, Azimi AR. Multiple sclerosis and related disorders. 2020:102195.
453. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids. Saghazadeh A, Rezaei N. International Immunopharmacology. 2020;84.
454. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19). Salamanna F, Maglio M, Landini MP, Fini M. Platelets. 2020:1-6.
455. Chest Computed Tomography Manifestation of Coronavirus Disease 2019 (COVID-19) in Patients With Cardiothoracic Conditions. Salehi S, Abedi A, Radmard AR, Sorouri M, Gholamrezanezhad A. Journal of thoracic imaging. 2020.
456. No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science. Salerno M, Sessa F, Piscopo A, Montana A, Torrisi M, Patane F, et al. Journal of clinical medicine. 2020;9(5). http://dx.doi.org/10.3390/jcm9051472.
457. Global Ranking of COVID-19-Related Mortality by Country using a Novel Pandemic Efficiency Index (PEI). Salihu HM, Dongarwar D, Aliyu MH, Azuine RE. International journal of MCH and AIDS. 2020;9(2):182-5. http://dx.doi.org/10.21106/ijma.378. Epub 2020 Apr 23.
458. Estimating the burden of SARS-CoV-2 in France. Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, et al. Science (New York, NY). 2020.
459. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Sama IE, Ravera A, Santema BT, van Goor H, Ter Maaten JM, Cleland JGF, et al. European heart journal. 2020;41(19):1810-7. http://dx.doi.org/10.1093/eurheartj/ehaa373.
460. New Policy and Regulations for a Radiology-Oncology Center During the COVID-19 Outbreak in Tehran, Iran. Samiee S, Hadjilooei F, Alamolhoda M, Akhlaghpoor S. Advances in Radiation Oncology. 2020.
461. Innovation During COVID-19: Improving Addiction Treatment Access. Samuels EA, Clark SA, Wunsch C, Keeler LAJ, Reddy N, Vanjani R, et al. Journal of addiction medicine. 2020.
462. Evidence for Use or Disuse of Renin–Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder. Sankrityayan H, Kale A, Sharma N, Anders HJ, Gaikwad AB. Journal of Cardiovascular Pharmacology and Therapeutics. 2020.
463. Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control? Sardu C, D'Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. Diabetes care. 2020. http://dx.doi.org/10.2337/dc20-0723.
464. Distribution of the SARS-CoV-2 Pandemic and Its Monthly Forecast Based on Seasonal Climate Patterns. Scafetta N. International journal of environmental research and public health. 2020;17(10). http://dx.doi.org/10.3390/ijerph17103493.
465. Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. Schunemann HJ, Khabsa J, Solo K, Khamis AM, Brignardello-Petersen R, El-Harakeh A, et al. Annals of internal medicine. 2020. http://dx.doi.org/10.7326/M20-2306.
466. Frequency of asymptomatic and symptomatic respiratory virus detection in pediatric hematopoietic cell transplant patients. Schuster JE, Banerjee D, Ahmed I, Selvarangan R. Pediatric transplantation. 2020:e13732. http://dx.doi.org/10.1111/petr.13732.
467. Cutaneous Manifestations of a 21st Century Worldwide Fungal Epidemic Possibly Complicating the COVID-19 Pandemic to Jointly Menace Mankind. Schwartz RA, Kapila R. Dermatologic Therapy. 2020.
468. Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience. Secco GG, Tarantini G, Mazzarotto P, Garbo R, Parisi R, Maggio S, et al. Catheterization and Cardiovascular Interventions. 2020.
469. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike. Seghatchian J, Lanza F. Transfusion and Apheresis Science. 2020.
470. Exosomes Derived From Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Stem cells and development. 2020.
471. Bacteremia and Blood Culture Utilization During COVID-19 Surge in New York City. Sepulveda J, Westblade LF, Whittier S, Satlin MJ, Greendyke WG, Aaron JG, et al. Journal of clinical microbiology. 2020.
472. Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. Shaker MS, Mosnaim G, Oppenheimer J, Stukus D, Abrams EM, Greenhawt M. The journal of allergy and clinical immunology In practice. 2020. http://dx.doi.org/10.1016/j.jaip.2020.05.007.
473. Myocardial injury is associated with higher mortality in patients with coronavirus disease 2019: A meta-analysis. Shao MJ, Shang LX, Luo JY, Shi J, Zhao Y, Li XM, et al. Journal of Geriatric Cardiology. 2020;17(4):224-8.
474. Initial experiences of US neurologists in practice during the COVID-19 pandemic via survey. Sharma A, Maxwell CR, Farmer J, Greene-Chandos D, LaFaver K, Benameur K. Neurology. 2020. http://dx.doi.org/10.1212/WNL.0000000000009844.
475. Covid-19: Pandemic healthcare centres should have already existed. Sharma N, Anderson D. The BMJ. 2020;369.
476. COVID-19 and Acute Kidney Injury requiring Kidney Replacement Therapy: A Bad Prognostic Sign. Shekhar R, Upadhyaya S, Shah S, Kapuria D. medRxiv. 2020:2020.05.08.20096040.
477. Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19. Shi L, Wang Y, Wang Y, Duan G, Yang H. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.05.013.
478. To Do or Not to Do?—A Review of Cancer Surgery Triage Guidelines in COVID-19 Pandemic. Shinde RS, Naik MD, Shinde SR, Bhandare MS, Chaudhari VA, Shrikhande SV, et al. Indian Journal of Surgical Oncology. 2020.
479. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Sia SF, Yan LM, Chin AWH, Fung K, Choy KT, Wong AYL, et al. Nature. 2020.
480. Prehabilitation May Help Mitigate an Increase in COVID-19 Peripandemic Surgical Morbidity and Mortality. Silver JK. Am J Phys Med Rehabil. 2020;99(6):459-63. http://dx.doi.org/10.1097/PHM.0000000000001452.
481. “Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”. Singh AK, Singh A, Singh R, Misra A. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):589-96.
482. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies. Singh AK, Singh A, Singh R, Misra A. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):641-8.
483. Knowledge and Perception Towards Universal Safety Precautions During Early Phase of the COVID-19 Outbreak in Nepal. Singh DR, Sunuwar DR, Karki K, Ghimire S, Shrestha N. Journal of community health. 2020.
484. Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series. Singh S, Chakravarty T, Chen P, Akhmerov A, Falk J, Friedman O, et al. Basic Research in Cardiology. 2020;115(4).
485. COVID-19 infection in children. Sinha IP, Harwood R, Semple MG, Hawcutt DB, Thursfield R, Narayan O, et al. The Lancet Respiratory medicine. 2020;8(5):446-7. http://dx.doi.org/10.1016/S2213-2600(20)30152-1. Epub 2020 Mar 27.
486. Managing COVID-19 in resource-limited settings: Critical care considerations. Siow WT, Liew MF, Shrestha BR, Muchtar F, See KC. Critical Care. 2020;24(1).
487. What should a cardiologist know about coronavirus disease 2019? Sławiński G, Lewicka E. Kardiologia Polska. 2020;78(4):278-83.
488. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Song JC, Wang G, Zhang W, Zhang Y, Li WQ, Zhou Z. Military Medical Research. 2020;7(1).
489. Study on assessing early epidemiological parameters of COVID-19 epidemic in China. Song QQ, Zhao H, Fang LQ, Liu W, Zheng C, Zhang Y. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(4):461-5.
490. Humanism in the Age of COVID-19: Renewing Focus on Communication and Compassion. Sonis JD, Kennedy M, Aaronson EL, Baugh JJ, Raja AS, Yun BJ, et al. The western journal of emergency medicine. 2020;21(3):499-502. http://dx.doi.org/10.5811/westjem.2020.4.47596.
491. Lessons learned from chest CT in COVID-19. Soyer P. Diagnostic and Interventional Imaging. 2020;101(5):261-2.
492. The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. Ssentongo P, Ssentongo AE, Heilbrunn ES, Chinchilli VM. medRxiv. 2020:2020.05.10.20097253.
493. The kidney in COVID-19: protagonist or figurant? Staico MF, Zaffanello M, Di Pietro G, Fanos V, Marcialis MA. Panminerva medica. 2020. http://dx.doi.org/10.23736/S0031-0808.20.03965-8.
494. Dermatology residents and the care of patients with coronavirus disease 2019 (COVID-19). Stoj VJ, Grant-Kels JM. Journal of the American Academy of Dermatology. 2020;82(6):1572-3.
495. COVID-19 from the perspective of an immunologist. Strizova Z, Milota T, Bartunkova J. Casopis lekaru ceskych. 2020;159(2):67-71.
496. Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy). Stroppa EM, Toscani I, Citterio C, Anselmi E, Zaffignani E, Codeluppi M, et al. Future oncology (London, England). 2020.
497. Tracheotomy in COVID-19 patients: Optimizing patient selection and identifying prognostic indicators. Stubington TJ, Mallick AS, Garas G, Stubington E, Reddy C, Mansuri MS. Head & neck. 2020. http://dx.doi.org/10.1002/hed.26280.
498. The renin-angiotensin system - a therapeutic target in COVID-19? Sturrock BR, Milne K, Chevassut TJ. Clinical medicine (London, England). 2020. http://dx.doi.org/10.7861/clinmed.2020-0146.
499. Cardiovascular Manifestation and Treatment in COVID-19. Su YB, Kuo MJ, Lin TY, Chien CS, Yang YP, Chou SJ, et al. Journal of the Chinese Medical Association : JCMA. 2020. http://dx.doi.org/10.1097/JCMA.0000000000000352.
500. 'Distancing is impossible': refugee camps race to avert coronavirus catastrophe. Subbaraman N. Nature. 2020;581(7806):18.
501. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Sud A, Jones M, Broggio J, Loveday C, Torr B, Garrett A, et al. Annals of oncology : official journal of the European Society for Medical Oncology. 2020. http://dx.doi.org/10.1016/j.annonc.2020.05.009.
502. A cloth mask for under-resourced healthcare settings in the COVID19 pandemic. Sugrue M, O’Keeffe D, Sugrue R, MacLean L, Varzgalis M. Irish Journal of Medical Science. 2020.
503. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel? Sun DW, Zhang D, Tian RH, Li Y, Wang YS, Cao J, et al. Clinica chimica acta; international journal of clinical chemistry. 2020;508:122-9. http://dx.doi.org/10.1016/j.cca.2020.05.027.
504. Clinical Features of Patients with Coronavirus Disease 2019 (COVID-19) from a Designated Hospital in Beijing, China. Sun L, Shen L, Fan J, Gu F, Hu M, An Y, et al. Journal of medical virology. 2020.
505. Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19. Sun L, Song F, Shi N, Liu F, Li S, Li P, et al. Journal of Clinical Virology. 2020;128.
506. Editorial: Challenges to Opioid Use Disorders During COVID-19. Sun Y, Bao Y, Kosten T, Strang J, Shi J, Lu L. American Journal on Addictions. 2020;29(3):174-5.
507. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C, et al. Journal of autoimmunity. 2020:102473. http://dx.doi.org/10.1016/j.jaut.2020.102473.
508. Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non-COVID-19 Sepsis but Carries a Moderately Increased Risk of Death. Sunden-Cullberg J. Hypertension (Dallas, Tex : 1979). 2020;75(6):e15-e6. http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.15178. Epub 2020 Apr 10.
509. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? Tadic M, Cuspidi C, Mancia G, Dell'Oro R, Grassi G. Pharmacological research. 2020:104906.
510. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Tamara A, Tahapary DL. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):655-9.
511. Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks. Tatara AM. Tissue engineering Part A. 2020;26(9):468-74. http://dx.doi.org/10.1089/ten.TEA.2020.0094. Epub 2020 Apr 15.
512. 2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases. Taxonera C, Sagastagoitia I, Alba C, Mañas N, Olivares D, Rey E. Alimentary Pharmacology and Therapeutics. 2020.
513. Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model. Tejera-Vaquerizo A, Nagore E. Journal of the European Academy of Dermatology and Venereology. 2020.
514. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series. Thibodeaux K, Speyrer M, Raza A, Yaakov R, Serena TE. Journal of wound care. 2020;29:S4-s8. http://dx.doi.org/10.12968/jowc.2020.29.Sup5a.S4.
515. The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the "cytokine storm" in COVID-19 patients: a hypothesis. Thomas G, Frederick E, Hausburg M, Goldberg L, Hoke M, Roshon M, et al. Patient safety in surgery. 2020;14:21. http://dx.doi.org/10.1186/s13037-020-00248-4. eCollection 2020.
516. Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom. Thomas W, Varley J, Johnston A, Symington E, Robinson M, Sheares K, et al. Thrombosis Research. 2020;191:76-7.
517. Hepatic complications of COVID-19 and its treatment. Tian D, Ye Q. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.26036.
518. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.26050.
519. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, et al. Autoimmunity reviews. 2020:102568.
520. Glycemic control in type 1 diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity. Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E. Diabetes technology & therapeutics. 2020. http://dx.doi.org/10.1089/dia.2020.0169.
521. COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions. Triggle CR, Bansal D, Farag EABA, Ding H, Sultan AA. mSphere. 2020;5(3).
522. Current epidemiological and clinical features of COVID-19; a global perspective from China. Tu H, Tu S, Gao S, Shao A, Sheng J. Journal of Infection. 2020.
523. Coexistence of COVID-19 and acute ischemic stroke report of four cases. TunÇ A, ÜNlÜBaŞ Y, Alemdar M, AkyÜ ZE. Journal of Clinical Neuroscience. 2020.
524. Managing care for patients with sinonasal and anterior skull base cancers during the COVID-19 pandemic. Turri-Zanoni M, Battaglia P, Karligkiotis A, Locatelli D, Castelnuovo P. Head & neck. 2020. http://dx.doi.org/10.1002/hed.26257.
525. SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. Uddin M, Mustafa F, Rizvi TA, Loney T, Suwaidi HA, Al-Marzouqi AHH, et al. Viruses. 2020;12(5).
526. Examining the impact of COVID-19 on stress and coping strategies in individuals with disabilities and chronic conditions. Umucu E, Lee B. Rehabilitation psychology. 2020.
527. How can we evaluate an interrelation of symptoms? Usuzaki T, Chiba S, Shimoyama M. Archives of Gerontology and Geriatrics. 2020;89.
528. Renin-angiotensin-aldosterone system inhibitors in patients with covid-19. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. New England Journal of Medicine. 2020;382(17):1653-9.
529. A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19. Valencia-Sanchez C, Wingerchuk DM. Multiple Sclerosis and Related Disorders. 2020;42.
530. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM, et al. The Cochrane database of systematic reviews. 2020;5:CD013600.
531. [COVID19-Tracker: a shiny app to analise data on SARS-CoV-2 epidemic in Spain]. Valls J, Tobias A, Satorra P, Tebe C. Gaceta sanitaria. 2020. http://dx.doi.org/10.1016/j.gaceta.2020.04.002.
532. Cardiothoracic robotic assisted surgery in times of COVID-19. Van den Eynde J, De Groote S, Van Lerberghe R, Van den Eynde R, Oosterlinck W. Journal of Robotic Surgery. 2020.
533. [The first 29 COVID-19-patients in a clinic: early experiences from a Dutch hospital]. Van der Moeren N, Talman S, van den Bijllaardt W, Kant M, Heukels P, Bentvelsen RG, et al. Nederlands tijdschrift voor geneeskunde. 2020;164.
534. Care for adult non-ICU covid-19 patients: Early experiences from a Belgian tertiary care centre. Van Halem K, Cox J, Messiaen P, Pat K, Declercq C, Meersman A, et al. Netherlands Journal of Medicine. 2020;78(3):111-5.
535. Strategies to Promote Social Connections Among Older Adults During 'Social Distancing' Restrictions. Van Orden KA, Bower E, Lutz J, Silva C, Gallegos AM, Podgorski CA, et al. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2020. http://dx.doi.org/10.1016/j.jagp.2020.05.004.
536. COVID-19 in India: Moving from containment to mitigation. Varghese GM, John R. Indian Journal of Medical Research. 2020;151(2):136-9.
537. Mild versus severe COVID-19: Laboratory markers. Velavan TP, Meyer CG. International Journal of Infectious Diseases. 2020;95:304-7.
538. Time-to-Death approach in revealing Chronicity and Severity of COVID-19 across the World. Verma V, Vishwakarma RK, Verma A, Nath DC, Khan HTA. PLoS ONE. 2020;15(5).
539. Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment. Villani A, Fabbrocini G, Costa C, Scalvenzi M. Journal of the American Academy of Dermatology. 2020;82(6):e205.
540. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19. Vitali C, Minniti A, Caporali R, Del Papa N. Thrombosis Research. 2020;192:21-2.
541. Rare Anaemias, Sickle-Cell Disease and COVID-19. Vives Corrons JL, De Sanctis V. Acta bio-medica : Atenei Parmensis. 2020;91(2):216-7. http://dx.doi.org/10.23750/abm.v91i2.9532.
542. Histopathology and genetic susceptibility in COVID-19 pneumonia. von der Thüsen J, van der Eerden M. European Journal of Clinical Investigation. 2020.
543. Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates. Vrsalovic M, Vrsalovic Presecki A. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.05.022.
544. Wuhan Covid19 data – more questions than answers. Walach H, Hockertz S. Toxicology. 2020;440.
545. COVID-19 in Correctional and Detention Facilities - United States, February-April 2020. Wallace M, Hagan L, Curran KG, Williams SP, Handanagic S, Bjork A, et al. MMWR Morbidity and mortality weekly report. 2020;69(19):587-90.
546. Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic. Wallis CJD, Novara G, Marandino L, Bex A, Kamat AM, Karnes RJ, et al. Eur Urol. 2020. http://dx.doi.org/10.1016/j.eururo.2020.04.063.
547. Androgen sensitivity gateway to COVID-19 disease severity. Wambier CG, Goren A, Vaño-Galván S, Ramos PM, Ossimetha A, Nau G, et al. Drug Development Research. 2020.
548. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis. Wang H, Qiu P, Liu J, Wang F, Zhao Q. Clinics and Research in Hepatology and Gastroenterology. 2020.
549. Spontaneous pneumomediastinum: A probable unusual complication of Coronavirus disease 2019 (COVID-19) pneumonia. Wang J, Su X, Zhang T, Zheng C. Korean Journal of Radiology. 2020;21(5):627-8.
550. Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China. Wang Y, Liu Y, Liu L, Wang X, Luo N, Li L. The Journal of infectious diseases. 2020;221(11):1770-4. http://dx.doi.org/10.1093/infdis/jiaa119.
551. Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China. Wang Y, Tong J, Qin Y, Xie T, Li J, Li J, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa629.
552. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Lancet. 2020;395(10236):1569-78. http://dx.doi.org/10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
553. The Risk of Children Hospitalized With Severe COVID-19 in Wuhan. Wang Y, Zhu F, Wang C, Wu J, Liu J, Chen X, et al. The Pediatric infectious disease journal. 2020.
554. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Wang Z, Du Z, Zhu F. Diabetes research and clinical practice. 2020;164:108214. http://dx.doi.org/10.1016/j.diabres.2020.108214.
555. Anti-Coagulant and Anti-Platelet Therapy in the COVID-19 Patient: A Best Practices Quality Initiative Across a Large Health System. Watson RA, Johnson DM, Dharia RN, Merli GJ, Doherty JU. Hospital practice (1995). 2020. http://dx.doi.org/10.1080/21548331.2020.1772639.
556. TERAVOLT: Thoracic Cancers International COVID-19 Collaboration. Whisenant JG, Trama A, Torri V, De Toma A, Viscardi G, Cortellini A, et al. Cancer cell. 2020. http://dx.doi.org/10.1016/j.ccell.2020.05.008.
557. Covid-19: Low skilled men have highest death rate of working age adults. Wise J. BMJ (Clinical research ed). 2020;369:m1906.
558. Covid-19: Known risk factors fail to explain the increased risk of death among people from ethnic minorities. Wise J. BMJ (Clinical research ed). 2020;369:m1873.
559. COVID-19 and toxicity from potential treatments: Panacea or poison. Wong A. EMA - Emergency Medicine Australasia. 2020.
560. Household Transmission of SARS-CoV-2, Zhuhai, China, 2020. Wu J, Huang Y, Tu C, Bi C, Chen Z, Luo L, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
561. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y, et al. Clinical journal of the American Society of Nephrology : CJASN. 2020. http://dx.doi.org/10.2215/CJN.04160320.
562. Recovery from COVID-19 in two patients with coexisted HIV infection. Wu Q, Chen T, Zhang H. Journal of medical virology. 2020.
563. Perinatal depressive and anxiety symptoms of pregnant women along with COVID-19 outbreak in China. Wu Y, Zhang C, Liu H, Duan C, Li C, Fan J, et al. Am J Obstet Gynecol. 2020. http://dx.doi.org/10.1016/j.ajog.2020.05.009.
564. An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19. Xia X, Wen M, Zhan S, He J, Chen W. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2020;40(3):333-6.
565. CRISPR-Cas Systems Based Molecular Diagnostic Tool for Infectious Diseases and Emerging 2019 Novel Coronavirus (COVID-19) Pneumonia. Xiang X, Qian K, Zhang Z, Lin F, Xie Y, Liu Y, et al. Journal of drug targeting. 2020:1-10.
566. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Intensive Care Medicine. 2020;46(5):837-40.
567. Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV. Xie M, Chen Q. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;94:119-24. http://dx.doi.org/10.1016/j.ijid.2020.03.071. Epub 2020 Apr 1.
568. Management of COVID-19: the Zhejiang experience. Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, et al. Zhejiang da xue xue bao Yi xue ban = Journal of Zhejiang University Medical sciences. 2020;49(2):147-57.
569. Effective treatment of severe COVID-19 patients with tocilizumab. Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. Proc Natl Acad Sci U S A. 2020;117(20):10970-5. http://dx.doi.org/10.1073/pnas.2005615117. Epub 2020 Apr 29.
570. Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic review. Yaacoub S, Schunemann HJ, Khabsa J, El-Harakeh A, Khamis AM, Chamseddine F, et al. BMJ global health. 2020;5(5). http://dx.doi.org/10.1136/bmjgh-2020-002650.
571. COVID-19 and Cardiovascular diseases. Scoping review study. Yahia F, Zakhama L, Ben Abdelaziz A. La Tunisie medicale. 2020;98(4):283-94.
572. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, et al. BMJ Open Diabetes Research and Care. 2020;8(1).
573. Clinical characteristics and outcomes of cancer patients with COVID-19. Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Journal of medical virology. 2020.
574. Corona Virus Disease 2019, a growing threat to children? Yang P, Liu P, Li D, Zhao D. Journal of Infection. 2020;80(6):671-93.
575. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study. Yang X, Cai S, Luo Y, Zhu F, Hu M, Zhao Y, et al. Crit Care Med. 2020. http://dx.doi.org/10.1097/CCM.0000000000004447.
576. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery. Yanuck SF, Pizzorno J, Messier H, Fitzgerald KN. Integrative medicine (Encinitas, Calif). 2020;19:8-35.
577. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. Yin S, Huang M, Li D, Tang N. Journal of Thrombosis and Thrombolysis. 2020.
578. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China. Yin S, Peng Y, Ren Y, Hu M, Tang L, Xiang Z, et al. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2020;128:104397.
579. A global treatments for coronaviruses including COVID-19. Yousefi B, Valizadeh S, Ghaffari H, Vahedi A, Karbalaei M, Eslami M. Journal of Cellular Physiology. 2020.
580. Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19. Yu B, Li C, Chen P, Zhou N, Wang L, Li J, et al. Science China Life sciences. 2020. http://dx.doi.org/10.1007/s11427-020-1732-2.
581. Osteoporosis Management in the Era of COVID-19. Yu EW, Tsourdi E, Clarke BL, Bauer DC, Drake MT. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2020.
582. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. The Lancet Infectious Diseases. 2020;20(5):559-64.
583. A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period. Yu P, Zhu J, Zhang Z, Han Y. The Journal of infectious diseases. 2020;221(11):1757-61. http://dx.doi.org/10.1093/infdis/jiaa077.
584. Treatment of COVID-19 guided by holistic view of traditional Chinese medicine-therapy aimed at both viral and host. Yuan R, Xin QQ, Tang SH, Cong WH. Zhongguo Zhongyao Zazhi. 2020;45(7):1521-5.
585. Estimation of the number of blood donors during the COVID-19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission. Yuan Z, Chen D, Chen X, Wei Y. Transfusion. 2020. http://dx.doi.org/10.1111/trf.15858.
586. COVID-19 and Multiorgan Response. Zaim S, Chong JH, Sankaranarayanan V, Harky A. Current problems in cardiology. 2020:100618. http://dx.doi.org/10.1016/j.cpcardiol.2020.100618.
587. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Zangrillo A, Beretta L, Scandroglio AM, Monti G, Fominskiy E, Colombo S, et al. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 2020.
588. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.05.055.
589. Clinical and Imaging features of COVID-19 Patients: Analysis of Data from High-Altitude Areas. Zeng J, Peng S, Lei Y, Huang J, Guo Y, Zhang X, et al. Journal of Infection. 2020;80(6):e34-e6.
590. Histological pattern in Covid-19 induced viral rash. Zengarini C, Orioni G, Cascavilla A, Horna Solera C, Fulgaro C, Misciali C, et al. Journal of the European Academy of Dermatology and Venereology. 2020.
591. Obesity predisposes to the risk of higher mortality in young COVID-19 patients. Zhang F, Xiong Y, Wei Y, Hu Y, Wang F, Li G, et al. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.26039.
592. Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography. Zhang K, Liu X, Shen J, Li Z, Sang Y, Wu X, et al. Cell. 2020.
593. Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19). Zhang L, Yu J, Zhou Y, Shen M, Sun L. American Journal of Chinese Medicine. 2020.
594. Viral and host factors related to the clinical outcome of COVID-19. Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z, et al. Nature. 2020. http://dx.doi.org/10.1038/s41586-020-2355-0.
595. ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis. Zhang X, Yu J, Pan LY, Jiang HY. Pharmacological research. 2020:104927. http://dx.doi.org/10.1016/j.phrs.2020.104927.
596. The Clinical Characteristics and Outcomes of Diabetes Mellitus and Secondary Hyperglycaemia Patients with Coronavirus Disease 2019: a Single-center, Retrospective, Observational Study in Wuhan. Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu N, et al. Diabetes, obesity & metabolism. 2020.
597. Investigation of transmission chain of a cluster COVID-19 cases. Zhao H, Li BS, Xia Y, Zhou HL, Li TR, Zeng Y, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41:E064.
598. Advances in the relationship between coronavirus infection and cardiovascular diseases. Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z, et al. Biomedicine and Pharmacotherapy. 2020;127.
599. Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients-indications for predictive, preventive, and personalized medical approach. Zhao X, Wang K, Zuo P, Liu Y, Zhang M, Xie S, et al. The EPMA journal. 2020:1-7. http://dx.doi.org/10.1007/s13167-020-00208-z.
600. Antenatal corticosteroids for pregnant women with COVID-19 infection and preterm prelabor rupture of membranes: a decision analysis. Zhou CG, Packer CH, Hersh AR, Caughey AB. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2020:1-9. http://dx.doi.org/10.1080/14767058.2020.1763951.
601. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors. Zhou X, Zhu J, Xu T. Clinical and experimental hypertension (New York, NY : 1993). 2020:1-5.
602. The role of ACEIs/ARBs in COVID-19: Friend or foe? Zhou Z, Qiu Y, Tao J. Medical Hypotheses. 2020;142.
603. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Current Cardiology Reports. 2020;22(5).
604. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features. Zimmermann P, Curtis N. The Pediatric infectious disease journal. 2020;39(6):469-77. Update tot 14-05-2020
1. COVID-19, Australia: Epidemiology Report 13 (Reporting week to 23:59 AEST 26 April 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.35.
2. Correction to Lancet Respir Med 2020; 8: 506–17 (The Lancet Respiratory Medicine (2020) 8(5) (506–517), (S2213260020301612), (10.1016/S2213-2600(20)30161-2)). The Lancet Respiratory Medicine. 2020;8(5):e42.
3. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications? Adamowicz J, Juszczak K, Drewa T. Medical Hypotheses. 2020;140.
4. COVID-19 cases are less prevalent in countries where malaria is endemic, suggesting a role for anti-malarial drugs as prophylaxis. Adams D, Alshaban F. Eye Reports. 2020;6(1):S11-S6.
5. Updated estimates of comorbidities associated with risk for COVID-19 complications based on US data. Adams ML, Grandpre J, Katz DL. medRxiv. 2020.
6. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States. Adams ML, Katz DL, Grandpre J. Emerging infectious diseases. 2020;26(8).
7. Cracking the code to the 2019 novel coronavirus (COVID-19): Lessons from the eye. Adams N. Eye Reports. 2020;6(1):S1-S6.
8. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Diagnosis (Berlin, Germany). 2020;7(2):91-6. http://dx.doi.org/10.1515/dx-2020-0046.
9. Multiple Myeloma in the Time of COVID-19. Al Saleh AS, Sher T, Gertz MA. Acta Haematologica. 2020.
10. Demographic, clinical, and outcomes of confirmed cases of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in Najran, Kingdom of Saudi Arabia (KSA); A retrospective record based study. Al Sulayyim HJ, Khorshid SM, Al Moummar SH. Journal of Infection and Public Health. 2020.
11. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Kidney international. 2020.
12. Battle Buddies: Rapid Deployment of a Psychological Resilience Intervention for Healthcare Workers during the COVID-19 Pandemic. Albott CS, Wozniak JR, McGlinch BP, Wall MH, Gold BS, Vinogradov S. Anesthesia and analgesia. 2020.
13. Renin-angiotensin-aldosterone system and COVID-19 infection. Alexandre J, Cracowski JL, Richard V, Bouhanick B. Annales d'endocrinologie. 2020. http://dx.doi.org/10.1016/j.ando.2020.04.005.
14. The potential for COVID-19 to contribute to compassion fatigue in critical care nurses. Alharbi J, Jackson D, Usher K. Journal of clinical nursing. 2020.
15. Risk of reactivation or reinfection of novel coronavirus (COVID-19). Alizargar J. Journal of the Formosan Medical Association. 2020.
16. The dipeptidyl peptidase-4 expression in some MERS-CoV naturally infected dromedary camels in Saudi Arabia 2018-2019. Alnaeem A, Kasem S, Qasim I, Al-Doweriej A, Refaat M, Al-Shabebi A, et al. Virusdisease. 2020:1-4. http://dx.doi.org/10.1007/s13337-020-00586-y.
17. The correlation between the spread of COVID-19 infections and weather variables in 30 Chinese provinces and the impact of Chinese government mitigation plans. Al-Rousan N, Al-Najjar H. European review for medical and pharmacological sciences. 2020;24(8):4565-71. http://dx.doi.org/10.26355/eurrev_202004_21042.
18. Emergence of COVID-19 Infection: What Is Known and What Is to Be Expected - Narrative Review Article. Altakarli NS. Dubai Medical Journal. 2020;3(1):13-8.
19. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey. Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. Journal of medical virology. 2020.
20. Endocrinology in the time of COVID-19: Management of adrenal insufficiency. Arlt W, Baldeweg SE, Pearce SHS, Simpson HL. European journal of endocrinology. 2020. http://dx.doi.org/10.1530/EJE-20-0361.
21. SARS-CoV-2 shedding and infectivity. Atkinson B, Petersen E. The Lancet. 2020;395(10233):1339-40.
22. Acute Pulmonary Embolism in SARS-CoV-2 Infection Treated with Surgical Embolectomy. Audo A, Bonato V, Cavozza C, Maj G, Pistis G, Secco GG. The Annals of thoracic surgery. 2020. http://dx.doi.org/10.1016/j.athoracsur.2020.04.013.
23. Sustainable health promotion for the seniors during COVID-19 outbreak: a lesson from Tokyo. Aung MN, Yuasa M, Koyanagi Y, Aung TNN, Moolphate S, Matsumoto H, et al. J Infect Dev Ctries. 2020;14(4):328-31. http://dx.doi.org/10.3855/jidc.12684.
24. COVID-19 presenting as stroke. Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. Brain, behavior, and immunity. 2020.
25. Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis. Aziz M, Fatima R, Assaly R. Journal of medical virology. 2020.
26. Myocardial injury and COVID-19: Possible mechanisms. Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Life sciences. 2020;253.
27. Do we know the diagnostic properties of the tests used in COVID-19? A rapid review of recently published literature. Bachelet VC. Medwave. 2020;20(3):e7890. http://dx.doi.org/10.5867/medwave.2020.03.7891.
28. Potential impact of the COVID-19 pandemic on financial toxicity in cancer survivors. Baddour K, Kudrick LD, Neopaney A, Sabik LM, Peddada SD, Nilsen ML, et al. Head and Neck. 2020.
29. Purposing Saikosaponins for the treatment of COVID-19. Bahbah EI, Negida A, Nabet MS. Medical Hypotheses. 2020;140.
30. COVID-19 infection in kidney transplant recipients. Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. Kidney international. 2020.
31. Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency. Barbieri L, Talavera Urquijo E, Parise P, Nilsson M, Reynolds JV, Rosati R. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2020.
32. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria. Barrasa H, Rello J, Tejada S, Martín A, Balziskueta G, Vinuesa C, et al. Anaesthesia Critical Care and Pain Medicine. 2020.
33. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection. Barton MC, Bennett KV, Cook JR, Gallup GG, Platek SM. Medical Hypotheses. 2020;141.
34. Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States. Basu A. Health affairs (Project Hope). 2020:101377hlthaff202000455. http://dx.doi.org/10.1377/hlthaff.2020.00455.
35. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. Becerra-Flores M, Cardozo T. Int J Clin Pract. 2020. http://dx.doi.org/10.1111/ijcp.13525.
36. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count. Bi X, Su Z, Yan H, Du J, Wang J, Chen L, et al. Platelets. 2020:1-6. http://dx.doi.org/10.1080/09537104.2020.1760230.
37. [First case of COVID-19 treated with tocilizumab in Iceland]. Bjornsson AH, Olafsdottir T, Thormar KM, Kristjansson M, Thorisdottir AS, Ludviksson BR, et al. Laeknabladid. 2020;106(5):247-50. http://dx.doi.org/10.17992/lbl.2020.05.581.
38. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19). Blauvelt CA, Chiu C, Donovan AL, Prahl M, Shimotake TK, George RB, et al. Obstetrics and gynecology. 2020. http://dx.doi.org/10.1097/AOG.0000000000003949.
39. Telemedicine Online Visits in Urology During the COVID-19 Pandemic—Potential, Risk Factors, and Patients’ Perspective. Boehm K, Ziewers S, Brandt MP, Sparwasser P, Haack M, Willems F, et al. European Urology. 2020.
40. Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology. Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, Díez-Villanueva P, Ayesta A, Sanchis Forés J, et al. Revista Espanola de Cardiologia. 2020.
41. Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints—Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States. Braunstein LZ, Gillespie EF, Hong L, Xu A, Bakhoum SF, Cuaron J, et al. Advances in Radiation Oncology. 2020.
42. Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic. Brough HA, Kalayci O, Sediva A, Untersmayr E, Munblit D, Rodriquez Del Rio P, et al. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2020.
43. SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy. Cafarotti S. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020.
44. Psychological impact and coping strategies of frontline medical staff in Hunan between January and March 2020 during the outbreak of coronavirus disease 2019 (COVID) in Hubei, China. Cai H, Tu B, Ma J, Chen L, Fu L, Jiang Y, et al. Medical Science Monitor. 2020;26.
45. Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People's Republic of China. Cai Y, Hao Z, Gao Y, Ping W, Wang Q, Peng S, et al. Journal of Thoracic Oncology. 2020.
46. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? Capuano A, Scavone C, Racagni G, Scaglione F. Pharmacological research. 2020;157:104849. http://dx.doi.org/10.1016/j.phrs.2020.104849.
47. Early Self-Proning in Awake, Non-intubated Patients in the Emergency Department: A Single ED's Experience during the COVID-19 Pandemic. Caputo ND, Strayer RJ, Levitan R. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2020.
48. Can pioglitazone be potentially useful therapeutically in treating patients with covid-19? Carboni E, Carta AR, Carboni E. Medical Hypotheses. 2020;140.
49. In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention? Carta MG, Orrù G, Scano A, Coghe F, Nunnari G, Facchini G, et al. European review for medical and pharmacological sciences. 2020;27(4):3434-6.
50. [Venous thrombotic risk related to SARS-CoV-2 : prevalence, recommendations and perspectives]. Casini A, Fontana P, Glauser F, Robert-Ebadi H, Righini M, Blondon M. Revue medicale suisse. 2020;16(692):951-4.
51. Skull base surgery during the Covid-19 pandemic: The Italian skull base society recommendations. Castelnuovo P, Turri-Zanoni M, Karligkiotis A, Battaglia P, Pozzi F, Locatelli D, et al. International forum of allergy & rhinology. 2020.
52. Emerging and reemerging respiratory viral infections up to covid-19. Çelik İ, Saatçi E, Eyüboğlu FÖ. Turkish Journal of Medical Sciences. 2020;50:557-62.
53. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory. Ceriello A. Diabetes Research and Clinical Practice. 2020;163.
54. COVID-19 pandemic - A focused review for clinicians. Cevik M, Bamford C, Ho A. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020.
55. Covid-19 pandemic by the “real-time” monitoring: the Tunisian case and lessons for global epidemics in the context of 3PM strategies. Chaari L, Golubnitschaja O. EPMA Journal. 2020.
56. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Lee SS. European review for medical and pharmacological sciences. 2020;24(7):4016-26.
57. Clinical and immunological features of severe and moderate coronavirus disease 2019. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Journal of Clinical Investigation. 2020;130(5):2620-9.
58. Potential of live pathogen vaccines for defeating the COVID-19 pandemic: history and mechanism. Chen JW, Chen JM. Journal of medical virology. 2020.
59. Impact of fundamental diseases on patients with COVID-19. Chen Y, Li T, Ye Y, Chen Y, Pan J. Disaster medicine and public health preparedness. 2020:1-15. http://dx.doi.org/10.1017/dmp.2020.139.
60. Epidemiological analysis of the early 38 fatalities in Hubei, China, of the coronavirus disease 2019. Chen Y, Zhao M, Wu Y, Zang S. Journal of global health. 2020;10(1):011004. http://dx.doi.org/10.7189/jogh-10-011004.
61. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty. Cheng P, Zhu H, Witteles RM, Wu JC, Quertermous T, Wu SM, et al. Current cardiology reports. 2020;22(5):34. http://dx.doi.org/10.1007/s11886-020-01293-2.
62. Expanding the concept of the professional integrity of obstetrics during a public health emergency. Chervenak FA, Grunebaum A, Bornstein E, Wasden S, Katz A, Rochelson BL, et al. J Perinat Med. 2020. http://dx.doi.org/10.1515/jpm-2020-0174.
63. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. Science. 2020;368(6489):395-400.
64. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte). Chong EA, Roeker LE, Shadman M, Davids MS, Schuster SJ, Mato AR. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020.
65. COVID-19 fault lines. Choo EK. The Lancet. 2020;395(10233):1333.
66. Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO). Chow J, Alhussaini A, Calvillo-Arguelles O, Billia F, Luk A. CJC open. 2020. http://dx.doi.org/10.1016/j.cjco.2020.04.003.
67. Endocrinology in the time of COVID-19: Management of Hyponatraemia and Diabetes Insipidus. Christ Crain M, Hoorn EJ, Sherlock M, Thompson CJ, Wass JAH. European journal of endocrinology. 2020. http://dx.doi.org/10.1530/EJE-20-0338.
68. COVID-19: extending or relaxing distancing control measures. Colbourn T. The Lancet Public Health. 2020;5(5):e236-e7.
69. Covid-19 in Brazil: Advantages of a socialized unified health system and preparation to contain cases. Croda J, Oliveira WK, Frutuoso RL, Mandetta LH, Baia-Da-silva DC, Brito-Sousa JD, et al. Revista da Sociedade Brasileira de Medicina Tropical. 2020;53.
70. People experiencing homelessness urgently need to be recognised as a high risk group for COVID-19. Cumming C, Wood L, Davies A. Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals. 2020. http://dx.doi.org/10.1002/hpja.355.
71. COVID-19 and RAS: Unravelling an unclear relationship. D’ardes D, Boccatonda A, Rossi I, Guagnano MT, Santilli F, Cipollone F, et al. International Journal of Molecular Sciences. 2020;21(8).
72. The ACE-2 in COVID-19: Foe or Friend? Dalan R, Bornstein SR, El-Armouche A, Rodionov RN, Markov A, Wielockx B, et al. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2020.
73. Disruption of Arthroplasty Practice in an Orthopedic Center in Northern Italy During the Coronavirus Disease 2019 Pandemic. D'Apolito R, Faraldi M, Ottaiano I, Zagra L. Journal of Arthroplasty. 2020.
74. Understanding novel COVID-19: its impact on organ failure and risk assessment for diabetic and cancer patients. Dariya B, Nagaraju GP. Cytokine & Growth Factor Reviews. 2020.
75. Moral outrage in COVID19- Understandable but not a strategy. Davidson PM, Padula WV, Daly J, Jackson D. Journal of clinical nursing. 2020. http://dx.doi.org/10.1111/jocn.15318.
76. Caring for Children and Adolescents With Eating Disorders in the Current Coronavirus 19 Pandemic: A Singapore Perspective. Davis C, Ng KC, Oh JY, Baeg A, Rajasegaran K, Chew CSE. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2020. http://dx.doi.org/10.1016/j.jadohealth.2020.03.037.
77. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males? de Groot NG, Bontrop RE. Immunogenetics. 2020.
78. Immediate impact of COVID-19 on transplant activity in the Netherlands. de Vries APJ, Alwayn IPJ, Hoek RAS, van den Berg AP, Ultee FCW, Vogelaar SM, et al. Transplant immunology. 2020:101304. http://dx.doi.org/10.1016/j.trim.2020.101304.
79. Risks Posed to Corneal Transplant Recipients by COVID-19-Affected Donors. Desautels JD, Moshirfar M, Martheswaran T, Shmunes KM, Ronquillo YC. Ophthalmology and therapy. 2020:1-9. http://dx.doi.org/10.1007/s40123-020-00254-w.
80. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know. Dhawan R, Gundry RL, Brett-Major DM, Mahr C, Thiele GM, Lindsey ML, et al. Journal of Molecular and Cellular Cardiology. 2020;144:12-4.
81. Emergence of novel coronavirus sars-cov2 in China and the response in Mexico. Díaz-Quiñonez JA. Gaceta Medica de Mexico. 2020;156(2):91-3.
82. Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19. Ding M, Zhang Q, Li Q, Wu T, Huang YZ. Respiratory Medicine. 2020;167.
83. Covid-19 outbreak progression in italian regions: Approaching the peak by the end of march in northern Italy and first week of april in southern Italy. Distante C, Piscitelli P, Miani A. International Journal of Environmental Research and Public Health. 2020;17(9).
84. ISIDOG recommendations concerning COVID-19 and pregnancy. Donders F, Lonnée-Hoffmann R, Tsiakalos A, Mendling W, De Oliveira JM, Judlin P, et al. Diagnostics. 2020;10(4).
85. The role of imaging in the detection and management of COVID-19: a review. Dong D, Tang Z, Wang S, Hui H, Gong L, Lu Y, et al. IEEE Reviews in Biomedical Engineering. 2020.
86. Dengue Fever and Severe Dengue in Barbados, 2008-2016. Douglas KO, Dutta SK, Martina B, Anfasa F, Samuels TA, Hilaire MG. Tropical medicine and infectious disease. 2020;5(2). http://dx.doi.org/10.3390/tropicalmed5020068.
87. Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2. Ebrahimi SA. Drug Development Research. 2020.
88. Prolonged grief disorder following the Coronavirus (COVID-19) pandemic. Eisma MC, Boelen PA, Lenferink LIM. Psychiatry Research. 2020;288.
89. Let food be the medicine but not for coronavirus: utrition and food science telling myths from facts. El Ghoch M, Valerio A. Journal of Population Therapeutics and Clinical Pharmacology. 2020;27(2):e1-e4.
90. Natural products may interfere with SARS-CoV-2 attachment to the host cell. Elfiky AA. Journal of biomolecular structure & dynamics. 2020:1-16.
91. Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks? El-Hage W, Hingray C, Lemogne C, Yrondi A, Brunault P, Bienvenu T, et al. Encephale. 2020.
92. A systematic scoping review of COVID-19 during pregnancy and childbirth. Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S, et al. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2020.
93. Combination of biodata mining and computational modelling in identification and characterization of ORF1ab polyprotein of SARS-CoV-2 isolated from oronasopharynx of an Iranian patient. Emameh RZ, Nosrati H, Taheri RA. Biological Procedures Online. 2020;22(1).
94. Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical Recovery. Engelman DT, Lother S, George I, Funk DJ, Ailawadi G, Atluri P, et al. The Annals of thoracic surgery. 2020.
95. Adapting to the COVID-19 pandemic in New York City. Escalon MX, Herrera J. American journal of physical medicine & rehabilitation. 2020.
96. Potential lethal outbreak of coronavirus disease (COVID-19) among the elderly in retirement homes and long-term facilities, France, March 2020. Etard JF, Vanhems P, Atlani-Duault L, Ecochard R. Eurosurveillance. 2020;25(15).
97. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies. Fagone P, Ciurleo R, Lombardo SD, Iacobello C, Palermo CI, Shoenfeld Y, et al. Autoimmun Rev. 2020:102571. http://dx.doi.org/10.1016/j.autrev.2020.102571.
98. Acute kidney injury in SARS-CoV-2 infected patients. Fanelli V, Fiorentino M, Cantaluppi V, Gesualdo L, Stallone G, Ronco C, et al. Critical Care. 2020;24(1).
99. AGS Position Statement: Resource Allocation Strategies and Age-Related Considerations in the COVID-19 Era and Beyond. Farrell TW, Ferrante LE, Brown T, Francis L, Widera E, Rhodes R, et al. Journal of the American Geriatrics Society. 2020. http://dx.doi.org/10.1111/jgs.16537.
100. Rationing Limited Health Care Resources in the COVID-19 Era and Beyond: Ethical Considerations Regarding Older Adults. Farrell TW, Francis L, Brown T, Ferrante LE, Widera E, Rhodes R, et al. Journal of the American Geriatrics Society. 2020. http://dx.doi.org/10.1111/jgs.16539.
101. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland M, et al. The Lancet. 2020;395(10234):1407-9.
102. African American COVID-19 Mortality: A Sentinel Event. Ferdinand KC, Nasser SA. Journal of the American College of Cardiology. 2020.
103. The battle against COVID-19: mortality in Italy. Ferrari R, Maggioni AP, Tavazzi L, Rapezzi C. European heart journal. 2020.
104. Critically ill SARS-CoV-2-infected patients are not stratified as sepsis by the qSOFA. Ferreira M, Blin T, Collercandy N, Szychowiak P, Dequin PF, Jouan Y, et al. Annals of Intensive Care. 2020;10(1).
105. Correlating Covid-19 mortality and infection levels. Gadgil M, Gadgil C. medRxiv. 2020:2020.05.01.20087320.
106. Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2019. Gaibazzi N, Martini C, Mattioli M, Tuttolomondo D, Guidorossi A, Suma S, et al. medRxiv. 2020:2020.05.01.20087114.
107. Cancer is associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis. Gao Y, Liu M, Shi S, Chen Y, Sun Y, Chen J, et al. medRxiv. 2020:2020.05.01.20087031.
108. Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis. Garcia KS, Moutinho BD, de Azevedo MFC, Queiroz NSF, Milani LR, Sanches LN, et al. Inflammatory Intestinal Diseases.1-5.
109. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, et al. The New England journal of medicine. 2020. http://dx.doi.org/10.1056/NEJMoa2012410.
110. Reply to letter to the editor regarding article: Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis (Ghosal et al.). Ghosal S. Diabetes & metabolic syndrome. 2020;14(4):449. http://dx.doi.org/10.1016/j.dsx.2020.04.028.
111. Sirna could be a potential therapy for covid-19. Ghosh S, Firdous SM, Nath A. EXCLI Journal. 2020;19:528-31.
112. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study. Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, et al. medRxiv. 2020:2020.05.02.20088336.
113. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Mayo Clin Proc. 2020. http://dx.doi.org/10.1016/j.mayocp.2020.03.024.
114. Fulminant Acute Kidney Injury in a Young Patient with Novel Coronavirus 2019. Gopalakrishnan A, Mossaid A, Lo KB, Vasudevan V, McCullough PA, Rangaswami J. Cardiorenal medicine. 2020:1-6. http://dx.doi.org/10.1159/000508179.
115. COVID-19 and Cancer: a Comprehensive Review. Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. Curr Oncol Rep. 2020;22(5):53. http://dx.doi.org/10.1007/s11912-020-00934-7.
116. Arterial thromboembolic complications in COVID-19 in low risk patients despite prophylaxis. Griffin DO, Jensen A, Khan M, Chin J, Chin K, Parnell R, et al. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16792.
117. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease. Griffin DO, Jensen A, Khan M, Chin J, Chin K, Saad J, et al. Emerging infectious diseases. 2020;26(8).
118. Uncertainties on the prognostic value of D-dimers in COVID-19 patients. Gris JC, Quéré I, Pérez-Martin A, Lefrant JY, Sotto A. Journal of thrombosis and haemostasis : JTH. 2020.
119. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. Gross S, Jahn C, Cushman S, Bar C, Thum T. Journal of molecular and cellular cardiology. 2020. http://dx.doi.org/10.1016/j.yjmcc.2020.04.031.
120. Critically ill COVID-19 patient. Halaçli B, Kaya A, Topeli A. Turkish Journal of Medical Sciences. 2020;50:585-91.
121. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis. Hamadani M, Zhang MJ, Tang XY, Fei M, Brunstein C, Chhabra S, et al. Biology of Blood and Marrow Transplantation. 2020.
122. Maternal Death Due to COVID-19 Disease. Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, Seferovic MD, Aski SK, Arian SE, et al. Am J Obstet Gynecol. 2020. http://dx.doi.org/10.1016/j.ajog.2020.04.030.
123. Patients with cancer in the era of 2019 novel coronavirus disease. Hartemink KJ, van Akkooi ACJ, Houwink API, Voest EE. European Journal of Cancer. 2020;132:125-6.
124. Lupus anticoagulant is frequent in patients with Covid-19. Harzallah I, Debliquis A, Drénou B. Journal of thrombosis and haemostasis : JTH. 2020.
125. [Diagnosis and treatment of an elderly patient with secondary cerebral infarction caused by COVID-19]. He J, Cheng G, Xu W, Zhang L, Zeng Z. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2020;40(3):351-2. http://dx.doi.org/10.12122/j.issn.1673-4254.2020.03.10.
126. Strategic plan for management of COVID-19 in paediatric haematology and oncology departments. He Y, Lin Z, Tang D, Yang Y, Wang T, Yang M. The Lancet Haematology. 2020;7(5):e359-e62.
127. The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions. Hens N, Vranck P, Molenberghs G. European heart journal Acute cardiovascular care. 2020:2048872620924922.
128. Pollen likely seasonal factor in inhibiting flu-like epidemics. A Dutch study into the inverse relation between pollen counts, hay fever and flu-like incidence 2016–2019. Hoogeveen MJ. Science of the Total Environment. 2020;727.
129. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Hou H, Wang T, Zhang B, Luo Y, Mao L, Wang F, et al. Clinical & translational immunology. 2020;9(5):e01136. http://dx.doi.org/10.1002/cti2.1136. eCollection 2020 May.
130. Using IL-2R/lymphocyte for predicting the clinical progression of patients with COVID-19. Hou H, Zhang B, Huang H, Luo Y, Wu S, Tang G, et al. Clinical and experimental immunology. 2020. http://dx.doi.org/10.1111/cei.13450.
131. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. Hou W, Zhang W, Jin R, Liang L, Xu B, Hu Z. Infectious diseases (London, England). 2020:1-8. http://dx.doi.org/10.1080/23744235.2020.1759817.
132. Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China. Hu L, Chen S, Fu Y, Gao Z, Long H, Wang JM, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa539.
133. Insights from nanomedicine into chloroquine efficacy against COVID-19. Hu TY, Frieman M, Wolfram J. Nature Nanotechnology. 2020;15(4):247-9.
134. Estimation of COVID-19 case fatality ratio based on a bi-directional correction method. Hu W, Liu X, Wang T, Zhou C, Liu D, Zhang Y, et al. medRxiv. 2020:2020.05.02.20089144.
135. Epidemiological features and medical care-seeking process of patients with covid-19 in wuhan, china. Hua J, Chen R, Zhao L, Wu X, Guo Q, He C, et al. ERJ Open Research. 2020;6(2).
136. Individualized prediction nomograms for disease progression in mild COVID-19. Huang J, Cheng A, Lin S, Zhu Y, Chen G. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25969.
137. Head and neck survivorship care in the times of the SARS-CoV-2 pandemic. Huang VW, Imam SA, Nguyen SA. Head and Neck. 2020.
138. Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol. Huang Z, Zhuang D, Xiong B, Deng DX, Li H, Lai W. Biomedicine and Pharmacotherapy. 2020;127.
139. SARS – CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis). Ietto G. Medical Hypotheses. 2020;141.
140. COVID-19: Symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital. Ihle-Hansen H, Berge T, Tveita A, Ronning EJ, Erno PE, Andersen EL, et al. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2020;140(7). http://dx.doi.org/10.4045/tidsskr.20.0301. Print 2020 May 5.
141. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, et al. European heart journal. 2020. http://dx.doi.org/10.1093/eurheartj/ehaa388.
142. Logic in the time of coronavirus. Inglis TJJ. Journal of medical microbiology. 2020.
143. Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review. Ingraham NE, Barakat AG, Reilkoff R, Bezdicek T, Schacker T, Chipman JG, et al. The European respiratory journal. 2020.
144. Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center. Itelman E, Wasserstrum Y, Segev A, Avaky C, Negru L, Cohen D, et al. The Israel Medical Association journal : IMAJ. 2020;22(5):271-4.
145. The epidemiologic parameters for COVID-19: A Systematic Review and Meta-Analysis. Izadi N, Taherpour N, Mokhayeri Y, Sotoodeh Ghorbani S, Rahmani K, Hashemi Nazari SS. medRxiv. 2020:2020.05.02.20088385.
146. COVID-19: A case report from Bangladesh perspective. Jahan Y, Rahman S, Rahman A. Respiratory Medicine Case Reports. 2020;30.
147. COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus. Jan H, Faisal S, Khan A, Khan S, Usman H, Liaqat R, et al. Discoveries (Craiova, Romania). 2020;8(2):e108. http://dx.doi.org/10.15190/d.2020.5.
148. A rapid review of evidence and recommendations from the SIOPE Radiation Oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises. Janssens GO, Mandeville HC, Timmermann B, Maduro JH, Alapetite C, Padovani L, et al. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2020.
149. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic]. Javelot H, Llorca PM, Drapier D, Fakra E, Hingray C, Meyer G, et al. Encephale. 2020. http://dx.doi.org/10.1016/j.encep.2020.04.006.
150. COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series. Jesenak M, Banovcin P, Diamant Z. Allergy. 2020. http://dx.doi.org/10.1111/all.14353.
151. Coronavirus disease 2019 (COVID-19) outbreak at the Department of Ophthalmology, Oslo University Hospital, Norway. Jørstad Ø K, Moe MC, Eriksen K, Petrovski G, Bragadóttir R. Acta Ophthalmologica. 2020;98(3):e388-e9.
152. Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach. Joshi A, Joshi BC, Mannan MAU, Kaushik V. Informatics in Medicine Unlocked. 2020;19.
153. A crisis within the crisis: The mental health situation of refugees in the world during the 2019 coronavirus (2019-nCoV) outbreak. Júnior JG, de Sales JP, Moreira MM, Pinheiro WR, Lima CKT, Neto MLR. Psychiatry Research. 2020;288.
154. COVID-19: an Immunopathological View. Kadkhoda K. mSphere. 2020;5(2).
155. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19. Kai H, Kai M. Hypertension Research. 2020.
156. Partha Kar: What will come after the covid-19 crisis? Kar P. The BMJ. 2020;369.
157. Potential effect of natural and anabolizan steroids in elderly patient with COVID-19. Karaahmet F, Karaahmet OZ. Medical Hypotheses. 2020;140.
158. COVID-19 and viral hepatitis elimination programs: Are we stepping backward? Karimi-Sari H, Rezaee-Zavareh MS. Liver international : official journal of the International Association for the Study of the Liver. 2020.
159. The Indian perspective of COVID-19 outbreak. Kaushik S, Kaushik S, Sharma Y, Kumar R, Yadav JP. Virusdisease. 2020:1-8. http://dx.doi.org/10.1007/s13337-020-00587-x.
160. Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards. Khalatbari-Soltani S, Cumming RG, Delpierre C, Kelly-Irving M. Journal of epidemiology and community health. 2020. http://dx.doi.org/10.1136/jech-2020-214297.
161. An Overview of Signal Processing Techniques for Remote Health Monitoring Using Impulse Radio UWB Transceiver. Khan F, Ghaffar A, Khan N, Cho SH. Sensors (Basel, Switzerland). 2020;20(9).
162. Covid-19. Kim KH. International Neurourology Journal. 2020;24(1):1.
163. Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports. Kim NY, Ha E, Moon JS, Lee YH, Choi EY. Diabetes & metabolism journal. 2020;44(2):349-53.
164. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Thromb Res. 2020. http://dx.doi.org/10.1016/j.thromres.2020.04.041.
165. Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic. Komiyama M, Hasegawa K. European cardiology. 2020;15:e16. http://dx.doi.org/10.15420/ecr.2020.11. eCollection 2020 Feb.
166. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection. Kong Q, Xiang Z, Wu Y, Gu Y, Guo J, Geng F. Molecular cancer. 2020;19(1):80.
167. SARS-CoV-2 detection in patients with influenza-like illness. Kong WH, Li Y, Peng MW, Kong DG, Yang XB, Wang L, et al. Nature Microbiology. 2020;5(5):675-8.
168. [Diabetes and COVID-19 infection]. Kosinski C, Zanchi A, Wojtusciszyn A. Revue medicale suisse. 2020;16(692):939-43.
169. Challenges posed by COVID-19 to children with cancer. Kotecha RS. The Lancet Oncology. 2020;21(5):e235.
170. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. Critical Care. 2020;24(1).
171. COVID-19 - toward a comprehensive understanding of the disease. Kowalik MM, Trzonkowski P, Lasinska-Kowara M, Mital A, Smiatacz T, Jaguszewski M. Cardiology journal. 2020. http://dx.doi.org/10.5603/CJ.a2020.0065.
172. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections. Kruglikov IL, Scherer PE. Obesity (Silver Spring, Md). 2020.
173. Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic. Kumar S, Chmura S, Robinson C, Lin SH, Gadgeel SM, Donington J, et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020. http://dx.doi.org/10.1016/j.jtho.2020.04.016.
174. Coronavirus in water environments: Occurrence, persistence and concentration methods - A scoping review. La Rosa G, Bonadonna L, Lucentini L, Kenmoe S, Suffredini E. Water research. 2020;179:115899. http://dx.doi.org/10.1016/j.watres.2020.115899.
175. Sex-specific SARS-CoV2 mortality: Among hormone-modulated ace2 expression, risk of venous thromboembolism and hypovitaminosis D. La Vignera S, Cannarella R, Condorelli RA, Torre F, Aversa A, Calogero AE. International Journal of Molecular Sciences. 2020;21(8).
176. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS. Lacy JM, Brooks EG, Akers J, Armstrong D, Decker L, Gonzalez A, et al. The American journal of forensic medicine and pathology. 2020. http://dx.doi.org/10.1097/PAF.0000000000000567.
177. Global coronavirus disease 2019: What has daily cumulative index taught us? Lai CC, Wang CY, Wang YH, Hsueh PR. International journal of antimicrobial agents. 2020:106001. http://dx.doi.org/10.1016/j.ijantimicag.2020.106001.
178. Racial Capitalism: A Fundamental Cause of Novel Coronavirus (COVID-19) Pandemic Inequities in the United States. Laster Pirtle WN. Health education & behavior : the official publication of the Society for Public Health Education. 2020:1090198120922942.
179. Biomarkers of biological age as predictors of COVID-19 disease severity. Lauc G, Sinclair D. Aging. 2020;12(8):6490-1. http://dx.doi.org/10.18632/aging.103052. Epub 2020 Apr 8.
180. Mitigation of Head and Neck Cancer Service Disruption During COVID-19 in Hong Kong Through Telehealth and Multi-institution Collaboration. Lee AK, R.H.C FR, E.H.L FR, Cheng HK, Fanzca, E.W.W FR, et al. Head & neck. 2020.
181. Battling COVID-19: Critical care and peri-operative healthcare resource management strategies in a tertiary academic medical centre in Singapore. Lee CCM, Thampi S, Lewin B, Lim TJD, Rippin B, Wong WH, et al. Anaesthesia. 2020.
182. COVID-19: a need for real-time monitoring of weekly excess deaths. Leon DA, Shkolnikov VM, Smeeth L, Magnus P, Pechholdová M, Jarvis CI. The Lancet. 2020;395(10234):e81.
183. Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China. Leung C. Mechanisms of Ageing and Development. 2020;188.
184. Global rheumatology in the time of COVID-19. Lewandowski LB, Hsieh E. The Lancet Rheumatology. 2020;2(5):e254-e5.
185. COVID-19 prevention and control strategies for psychiatric hospitals. Li C, Zhao W, He C, Wu D, Yue Y, Chen Y. Psychiatry Research. 2020;289.
186. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study. Li D, Chen Y, Jia Y, Tong L, Tong J, Wang W, et al. Circ Res. 2020. http://dx.doi.org/10.1161/CIRCRESAHA.120.317070.
187. Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study. Li D, Chen Y, Liu H, Jia Y, Li F, Wang W, et al. Signal Transduction and Targeted Therapy. 2020;5(1).
188. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Li H, Chen C, Hu F, Wang J, Zhao Q, Gale RP, et al. Leukemia. 2020. http://dx.doi.org/10.1038/s41375-020-0848-3.
189. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16797.
190. The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis. Li JW, Han TW, Woodward M, Anderson CS, Zhou H, Chen YD, et al. Progress in Cardiovascular Diseases. 2020.
191. Acute respiratory failure in COVID-19: is it "typical" ARDS? Li X, Ma X. Crit Care. 2020;24(1):198. http://dx.doi.org/10.1186/s13054-020-02911-9.
192. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia. Li Y, Hu Y, Yu J, Ma T. Laboratory Investigation. 2020.
193. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study. Lian N, Xie H, Lin S, Huang J, Zhao J, Lin Q. Clinical Microbiology and Infection. 2020.
194. Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID-19 pandemic. Liao J, He X, Gong Q, Yang L, Zhou C, Li J. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2020.
195. COVID-19 and what pediatric rheumatologists should know: A review from a highly affected country. Licciardi F, Giani T, Baldini L, Favalli EG, Caporali R, Cimaz R. Pediatric Rheumatology. 2020;18(1).
196. COVID-19 pneumonia patient without clear epidemiological history outside Wuhan: An analysis of the radiographic and clinical features. Lin C, Chen Z, Xie B, Sun Z, Ding Y, Li X, et al. Clinical Imaging. 2020;65:82-4.
197. COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics. Ling L, Joynt GM, Lipman J, Constantin JM, Joannes-Boyau O. Anaesthesia, critical care & pain medicine. 2020;39(2):163-6. http://dx.doi.org/10.1016/j.accpm.2020.02.002. Epub 2020 Feb 20.
198. In Silico Design of Antiviral Peptides Targeting the Spike Protein of SARS-CoV-2. Ling R, Dai Y, Huang B, Huang W, Lu X, Jiang Y. Peptides. 2020:170328. http://dx.doi.org/10.1016/j.peptides.2020.170328.
199. Hypertension in patients with coronavirus disease 2019 (COVID-19): A pooled analysis. Lippi G, Wong J, Henry BM. Polish Archives of Internal Medicine. 2020;130(4):304-9.
200. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. Journal of Clinical Virology. 2020;127.
201. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Liu F, Zhang Q, Huang C, Shi C, Wang L, Shi N, et al. Theranostics. 2020;10(12):5613-22. http://dx.doi.org/10.7150/thno.45985. eCollection 2020.
202. Clinical and radiological changes of hospitalised patients with COVID-19 pneumonia from disease onset to acute exacerbation: a multicentre paired cohort study. Liu J, Chen T, Yang H, Cai Y, Yu Q, Chen J, et al. Eur Radiol. 2020. http://dx.doi.org/10.1007/s00330-020-06916-4.
203. Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19. Liu K, Chen Y, Wu D, Lin R, Wang Z, Pan L. Complementary therapies in clinical practice. 2020;39:101132. http://dx.doi.org/10.1016/j.ctcp.2020.101132. Epub 2020 Mar 6.
204. Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China. Liu S, Luo H, Wang Y, Cuevas LE, Wang D, Ju S, et al. 2020.
205. Conjunctivitis and COVID-19: a meta-analysis. Loffredo L, Pacella F, Pacella E, Tiscione G, Oliva A, Violi F. Journal of medical virology. 2020.
206. Response to Char's comment: Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. Long-Quan L, Tian H, Yong-Qing W, Zheng-Ping W, Yuan L, Tao-Bi H, et al. Journal of medical virology. 2020.
207. Raids on Immigrant Communities During the Pandemic Threaten the Country's Public Health. Lopez MM, Holmes SM. American journal of public health. 2020:e1-e2.
208. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Lother SA, Abassi M, Agostinis A, Bangdiwala AS, Cheng MP, Drobot G, et al. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2020. http://dx.doi.org/10.1007/s12630-020-01684-7.
209. Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission. Lu D, Sang L, Du S, Li T, Chang Y, Yang XA. Journal of Medical Virology. 2020.
210. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic. Lu X, Xiang Y, Du H, Wing-Kin Wong G. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2020.
211. Covid-19: Supporting nurses' psychological and mental health. Maben J, Bridges J. Journal of clinical nursing. 2020.
212. The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy. Maggi U, De Carlis L, Yiu D, Colledan M, Regalia E, Rossi G, et al. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020.
213. Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective. Magrone T, Magrone M, Jirillo E. Endocrine, metabolic & immune disorders drug targets. 2020.
214. Emerging Biomolecular Testing to Assess Risk of Mortality from COVID-19 Infection. Mahmoudi M. Molecular pharmaceutics. 2020. http://dx.doi.org/10.1021/acs.molpharmaceut.0c00371.
215. COVID-19 outcomes in patients with hematologic disease. Malard F, Genthon A, Brissot E, van de Wyngaert Z, Marjanovic Z, Ikhlef S, et al. Bone Marrow Transplantation. 2020:1-5.
216. Acute necrotising encephalopathy is more severe when associated with influenza. Manchoon C, Hedderly T, Lascelles K, Lin JP, Siddiqui A, King-Im JU, et al. Developmental Medicine and Child Neurology. 2020;62:39.
217. A single centre study of viral community-acquired pneumonia in children: No evidence of SARS-CoV-2 from October 2019 to March 2020. Mancino E, Cristiani L, Pierangeli A, Scagnolari C, Nenna R, Petrarca L, et al. Journal of Clinical Virology. 2020;128.
218. Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2. Mani Mishra P, Uversky VN, Nandi CK. Medical Hypotheses. 2020;140.
219. Estimating the COVID-19 infection rate: Anatomy of an inference problem. Manski CF, Molinari F. Journal of econometrics. 2020. http://dx.doi.org/10.1016/j.jeconom.2020.04.041.
220. Situation analysis and an insight into assessment of pandemic COVID-19. Mansuri FMA. Journal of Taibah University Medical Sciences. 2020;15(2):85-6.
221. The COVID-19 outbreak: The latest challenge to psychological and psychiatric intervention. Marazziti D. Clinical Neuropsychiatry. 2020;17(2):39-40.
222. COVID-19 and chronic diseases: Current knowledge, future steps and the MaCroScopio project. Martini N, Piccinni C, Pedrini A, Maggioni A. Recenti progressi in medicina. 2020;111(4):198-201.
223. Survival study of hospitalized patients with concurrent Covid-19 and haematological malignancies. Martin-Moro F, Marquet J, Piris M, Michael BM, Saez AJ, Corona M, et al. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16801.
224. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Martins-Filho PR, Tavares CSS, Santos VS. European Journal of Internal Medicine. 2020.
225. Staffing with disease-based epidemiologic indices may reduce shortage of intensive care unit staff during the COVID-19 pandemic. Mascha EJ, Schober P, Schefold JC, Stueber F, Luedi MM. Anesthesia and analgesia. 2020.
226. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Mastaglio S, Ruggeri A, Risitano AM, Angelillo P, Yancopoulou D, Mastellos DC, et al. Clinical immunology (Orlando, Fla). 2020;215:108450. http://dx.doi.org/10.1016/j.clim.2020.108450.
227. Candidate drugs against SARS-CoV-2 and COVID-19. McKee DL, Sternberg A, Stange U, Laufer S, Naujokat C. Pharmacological Research. 2020;157.
228. Case fatality rate of COVID-19: absence of epidemiological pattern. Medeiros de Figueiredo A, Daponte A, Moreira Marculino de Figueiredo DC, Gil-García E, Kalache A. Gaceta sanitaria. 2020.
229. Nutritional status and COVID-19: an opportunity for lasting change? Mehta S. Clinical medicine (London, England). 2020.
230. Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan. Mei H, Dong X, Wang Y, Tang L, Hu Y. The Lancet Oncology. 2020;21(5):634-6.
231. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L, et al. PLoS pathogens. 2020;16(4):e1008520.
232. Functional role of dietary intervention to improve the outcome of COVID-19: A hypothesis of work. Messina G, Polito R, Monda V, Cipolloni L, Di Nunno N, Di Mizio G, et al. International Journal of Molecular Sciences. 2020;21(9).
233. Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics. Meziyerh S, Zwart TC, van Etten RW, Janson JA, van Gelder T, Alwayn IPJ, et al. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020.
234. Estimating instant case fatality rate of COVID-19 in China. Mi YN, Huang TT, Zhang JX, Qin Q, Gong YX, Liu SY, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
235. The Italian war-like measures to fight coronavirus spreading: Re-open closed hospitals now. Miani A, Burgio E, Piscitelli P, Lauro R, Colao A. EClinicalMedicine. 2020;21.
236. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. Michalakis K, Ilias I. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):469-71.
237. Incidence of venous thromboembolism in hospitalized patients with COVID-19. Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Muller MCA, et al. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14888.
238. From first COVID-19 case to current outbreak: A vietnamese report. Minh Duc N, Duc Ha H, Anh Tuan T, Lien Bang MT, Hong Duc P, Minh Thong P. Electronic Journal of General Medicine. 2020;17(4):1-4.
239. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. Minotti C, Tirelli F, Barbieri E, Giaquinto C, Donà D. Journal of Infection. 2020.
240. Is BCG vaccination causally related to reduced COVID-19 mortality? Miyasaka M. EMBO molecular medicine. 2020. http://dx.doi.org/10.15252/emmm.202012661.
241. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19. Mourad JJ, Levy BI. Nature Reviews Cardiology. 2020;17(5):313.
242. Lockdown and isolation: Psychological aspects of covid-19 pandemic in the general population. Mucci F, Mucci N, Diolaiuti F. Clinical Neuropsychiatry. 2020;17(2):63-4.
243. Covid-19: "steady the front line! There is no retreat from here". Muir G, Boff J. The BMJ. 2020;369.
244. Coronavirus in pregnancy and delivery: rapid review. Mullins E, Evans D, Viner RM, O'Brien P, Morris E. Ultrasound Obstet Gynecol. 2020;55(5):586-92. http://dx.doi.org/10.1002/uog.22014.
245. Mortality Rates of Patients with Proximal Femoral Fracture in a Worldwide Pandemic: Preliminary Results of the Spanish HIP-COVID Observational Study. Munoz Vives JM, Jornet-Gibert M, Camara-Cabrera J, Esteban PL, Brunet L, Delgado-Flores L, et al. J Bone Joint Surg Am. 2020. http://dx.doi.org/10.2106/JBJS.20.00686.
246. Covid-19 outbreak on Malawi perspective. Munthali GNC, Xuelian W. Electronic Journal of General Medicine. 2020;17(4):1-3.
247. Care for Critically Ill Patients with COVID-19. Murthy S, Gomersall CD, Fowler RA. JAMA - Journal of the American Medical Association. 2020;323(15):1499-500.
248. Handling the COVID-19 pandemic in the oncological setting. Mussetti A, Maluquer C, Albasanz-Puig A, Gudiol C, Moreno-Gonzalez G, Corradini P, et al. The Lancet Haematology. 2020;7(5):e365-e6.
249. The 'Heart Kuznets Curve'? Understanding the relations between economic development and cardiac conditions. Nagano H, Puppim de Oliveira JA, Barros AK, Costa Junior ADS. World development. 2020;132:104953. http://dx.doi.org/10.1016/j.worlddev.2020.104953. Epub 2020 Apr 30.
250. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol. Naksuk N, Lazar S, Peeraphatdit TB. European heart journal Acute cardiovascular care. 2020:2048872620922784. http://dx.doi.org/10.1177/2048872620922784.
251. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus. Ngonghala CN, Iboi E, Eikenberry S, Scotch M, MacIntyre CR, Bonds MH, et al. Mathematical biosciences. 2020:108364. http://dx.doi.org/10.1016/j.mbs.2020.108364.
252. Rising to the Challenge of COVID-19: Advice for Pulmonary and Critical Care and an Agenda for Research. Niederman MS, Richeldi L, Chotirmall SH, Bai C. Am J Respir Crit Care Med. 2020;201(9):1019-22. http://dx.doi.org/10.1164/rccm.202003-0741ED.
253. Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child. Nilsson A, Edner N, Albert J, Ternhag A. Infectious Diseases. 2020;52(6):419-22.
254. Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal. Nogueira PJ, Nobre MA, Nicola PJ, Furtado C, Vaz Carneiro A. Acta medica portuguesa. 2020.
255. SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship. Oberemok VV, Laikova KV, Yurchenko KA, Fomochkina II, Kubyshkin AV. Inflammation Research. 2020.
256. National Response to COVID-19 in the Republic of Korea and Lessons Learned for Other Countries. Oh J, Lee JK, Schwarz D, Ratcliffe HL, Markuns JF, Hirschhorn LR. Health systems and reform. 2020;6(1):e1753464. http://dx.doi.org/10.1080/23288604.2020.1753464.
257. COVID-19 and Nigeria: putting the realities in context. Ohia C, Bakarey AS, Ahmad T. International Journal of Infectious Diseases. 2020;95:279-81.
258. RARE CASE OF PULMONARY NECROTIC RHODOCOCCUS EQUI INFECTION IN A KIDNEY PANCREAS TRANSPLANT RECIPIENT. Omar K, Sharfuddin A. American Journal of Kidney Diseases. 2020;75(4):614.
259. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Pal R, Bhadada SK. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020.
260. Letter: Covid-19, and vitamin D. Panarese A, Shahini E. Alimentary Pharmacology and Therapeutics. 2020;51(10):993-5.
261. COVID-19 Related Mortality: Is the BCG Vaccine Truly Effective? Paredes Mogica JA, Nava V, Torres J. medRxiv. 2020:2020.05.01.20087411.
262. Ethnicity and COVID-19: an urgent public health research priority. Pareek M, Bangash MN, Pareek N, Pan D, Sze S, Minhas JS, et al. The Lancet. 2020;395(10234):1421-2.
263. Pancreatic Cancer During COVID-19 Pandemic: Treat or Not to Treat? Patel R, Saif W. JOP : Journal of the pancreas. 2020;21(2):27-8.
264. Dupilumab and COVID-19: what should we expect? Patruno C, Stingeni L, Fabbrocini G, Hansel K, Napolitano M. Dermatologic therapy. 2020. http://dx.doi.org/10.1111/dth.13502.
265. Cardiac Troponin-I may be a predictor of complications and mortality in COVID-19 patients. Paul P. Current medicine research and practice. 2020. http://dx.doi.org/10.1016/j.cmrp.2020.05.001.
266. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, et al. Journal of the American Society of Nephrology : JASN. 2020.
267. SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens. Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, et al. Journal of medical virology. 2020.
268. The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth. Peters AL, Garg S. Diabetes technology & therapeutics. 2020. http://dx.doi.org/10.1089/dia.2020.0187.
269. Obesity a risk factor for increased COVID19 prevalence, severity and lethality (Review). Petrakis D, Margina D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. Molecular medicine reports. 2020. http://dx.doi.org/10.3892/mmr.2020.11127.
270. Obesity‑a risk factor for increased COVID‑19 prevalence, severity and lethality. Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. Molecular Medicine Reports.
271. Nipah virus: Past outbreaks and future containment. Pillai VS, Krishna G, Veettil MV. Viruses. 2020;12(4).
272. SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons? Pitocco D, Tartaglione L, Viti L, Di Leo M, Pontecorvi A, Caputo S. Diabetes Research and Clinical Practice. 2020;163.
273. The psychological impact of sars-cov-2 quarantine: Observations through the lens of the polyvagal theory. Poli A, Gemignani A, Conversano C. Clinical Neuropsychiatry. 2020;17(2):112-4.
274. Fear, anxiety and health-related consequences after the COVID-19 epidemic. Porcelli P. Clinical Neuropsychiatry. 2020;17(2):103-11.
275. The COVID-19 pandemic is a paradoxical challenge to our nervous system: A polyvagal perspective. Porges SW. Clinical Neuropsychiatry. 2020;17(2):135-8.
276. Risk for pathological contamination fears at coronavirus time: Proposal of early intervention and prevention strategies. Pozza A, Mucci F, Marazziti D. Clinical Neuropsychiatry. 2020;17(2):100-2.
277. Regional Planning for Extracorporeal Membrane Oxygenation Allocation During COVID-19. Prekker ME, Brunsvold ME, Bohman JK, Fischer G, Gram KL, Litell JM, et al. Chest. 2020.
278. [Recommendations of the Society of Gastroenterology of Peru to avoid the spread of SARS-CoV-2 through digestive endoscopy procedures]. Prochazka Za Rate RA, Cabrera Cabrejos MC, Piscoya A, Vera Calderon AF. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru. 2020;40(1):95-9.
279. [Laboratory testing techniques for SARS-CoV-2]. Qiu F, Wang H, Zhang Z, Cao L, Wang C, Wu J, et al. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2020;40(2):164-7. http://dx.doi.org/10.12122/j.issn.1673-4254.2020.02.04.
280. Covid-19: The precarious position of Spain's nursing homes. Rada AG. The BMJ. 2020;369.
281. Risk Factors of the Severity of COVID-19: A Meta-Analysis. Rahman A, Sathi NJ. medRxiv. 2020.
282. Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-a Living Working Document. Rajagopal K, Keller SP, Akkanti B, Bime C, Loyalka P, Cheema FH, et al. Circulation Heart failure. 2020;13(5):e007175. http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007175. Epub 2020 May 1.
283. Criminal Justice-Involved Women Navigate COVID-19: Notes From the Field. Ramaswamy M, Hemberg J, Faust A, Wickliffe J, Comfort M, Lorvick J, et al. Health education & behavior : the official publication of the Society for Public Health Education. 2020:1090198120927304. http://dx.doi.org/10.1177/1090198120927304.
284. The Cardiologist at the time of Coronavirus: A perfect storm. Rapezzi C, Ferrari R. European Heart Journal. 2020;41(13):1320-2.
285. Bronchoscopy, laryngoscopy, and esophagoscopy during the COVID-19 pandemic. Reddy PD, Nguyen SA, Deschler D. Head and Neck. 2020.
286. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Chin Med J (Engl). 2020;133(9):1015-24. http://dx.doi.org/10.1097/CM9.0000000000000722.
287. Stability and infectivity of coronaviruses in inanimate environments. Ren SY, Wang WB, Hao YG, Zhang HR, Wang ZC, Chen YL, et al. World journal of clinical cases. 2020;8(8):1391-9. http://dx.doi.org/10.12998/wjcc.v8.i8.1391.
288. Clinical trials and the COVID-19 pandemic. Retsas S. Hellenic journal of nuclear medicine. 2020;23(1):4-5. http://dx.doi.org/10.1967/s002449912014.
289. COVID-19 patients and the radiology department – advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Revel MP, Parkar AP, Prosch H, Silva M, Sverzellati N, Gleeson F, et al. European Radiology. 2020.
290. Encountering COVID-19 as Endocrinologists. Rhee EJ, Kim JH, Moon SJ, Lee WY. Endocrinology and metabolism (Seoul, Korea). 2020.
291. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North – supports vitamin D as a factor determining severity. Rhodes JM, Subramanian S, Laird E, Anne Kenny R. Alimentary Pharmacology and Therapeutics. 2020.
292. Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. JAMA - Journal of the American Medical Association. 2020:E1-E8.
293. Long-term conditions and severe acute respiratory syndrome SARS-CoV-2 (COVID-19). Robinson P. British journal of community nursing. 2020;25(5):247-51. http://dx.doi.org/10.12968/bjcn.2020.25.5.247.
294. PROGNOSTIC FACTORS FOR CLINICAL COURSE OF PATIENTS WITH COVID-19: PROTOCOL FOR A RAPID LIVING SYSTEMATIC REVIEW. Rocha Filho CR, Pinto ACPN, Rocha AP, Milby KMM, Reis FSdA, Civile VT, et al. medRxiv. 2020:2020.05.06.20087692.
295. A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. Roche JA, Roche R. FASEB Journal. 2020.
296. A global recommendation for restrictive provision of fertility treatments during the COVID-19 pandemic. Rodriguez-Wallberg KA, Wikander I. Acta Obstetricia et Gynecologica Scandinavica. 2020;99(5):569-70.
297. COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020. Rosenberg ES, Dufort EM, Blog DS, Hall EW, Hoefer D, Backenson BP, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa549.
298. COVID-19: a challenge for oncology services. Routy B, Derosa L, Zitvogel L, Kroemer G. Journal. 2020(Issue).
299. Hypertension prevalence in human Coronavirus: The role of ACE system in infection spread and severity. Ruocco G, Feola M, Palazzuoli A. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
300. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine. Sahraei Z, Shabani M, Shokouhi S, Saffaei A. International Journal of Antimicrobial Agents. 2020;55(4).
301. Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians. Sahu KK, Jindal V, Siddiqui AD, Cerny J. Blood Cells, Molecules, and Diseases. 2020;83.
302. The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection. Saleh M, Gabriels J, Chang D, Kim BS, Mansoor A, Mahmood E, et al. Circulation Arrhythmia and electrophysiology. 2020.
303. The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19. Salem ML, El-Hennawy D. Medical Hypotheses. 2020;140.
304. The Surge after the Surge: Cardiac Surgery post-COVID-19. Salenger R, Etchill EW, Ad N, Matthew T, Alejo D, Whitman G, et al. The Annals of thoracic surgery. 2020. http://dx.doi.org/10.1016/j.athoracsur.2020.04.018.
305. Status of SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN). Sánchez-Álvarez JE, Fontán MP, Martín CJ, Pelícano MB, Reina CJC, Prieto Á MS, et al. Nefrologia. 2020.
306. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, Henry BM, Lippi G. Mayo Clin Proc. 2020. http://dx.doi.org/10.1016/j.mayocp.2020.03.026.
307. COVID-19 in Children: Clinical Approach and Management. Sankar J, Dhochak N, Kabra SK, Lodha R. Indian Journal of Pediatrics. 2020.
308. Update on coronavirus disease 2019 (COVID-19). Santantonio TA, Messina G. Open Neurology Journal. 2020;14(1):4-5.
309. Ethnicity and risk of death in patients hospitalised for COVID-19 infection: an observational cohort study in an urban catchment area. Sapey E, Gallier S, Mainey C, Nightingale P, McNulty D, Crothers H, et al. medRxiv. 2020:2020.05.05.20092296.
310. SARS-CoV-2 / 2019-novel corona virus: An epidemic to pandemic. Sarkar A, Kundu M, Venkataramana P, Chakraborty P. International Journal of Research in Pharmaceutical Sciences. 2020;11:37-42.
311. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19. Schmulson M, Dávalos MF, Berumen J. Revista de Gastroenterologia de Mexico. 2020.
312. The ethical challenges of the SARS-CoV-2 pandemic in the global south and the global north - same and different. Schuklenk U. Developing world bioethics. 2020.
313. Can You Catch It? Lessons Learned and Modification of ED Triage Symptom- and Travel-Screening Strategy. Schwedhelm MM, Herstein JJ, Watson SM, Mead AL, Maddalena L, Liston DD, et al. Journal of emergency nursing. 2020.
314. SARS-CoV-2 spread in Northern Italy: what about the pollution role? Sciomer S, Moscucci F, Magri D, Badagliacca R, Piccirillo G, Agostoni P. Environmental monitoring and assessment. 2020;192(6):325. http://dx.doi.org/10.1007/s10661-020-08317-y.
315. DIC in COVID-19: Implications for Prognosis and Treatment? Seitz R, Schramm W. Journal of thrombosis and haemostasis : JTH. 2020.
316. Interdisciplinary Perspectives on Health Literacy Research Around the World: More Important Than Ever in a Time of COVID-19. Sentell T, Vamos S, Okan O. International journal of environmental research and public health. 2020;17(9). http://dx.doi.org/10.3390/ijerph17093010.
317. Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence. Setti L, Passarini F, De Gennaro G, Barbieri P, Pallavicini A, Ruscio M, et al. International journal of environmental research and public health. 2020;17(9). http://dx.doi.org/10.3390/ijerph17092986.
318. Elevated D-Dimer Levels are Associated with Increased Risk of Mortality in COVID-19: A Systematic Review and Meta-Analysis. Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, et al. medRxiv. 2020:2020.04.29.20085407.
319. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19. Shah SJ, Barish PN, Prasad PA, Kistler AL, Neff N, Kamm J, et al. medRxiv. 2020:2020.05.02.20082461.
320. Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2. Shajahan A, Supekar NT, Gleinich AS, Azadi P. Glycobiology. 2020. http://dx.doi.org/10.1093/glycob/cwaa042.
321. Covid-19 and perioperative mortality; where do we stand? Shakiba B, Irani S. EClinicalMedicine. 2020;22.
322. Diagnostic Testing for the Novel Coronavirus. Sharfstein JM, Becker SJ, Mello MM. JAMA - Journal of the American Medical Association. 2020;323(15):1437-8.
323. Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic. Sharma A, Crosby DL. Head and Neck. 2020.
324. Sex Differences in Mortality from COVID-19 Pandemic: Are Men Vulnerable and Women Protected? Sharma G, Volgman AS, Michos ED. JACC Case reports. 2020. http://dx.doi.org/10.1016/j.jaccas.2020.04.027.
325. The Contact Activation System as a Potential Therapeutic Target in Patients with COVID-19. Shatzel JJ, DeLoughery EP, Lorentz CU, Tucker EI, Aslan JE, Hinds MT, et al. Research and Practice in Thrombosis and Haemostasis. 2020.
326. Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic. Shaverdian N, Shepherd A, Rimner A, Wu AJ, Simone CB, 2nd, Gelblum DY, et al. Advances in radiation oncology. 2020. http://dx.doi.org/10.1016/j.adro.2020.04.015.
327. Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today. Sheikh JA, Singh J, Singh H, Jamal S, Khubaib M, Kohli S, et al. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2020:104330.
328. Are COVID-19 survivors at increased risk for suicide? Sher L. Acta neuropsychiatrica. 2020:1-4. http://dx.doi.org/10.1017/neu.2020.21.
329. Mental health framework: coronavirus pandemic in post-Katrina New Orleans. Shervington DO, Richardson L. Journal of injury & violence research. 2020;12(2). http://dx.doi.org/10.5249/jivr.v12i2.1538.
330. Can melatonin reduce the severity of COVID-19 pandemic? Shneider A, Kudriavtsev A, Vakhrusheva A. International reviews of immunology. 2020:1-10.
331. Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era. Silverman DA, Lin C, Tamaki A, Puram SV, Carrau RL, Seim NB, et al. Head and Neck. 2020.
332. The COVID-19 pandemic: Major risks to healthcare and other workers on the front line. Sim MR. Occupational and Environmental Medicine. 2020;77(5):281-2.
333. Covid-19, prison crowding, and release policies. Simpson PL, Butler TG. The BMJ. 2020;369.
334. Guidelines for the management of diabetes in care homes during the Covid-19 pandemic. Sinclair A, Dhatariya K, Burr O, Nagi D, Higgins K, Hopkins D, et al. Diabetic medicine : a journal of the British Diabetic Association. 2020. http://dx.doi.org/10.1111/dme.14317.
335. Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies. Singh T, Heston SM, Langel SN, Blasi M, Hurst JH, Fouda GG, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa547.
336. Bocaparvovirus infection in childrenin the republic of Belarus: Molecular and epidemiological aspects. Sivets NV, Shmeleva NP, Lapo TP. Jurnal Infektologii. 2019;11(4):113-21.
337. What should a cardiologist know about coronavirus disease 2019? Sławiński G, Lewicka E. Kardiologia polska. 2020;78(4):278-83.
338. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Solé G, Salort-Campana E, Pereon Y, Stojkovic T, Wahbi K, Cintas P, et al. Revue Neurologique. 2020.
339. Clinical and epidemiological features of COVID-19 family clusters in Beijing, China. Song R, Han B, Song M, Wang L, Conlon CP, Dong T, et al. Journal of Infection. 2020.
340. Will Buying Follow Others Ease Their Threat of Death? An Analysis of Consumer Data during the Period of COVID-19 in China. Song W, Jin X, Gao J, Zhao T. International journal of environmental research and public health. 2020;17(9). http://dx.doi.org/10.3390/ijerph17093215.
341. Epidemic characteristics and trend analysis of the COVID-19 in Hubei province. Song Y, Liu M, Jia WP, Wang SS, Cao WZ, Han K, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41:E053.
342. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Søreide K, Hallet J, Matthews JB, Schnitzbauer AA, Line PD, Lai PBS, et al. British Journal of Surgery. 2020.
343. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. Thrombosis and haemostasis. 2020.
344. Hospital-based use of thromboprophylaxis in patients with COVID-19. Spyropoulos AC, Ageno W, Barnathan ES. The Lancet. 2020;395(10234):e75.
345. COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence? Sridharan GK, Kotagiri R, Chandiramani VH, Mohan BP, Vegunta R, Vegunta R, et al. American journal of therapeutics. 2020. http://dx.doi.org/10.1097/MJT.0000000000001196.
346. COVID-19, fear and the future: An attachment perspective. Steele H. Clinical Neuropsychiatry. 2020;17(2):97-9.
347. Urologic surgery and COVID-19: How the pandemic is changing the way we operate. Steward J, Kitley WR, Schmidt CM, Sundaram CP. Journal of endourology. 2020.
348. Prevention and therapy of covid-19 via exogenous estrogen treatment for both male and female patients; An opinion paper. Suba Z. Journal of Pharmacy and Pharmaceutical Sciences. 2020;23(1):75-85.
349. Novel coronavirus (Covid-19)-a critical review. Sudan P, Goswami M, Arockia Babu M. International Journal of Research in Pharmaceutical Sciences. 2020;11:43-7.
350. The role of extracorporeal life support for patients with COVID-19: Preliminary results from a statewide experience. Sultan I, Habertheuer A, Usman AA, Kilic A, Gnall E, Friscia ME, et al. Journal of Cardiac Surgery. 2020.
351. Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study. Sun H, Ning R, Tao Y, Yu C, Deng X, Zhao C, et al. Journal of the American Geriatrics Society. 2020. http://dx.doi.org/10.1111/jgs.16533.
352. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Sun X, Wang T, Cai D, Hu Z, Chen J, Liao H, et al. Cytokine and Growth Factor Reviews. 2020.
353. Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease. Suwanwongse K, Shabarek N. Cureus. 2020;12(4):e7561. http://dx.doi.org/10.7759/cureus.7561.
354. Considerations for cardiac catheterization laboratory procedures during the COVID-19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates. Szerlip M, Anwaruddin S, Aronow HD, Cohen MG, Daniels MJ, Dehghani P, et al. Catheterization and Cardiovascular Interventions. 2020.
355. Will the antimalarial drug take over to combat COVID-19? T.K S, G S. Journal of Public Health (Germany). 2020.
356. A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the Elderly. Tabrizi S, Trippa L, Cagney D, Tanguturi S, Ventz S, Fell G, et al. Neuro-oncology. 2020.
357. Skin cancer triage and management during COVID-19 pandemic. Tagliaferri L, Di Stefani A, Schinzari G, Fionda B, Rossi E, Del Regno L, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020.
358. Managing the COVID-19 Pandemic as a National Radiation Oncology Centre in Singapore. Tan BF, Tuan JKL, Yap SP, Ho SZ, Wang MLC. Clinical oncology (Royal College of Radiologists (Great Britain)). 2020. http://dx.doi.org/10.1016/j.clon.2020.04.006.
359. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. Journal of Medical Virology. 2020.
360. A quick evaluation method of nosocomial infection risk for cancer hospitals during the COVID-19 pandemic. Tang Z, Sun B, Xu B. Journal of Cancer Research and Clinical Oncology. 2020.
361. Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19. Tedeschi S, Giannella M, Bartoletti M, Trapani F, Tadolini M, Borghi C, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
362. Thrombosis management in times of COVID-19 epidemy; a Dutch perspective. Ten Cate H. Thrombosis Journal. 2020;18(1).
363. After corona: there is life after the pandemic. Tesarik J. Reproductive BioMedicine Online. 2020.
364. Navigating the challenges of the COVID-19 outbreak: perspectives from the radiation oncology service in singapore. Tey J, Ho S, Choo BA, Ho F, Yap SP, Tuan JKL, et al. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2020.
365. What do monitoring platelet counts in COVID-19 teach us? Thachil J. Journal of thrombosis and haemostasis : JTH. 2020.
366. Laboratory haemostasis monitoring in COVID-19. Thachil J, Tang N, Gando S, Falanga A, Levi M, Clark C, et al. Journal of thrombosis and haemostasis : JTH. 2020.
367. A primer on COVID-19 Mathematical Models. Thomas DM, Sturdivant R, Dhurandhar NV, Debroy S, Clark N. Obesity (Silver Spring, Md). 2020. http://dx.doi.org/10.1002/oby.22881.
368. Letter: Covid-19, and vitamin D. Authors' reply. Tian Y, Rong L. Alimentary Pharmacology and Therapeutics. 2020;51(10):995-6.
369. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Tian Y, Rong L, Nian W, He Y. Alimentary Pharmacology and Therapeutics. 2020;51(9):843-51.
370. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2020:194599820926473. http://dx.doi.org/10.1177/0194599820926473.
371. The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region. Trapani D, Marra A, Curigliano G. European journal of cancer (Oxford, England : 1990). 2020;132:199-206. http://dx.doi.org/10.1016/j.ejca.2020.04.017.
372. COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine. Vaiarelli A, Bulletti C, Cimadomo D, Borini A, Alviggi C, Ajossa S, et al. Reproductive BioMedicine Online. 2020.
373. Using Machine Learning to Estimate Unobserved COVID-19 Infections in North America. Vaid S, Cakan C, Bhandari M. J Bone Joint Surg Am. 2020. http://dx.doi.org/10.2106/JBJS.20.00715.
374. COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. Vecchio S, Ramella R, Drago A, Carraro D, Littlewood R, Somaini L. Psychiatry Research. 2020;289.
375. Mild versus severe COVID-19: Laboratory markers. Velavan TP, Meyer CG. International Journal of Infectious Diseases. 2020;95:304-7.
376. Estimation of the probability of reinfection with COVID-19 coronavirus by the SEIRUS model. Victor AO. JMIR public health and surveillance. 2020. http://dx.doi.org/10.2196/19097.
377. Understanding pathways to death in patients with COVID-19. Vincent JL, Taccone FS. The Lancet Respiratory Medicine. 2020;8(5):430-2.
378. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Thrombosis and haemostasis. 2020.
379. The Use of Bronchoscopy during the COVID-19 Pandemic: CHEST/AABIP Guideline and Expert Panel Report. Wahidi MM, Shojaee S, Lamb CR, Ost D, Maldonado F, Eapen G, et al. Chest. 2020. http://dx.doi.org/10.1016/j.chest.2020.04.036.
380. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, et al. Crit Care. 2020;24(1):188. http://dx.doi.org/10.1186/s13054-020-02895-6.
381. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. Wang F, Hou H, Luo Y, Tang G, Wu S, Huang M, et al. JCI insight. 2020.
382. CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA. Wang F, Yang Y, Dong K, Yan Y, Zhang S, Ren H, et al. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2020.
383. Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series. Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Journal of Thrombosis and Haemostasis. 2020.
384. Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China. Wang K, Zuo P, Liu Y, Zhang M, Zhao X, Xie S, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa538.
385. Statistical and network analysis of 1212 COVID-19 patients in Henan, China. Wang P, Lu JA, Jin Y, Zhu M, Wang L, Chen S. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
386. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al. Research (Washington, DC). 2020;2020:2402961. http://dx.doi.org/10.34133/2020/2402961. eCollection 2020.
387. Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Wang X, Zhou Q, He Y, Liu L, Ma X, Wei X, et al. The European respiratory journal. 2020. http://dx.doi.org/10.1183/13993003.00544-2020.
388. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia. Wang Y, Jiang W, He Q, Wang C, Wang B, Zhou P, et al. Signal Transduction and Targeted Therapy. 2020;5(1).
389. Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes. Wang Z, Zheutlin AB, Kao Y-H, Ayers KL, Gross SJ, Kovatch P, et al. medRxiv. 2020.
390. The 2019 novel coronavirus (2019-nCoV)-transmission, symptoms and treatment. Wawrzyniak A, Kuczborska K, Lipińska-Opałka A, Bȩdzichowska A, Kalicki B. Pediatria i Medycyna Rodzinna. 2019;15(4):C1-C5.
391. Covid-19 lockdown: a perfect storm for older people's mental health. Webb L. Journal of psychiatric and mental health nursing. 2020.
392. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Cell Discovery. 2020;6(1).
393. Severe maternal morbidity and mortality associated with COVID-19: The risk should not be down-played. Westgren M, Pettersson K, Hagberg H, Acharya G. Acta Obstet Gynecol Scand. 2020. http://dx.doi.org/10.1111/aogs.13900.
394. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Journal of thrombosis and haemostasis : JTH. 2020.
395. Can we contain the COVID-19 outbreak with the same measures as for SARS? Wilder-Smith A, Chiew CJ, Lee VJ. The Lancet Infectious Diseases. 2020;20(5):e102-e7.
396. Coronavirus disease 2019 (COVID-19) in neurology and neurosurgery: A scoping review of the early literature. Wilson MP, Jack AS. Clinical Neurology and Neurosurgery. 2020;193.
397. Covid-19: Cancer mortality could rise at least 20% because of pandemic, study finds. Wise J. BMJ (Clinical research ed). 2020;369:m1735.
398. COVID-19 Pandemic: Ways Forward. Wong RLM, Lai KHW, Huang SS, Jonas JB, Lam DSC. Asia-Pacific journal of ophthalmology (Philadelphia, Pa). 2020;9(2):59-60.
399. Zooming Towards a Telehealth Solution for Vulnerable Children with Obesity During COVID-19. Woo Baidal JA, Chang J, Hulse E, Turetsky R, Parkinson K, Rausch JC. Obesity (Silver Spring, Md). 2020.
400. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study. Xiao AT, Tong YX, Gao C, Zhu L, Zhang YJ, Zhang S. Journal of Clinical Virology. 2020;127.
401. Association Between Hypoxemia and Mortality in Patients With COVID-19. Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al. Mayo Clin Proc. 2020. http://dx.doi.org/10.1016/j.mayocp.2020.04.006.
402. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, et al. Investigative radiology. 2020;55(6):332-9. http://dx.doi.org/10.1097/RLI.0000000000000674.
403. Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice. Xu G, Yang Y, Du Y, Peng F, Hu P, Wang R, et al. Clinical Reviews in Allergy and Immunology. 2020.
404. Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection. Xu T, Huang R, Zhu L, Wang J, Cheng J, Zhang B, et al. Journal of medical virology. 2020.
405. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, et al. BMJ open diabetes research & care. 2020;8(1).
406. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19. Yang J, Li H, Hu S, Zhou Y. Aging. 2020;12(8):6518-35. http://dx.doi.org/10.18632/aging.103100. Epub 2020 Apr 27.
407. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. International Journal of Infectious Diseases. 2020;94:91.
408. The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients. Yang R, Gui X, Zhang Y, Xiong Y. Expert review of respiratory medicine. 2020:1-4.
409. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. Yang Y, Shen C, Li J, Yuan J, Wei J, Huang F, et al. The Journal of allergy and clinical immunology. 2020. http://dx.doi.org/10.1016/j.jaci.2020.04.027.
410. Novel coronavirus 2019 infections current status. Yeşil E, Hacımustafaoğlu M. Guncel Pediatri. 2020;18(1):134-9.
411. Risk Factors and clinical features of deterioration of COVID-19 Patients in Zhejiang, China: a single-centered, retrospective study. Yi P, Yang X, Ding C, Chen Y, Xu K, Ni Q, et al. 2020.
412. Correlation between Heart fatty acid binding protein and severe COVID-19: A case-control study. Yin L, Mou H, Shao J, Zhu Y, Pang X, Yang J, et al. PLoS One. 2020;15(4):e0231687. http://dx.doi.org/10.1371/journal.pone.0231687. eCollection 2020.
413. Connecting clusters of COVID-19: an epidemiological and serological investigation. Yong SEF, Anderson DE, Wei WE, Pang J, Chia WN, Tan CW, et al. The Lancet Infectious diseases. 2020.
414. Association Between Clinical Manifestations and Prognosis in Patients with COVID-19. Yu T, Cai S, Zheng Z, Cai X, Liu Y, Yin S, et al. Clinical therapeutics. 2020. http://dx.doi.org/10.1016/j.clinthera.2020.04.009.
415. Epidemiological and Clinical Characteristics of 333 Confirmed Cases with Coronavirus Disease 2019 in Shanghai, China. Yu X, Sun X, Cui P, Pan H, Lin S, Han R, et al. Transboundary and emerging diseases. 2020.
416. The application of Temporary Ark Hospitals in controlling COVID-19 spread: the experiences of one Temporary Ark Hospital, Wuhan, China. Yuan Y, Qiu T, Wang T, Zhou J, Ma Y, Liu X, et al. Journal of medical virology. 2020.
417. Presepsin in risk stratification of SARS-CoV-2 patients. Zaninotto M, Mion MM, Cosma C, Rinaldi D, Plebani M. Clinica Chimica Acta. 2020;507:161-3.
418. Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain. Zareifopoulos N, Lagadinou M, Karela A, Platanaki C, Karantzogiannis G, Velissaris D. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 2020;90(2). http://dx.doi.org/10.4081/monaldi.2020.1342.
419. Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China. Zhang J, Yu M, Tong S, Liu LY, Tang LV. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2020;127:104392. http://dx.doi.org/10.1016/j.jcv.2020.104392.
420. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver International. 2020.
421. Clinical outcomes of COVID-19 cases and influencing factors in Guangdong province. Zhang YT, Deng AP, Hu T, Chen XG, Zhuang YL, Tan XH, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41:E057.
422. An update on the status of COVID-19: a comprehensive review. Zhao N, Zhou ZL, Wu L, Zhang XD, Han SB, Bao HJ, et al. European review for medical and pharmacological sciences. 2020;24(8):4597-606. http://dx.doi.org/10.26355/eurrev_202004_21046.
423. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening. Zhao X, Jiang Y, Zhao Y, Xi H, Liu C, Qu F, et al. European Journal of Clinical Microbiology and Infectious Diseases. 2020.
424. Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study. Zhao XY, Xu XX, Yin HS, Hu QM, Xiong T, Tang YY, et al. BMC infectious diseases. 2020;20(1):311.
425. Clinical and transmission dynamics characteristics of 406 children with coronavirus disease 2019 in China: A review. Zhen-Dong Y, Gao-Jun Z, Run-Ming J, Zhi-Sheng L, Zong-Qi D, Xiong X, et al. Journal of Infection. 2020.
426. Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020. Zheng Y, Xiong C, Liu Y, Qian X, Tang Y, Liu L, et al. Pharmacological research. 2020;157:104821. http://dx.doi.org/10.1016/j.phrs.2020.104821.
427. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study. Zheng Y, Zhang Y, Chi H, Chen S, Peng M, Luo L, et al. Clinical chemistry and laboratory medicine. 2020.
428. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Journal of Infection. 2020.
429. Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis. Zhong H, Wang Y, Zhang ZL, Liu YX, Le KJ, Cui M, et al. Pharmacological research. 2020:104872. http://dx.doi.org/10.1016/j.phrs.2020.104872.
430. Towards precision management of cardiovascular patients with COVID-19 to reduce mortality. Zhou K, Yang S, Jia P. Progress in cardiovascular diseases. 2020.
431. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Cell Metabolism. 2020.
432. Preliminary estimates of the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020. Zhuang Z, Zhao S, Lin Q, Cao P, Lou Y, Yang L, et al. International Journal of Infectious Diseases. 2020;95:308-10.
433. Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak. Zingone F, Buda A, Savarino EV. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2020. http://dx.doi.org/10.1016/j.dld.2020.04.004.
434. Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019. Zou X, Li S, Fang M, Hu M, Bian Y, Ling J, et al. Crit Care Med. 2020. http://dx.doi.org/10.1097/CCM.0000000000004411.
435. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China. Zou Y, Guo H, Zhang Y, Zhang Z, Liu Y, Wang J, et al. Bioscience trends. 2020.
436. Neutrophil extracellular traps in COVID-19. Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. JCI insight. 2020. Update tot 07-05-2020
1. The race against COVID-19. Nature Nanotechnology. 2020;15(4):239-40.
2. Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs). Swiss Medical Weekly. 2020;150(13).
3. Recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. 2020;22(4):285-9.
4. The scandals of covid-19. Abbasi K. The BMJ. 2020;369.
5. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. Abd El-Aziz TM, Stockand JD. Infection, Genetics and Evolution. 2020;83.
6. The possible immunological pathways for the variable immunopathogenesis of COVID—19 infections among healthy adults, elderly and children. Abdulamir AS, Hafidh RR. Electronic Journal of General Medicine. 2020;17(4):1-4.
7. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view. Abduljalil JM, Abduljalil BM. New Microbes and New Infections. 2020;35.
8. A critical appraisal of COVID-19 in Malaysia and beyond. Abdullah JM, Wan Ismail WFN, Mohamad I, Ab Razak A, Harun A, Musa KI, et al. Malaysian Journal of Medical Sciences. 2020;27(2):1-9.
9. Modelling spatial variations of coronavirus disease (COVID-19) in Africa. Adekunle IA, Onanuga AT, Akinola OO, Ogunbanjo OW. Science of the Total Environment. 2020;729.
10. Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients. Agarwal S, June CH. Cancer discovery. 2020.
11. One Health approach and Coronavirus Disease 2019. Ahmad T, Hui J. Human Vaccines and Immunotherapeutics. 2020;16(4):931-2.
12. Investigation of effective climatology parameters on COVID-19 outbreak in Iran. Ahmadi M, Sharifi A, Dorosti S, Jafarzadeh Ghoushchi S, Ghanbari N. Science of the Total Environment. 2020;729.
13. Radiological approaches to covid-19 pneumonia. Akçay Ş, Özlü T, Yilmaz A. Turkish Journal of Medical Sciences. 2020;50:604-10.
14. Understanding dynamics of pandemics. Akin L, Gözel MG. Turkish Journal of Medical Sciences. 2020;50:515-9.
15. Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice. Al Mutair A, Ambani Z. Journal of International Medical Research. 2019;48(1).
16. Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19. Alessandro C, Lorenzo A, Anne AS, Pierre F, Bernhard G, Lukas G, et al. Swiss Medical Weekly. 2020;150(15).
17. Clinical trials for coronavirus disease 2019: What is being evaluated and what is not. Arabi Y, Asseri A, Webb S, Marshall J, Al Moamary M. Annals of Thoracic Medicine. 2020;15(2):49-51.
18. Drugs and the renin-angiotensin system in covid-19. Aronson JK, Ferner RE. The BMJ. 2020;369.
19. Potential of Heparin and Nafamostat Combination Therapy for COVID-19. Asakura H, Ogawa H. Journal of thrombosis and haemostasis : JTH. 2020.
20. COVID-19: Driving while looking in the rear-view mirror. Ashton J. Journal of the Royal Society of Medicine. 2020;113(4):161-2.
21. Thoughts on COVID-19 and autoimmune diseases. Askanase AD, Khalili L, Buyon JP. Lupus Science and Medicine. 2020;7(1).
22. N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome. Assimakopoulos SF, Marangos M. Medical Hypotheses. 2020;140.
23. Follow-up studies in COVID-19 recovered patients - is it mandatory? Balachandar V, Mahalaxmi I, Subramaniam M, Kaavya J, Senthil Kumar N, Laldinmawii G, et al. Science of the Total Environment. 2020;729.
24. Psychological preparedness for the COVID-19 pandemic, perspectives from India. Banerjee DD. Psychiatry Research. 2020;288.
25. COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications. Barchetta I, Cavallo MG, Baroni MG. Diabetes Research and Clinical Practice. 2020;163.
26. Investigating the determinants of high Case-Fatality Rate for COVID-19 in Italy. Barone-Adesi F, Ragazzoni L, Schmid M. Disaster medicine and public health preparedness. 2020:1-4.
27. Clinical features and outcomes of inpatients with neurological disease and COVID-19. Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, et al. medRxiv. 2020:2020.04.28.20082735.
28. Open access epidemiologic data and an interactive dashboard to monitor the COVID-19 outbreak in Canad. Berry I, Soucy JPR, Tuite A, Fisman D. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2020;192(15):E420.
29. The COVID-19 Pandemic and Implications for Gynaecologic Cancer Care. Bhatla N, Singhal S. Indian Journal of Gynecologic Oncology. 2020;18(2).
30. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. The Lancet Infectious Diseases. 2020.
31. 2019-NCOV/COVID-19 - Approaches to viral vaccine development and preventive measures. Bilal M, Nazir MS, Parra-Saldivar R, Iqbal HMN. Journal of Pure and Applied Microbiology. 2020;14(1):25-9.
32. The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic. Bitar N, Kattan J, Kourie HR, Mukherji D, Saghir NE. Future Oncology. 2020;16(11):615-7.
33. A spatio-temporal analysis for exploring the effect of temperature on COVID-19 early evolution in Spain. Briz-Redón Á, Serrano-Aroca Á. Science of the Total Environment. 2020;728.
34. Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic. Bruinen de Bruin Y, Lequarre AS, McCourt J, Clevestig P, Pigazzani F, Zare Jeddi M, et al. Safety Science. 2020;128.
35. Health surveillance during covid-19 pandemic. Calvo RA, Deterding S, Ryan RM. The BMJ. 2020;369.
36. High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. Cao W, Liu X, Bai T, Fan H, Hong K, Song H, et al. Open Forum Infectious Diseases. 2020;7(3):1-6.
37. COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System. Caraballo C, McCullough M, Fuery M, Chouairi F, Keating C, Ravindra N, et al. medRxiv. 2020:2020.04.27.20082016.
38. Coronaviruses: Facts, Myths, and Hypotheses. Carbone M, Green JB, Bucci EM, Lednicky JA. Journal of Thoracic Oncology. 2020;15(5):675-8.
39. A new clinical trial to test high-dose vitamin C in patients with COVID-19. Carr AC. Critical Care. 2020;24(1).
40. The true challenges of the COVID-19 epidemics: The need for essential levels of care for all. Carta MG, Romano F, Orrù G. Open Respiratory Medicine Journal. 2020;14(1):8-9.
41. COVID-19 and diabetes management: What should be considered? Ceriello A, Stoian AP, Rizzo M. Diabetes Research and Clinical Practice. 2020;163.
42. How Can Blockchain Help People in the Event of Pandemics Such as the COVID-19? Chang MC, Park D. Journal of Medical Systems. 2020;44(5).
43. Important Steps to Control COVID-19/SARS-CoV-2 Infection. Chatterjee S. SN Comprehensive Clinical Medicine. 2020.
44. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)? Cheng RZ. Medicine in Drug Discovery. 2020;5.
45. Suggesting Ritonavir against COVID-19/SARS-CoV-2. Choudhury S, Mazumder MK. Medical Hypotheses. 2020;140.
46. The third coronavirus epidemic in the third millennium: What's next? Čivljak R, Markotić A, Kuzman I. Croatian Medical Journal. 2020;61(1):1-4.
47. Phytotherapeutics and SARS-CoV-2 infection: Potential role of bioflavonoids. Coppola M, Mondola R. Medical Hypotheses. 2020;140.
48. CT Imaging and Differential Diagnosis of COVID-19. Dai WC, Zhang HW, Yu J, Xu HJ, Chen H, Luo SP, et al. Canadian Association of Radiologists Journal. 2020;71(2):195-200.
49. The role of multimodality imaging in COVID-19 patients: from diagnosis to clinical monitoring and prognosis. D'Andrea A, Di Giannuario G, Marrazzo G, Riegler L, Mele D, Rizzo M, et al. Giornale italiano di cardiologia (2006). 2020;21(5):345-53.
50. Predicting community mortality risk due to CoVID-19 using machine learning and development of a prediction tool. Das A, Mishra S, Gopalan SS. medRxiv. 2020:2020.04.27.20081794.
51. Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Day AT, Sher DJ, Lee RC, Truelson JM, Myers LL, Sumer BD, et al. Oral Oncology. 2020;105.
52. SARS-CoV-2 Pandemic, COVID-19 Case Fatality Rates and Deaths per Million Populations in India. Dey JK, Dey SK.
53. Coronavirus diseases (COVID-19) current status and future perspectives: A narrative review. Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, et al. International Journal of Environmental Research and Public Health. 2020;17(8).
54. Chest CT findings of COVID-19 pneumonia by duration of symptoms. Ding X, Xu J, Zhou J, Long Q. European Journal of Radiology. 2020;127.
55. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, Ferraz da Silva LF, Pierre de Oliveira E, Nascimento Saldiva PH, et al. Journal of thrombosis and haemostasis : JTH. 2020.
56. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Journal of the American College of Cardiology. 2020;75(18):2352-71.
57. Simplified model of Covid-19 epidemic prognosis under quarantine and estimation of quarantine effectiveness. Dziugys A, Bieliunas M, Skarbalius G, Misiulis E, Navakas R. medRxiv. 2020:2020.04.28.20083428.
58. To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Eikenberry SE, Mancuso M, Iboi E, Phan T, Eikenberry K, Kuang Y, et al. Infectious Disease Modelling. 2020;5:293-308.
59. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Elfiky AA. Life sciences. 2020;253.
60. The role of the american heart association in the global COVID-19 pandemic. Elkind MSV, Harrington RA, Benjamin IJ. Circulation. 2020:E743-E5.
61. Severe COVID-19 infection associated with endothelial activation. Escher R, Breakey N, Lämmle B. Thrombosis Research. 2020;190:62.
62. Sonography of the Lungs: Diagnosis and Surveillance of Patients With COVID-19. Evans KD, Yang Q, Liu Y, Ye R, Peng C. Journal of Diagnostic Medical Sonography. 2020.
63. Dapsone and doxycycline could be potential treatment modalities for COVID-19. Farouk A, Salman S. Medical Hypotheses. 2020;140.
64. Excess mortality during COVID-19 in five European countries and a critique of mortality analysis data. Felix-Cardoso J, Vasconcelos H, Rodrigues P, Cruz-Correia R. medRxiv. 2020:2020.04.28.20083147.
65. COVID-19: Immunology and treatment options. Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. Clinical Immunology. 2020;215.
66. New challenges in the COVID-19 pandemic. Fiedorowicz JG. Journal of Psychosomatic Research. 2020;133.
67. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement. Fleming AB, Raabe V. Journal of Clinical Virology. 2020;127.
68. Surveillance to improve evidence for community control decisions during the COVID-19 pandemic – Opening the animal epidemic toolbox for Public Health. Foddai A, Lindberg A, Lubroth J, Ellis-Iversen J. One Health. 2020;9.
69. The fight against COVID-19 and the restoration of trust in Chinese medical professionals. Gan Y, Chen Y, Wang C, Latkin C, Hall BJ. Asian Journal of Psychiatry. 2020;51.
70. Erratum: Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020 (MMWR. Morbidity and mortality weekly report). Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, et al. MMWR Morbidity and mortality weekly report. 2020;69(15):458-64.
71. COVID-19 pneumonia: ARDS or not? Gattinoni L, Chiumello D, Rossi S. Critical Care. 2020;24(1).
72. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality. Geier MR, Geier DA. Medical Hypotheses. 2020;140.
73. Community Transmission of SARS-CoV-2 at Two Family Gatherings - Chicago, Illinois, February-March 2020. Ghinai I, Woods S, Ritger KA, McPherson TD, Black SR, Sparrow L, et al. MMWR Morbidity and mortality weekly report. 2020;69(15):446-50.
74. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. Cell Host and Microbe. 2020.
75. Case fatality rate analysis of Italian COVID-19 outbreak. Giangreco G. Journal of medical virology. 2020.
76. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Giannis D, Ziogas IA, Gianni P. Journal of Clinical Virology. 2020;127.
77. Research on COVID-19 virus spreading statistics based on the examples of the cases from different counties. Gondauri D, Mikautadze E, Batiashvili M. Electronic Journal of General Medicine. 2020;17(4).
78. Inaccurate conclusions by Tang and colleagues. Greenstein YY. Journal of thrombosis and haemostasis : JTH. 2020.
79. On the global trends and spread of the COVID-19 outbreak: preliminary assessment of the potential relation between location-specific temperature and UV index. Gunthe SS, Swain B, Patra SS, Amte A. Journal of Public Health (Germany). 2020.
80. COVID-19 update. Haberal M. Experimental and Clinical Transplantation. 2020;18(2):139.
81. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster. Han Y, Jiang M, Xia D, He L, Lv X, Liao X, et al. Clinical Immunology. 2020;214.
82. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Hao F, Tan W, Jiang L, Zhang L, Zhao X, Zou Y, et al. Brain, behavior, and immunity. 2020.
83. Etiology and genetic evolution of canine coronavirus circulating in five provinces of China, during 2018–2019. He HJ, Zhang W, Liang J, Lu M, Wang R, Li G, et al. Microbial Pathogenesis. 2020;145.
84. The clinical course and its correlated immune status in COVID-19 pneumonia. He R, Lu Z, Zhang L, Fan T, Xiong R, Shen X, et al. Journal of Clinical Virology. 2020;127.
85. The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities. Helmich RC, Bloem BR. Journal of Parkinson's Disease. 2020;10(2):351-4.
86. On the alert for cytokine storm: Immunopathology in COVID-19. Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, et al. Arthritis & rheumatology (Hoboken, NJ). 2020.
87. Modifiable and non-modifiable risk factors for COVID-19: results from UK Biobank. Ho FK, Celis-Morales CA, Gray SR, Katikireddi SV, Niedzwiedz CL, Hastie C, et al. medRxiv. 2020:2020.04.28.20083295.
88. Will covid-19 become the next neglected tropical disease? Hotez PJ, Bottazziid ME, Singhid SK, Brindley PJ, Kamhawi S. PLoS Neglected Tropical Diseases. 2020;14(4).
89. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Hrusak O, Kalina T, Wolf J, Balduzzi A, Provenzi M, Rizzari C, et al. European Journal of Cancer. 2020;132:11-6.
90. CT imaging of two cases of one family cluster 2019 novel coronavirus (2019-nCoV) pneumonia: Inconsistency between clinical symptoms amelioration and imaging sign progression. Hu X, Chen J, Jiang X, Tao S, Zhen Z, Zhou C, et al. Quantitative Imaging in Medicine and Surgery. 2020;10(2):508-10.
91. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. Hu X, Xing Y, Jia J, Ni W, Liang J, Zhao D, et al. Science of the Total Environment. 2020;728.
92. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression: Diabetes and COVID-19. Huang I, Lim MA, Pranata R. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):395-403.
93. COVID-19 in posttransplant patients—report of 2 cases. Huang J, Lin H, Wu Y, Fang Y, Kumar R, Chen G, et al. American Journal of Transplantation. 2020.
94. A correlation study of CT and clinical features of different clinical types of COVID-19. Huang L, Han R, Yu P, Wang S, Xia L. Chinese Journal of Radiology (China). 2020;54(4):300-4.
95. COVID-19 in patients with cardiovascular diseases. Hulot JS. Archives of Cardiovascular Diseases. 2020;113(4):225-6.
96. Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures. Ioannidis JPA. European Journal of Clinical Investigation. 2020;50(4).
97. A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): An Iranian treatment protocol. Jamaati H, Dastan F, Tabarsi P, Marjani M, Saffaei A, Hashemian SM. Iranian Journal of Pharmaceutical Research. 2020;19(1):31-6.
98. Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA? Javed B, Sarwer A, Soto EB, Mashwani ZUR. Drugs and Therapy Perspectives. 2020.
99. Coronavirus disease-19: Summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea. Jeong EK, Park O, Park YJ, Park SY, Kim YM, Kim J, et al. Osong Public Health and Research Perspectives. 2020;11(2):81-4.
100. COVID-19: Mitigation or suppression? Kassem AM. Arab Journal of Gastroenterology. 2020;21(1):1-2.
101. The 2019 novel coronavirus (COVID-19) outbreak in China and world: A new lesson for public health system. Kuca K. Letters in Drug Design and Discovery. 2020;17(4):364-5.
102. What is the current state of knowledge about the novel coronavirus infection during pregnancy? Kurdoğlu M, Khaki A. International Journal of Women's Health and Reproduction Sciences. 2020;8(2):110-1.
103. Collateral consequences of COVID-19 epidemic in Greater Paris. Lapostolle F, Agostinucci JM, Alhéritière A, Petrovic T, Adnet F. Resuscitation. 2020;151:6-7.
104. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. The Lancet Child and Adolescent Health. 2020;4(5):e10-e1.
105. COVID-19 in Italy: momentous decisions and many uncertainties. Lazzerini M, Putoto G. The Lancet Global Health. 2020;8(5):e641-e2.
106. COVID19: The need for public health in a time of emergency. Lee A, Morling J. Public Health. 2020;182:188-9.
107. Early preemptive immunomodulators (Corticosteroids) for severe pneumonia patients infected with SARS-COV-2. Lee KY, Rhim JW, Kang JH. Korean Journal of Pediatrics. 2020;63(4):117-8.
108. Strategies for Prevention of Coronavirus Disease 2019 in the Dental Field. Lee YH, Auh QS. Oral diseases. 2020.
109. CT imaging of the 2019 novel coronavirus (2019-NCoV) pneumonia. Lei J, Li J, Li X, Qi X. Radiology. 2020;295(1):18.
110. Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. Leung C. Journal of medical virology. 2020.
111. COVID-19 infection may cause ketosis and ketoacidosis. Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. Diabetes, obesity & metabolism. 2020.
112. The application of strong matrix management and PDCA cycle in the management of severe COVID-19 patients. Li Y, Wang H, Jiao J. Critical Care. 2020;24(1).
113. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19. Liu Y, Liao W, Wan L, Xiang T, Zhang W. Viral immunology. 2020.
114. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Thrombosis Research. 2020;191:9-14.
115. The Wuhan SARS-CoV-2—What's next for China. Lu H, Stratton CW, Tang YW. Journal of Medical Virology. 2020;92(6):546-7.
116. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China. Luo E, Zhang D, Luo H, Liu B, Zhao K, Zhao Y, et al. Chinese Medicine (United Kingdom). 2020;15(1).
117. Global COVID-19 fatality analysis reveals Hubei-like countries potentially with severe outbreaks. Lv B, Li Z, Chen Y, Long C, Fu X. The Journal of infection. 2020.
118. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Ma J, Xia P, Zhou Y, Liu Z, Zhou X, Wang J, et al. Clinical Immunology. 2020;214.
119. Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study. Ma J, Yin J, Qian Y, Wu Y. Journal of Infection. 2020.
120. Indian society of anaesthesiologists (ISA national) advisory and position statement regarding COVID-19. Malhotra N, Joshi M, Datta R, Bajwa S, Mehdiratta L. Indian Journal of Anaesthesia. 2020;64(4):259-63.
121. COVID-19 and globalization. Mas-Coma S, Jones MK, Marty AM. One Health. 2020;9.
122. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. New England Journal of Medicine. 2020.
123. Preparedness is Essential for Western Pacific Islands during the COVID-19 Pandemic. Mei Y, Hu J. Disaster medicine and public health preparedness. 2020:1-11.
124. Use of antiviral drugs to reduce COVID-19 transmission. Mitjà O, Clotet B. The Lancet Global Health. 2020;8(5):e639-e40.
125. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Monteil V, Kwon H, Prado P, Hagelkrüys A, Wimmer RA, Stahl M, et al. Cell. 2020.
126. A review of initial data on pregnancy during the COVID-19 out-break: Implications for assisted reproductive treatments. Monteleone PAA, Nakano M, Lazar V, Gomes AP, de Martin H, Bonetti TCS. Jornal Brasileiro de Reproducao Assistida. 2020;24(2):219-25.
127. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Annals of the Rheumatic Diseases. 2020;79(5):667-8.
128. Balancing the Effects of COVID-19 Against Potential Progression and Mortality in High-risk Prostate Cancer. Moschovas MC, Sighinolfi MC, Rocco B, Bhat S, Onol F, Rogers T, et al. European Urology. 2020.
129. Is reporting many cases of COVID-19 in Iran due to strength or weakness of iran’s health system? Mounesan L, Eybpoosh S, Haghdoost A, Moradi G, Mostafavi E. Iranian Journal of Microbiology. 2020;12(2):73-6.
130. COVID-19 pandemic and environmental pollution: A blessing in disguise? Muhammad S, Long X, Salman M. Science of the Total Environment. 2020;728.
131. Global spread of coronavirus disease 2019 and malaria: An epidemiological paradox in the early stage of a pandemic. Napoli PE, Nioi M. Journal of Clinical Medicine. 2020;9(4).
132. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. Nikpouraghdam M, Jalali Farahani A, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Journal of Clinical Virology. 2020;127.
133. Clinical characteristics of older patients infected with COVID-19: A descriptive study. Niu S, Tian S, Lou J, Kang X, Zhang L, Lian H, et al. Archives of Gerontology and Geriatrics. 2020;89.
134. Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic. Obi AT, Barnes GD, Wakefield TW, Brown Rvt S, Eliason JL, Arndt E, et al. Journal of vascular surgery Venous and lymphatic disorders. 2020.
135. Management of a radiotherapy center during the COVID-19 outbreak: The experience of the Mulhouse hospital centre (France). Ohnleiter T, Piot L, Rogenmuser A, Noirclerc M, Hamlaoui R, Grandgirard A. Cancer/Radiotherapie. 2020.
136. Coronavirus disease 2019 (COVID-19) outbreak: Could pigs be vectors for human infections? Opriessnig T, Huang YW. Xenotransplantation. 2020;27(2).
137. Psychological intervention measures during the COVID-19 pandemic. Orrù G, Ciacchini R, Gemignani A, Conversano C. Clinical Neuropsychiatry. 2020;17(2):76-9.
138. Sedating ventilated COVID-19 patients with inhalational anesthetic drugs. Orser BA, Wang DS, Lu WY. EBioMedicine. 2020;55.
139. Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India. Paital B, Das K, Parida SK. Science of the Total Environment. 2020;728.
140. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Pal R, Bhadada SK. Diabetes Research and Clinical Practice. 2020;163.
141. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis. Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Journal of thrombosis and haemostasis : JTH. 2020.
142. COVID-19: Clinical, biological and radiological characteristics in adults, infants and pregnant women. An up-to-date review at the heart of the pandemic. Plaçais L, Richier Q. Revue de Medecine Interne. 2020.
143. Covid-19: why we need a national health and social care service. Pollock AM, Clements L, Harding-Edgar L. The BMJ. 2020;369.
144. Venous thromboembolism in COVID-19 patients. Porfidia A, Pola R. Journal of thrombosis and haemostasis : JTH. 2020.
145. Temperature significantly changes COVID-19 transmission in (sub)tropical cities of Brazil. Prata DN, Rodrigues W, Bermejo PH. Science of the Total Environment. 2020;729.
146. Corona virus-An upadated review. Priyanka K, Sowdameni T, Mujeebuddin CS. International Journal of Pharmaceutical Sciences Review and Research. 2020;61(1):138-44.
147. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, et al. Journal of thrombosis and haemostasis : JTH. 2020.
148. COVID-19 patients and the radiology department - advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Revel MP, Parkar AP, Prosch H, Silva M, Sverzellati N, Gleeson F, et al. European radiology. 2020.
149. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North - supports vitamin D as a factor determining severity. Rhodes JM, Subramanian S, Laird E, Anne Kenny R. Alimentary pharmacology & therapeutics. 2020.
150. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB. Rico-Mesa JS, White A, Anderson AS. Current Cardiology Reports. 2020;22(5).
151. Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report. Rodriguez JA, Rubio-Gomez H, Roa AA, Miller N, Eckardt PA. IDCases. 2020;20.
152. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients. Roncon L, Zuin M, Zonzin P. Thrombosis Research. 2020;190:102.
153. Cardiac patients and COVID-19: What the general practitioner should know. Ryczek R, Krzesiński P. Pediatria i Medycyna Rodzinna. 2019;15(4):C6-C9.
154. Angiotensin receptor blockers and COVID-19. Saavedra JM. Pharmacological Research. 2020;156.
155. Is Pakistan prepared to tackle the coronavirus epidemic? Saqlain M, Munir MM, Ahmed A, Tahir AH, Kamran S. Drugs and Therapy Perspectives. 2020;36(5):213-4.
156. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria? Sargin G, Yavaşoğlu Sİ, Yavasoglu I. Medical Hypotheses. 2020;140.
157. A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic. Schmeiser T, Broll M, Dormann A, Fräbel C, Hermann W, Hudowenz O, et al. Zeitschrift fur Rheumatologie. 2020.
158. Coronavirus and diabetes: an update. Seewoodhary J, Oozageer R. Practical Diabetes. 2020;37(2):41-2.
159. New Early Warning Score: off-label approach for Covid-19 outbreak patient deterioration in the community. Semeraro F, Scquizzato T, Scapigliati A, Ristagno G, Gamberini L, Tartaglione M, et al. Resuscitation. 2020;151:24-5.
160. Review of Artificial Intelligence Techniques in Imaging Data Acquisition, Segmentation and Diagnosis for COVID-19. Shi F, Wang J, Shi J, Wu Z, Wang Q, Tang Z, et al. IEEE Reviews in Biomedical Engineering. 2020.
161. The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective. Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. AIDS and behavior. 2020.
162. Resorting to mathematical modelling approach to contain the coronavirus disease 2019 (COVID-19) outbreak. Shrivastava S, Shrivastava P. Journal of Acute Disease. 2020;9(2):49-50.
163. Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? Silberstein M. Medical Hypotheses. 2020;140.
164. 3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials. Sisay M. Pharmacological Research. 2020;156.
165. Association between climate variables and global transmission oF SARS-CoV-2. Sobral MFF, Duarte GB, da Penha Sobral AIG, Marinho MLM, de Souza Melo A. Science of the Total Environment. 2020;729.
166. The Impact of COVID-19 on Bariatric Surgery: Re-Defining Psychosocial Care. Sockalingam S, Leung SE, Cassin SE. Obesity (Silver Spring, Md). 2020.
167. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Song JC, Wang G, Zhang W, Zhang Y, Li WQ, Zhou Z. Military Medical Research. 2020;7(1):19.
168. Mental health problems faced by healthcare workers due to the COVID-19 pandemic–A review. Spoorthy MS. Asian Journal of Psychiatry. 2020;51.
169. The different clinical characteristics of corona virus disease cases between children and their families in China–the character of children with COVID-19. Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, et al. Emerging Microbes and Infections. 2020;9(1):707-13.
170. Understanding of COVID-19 based on current evidence. Sun P, Lu X, Xu C, Sun W, Pan B. Journal of Medical Virology. 2020;92(6):548-51.
171. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis. Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Journal of Medical Virology. 2020;92(6):612-7.
172. COVID-19 and student nurses: a view from England. Swift A, Banks L, Baleswaran A, Cooke N, Little C, McGrath L, et al. Journal of clinical nursing. 2020.
173. Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic. Takhar A, Walker A, Tricklebank S, Wyncoll D, Hart N, Jacob T, et al. European Archives of Oto-Rhino-Laryngology. 2020.
174. Clinical features of children with SARS-CoV-2 infection: an analysis of 13 cases from Changsha, China. Tan X, Huang J, Zhao F, Zhou Y, Li JQ, Wang XY. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. 2020;22(4):294-8.
175. Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'. Tang N. Journal of thrombosis and haemostasis : JTH. 2020.
176. COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. Tapper EB, Asrani SK. Journal of hepatology. 2020.
177. Hematological findings and complications of COVID-19. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. American journal of hematology. 2020.
178. Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms. Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Journal of Cardiac Failure. 2020.
179. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients. Testa S, Paoletti O, Giorgi-Pierfranceschi M, Pan A. Internal and emergency medicine. 2020.
180. India under COVID-19 lockdown. The L. The Lancet. 2020;395(10233):1315.
181. COVID-19: Leaving Lockdown - Of Schrodinger, Cats, Testing and Masks. Thomson GA. International journal of clinical practice. 2020:e13519.
182. Localising an asset-based COVID-19 response in Ecuador. Torres I, Sacoto F. The Lancet. 2020;395(10233):1339.
183. The psychological impact of COVID-19 on medical students [Letter]. Ullah R, Amin S. Psychiatry Research. 2020;288.
184. Cancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis? Vrdoljak E, Sullivan R, Lawler M. European Journal of Cancer. 2020;132:98-9.
185. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L, et al. British Journal of Haematology. 2020.
186. Potential neurological symptoms of COVID-19. Wang HY, Li XL, Yan ZR, Sun XP, Han J, Zhang BW. Therapeutic Advances in Neurological Disorders. 2020;13.
187. Systematic investigations of COVID-19 in 283 cancer patients. Wang J, Song Q, Chen Y, Wang Z, Chu Q, Gong H, et al. medRxiv. 2020:2020.04.28.20083246.
188. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. Wang Y, Kang H, Liu X, Tong Z. Journal of Medical Virology. 2020;92(6):538-9.
189. Combating COVID-19: health equity matters. Wang Z, Tang K. Nature Medicine. 2020;26(4):458.
190. Obesity and SARS-CoV-2: a population to safeguard. Watanabe M, Risi R, Tuccinardi D, Baquero CJ, Manfrini S, Gnessi L. Diabetes/metabolism research and reviews. 2020:e3325.
191. Determining risk factors for mortality in liver transplant patients with COVID-19. Webb GJ, Moon AM, Barnes E, Barritt AS, Marjot T. The Lancet Gastroenterology and Hepatology. 2020.
192. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19. Wei XS, Wang X, Niu YR, Ye LL, Peng WB, Wang ZH, et al. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2020.
193. Isolation, quarantine, social distancing and community containment: Pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. Wilder-Smith A, Freedman DO. Journal of Travel Medicine. 2020;27(2).
194. Challenges of Covid-19 Pandemic for Dermatology. Wollina U. Dermatologic therapy. 2020.
195. Clinical features and outcome of treatment for novel coronavirus pneumonia: a meta-analysis. Wu YY, Li HY, Xu XB, Zheng KX, Qi XS, Guo XZ. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2020;28(3):240-6.
196. Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV. Xie M, Chen Q. International Journal of Infectious Diseases. 2020;94:119-24.
197. Beware of the second wave of COVID-19. Xu S, Li Y. The Lancet. 2020;395(10233):1321-2.
198. Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19. Xu T, Chen C, Zhu Z, Cui M, Chen C, Dai H, et al. International Journal of Infectious Diseases. 2020;94:68-71.
199. Clinical characteristics and risk assessment of newborns born to mothers with COVID-19. Yang P, Wang X, Liu P, Wei C, He B, Zheng J, et al. Journal of Clinical Virology. 2020;127.
200. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients. Yongchen Z, Shen H, Wang X, Shi X, Li Y, Yan J, et al. Emerging microbes & infections. 2020:1-14.
201. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Zaigham M, Andersson O. Acta Obstetricia et Gynecologica Scandinavica. 2020.
202. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Journal of Clinical Virology. 2020;127.
203. Specific ACE2 Expression in Small Intestinal Enterocytes may Cause Gastrointestinal Symptoms and Injury after 2019-nCoV Infection. Zhang H, Li HB, Lyu JR, Lei XM, Li W, Wu G, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
204. Risk prediction for poor outcome and death in hospital in-patients with COVID-19: derivation in Wuhan, China and external validation in London, UK. Zhang H, Shi T, Wu X, Zhang X, Wang K, Bean D, et al. medRxiv. 2020:2020.04.28.20082222.
205. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Clinical Microbiology and Infection. 2020.
206. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. Journal of thrombosis and haemostasis : JTH. 2020.
207. New understanding of the damage of SARS-CoV-2 infection outside the respiratory system. Zhang Y, Geng X, Tan Y, Li Q, Xu C, Xu J, et al. Biomedicine and Pharmacotherapy. 2020;127.
208. Quantifying the association between domestic travel and the exportation of novel coronavirus (2019-nCoV) cases from Wuhan, China in 2020: A correlational analysis. Zhao S, Zhuang Z, Cao P, Ran J, Gao D, Lou Y, et al. Journal of Travel Medicine. 2020;27(2).
209. Risk-adapted Treatment Strategy For COVID-19 Patients. Zheng C, Wang J, Guo H, Lu Z, Ma Y, Zhu Y, et al. International Journal of Infectious Diseases. 2020;94:74-7.
210. Mental health and a novel coronavirus (2019-nCoV) in China. Zheng W. Journal of Affective Disorders. 2020;269:201-2.
211. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu. Zheng Y, Xu H, Yang M, Zeng Y, Chen H, Liu R, et al. Journal of Clinical Virology. 2020;127.
212. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Current Cardiology Reports. 2020;22(5).
213. Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Journal of medical virology. 2020. Update tot 30-04-2020
1. Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States. Nature medicine. 2020. http://dx.doi.org/10.1038/s41591-020-0877-5.
2. Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York. Journal of the American Society of Nephrology : JASN. 2020. http://dx.doi.org/10.1681/ASN.2020030375.
3. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morbidity and mortality weekly report. 2020;69(13):382-6.
4. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view. Abduljalil JM, Abduljalil BM. New Microbes and New Infections. 2020;35.
5. Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19. Abraham WT, Fiuzat M, Psotka MA, O'Connor CM. JACC: Heart Failure. 2020;8(5):423-5.
6. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature. Aggarwal G, Lippi G, Michael Henry B. International journal of stroke : official journal of the International Stroke Society. 2020:1747493020921664. http://dx.doi.org/10.1177/1747493020921664.
7. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Journal of cardiac surgery. 2020. http://dx.doi.org/10.1111/jocs.14538.
8. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al. Journal of Microbiology and Biotechnology. 2020;30(3):313-24.
9. The first clusters of Middle East respiratory syndrome coronavirus in Oman: Time to act. Al Awaidy ST, Al Maqbali AA, Omer I, Al Mukhaini S, Al Risi MA, Al Maqbali MS, et al. Journal of Infection and Public Health. 2020.
10. [New insights into the seriousness of acute myocardial injury during COVID-19]. Alderighi C, Rasoini R, Ambrosio G, Valente S, Gensini GF. Giornale italiano di cardiologia (2006). 2020;21(5):328-31. http://dx.doi.org/10.1714/3343.33128.
11. Evidence informing the UK's COVID-19 public health response must be transparent. Alwan NA, Bhopal R, Burgess RA, Colburn T, Cuevas LE, Smith GD, et al. The Lancet. 2020;395(10229):1036-7.
12. Response of a European surgical department to the COVID-19 crisis. Andrea P, Beat M, Graziano O, Frédéric T, Christian T. Swiss Medical Weekly. 2020;150(15).
13. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Arachchillage DR, Laffan M. Journal of thrombosis and haemostasis : JTH. 2020.
14. The outbreak of Coronavirus Disease 2019 (COVID-19)—An emerging global health threat. Arshad Ali S, Baloch M, Ahmed N, Arshad Ali A, Iqbal A. Journal of Infection and Public Health. 2020;13(4):644-6.
15. COVID-19 outbreak: Challenges for Addiction services in India. Arya S, Gupta R. Asian Journal of Psychiatry. 2020;51.
16. Art of prevention: Life in the time of coronavirus. Baghchechi M, Dunn J, Jaipaul N, Jacob SE. International Journal of Women's Dermatology. 2020.
17. The Coronavirus Disease 2019 (COVID-19) Pandemic. Baloch S, Baloch MA, Zheng T, Pei X. The Tohoku journal of experimental medicine. 2020;250(4):271-8. http://dx.doi.org/10.1620/tjem.250.271.
18. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Barazzoni R, Bischoff SC, Breda J, Wickramasinghe K, Krznaric Z, Nitzan D, et al. Clinical Nutrition. 2020.
19. Sentiment analysis of nationwide lockdown due to COVID 19 outbreak: Evidence from India. Barkur G, Vibha, Kamath GB. Asian Journal of Psychiatry. 2020;51.
20. Sars-cov-2 (Covid-19) by the numbers. Bar-On YM, Flamholz A, Phillips R, Milo R. eLife. 2020;9.
21. [It's world war at CoViD-19. The first battle on the front of the viral invasion against the exitus for interstitial pneumonia was decisive.]. Basta G, Del Turco S, Caselli C, Melani L, Vianello A. Recenti progressi in medicina. 2020;111(4):238-52. http://dx.doi.org/10.1701/3347.33187.
22. Editorial Concern - Possible Reporting of the Same Patients with COVID-19 in Different Reports. Bauchner H, Golub RM, Zylke J. JAMA - Journal of the American Medical Association. 2020;323(13):1256.
23. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection. Bermejo-Martin JF, Almansa R, Menéndez R, Mendez R, Kelvin DJ, Torres A. Journal of Infection. 2020;80(5):e23-e4.
24. Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic. Bhattacharjee A, Patil VM, Dikshit R, Prabhash K, Singh A, Chaturvedi P. Head & neck. 2020. http://dx.doi.org/10.1002/hed.26196.
25. Covid-19 worldwide: We need precise data by age group and sex urgently. Bhopal R. The BMJ. 2020;369.
26. Covid-19 risks and response in South Asia. Bhutta ZA, Basnyat B, Saha S, Laxminarayan R. The BMJ. 2020;368.
27. Statins in coronavirus outbreak: It's time for experimental and clinical studies. Bifulco M, Gazzerro P. Pharmacological Research. 2020;156.
28. Emergence of Novel Coronavirus and COVID-19: whether to stay or die out? Biswas A, Bhattacharjee U, Chakrabarti AK, Tewari DN, Banu H, Dutta S. Critical reviews in microbiology. 2020:1-12.
29. COVID-19: opportunity arises from a world health crisis. Bonate PL. Journal of Pharmacokinetics and Pharmacodynamics. 2020;47(2):119-20.
30. Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment. Boopathi S, Poma AB, Kolandaivel P. Journal of biomolecular structure & dynamics. 2020:1-14. http://dx.doi.org/10.1080/07391102.2020.1758788.
31. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Bordi L, Nicastri E, Scorzolini L, Di Caro A, Capobianchi MR, Castilletti C, et al. Eurosurveillance. 2020;25(8).
32. A man in his nineties with fever and dry cough. Boren HK, Kjostolfsen GH, Aalokken TM, Latif N, Brekke H, Lind A, et al. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2020;140(6). http://dx.doi.org/10.4045/tidsskr.20.0218. Print 2020 Apr 21.
33. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort. Bouquet J, Tabor DE, Silver JS, Nair V, Tovchigrechko A, Griffin MP, et al. Respiratory Research. 2020;21(1).
34. Smoking upregulates angiotensin-converting Enzyme-2 receptor: A potential adhesion site for novel coronavirus SARS-CoV-2 (COVID-19). Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Journal of Clinical Medicine. 2020;9(3).
35. Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias. Brown EE, Kumar S, Rajji TK, Pollock BG, Mulsant BH. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2020. http://dx.doi.org/10.1016/j.jagp.2020.04.010.
36. COVID-19: Facts, Cultural Considerations, and Risk of Stigmatization. Bruns DP, Kraguljac NV, Bruns TR. Journal of transcultural nursing : official journal of the Transcultural Nursing Society. 2020:1043659620917724. http://dx.doi.org/10.1177/1043659620917724.
37. Anti-IL6R role in treatment of COVID-19-related ARDS. Buonaguro FM, Puzanov I, Ascierto PA. Journal of Translational Medicine. 2020;18(1).
38. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Butler MJ, Barrientos RM. Brain, Behavior, and Immunity. 2020.
39. Psychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 2020 During the Outbreak of Coronavirus Disease 2019 (COVID‑19) in Hubei, China. Cai H, Tu B, Ma J, Chen L, Fu L, Jiang Y, et al. Medical science monitor : international medical journal of experimental and clinical research. 2020;26:e924171.
40. Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres. Campi R, Amparore D, Capitanio U, Checcucci E, Salonia A, Fiori C, et al. European Urology. 2020.
41. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. Carnero Contentti E, Correa J. Multiple Sclerosis and Related Disorders. 2020;41.
42. The convalescent sera option for containing COVID-19. Casadevall A, Pirofski LA. Journal of Clinical Investigation. 2020;130(4):1545-8.
43. 2019-nCoV: Polite with children! Caselli D, Aricò M. Pediatric Reports. 2020;12(1).
44. Editorial – Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Ceccarelli M, Berretta M, Rullo EV, Nunnari G, Cacopardo B. European Review for Medical and Pharmacological Sciences. 2020;24(5):2781-3.
45. Systematic rapid "living" review on rehabilitation needs due to covid-19: update to march 31st 2020. Ceravolo MG, De Sire A, Andrenelli E, Negrini F, Negrini S. European journal of physical and rehabilitation medicine. 2020. http://dx.doi.org/10.23736/S1973-9087.20.06329-7.
46. Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated. Chaung J, Chan D, Pada S, Tambyah PA. Journal of medical virology. 2020.
47. Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis. Chen JY, Qiao K, Liu F, Wu B, Xu X, Jiao GQ, et al. Chinese medical journal. 2020.
48. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. Chen T, Dai Z, Mo P, Li X, Ma Z, Song S, et al. The journals of gerontology Series A, Biological sciences and medical sciences. 2020.
49. Reply to: "Reporting of all cardiac medications and their outcome in COVID-19". Cheng H, Wang Y, Wang GQ. Journal of medical virology. 2020.
50. Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2. Chiotos K, Hayes M, Kimberlin DW, Jones SB, James SH, Pinninti SG, et al. J Pediatric Infect Dis Soc. 2020. http://dx.doi.org/10.1093/jpids/piaa045.
51. Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis. Choudhury R, Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, et al. World journal of emergency surgery : WJES. 2020;15(1):29. http://dx.doi.org/10.1186/s13017-020-00305-4.
52. The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic. Chung CJ, Nazif TM, Wolbinski M, Hakemi E, Lebehn M, Brandwein R, et al. Journal of the American College of Cardiology. 2020.
53. Mathematical prediction of the time evolution of the COVID-19 pandemic in Italy by a Gauss error function and Monte Carlo simulations. Ciufolini I, Paolozzi A. European physical journal plus. 2020;135(4):355. http://dx.doi.org/10.1140/epjp/s13360-020-00383-y. Epub 2020 Apr 15.
54. Changes to management of a non-pandemic illness during the COVID-19 pandemic: case study of invasive management of acute coronary syndrome. Coffey S, Moynagh A, Green B, Edmond J, Wilkins GT, Pemberton J, et al. The New Zealand medical journal. 2020;133(1513):101-6.
55. Medically unexplained symptoms in the times of Covid-19 pandemic: a case-report. Colizzi M, Bortoletto R, Silvestri M, Mondini F, Puttini E, Cainelli C, et al. Brain, behavior, & immunity health. 2020:100073. http://dx.doi.org/10.1016/j.bbih.2020.100073.
56. First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments. Combs SE, Belka C, Niyazi M, Corradini S, Pigorsch S, Wilkens J, et al. Radiation Oncology. 2020;15(1).
57. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. medRxiv. 2020:2020.04.15.20067157.
58. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. Cure E, Cumhur Cure M. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):349-50.
59. Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19". Cure E, Cumhur Cure M. Journal of medical virology. 2020.
60. Mutated COVID-19 may foretell a great risk for mankind in the future. Dawood AA. New Microbes and New Infections. 2020;35.
61. The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections. Delanghe JR, Speeckaert MM, De Buyzere ML. Clinica Chimica Acta. 2020;505:192-3.
62. More prevalent, less deadly? Bayesian inference of the COVID19 Infection Fatality Ratio from mortality data. Delius GW, Powell BJ, Bees MA, Constable GWA, MacKay NJ, Pitchford JW. medRxiv. 2020:2020.04.19.20071811.
63. COVID-19 outbreak control, example of ministry of health of Turkey. Demirbilek Y, Pehlivanturk G, Ozguler ZO, Alp Mese E. Turkish journal of medical sciences. 2020;50:489-94. http://dx.doi.org/10.3906/sag-2004-187.
64. Lessons learned from 9/11: Mental health perspectives on the COVID-19 pandemic. DePierro J, Lowe S, Katz C. Psychiatry Research. 2020;288.
65. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, et al. Breast cancer research and treatment. 2020. http://dx.doi.org/10.1007/s10549-020-05644-z.
66. A new threat from an old enemy: Re-emergence of coronavirus (Review). Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, et al. International Journal of Molecular Medicine. 2020;45(6):1631-43.
67. Corona virus: A novel outbreak. Dogra A, Goyal B, Sharma AM. Biomedical and Pharmacology Journal. 2020;13(1):8-10.
68. Respiratory Support in Novel Coronavirus Disease (COVID-19) Patients, with a Focus on Resource-Limited Settings. Dondorp AM, Hayat M, Aryal D, Beane A, Schultz MJ. The American journal of tropical medicine and hygiene. 2020. http://dx.doi.org/10.4269/ajtmh.20-0283.
69. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017. Dong Y, Wang L, Burgner DP, Miller JE, Song Y, Ren X, et al. BMJ (Clinical research ed). 2020;369:m1043.
70. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China. Du RH, Liu LM, Yin W, Wang W, Guan LL, Yuan ML, et al. Annals of the American Thoracic Society. 2020.
71. Epidemic update of COVID-19 in Hubei Province compared with other regions in China. Du W, Han S, Li Q, Zhang Z. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.04.031.
72. COVID-19 as a factor influencing air pollution? Dutheil F, Baker JS, Navel V. Environmental Pollution. 2020;263.
73. First COVID-19 infections in the Philippines: A case report. Edrada EM, Lopez EB, Villarama JB, Salva Villarama EP, Dagoc BF, Smith C, et al. Tropical Medicine and Health. 2020;48(1).
74. Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective. Elfiky AA, Azzam EB. Journal of biomolecular structure & dynamics. 2020:1-9. http://dx.doi.org/10.1080/07391102.2020.1758789.
75. Andrographolide As a Potential Inhibitor of SARS-CoV-2 Main Protease: An In Silico Approach. Enmozhi SK, Raja K, Sebastine I, Joseph J. Journal of biomolecular structure & dynamics. 2020:1-10. http://dx.doi.org/10.1080/07391102.2020.1760136.
76. Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain. Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, Alarcón-De-la-Vega G, Alvarado-Arnez LE, Balderrama-Saavedra MA, et al. Travel Medicine and Infectious Disease. 2020.
77. Severe Acute Proximal Pulmonary Embolism and COVID-19: A Word of Caution. Fabre O, Rebet O, Carjaliu I, Radutoiu M, Gautier L, Hysi I. The Annals of thoracic surgery. 2020. http://dx.doi.org/10.1016/j.athoracsur.2020.04.005.
78. Clinical Features of COVID-19-Related Liver Damage. Fan Z, Chen L, Li J, Cheng X, Jingmao Y, Tian C, et al. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2020.
79. Analysis and forecast of COVID-19 spreading in China, Italy and France. Fanelli D, Piazza F. Chaos, solitons, and fractals. 2020;134:109761. http://dx.doi.org/10.1016/j.chaos.2020.109761. Epub 2020 Mar 21.
80. Introduction to the special issue: Tumor antigens in the time of the coronavirus pandemic. Finn OJ. Seminars in Immunology. 2020;47.
81. COVID-19 cacophony: is there any orchestra conductor? Flahault A. The Lancet. 2020;395(10229):1037.
82. COVID-19 Coagulopathy in Caucasian patients. Fogarty H, Townsend L, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Browne P, et al. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16749.
83. COVID-19 and the clinical hematology laboratory. Frater JL, Zini G, d'Onofrio G, Rogers HJ. Int J Lab Hematol. 2020. http://dx.doi.org/10.1111/ijlh.13229.
84. Assessing the severity of COVID-19. Freitas ARR, Napimoga M, Donalisio MR. Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil. 2020;29(2):e2020119.
85. Cardiopulmonary resuscitation after hospital admission with covid-19. Fritz Z, Perkins GD. The BMJ. 2020;369.
86. Why tocilizumab could be an effective treatment for severe COVID-19? Fu B, Xu X, Wei H. Journal of Translational Medicine. 2020;18(1).
87. Simulating and forecasting the cumulative confirmed cases of SARS-CoV-2 in China by Boltzmann function-based regression analyses. Fu X, Ying Q, Zeng T, Long T, Wang Y. Journal of Infection. 2020;80(5):578-606.
88. A cluster of the Corona Virus Disease 2019 caused by incubation period transmission in Wuxi, China. Gao Y, Shi C, Chen Y, Shi P, Liu J, Xiao Y, et al. Journal of Infection. 2020.
89. Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures. Gatto M, Bertuzzo E, Mari L, Miccoli S, Carraro L, Casagrandi R, et al. Proc Natl Acad Sci U S A. 2020. http://dx.doi.org/10.1073/pnas.2004978117.
90. Acute leukemia in the time of COVID-19. Gavillet M, Carr Klappert J, Spertini O, Blum S. Leukemia Research. 2020;92.
91. Denominator matters in estimating COVID-19 mortality rates. Gaye B, Fanidi A, Jouven X. European heart journal. 2020.
92. Estimation of Coronavirus Disease Case-Fatality Risk in Real Time. Ge Y, Sun S. Emerg Infect Dis. 2020;26(8). http://dx.doi.org/10.3201/eid2608.201096.
93. Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current evidence. Gengler I, Wang JC, Speth MM, Sedaghat AR. Laryngoscope Investigative Otolaryngology. 2020.
94. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used). Gentile S, Strollo F, Ceriello A. Diabetes Research and Clinical Practice. 2020;162.
95. Prediction of the number of deaths in India due to SARS-CoV-2 at 5–6 weeks. Ghosal S, Sengupta S, Majumder M, Sinha B. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):311-5.
96. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Giordano G, Blanchini F, Bruno R, Colaneri P, Di Filippo A, Di Matteo A, et al. Nature medicine. 2020. http://dx.doi.org/10.1038/s41591-020-0883-7.
97. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment. Gisondi P, Zaza G, Del Giglio M, Rossi M, Iacono V, Girolomoni G. Journal of the American Academy of Dermatology. 2020. http://dx.doi.org/10.1016/j.jaad.2020.04.085.
98. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future. Golchin A, Seyedjafari E, Ardeshirylajimi A. Stem Cell Reviews and Reports. 2020.
99. Novel Wuhan (2019-NCoV) coronavirus. Graham Carlos W, Dela Cruz CS, Cao B, Pasnick S, Jamil S. American Journal of Respiratory and Critical Care Medicine. 2020;201(4):P7-P8.
100. Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. JAMA - Journal of the American Medical Association. 2020.
101. Preparedness and lessons learned from the novel coronavirus disease. Gudi SK, Tiwari KK. International Journal of Occupational and Environmental Medicine. 2020;11(2):108-12.
102. Chloroquine in CovID-19: The Evidence. Gupta N, Agrawal S, Ish P. Monaldi Archives for Chest Disease. 2020;90(1):177-9.
103. The coronavirus pandemic: “the show must not go on”. Habibzadeh F, Lang T. International Journal of Occupational and Environmental Medicine. 2020;11(2):63-4.
104. CT morphology of COVID-19: Case report and review of literature. Hamer OW, Salzberger B, Gebauer J, Stroszczynski C, Pfeifer M. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2020;192(5):386-92. http://dx.doi.org/10.1055/a-1142-4094. Epub 2020 Mar 26.
105. Social responsibility of medical journal: A concern for covid-19 pandemic. Hamid ARAH. Medical Journal of Indonesia. 2020;29(1):1-3.
106. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics). Hamid S, Mir MY, Rohela GK. New Microbes and New Infections. 2020;35.
107. The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou. He G, Sun W, Fang P, Huang J, Gamber M, Cai J, et al. Journal of medical virology. 2020.
108. COVID-19 in persons with haematological cancers. He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, et al. Leukemia. 2020. http://dx.doi.org/10.1038/s41375-020-0836-7.
109. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Heffernan DS, Evans HL, Huston JM, Claridge JA, Blake DP, May AK, et al. Surgical infections. 2020. http://dx.doi.org/10.1089/sur.2020.101.
110. On the alert for cytokine storm: Immunopathology in COVID-19. Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, et al. Arthritis & rheumatology (Hoboken, NJ). 2020.
111. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Clinical chemistry and laboratory medicine. 2020.
112. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports. Henry BM, Lippi G. Journal of Critical Care. 2020;58:27-8.
113. Understanding epidemic data and statistics: A case study of COVID-19. Hoseinpour Dehkordi A, Alizadeh M, Derakhshan P, Babazadeh P, Jahandideh A. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25885.
114. COVID-19 in a High-Risk Dual Heart and Kidney Transplant Recipient. Hsu JJ, Gaynor P, Kamath M, Fan A, Al-Saffar F, Cruz D, et al. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020. http://dx.doi.org/10.1111/ajt.15936.
115. Comparing rapid scoring systems in mortality prediction of critical ill patients with novel coronavirus disease. Hu H, Yao N, Qiu Y. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2020. http://dx.doi.org/10.1111/acem.13992.
116. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, et al. Journal of Clinical Virology. 2020;127.
117. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Huang I, Lim MA, Pranata R. Diabetes & metabolic syndrome. 2020;14(4):395-403. http://dx.doi.org/10.1016/j.dsx.2020.04.018.
118. Coronavirus: from common cold to severe pulmonary failure: Chronology of a pandemia. Hufert F, Spiegel M. Monatsschrift fur Kinderheilkunde. 2020.
119. The spread of the COVID-19 coronavirus: Health agencies worldwide prepare for the seemingly inevitability of the COVID-19 coronavirus becoming endemic. Hunter P. EMBO Reports. 2020;21(4).
120. Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review. Jacobi A, Chung M, Bernheim A, Eber C. Clinical Imaging. 2020;64:35-42.
121. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients. Jacobs JP, Stammers AH, St Louis J, Hayanga JWA, Firstenberg MS, Mongero LB, et al. ASAIO journal (American Society for Artificial Internal Organs : 1992). 2020. http://dx.doi.org/10.1097/MAT.0000000000001185.
122. The sensitivity and specificity analyses of ambient temperature and population size on the transmission rate of the novel coronavirus (COVID-19) in different provinces of Iran. Jahangiri M, Jahangiri M, Najafgholipour M. Science of the Total Environment. 2020;728.
123. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L, et al. Stroke and Vascular Neurology. 2020.
124. Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (Trial version 1). Jin RM. Chinese Journal of Contemporary Pediatrics. 2020;22(2):96-9.
125. Does COVID-19 Disprove the Obesity Paradox in ARDS? Jose RJ, Manuel A. Obesity (Silver Spring, Md). 2020.
126. Patients with chronic illness urgently need integrated physical and psychological care during the COVID-19 outbreak. Kang C, Yang S, Yuan J, Xu L, Zhao X, Yang J. Asian Journal of Psychiatry. 2020;51.
127. Clinical and laboratory characteristics of acute infections with combined lesions to the respiratory and gastrointestinal tracts in children. Kanner EV, Pechkurov DV, Gorelov AV, Maksimov ML, Ermolaeva AS, Kanshina NN. Infektsionnye Bolezni. 2019;17(4):5-12.
128. Homeless mentally ill people and COVID-19 pandemic: The two-way sword for LMICs. Kar SK, Arafat SMY, Marthoenis M, Kabir R. Asian Journal of Psychiatry. 2020;51.
129. COVID-19 pandemic and addiction: Current problems and future concerns. Kar SK, Arafat SMY, Sharma P, Dixit A, Marthoenis M, Kabir R. Asian Journal of Psychiatry. 2020;51.
130. Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings. Karami P, Naghavi M, Feyzi A, Aghamohammadi M, Novin MS, Mobaien A, et al. Travel Medicine and Infectious Disease. 2020.
131. COVID-19 in People with Mental Illness: Challenges and Vulnerabilities. Kavoor AR. Asian Journal of Psychiatry. 2020;51.
132. Remote consultations in the era of COVID-19 pandemic: Preliminary experience in a regional Australian public acute mental health care setting. Kavoor AR, Chakravarthy K, John T. Asian Journal of Psychiatry. 2020;51.
133. A novel treatment approach to the novel coronavirus: An argument for the use of therapeutic plasma exchange for fulminant COVID-19. Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. Critical Care. 2020;24(1).
134. Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis. Kempton MJ. Journal of Medical Virology. 2020.
135. Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecological analysis of 65 countries. Kenyon C. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.04.007.
136. An Epidemiological Study on COVID-19: A Rapidly Spreading Disease. Khachfe HH, Chahrour M, Sammouri J, Salhab H, Makki BE, Fares M. Cureus. 2020;12(3):e7313. http://dx.doi.org/10.7759/cureus.7313.
137. [Diagnostic consideration and bedside estimation of the prognosis in COVID-19 patients]. Korsos A, Kupcsulik S, Lovas A, Hankovszky P, Molnar T, Szabo Z, et al. Orvosi hetilap. 2020;161(17):667-71. http://dx.doi.org/10.1556/650.2020.31815.
138. Hypertension, the renin-angiotensin system, and` the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Kreutz R, Algharably EAEH, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et al. Cardiovascular research. 2020.
139. Letter to the editor regarding article: Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis (Ghoshal et al.). Kumar A, Arora A, Sharma P. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):383.
140. More questions than answers, but a way ahead. La Manna G. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 2020;37(2).
141. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D. La Vignera S, Cannarella R, Condorelli RA, Torre F, Aversa A, Calogero AE. International journal of molecular sciences. 2020;21(8). http://dx.doi.org/10.3390/ijms21082948.
142. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists' perspective. Lambertini M, Toss A, Passaro A, Criscitiello C, Cremolini C, Cardone C, et al. ESMO Open. 2020;5(2).
143. [Intrahospital resuscitation of COVID-19 patients]. Laszlo I, Molnar C, Koszta G, Vegh T, Fabian A, Berhes M, et al. Orvosi hetilap. 2020;161(17):710-2. http://dx.doi.org/10.1556/650.2020.31816.
144. How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments. Ledford H. Nature. 2020;580(7803):311-2. http://dx.doi.org/10.1038/d41586-020-01056-7.
145. Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review). Lehrer S. World Academy of Sciences journal. 2020;2(3). http://dx.doi.org/10.3892/wasj.2020.42. Epub 2020 Mar 29.
146. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis. Li H, Xiang X, Ren H, Xu L, Zhao L, Chen X, et al. Journal of Infection. 2020.
147. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China. Li J, Wang X, Chen J, Zhang H, Deng A. JAMA cardiology. 2020. http://dx.doi.org/10.1001/jamacardio.2020.1624.
148. The impact of 2019 novel coronavirus on heart injury: A systemic review and Meta-analysis. Li JW, Han TW, Woodward M, Anderson CS, Zhou H, Chen YD, et al. Progress in cardiovascular diseases. 2020. http://dx.doi.org/10.1016/j.pcad.2020.04.008.
149. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: Protocol for a systematic review and meta-Analysis. Li Y, Liu X, Guo L, Li J, Zhong D, Zhang Y, et al. Systematic Reviews. 2020;9(1).
150. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. Lillicrap D. Journal of Thrombosis and Haemostasis. 2020;18(4):786-7.
151. Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study. Ling L, So C, Shum HP, Chan PKS, Lai CKC, Kandamby DH, et al. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 2020.
152. Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis. Lippi G, de Oliveira MHS, Henry BM. European journal of gastroenterology & hepatology. 2020.
153. Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases. Liu C, Wu C, Zheng X, Zeng F, Liu J, Wang P, et al. Journal of the Formosan Medical Association. 2020.
154. Response to the covid-19 epidemic: The chinese experience and implications for other countries. Liu W, Yue XG, Tchounwou PB. International Journal of Environmental Research and Public Health. 2020;17(7).
155. Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival. Liu W, Zhang S, Nekhai S, Liu S. Current clinical microbiology reports. 2020:1-7. http://dx.doi.org/10.1007/s40588-020-00140-w.
156. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, et al. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14869.
157. Understanding coronavirus disease (COVID-19) risk perceptions among the public to enhance risk communication efforts: A practical approach for outbreaks, Finland, February 2020. Lohiniva AL, Sane J, Sibenberg K, Puumalainen T, Salminen M. Eurosurveillance. 2020;25(13).
158. Cardiovascular complications in COVID-19. Long B, Brady WJ, Koyfman A, Gottlieb M. American Journal of Emergency Medicine. 2020.
159. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms. Lovato A, de Filippis C. Ear, nose, & throat journal. 2020:145561320920762.
160. Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19. Lu C, Li S, Liu Y. Annals of the Rheumatic Diseases. 2020.
161. COVID-19 Lung Injury and High Altitude Pulmonary Edema: A False Equation with Dangerous Implications. Luks AM, Swenson ER. Annals of the American Thoracic Society. 2020. http://dx.doi.org/10.1513/AnnalsATS.202004-327FR.
162. Tocilizumab treatment in COVID-19: A single center experience. Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Journal of Medical Virology. 2020.
163. Preparing for the Most Critically Ill Patients with COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation. Maclaren G, Fisher D, Brodie D. JAMA - Journal of the American Medical Association. 2020;323(13):1245-6.
164. The daily impact of COVID-19 in gastroenterology. Magro F, Abreu C, Rahier JF. United European Gastroenterology Journal. 2020.
165. Case- fatality rate in COVID- 19 patients: A meta-analysis of publicly accessible database. Maitra S, Biswas M, Bhattacharjee S. medRxiv. 2020:2020.04.09.20059683.
166. Targeting the Adipose Tissue in COVID-19. Malavazos AE, Corsi Romanelli MM, Bandera F, Iacobellis G. Obesity (Silver Spring, Md). 2020. http://dx.doi.org/10.1002/oby.22844.
167. [CoViD-19 and PPE: some of us will die because of the shortage.]. Mandrola J. Recenti progressi in medicina. 2020;111(4):183. http://dx.doi.org/10.1701/3347.33175.
168. Guide to the Forensic Pathology Practice on Death Cases Related to Corona Virus Disease 2019 （ COVID-19） （Trial Draft. Mao DM, Zhou N, Zheng D, Yue JC, Zhao QH, Luo B, et al. Fa yi xue za zhi. 2020;36(1):6-5.
169. A Case of SARS-CoV-2-pneumonia with successful antiviral therapy in a 77-year-old male with heart transplant. Mathies D, Rauschning D, Wagner U, Mueller F, Maibaum M, Binnemann C, et al. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020. http://dx.doi.org/10.1111/ajt.15932.
170. Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS-CoV-2 to fragile health systems of southern hemisphere countries this winter? Mendelson M. International Journal of Infectious Diseases. 2020;94:32-3.
171. Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience in New York City. Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, et al. Annals of oncology : official journal of the European Society for Medical Oncology. 2020. http://dx.doi.org/10.1016/j.annonc.2020.04.006.
172. Radiation therapy considerations during the COVID-19 Pandemic: Literature review and expert opinions. Mohindra P, Buckey CR, Chen S, Sio TN, Rong Y. Journal of applied clinical medical physics. 2020. http://dx.doi.org/10.1002/acm2.12898.
173. Escaping Pandora's box - Another novel coronavirus. Morens DM, Daszak P, Taubenberger JK. New England Journal of Medicine. 2020;382(14):1293-5.
174. Organ Donation During the Coronavirus Pandemic: An Evolving Saga in Uncharted Waters. Moris D, Shaw BI, Dimitrokallis N, Barbas AS. Transplant international : official journal of the European Society for Organ Transplantation. 2020.
175. Covid-19 nephropathy; an emerging condition caused by novel coronavirus infection. Mubarak M, Nasri H. Journal of Nephropathology. 2020;9(3).
176. The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis: A review. Nahama A, Ramachandran R, Cisternas AF, Ji H. Medicine in Drug Discovery. 2020;5.
177. Seattle's covid-19 lessons are yielding hope. Nelson B. The BMJ. 2020;369.
178. When health professionals look death in the eye: the mental health of professionals who deal daily with the 2019 coronavirus outbreak. Neto MLR, Almeida HG, Esmeraldo JD, Nobre CB, Pinheiro WR, de Oliveira CRT, et al. Psychiatry Research. 2020;288.
179. When basic supplies are missing, what to do? Specific demands of the local street population in times of coronavirus – a concern of social psychiatry. Neto MLR, de Souza RI, Quezado RMM, Mendonça ECS, de Araújo TI, Luz DCRP, et al. Psychiatry Research. 2020;288.
180. COVID-19 international outbreak and the need for a suitable estimation model: A second-order polynomial equation with constant coefficients based on imported infected cases seems inadequate. Niazkar HR, Niazkar M. Asian Pacific Journal of Tropical Medicine. 2020;13(4):185-6.
181. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? Novi G, Mikulska M, Briano F, Toscanini F, Tazza F, Uccelli A, et al. Multiple Sclerosis and Related Disorders. 2020;42.
182. Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality. Ogen Y. Science of the Total Environment. 2020;726.
183. What's New With the Old Coronaviruses? Ogimi C, Kim YJ, Martin ET, Huh HJ, Chiu CH, Englund JA. J Pediatric Infect Dis Soc. 2020. http://dx.doi.org/10.1093/jpids/piaa037.
184. Headaches Associated With Personal Protective Equipment – A Cross-Sectional Study Among Frontline Healthcare Workers During COVID-19. Ong JJY, Bharatendu C, Goh Y, Tang JZY, Sooi KWX, Tan YL, et al. Headache. 2020.
185. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. Pachetti M, Marini B, Benedetti F, Giudici F, Mauro E, Storici P, et al. J Transl Med. 2020;18(1):179. http://dx.doi.org/10.1186/s12967-020-02344-6.
186. Pediatric Otolaryngology Divisional and Institutional Preparatory Response at Seattle Children’s Hospital after COVID-19 Regional Exposure. Parikh SR, Bly RA, Bonilla-Velez J, Dahl JP, Evans SS, Horn DL, et al. Otolaryngology - Head and Neck Surgery (United States). 2020.
187. Changes in Subway Ridership in Response to COVID-19 in Seoul, South Korea: Implications for Social Distancing. Park J. Cureus. 2020;12(4):e7668. http://dx.doi.org/10.7759/cureus.7668.
188. On the front lines of coronavirus: The Italian response to covid-19. Paterlini M. The BMJ. 2020;368.
189. COVID-19 in Solid Organ Transplant Recipients: Initial Report from the US Epicenter. Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020. http://dx.doi.org/10.1111/ajt.15941.
190. How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation. Perini GF, Fischer T, Gaiolla RD, Rocha TB, Bellesso M, Teixeira LLC, et al. Hematology, transfusion and cell therapy. 2020. http://dx.doi.org/10.1016/j.htct.2020.04.002.
191. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, et al. Journal of Autoimmunity. 2020.
192. Understanding the emerging coronavirus: what it means for health security and infection prevention. Peters A, Vetter P, Guitart C, Lotfinejad N, Pittet D. Journal of Hospital Infection. 2020;104(4):440-8.
193. [Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society]. Pfeifer M, Ewig S, Voshaar T, Randerath W, Bauer T, Geiseler J, et al. Pneumologie (Stuttgart, Germany). 2020. http://dx.doi.org/10.1055/a-1157-9976.
194. Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19. Philip M, Lakhtakia S, Aggarwal R, Madan K, Saraswat V, Makharia G. Journal of Clinical and Experimental Hepatology. 2020.
195. Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. Piva S, Filippini M, Turla F, Cattaneo S, Margola A, De Fulviis S, et al. Journal of Critical Care. 2020;58:29-33.
196. Response letter to COIVD-19 Disease: Tackling a pandemic in 21st Century. Qian GQ, Ma AHY, Yang NB, Ruan LM. QJM : monthly journal of the Association of Physicians. 2020.
197. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis. Radmanesh F, Rodriguez-Pla A, Pincus MD, Burns JD. Journal of Clinical Neuroscience. 2020.
198. Challenges of managing the asymptomatic carriers of SARS-CoV-2. Rahimi F, Bezmin Abadi AT. Travel Med Infect Dis. 2020:101677. http://dx.doi.org/10.1016/j.tmaid.2020.101677.
199. Defending against the Novel Coronavirus (COVID-19) Outbreak: How Can the Internet of Things (IoT) help to save the World? Rahman MS, Peeri NC, Shrestha N, Zaki R, Haque U, Hamid SHA. Health policy and technology. 2020. http://dx.doi.org/10.1016/j.hlpt.2020.04.005.
200. Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives. Raj K, Rohit, Ghosh A, Singh S. Virusdisease. 2020:1-9. http://dx.doi.org/10.1007/s13337-020-00580-4.
201. Mental health of medical workers in Pakistan during the pandemic COVID-19 outbreak. Rana W, Mukhtar S, Mukhtar S. Asian Journal of Psychiatry. 2020;51.
202. Suicide Mortality and Coronavirus Disease 2019 - A Perfect Storm? Reger MA, Stanley IH, Joiner TE. JAMA Psychiatry. 2020.
203. Covid-19 and Iran: Swimming with hands tied! Reza G, Fatemeh H. Swiss Medical Weekly. 2020;150(15).
204. COVID-19 pandemic: Palliative care for elderly and frail patients at home and in residential and nursing homes. Roland K, Markus M. Swiss Medical Weekly. 2020;150(13).
205. Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography. Rotzinger DC, Beigelman-Aubry C, von Garnier C, Qanadli SD. Thrombosis Research. 2020;190:58-9.
206. Interleukin-6 blockade for severe COVID-19. Roumier M, Paule R, Groh M, Vallee A, Ackermann F. medRxiv. 2020:2020.04.20.20061861.
207. Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic – Case study from the Republic of Ireland. Rowan NJ, Laffey JG. Science of the Total Environment. 2020;725.
208. Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic. Roy NB, Telfer P, Eleftheriou P, de la Fuente J, Drasar E, Shah F, et al. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16687.
209. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China (Intensive Care Medicine, (2020), 10.1007/s00134-020-05991-x). Ruan Q, Yang K, Wang W, Jiang L, Song J. Intensive Care Medicine. 2020.
210. Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation and Cytokine Amplification in COVID-19. Ryan PM, Caplice NM. Obesity (Silver Spring, Md). 2020. http://dx.doi.org/10.1002/oby.22843.
211. Corona, COVID and kidney transplantation. Sahay M, Kute V, Prasad N. Indian Journal of Transplantation. 2020;14(1):1-4.
212. Routine childhood immunization may protect against COVID-19. Salman S, Salem ML. Medical Hypotheses. 2020;140.
213. Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China. Salzberger B, Glück T, Ehrenstein B. Infection. 2020;48(2):151-3.
214. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis. Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I, Antariksa B. The American journal of emergency medicine. 2020. http://dx.doi.org/10.1016/j.ajem.2020.04.052.
215. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine. Sarayani A, Cicali B, Henriksen CH, Brown JD. Research in social & administrative pharmacy : RSAP. 2020. http://dx.doi.org/10.1016/j.sapharm.2020.04.016.
216. Covid-19 and its impact on nephropathic patients: the experience at Ospedale "Guglielmo da Saliceto" in Piacenza. Scarpioni R, Manini A, Valsania T, De Amicis S, Albertazzi V, Melfa L, et al. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 2020;37(2).
217. COVID-19 pandemic: Triage for intensive-care treatment under resource scarcity. Scheidegger D, Fumeaux T, Hurst S, Salathé M. Swiss Medical Weekly. 2020;150(13).
218. Implications for forensic death investigations from first Swiss post-mortem CT in a case of non-hospital treatment with COVID-19. Schweitzer W, Ruder T, Baumeister R, Bolliger S, Thali M, Meixner E, et al. Forensic Imaging. 2020;21.
219. COVID-19 and Indonesia. Setiati S, Azwar MK. Acta medica Indonesiana. 2020;52(1):84-9.
220. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Shao F, Xu S, Ma X, Xu Z, Lyu J, Ng M, et al. Resuscitation. 2020;151:18-23.
221. What can we do for people exposed to multiple traumatic events during the coronavirus pandemic? Shi W, Hall BJ. Asian Journal of Psychiatry. 2020;51.
222. Today's Leadership Lesson: Mind the Wildlife and Prepare for Tomorrow's Disruption. Shore DA. Journal of health communication. 2020:1-2. http://dx.doi.org/10.1080/10810730.2020.1749193.
223. Covid-19: The outbreak caused by a new coronavirus. Sifuentes-Rodríguez E, Palacios-Reyes D. Boletin Medico del Hospital Infantil de Mexico. 2020;77(2):47-53.
224. COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population. Signorelli C, Scognamiglio T, Odone A. Acta bio-medica : Atenei Parmensis. 2020;91(3):175-9.
225. Prehabilitation May Help Mitigate an Increase in COVID-19 Peri-Pandemic Surgical Morbidity and Mortality. Silver JK. Am J Phys Med Rehabil. 2020. http://dx.doi.org/10.1097/PHM.0000000000001452.
226. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):303-10.
227. Home and Community-Based Physical Therapist Management of Adults With Post-Intensive Care Syndrome. Smith JM, Lee AC, Zeleznik H, Coffey Scott JP, Fatima A, Needham DM, et al. Physical therapy. 2020.
228. Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates. Sokouti M, Sadeghi R, Pashazadeh S, Eslami S, Sokouti M, Ghojazadeh M, et al. Archives of Medical Research. 2020.
229. CoviD-19, a clinical syndrome manifesting as hypersensitivity pneumonitis. Song YG, Shin HS. Infection and Chemotherapy. 2020;52(1):110-2.
230. Hospital pharmacists' pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Song Z, Hu Y, Zheng S, Yang L, Zhao R. Research in social & administrative pharmacy : RSAP. 2020.
231. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Soresina A, Moratto D, Chiarini M, Paolillo C, Baresi G, Foca E, et al. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2020. http://dx.doi.org/10.1111/pai.13263.
232. A hypothesis for pathobiology and treatment of COVID-19: the centrality of ACE1/ACE2 imbalance. Sriram K, Insel PA. British journal of pharmacology. 2020. http://dx.doi.org/10.1111/bph.15082.
233. Covid-19: Why Germany's case fatality rate seems so low. Stafford N. The BMJ. 2020;369.
234. Lessons from covid-19: Visiting patients at home and assessing comorbidities. Stevens AMH. The BMJ. 2020;369.
235. First cases of coronavirus disease 2019 (COVID-19) in France: Surveillance, investigations and control measures, January 2020. Stoecklin SB, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, et al. Eurosurveillance. 2020;25(6).
236. Epidemiology of Coronavirus COVID-19: Forecasting the Future Incidence in Different Countries. Stubinger J, Schneider L. Healthcare (Basel, Switzerland). 2020;8(2). http://dx.doi.org/10.3390/healthcare8020099.
237. SARS-CoV-2 Infection in Pregnancy - a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome. Stumpfe FM, Titzmann A, Schneider MO, Stelzl P, Kehl S, Fasching PA, et al. Geburtshilfe und Frauenheilkunde. 2020;80(4):380-90. http://dx.doi.org/10.1055/a-1134-5951. Epub 2020 Mar 26.
238. The different clinical characteristics of corona virus disease cases between children and their families in China–the character of children with COVID-19. Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, et al. Emerging Microbes and Infections. 2020;9(1):707-13.
239. Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. Suba Z. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2020;23(1):75-85. http://dx.doi.org/10.18433/jpps31069.
240. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak. Tanriverdi O. Medical oncology (Northwood, London, England). 2020;37(6):51. http://dx.doi.org/10.1007/s12032-020-01376-8.
241. Hematological findings and complications of COVID-19. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. American journal of hematology. 2020.
242. COVID-19 in the USA: a question of time. The L. The Lancet. 2020;395(10232):1229.
243. Letter: Covid-19 and vitamin D-authors' reply. Tian Y, Rong L. Alimentary pharmacology & therapeutics. 2020.
244. Outbreak trends of CoronaVirus (COVID-19) in India: A Prediction. Tiwari S, Kumar S, Guleria K. Disaster medicine and public health preparedness. 2020:1-9. http://dx.doi.org/10.1017/dmp.2020.115.
245. The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event. Tu H, Tu S, Gao S, Shao A, Sheng J. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.04.011.
246. [The coronavirus-induced COVID-19 pandemic. Previous experiences and scientific evidences at the end of March, 2020]. Varadi A, Ferenci T, Falus A. Orvosi hetilap. 2020;161(17):644-51. http://dx.doi.org/10.1556/650.2020.31830.
247. COVID-19 and smoking: A systematic review of the evidence. Vardavas CI, Nikitara K. Tobacco Induced Diseases. 2020;18.
248. Spinal muscular atrophy care in the COVID-19 pandemic era. Veerapandiyan A, Connolly AM, Finkel RS, Arya K, Mathews KD, Smith EC, et al. Muscle Nerve. 2020. http://dx.doi.org/10.1002/mus.26903.
249. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. Verdecchia P, Reboldi G, Cavallini C, Mazzotta G, Angeli F. Giornale italiano di cardiologia (2006). 2020;21(5):321-7. http://dx.doi.org/10.1714/3343.33127.
250. Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020. Verelst F, Kuylen E, Beutels P. Eurosurveillance. 2020;25(13).
251. The world's largest refugee camp prepares for covid-19. Vince G. The BMJ. 2020;368.
252. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Wang A, Zhao W, Xu Z, Gu J. Diabetes Research and Clinical Practice. 2020;162.
253. Epidemiological characteristics and transmission model of Corona Virus Disease 2019 in China. Wang D, Zhou M, Nie X, Qiu W, Yang M, Wang X, et al. Journal of Infection. 2020;80(5):e25-e7.
254. Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic. Wang J, Xu C, Wong YK, He Y, Adegnika AA, Kremsner PG, et al. The Lancet. 2020;395(10230):1094-6.
255. 15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study. Wang K, Zhang Z, Yu M, Tao Y, Xie M. Intensive Care Med. 2020. http://dx.doi.org/10.1007/s00134-020-06047-w.
256. Epidemiology of 2019 novel coronavirus in Jiangsu Province, China after wartime control measures: A population-level retrospective study. Wang KW, Gao J, Wang H, Wu XL, Yuan QF, Guo FY, et al. Travel Medicine and Infectious Disease. 2020.
257. Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm. Wang L, Li J, Guo S, Xie N, Yao L, Cao Y, et al. Science of the Total Environment. 2020;727.
258. Expert consensus on the nursing management of critically ill elderly patients with coronavirus disease 2019. Wang X, Sun C, Hu HX, Wang ZX, Wang H, Peng H, et al. Aging Medicine. 2020.
259. Novel Coronavirus Infection in Hospitalized Infants under 1 Year of Age in China. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. JAMA - Journal of the American Medical Association. 2020;323(13):1313-4.
260. Visit to singapore medical journal during covid-19 outbreak: Learning “beyond” the expectation. Widjaja FF, Suryaningrat WCHN. Medical Journal of Indonesia. 2020;29(1):3-5.
261. What goes on board aircraft? Passengers include Aedes, Anopheles, 2019-nCoV, dengue, Salmonella, Zika, et al. Wilson ME. Travel Medicine and Infectious Disease. 2020;33.
262. Covid-19: Death rate in England and Wales reaches record high because of covid-19. Wise J. BMJ (Clinical research ed). 2020;369:m1484.
263. The SARS-CoV-2 outbreak: What we know. Wu D, Wu T, Liu Q, Yang Z. International Journal of Infectious Diseases. 2020;94:44-8.
264. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. Wu Z, McGoogan JM. JAMA - Journal of the American Medical Association. 2020;323(13):1239-42.
265. Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19. Xia XY, Wu J, Liu HL, Xia H, Jia B, Huang WX. Journal of Clinical Virology. 2020;127.
266. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China. Xu B, Fan CY, Wang AL, Zou YL, Yu YH, He C, et al. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.04.012.
267. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Xu K, Chen Y, Yuan J, Yi P, Ding C, Wu W, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
268. Self-reported olfactory loss associates with outpatient clinical course in Covid-19. Yan CH, Faraji F, Prajapati DP, Ostrander BT, DeConde AS. International forum of allergy & rhinology. 2020. http://dx.doi.org/10.1002/alr.22592.
269. Coronavirus disease 2019: reassembly attack of coronavirus. Yang C, Qiu X, Fan H, Jiang M, Lao X, Zeng Y, et al. International journal of environmental health research. 2020:1-9. http://dx.doi.org/10.1080/09603123.2020.1747602.
270. Moral obligation, public leadership, and collective action for epidemic prevention and control: Evidence from the corona virus disease 2019 (COVID-19) emergency. Yang L, Ren Y. International Journal of Environmental Research and Public Health. 2020;17(8).
271. Clinical characteristics and risk assessment of newborns born to mothers with COVID-19. Yang P, Wang X, Liu P, Wei C, He B, Zheng J, et al. Journal of Clinical Virology. 2020;127.
272. Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients. Yang Z, Shi J, He Z, Lü Y, Xu Q, Ye C, et al. Aging. 2020;12.
273. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. Yang Z, Zeng Z, Wang K, Wong SS, Liang W, Zanin M, et al. Journal of Thoracic Disease. 2020;12(3):165-74.
274. Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients. Yao Q, Wang P, Wang X, Qie G, Meng M, Tong X, et al. Polish archives of internal medicine. 2020. http://dx.doi.org/10.20452/pamw.15312.
275. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, et al. British Journal of Anaesthesia. 2020.
276. Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster. Ye F, Xu S, Rong Z, Xu R, Liu X, Deng P, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
277. The pathogenesis and treatment of the ‘Cytokine Storm' in COVID-19. Ye Q, Wang B, Mao J. Journal of Infection. 2020.
278. Age-related rhesus macaque models of COVID-19. Yu P, Qi F, Xu Y, Li F, Liu P, Liu J, et al. Animal models and experimental medicine. 2020;3(1):93-7. http://dx.doi.org/10.1002/ame2.12108. eCollection 2020 Mar.
279. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression. Yu X, Sun S, Shi Y, Wang H, Zhao R, Sheng J. Crit Care. 2020;24(1):170. http://dx.doi.org/10.1186/s13054-020-02893-8.
280. COVID-19 pathophysiology: A review. Yuki K, Fujiogi M, Koutsogiannaki S. Clinical immunology (Orlando, Fla). 2020:108427. http://dx.doi.org/10.1016/j.clim.2020.108427.
281. Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Zaorsky NG, Yu JB, McBride SM, Dess RT, Jackson WC, Mahal BA, et al. Advances in Radiation Oncology. 2020.
282. SARS-CoV-2 Pandemic and The Need for Transplant-oriented Trials. Zaza G, Benedetti C, Fribourg M, Maggiore U, Azzi J, Riella LV, et al. Transplant international : official journal of the European Society for Organ Transplantation. 2020. http://dx.doi.org/10.1111/tri.13626.
283. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2? Zbinden-Foncea H, Francaux M, Deldicque L, Hawley JA. Obesity (Silver Spring, Md). 2020. http://dx.doi.org/10.1002/oby.22849.
284. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). Zha L, Li S, Pan L, Tefsen B, Li Y, French N, et al. Medical Journal of Australia. 2020.
285. The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study. Zhang J, Liu P, Wang M, Wang J, Chen J, Yuan W, et al. Zeitschrift fur Gesundheitswissenschaften = Journal of public health. 2020:1-4. http://dx.doi.org/10.1007/s10389-020-01291-2.
286. Progress and prospects on vaccine development against sars-cov-2. Zhang J, Zeng H, Gu J, Li H, Zheng L, Zou Q. Vaccines. 2020;8(2).
287. Distinct characteristics of COVID-19 patients with initial rRT-PCR positive and negative results for SARS-CoV-2. Zhang JJ, Cao YY, Dong X, Wang BC, Liao MY, Lin J, et al. Allergy. 2020.
288. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14859.
289. The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges. Zhang S, Diao MY, Duan L, Lin Z, Chen D. Intensive Care Medicine. 2020;46(4):591-3.
290. Emergence of SARS-like coronavirus in China: An update. Zhang Z, Xiao K, Zhang X, Roy A, Shen Y. Journal of Infection. 2020;80(5):e28-e9.
291. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. International Journal of Infectious Diseases. 2020;92:214-7.
292. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, et al. Bmj. 2020;369:m1443. http://dx.doi.org/10.1136/bmj.m1443.
293. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Zheng SQ, Yang L, Zhou PX, Li HB, Liu F, Zhao RS. Research in social & administrative pharmacy : RSAP. 2020.
294. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Current cardiology reports. 2020;22(5):32. http://dx.doi.org/10.1007/s11886-020-01292-3.
295. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Translational Pediatrics. 2020;9(1):51-60.
296. Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Journal of medical virology. 2020.
297. Clinical characteristics of a case series of children with coronavirus disease 2019. Zhu L, Wang J, Huang R, Liu L, Zhao H, Wu C, et al. Pediatric Pulmonology. 2020.
298. Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020. Zhuang Z, Zhao S, Lin Q, Cao P, Lou Y, Yang L, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.04.044.
299. Approaches to the management of patients in oral and maxillofacial surgery during COVID-19 pandemic. Zimmermann M, Nkenke E. Journal of Cranio-Maxillofacial Surgery. 2020.
300. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Zimmermann P, Curtis N. The Pediatric infectious disease journal. 2020;39(5):355-68. http://dx.doi.org/10.1097/INF.0000000000002660.
Literatuuroverzicht tot 23-04-2020
1. Department of Error: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (The Lancet, (S0140673620305663), (10.1016/S0140-6736(20)30566-3)). The Lancet. 2020.
2. [An update on the epidemiological characteristics of novel coronavirus pneumoniaCOVID-19]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):139-44. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2020.02.002.
3. [Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;17:E020. http://dx.doi.org/10.3760/cma.j.issn.1001-0939.2020.0020.
4. [Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43:E034. http://dx.doi.org/10.3760/cma.j.cn112147-20200227-00201.
5. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morbidity and mortality weekly report. 2020;69(12):343-6. http://dx.doi.org/10.15585/mmwr.mm6912e2.
6. Coronavirus papers: Debilitated patients rally after dose of survivors' blood. Nature. 2020. http://dx.doi.org/10.1038/d41586-020-00502-w.
7. Erratum: Department of Error (The Lancet (2020) 395(10229) (1054–1062), (S0140673620305663), (10.1016/S0140-6736(20)30566-3)). The Lancet. 2020;395(10229):1038.
8. The Novel Coronavirus Outbreak: What We Know and What We Don't. Cell. 2020;180(6):1034-6.
9. Stop the Wuhan virus. Nature. 2020;577(7791):450.
10. Airway management of COVID-19 patients with severe pneumonia. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery. 2020;55(4):E001.
11. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(2):145-51.
12. An update on the epidemiological characteristics of novel coronavirus pneumonia（COVID-19）. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(2):139-44.
13. Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020. Journal of Korean medical science. 2020;35(12):e132.
14. Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea. Osong public health and research perspectives. 2020;11(2):85-90. http://dx.doi.org/10.24171/j.phrp.2020.11.2.05.
15. COVID-19, Australia: Epidemiology Report 8 (Reporting period from 19:00 AEDT 14 March to 23:59 AEDT 22 March 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.28.
16. Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 14, 2020. Arch Acad Emerg Med. 2020;8(1):e24.
17. Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 15, 2020. Arch Acad Emerg Med. 2020;8(1):e25.
18. Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 16, 2020. Arch Acad Emerg Med. 2020;8(1):e26.
19. Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 17, 2020. Arch Acad Emerg Med. 2020;8(1):e28.
20. Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 22, 2020. Arch Acad Emerg Med. 2020;8(1):e32.
21. Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 23, 2020. Arch Acad Emerg Med. 2020;8(1):e36.
22. Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 25, 2020. Arch Acad Emerg Med. 2020;8(1):e38.
23. Erratum: Epidemiologic Features and Clinical Course of Patients Infected with SARS-CoV-2 in Singapore(Journal of Physical Chemistry (2020) DOI: 10.1001/jama.2020.3204). JAMA - Journal of the American Medical Association. 2020.
24. Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020. MMWR Morbidity and mortality weekly report. 2020;69(15):465-71. http://dx.doi.org/10.15585/mmwr.mm6915e4.
25. COVID-19, Australia: Epidemiology Report 6 (Reporting week ending 19:00 AEDT 7 March 2020). 2020;44.
26. COVID-19, Australia: Epidemiology Report 5 (Reporting week ending 19:00 AEDT 29 February 2020). 2020;44.
27. [Rapid investigation plan of clinical courses and key diagnosis and treatment equipment requirements for the patients of the 2019 Novel Coronavirus Pneumonia (COVID-19)]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(3):296-.
28. Radiological signs of a new coronavirus infection COVID-19 ;Лучевые проявления новой коронавирусной инфекции COVID-19. A AS, А АС. Diagnostic radiology and radiotherapy (E-Journal) / Лучевая диагностика и терапия. 2020.
29. Covid-19 infection and mortality - A physiologist's perspective enlightening clinical features and plausible interventional strategies. Abassi ZA, Skorecki K, Heyman SN, Kinaneh S, Armaly Z. American journal of physiology Lung cellular and molecular physiology. 2020.
30. Haemophilus parainfluenzae endocarditis with multiple cerebral emboli and infarcts in a young pregnant woman. Abu-Hishmeh M, Martin A, DeCastro A, Paul L. American Journal of Respiratory and Critical Care Medicine. 2019;199(9).
31. Special report: The simulations driving the world's response to COVID-19. Adam D. Nature. 2020;580(7803):316-8. http://dx.doi.org/10.1038/d41586-020-01003-6.
32. Individual and network characteristic associated with hospital-acquired Middle East Respiratory Syndrome coronavirus. Adegboye O, Saffary T, Adegboye M, Elfaki F. Journal of Infection and Public Health. 2019;12(3):343-9.
33. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Infectious Diseases of Poverty. 2020;9(1).
34. A Case Study Evaluating the Risk of Infection from Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) in a Hospital Setting Through Bioaerosols. Adhikari U, Chabrelie A, Weir M, Boehnke K, McKenzie E, Ikner L, et al. Risk analysis : an official publication of the Society for Risk Analysis. 2019;39(12):2608-24.
35. Bactrian camels shed large quantities of Middle East respiratory syndrome coronavirus (MERS-CoV) after experimental infection*. Adney DR, Letko M, Ragan IK, Scott D, van Doremalen N, Bowen RA, et al. Emerging Microbes and Infections. 2019;8(1):717-23.
36. Will COVID-19 be a litmus test for post-Ebola Sub-Saharan Africa? Agyeman AA, Laar A, Ofori-Asenso R. Journal of medical virology. 2020.
37. Are we ready for the new fatal Coronavirus: scenario of Pakistan? Ahmad T, Khan M, Khan FM, Hui J. Human Vaccines and Immunotherapeutics. 2020;16(3):736-8.
38. Epidemiological status of the middle east respiratory syndrome coronavirus in 2019: An update from january 1 to march 31, 2019. Ahmadzadeh J, Mobaraki K. International Journal of General Medicine. 2019;12:305-11.
39. The risk factors associated with MERS-CoV patient fatality: A global survey. Ahmadzadeh J, Mobaraki K, Mousavi SJ, Aghazadeh-Attari J, Mirza-Aghazadeh-Attari M, Mohebbi I. Diagnostic Microbiology and Infectious Disease. 2020;96(3).
40. Acute respiratory distress syndrome (ARDS) in hail region, Saudi Arabia. Ahmed HG, Alquwaiay FK, Al-Dhamadi HF, Alzamil AF, Alshammari IHE, Altayep KM. International Journal of Pharmaceutical Sciences and Research. 2020;11(2):987-92.
41. Middle east respiratory syndrome coronavirus (Mers-cov) in Oman: Current situation and going forward. Al Awaidy ST, Khamis F. Oman Medical Journal. 2019;34(3):181-3.
42. A dynamic immune response shapes COVID-19 progression. al Oe. Cell Host & Microbe. 2020.
43. Middle east respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia. Al-Abdely HM, Midgley CM, Alkhamis AM, Abedi GR, Lu X, Binder AM, et al. Emerging Infectious Diseases. 2019;25(4):753-66.
44. Diabetes mellitus, hypertension, and death among 32 patients with MERS-CoV infection, Saudi Arabia. Alanazi KH, Abedi GR, Midgley CM, Alkhamis A, Alsaqer T, Almoaddi A, et al. Emerging Infectious Diseases. 2020;26(1):166-8.
45. Middle east respiratory syndrome (MERS) infection in hematological and oncological patients: A case series from a tertiary care center in Saudi Arabia. Alaskar A, Bosaeed M, Rehan H, Mendoza MA, Alahmari B, Othman A, et al. Blood. 2019;134.
46. A novel coronavirus outbreak from Wuhan City in China, rapid need for emergency departments preparedness and response; a letter to editor. Alavi-Moghaddam M. Archives of Academic Emergency Medicine. 2020;8(1).
47. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns. Al-Awadhi AM, Al-Saifi K, Al-Awadhi A, Alhamadi S. Journal of behavioral and experimental finance. 2020:100326. http://dx.doi.org/10.1016/j.jbef.2020.100326.
48. Characteristics and outcome of viral pneumonia caused by influenza and Middle East respiratory syndrome-coronavirus infections: A 4-year experience from a tertiary care center. Al-Baadani A, Elzein F, Alhemyadi S, Khan O, Albenmousa A, Idrees M. Annals of Thoracic Medicine. 2019;14(3):179-85.
49. INCIDENTAL FINDINGS SUGGESTIVE OF COVID-19 IN ASYMPTOMATIC PATIENTS UNDERGOING NUCLEAR MEDICINE PROCEDURES IN A HIGH PREVALENCE REGION. Albano D, Bertagna F, Bertolia M, Bosio G, Lucchini S, Motta F, et al. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2020.
50. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation. Albarello F, Pianura E, Di Stefano F, Cristofaro M, Petrone A, Marchioni L, et al. International Journal of Infectious Diseases. 2020;93:192-7.
51. Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients. Alburikan KA, Abuelizz HA. Saudi Pharmaceutical Journal. 2020;28(2):161-4.
52. Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study. Alfaraj SH, Al-Tawfiq JA, Assiri AY, Alzahrani NA, Alanazi AA, Memish ZA. Travel Medicine and Infectious Disease. 2019;29:48-50.
53. Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to middle east respiratory syndrome coronavirus infection and disease. Algaissi A, Agrawal AS, Han S, Peng BH, Luo C, Li F, et al. Journal of Infectious Diseases. 2019;219(5):829-35.
54. Quantification of the middle east respiratory syndrome-coronavirus rna in tissues by quantitative real-time RT-PCR. Algaissi A, Agrawal AS, Hashem AM, Tseng CTK. Journal. 2020;2099(Issue):99-106.
55. The Role of Data Registries in the Time of COVID-19. Alger HM, Williams Iv JH, Walchok JG, Bolles MM, Fonarow GC, Rutan C. Circulation Cardiovascular quality and outcomes. 2020. http://dx.doi.org/10.1161/CIRCOUTCOMES.120.006766.
56. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Read Online: Critical Care Medicine | Society of Critical Care Medicine. 9000.
57. Structure and oligomerization of frataxin: Insights into the mechanisms of iron delivery and detoxification in mitochondria. Al-Karadaghi S, Soderberg C, Rajan S, Ahlgren EC, Shkumatov A, Gakh O, et al. FEBS Journal. 2013;280:111.
58. Descriptive Epidemiology, Clinical Characteristics and Outcomes for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infected Patients in AlAin – Abu Dhabi Emirate. Alkendi F, Nair SC, Hashmey R. Journal of Infection and Public Health. 2019;12(1):137.
59. Temporal dynamics of Middle East respiratory syndrome coronavirus in the Arabian Peninsula, 2012-2017. Alkhamis MA, Fernández-Fontelo A, Vanderwaal K, Abuhadida S, Puig P, Alba-Casals A. Epidemiology and Infection. 2019;147.
60. SAT-028 ACUTE KIDNEY INJURY ASSOCIATED WITH MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) INFECTION. Alkindi F, Boobes Y, Chandrasekhar Nair S, Hashmey R. Kidney International Reports. 2020;5(3):S13.
61. Seroepidemiological study of feline coronavirus (FCoV) infection in domiciled cats from Botucatu, São Paulo, Brazil. Almeida ACS, Galdino MV, Araújo JP. Pesquisa Veterinaria Brasileira. 2019;39(2):129-33.
62. A classifier prediction model to predict the status of Coronavirus COVID-19 patients in South Korea. Al-Najjar H, Al-Rousan N. Eur Rev Med Pharmacol Sci. 2020;24(6):3400-3. http://dx.doi.org/10.26355/eurrev_202003_20709.
63. MERS coronavirus outbreak: Implications for emerging viral infections. Al-Omari A, Rabaan AA, Salih S, Al-Tawfiq JA, Memish ZA. Diagnostic Microbiology and Infectious Disease. 2019;93(3):265-85.
64. Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: A retrospective study. Alqahtani FY, Aleanizy FS, Ali El Hadi Mohamed R, Alanazi MS, Mohamed N, Alrasheed MM, et al. Epidemiology and Infection. 2019;147.
65. Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome. Alraddadi BM, Qushmaq I, Al-Hameed FM, Mandourah Y, Almekhlafi GA, Jose J, et al. Influenza and other Respiratory Viruses. 2019;13(4):382-90.
66. Burden of Middle East respiratory syndrome coronavirus infection in Saudi Arabia. Al-Raddadi RM, Shabouni OI, Alraddadi ZM, Alzalabani AH, Al-Asmari AM, Ibrahim A, et al. Journal of Infection and Public Health. 2019.
67. Data Analysis of Coronavirus CoVID-19 Epidemic in South Korea Based on Recovered and Death Cases. Al-Rousan N, Al-Najjar H. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25850.
68. The clinical significance of filmarray pneumonia panel plus in diagnosing pneumonia due to MDRO. Alsalmi T, Aljohani S. Journal of Infection and Public Health. 2020;13(2):354-5.
69. Middle East Respiratory Syndrome Coronavirus epidemic impact on healthcare workers' risk perceptions, work and personal lives. Alsubaie S, Hani Temsah M, Al-Eyadhy AA, Gossady I, Hasan GM, Al-Rabiaah A, et al. Journal of infection in developing countries. 2019;13(10):920-6.
70. Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature. Al-Tawfiq JA, Auwaerter PG. Journal of Hospital Infection. 2019;101(1):20-9.
71. Middle East respiratory syndrome coronavirus in the last two years: Health care workers still at risk. Al-Tawfiq JA, Memish ZA. American Journal of Infection Control. 2019;47(10):1167-70.
72. Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus. Al-Tawfiq JA, Memish ZA. Semin Respir Crit Care Med. 2020. http://dx.doi.org/10.1055/s-0040-1709160.
73. Inquiring into Benefits of Independent Activation of Non-Classical Renin-Angiotensin System in the Clinical Prognosis and Reduction of COVID-19 mortality. Alvarez-Aragon LM, Cuesta-Munoz AL, Alvarez-Lopez I. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa402.
74. SARS-CoV-2 Vaccines: Status Report. Amanat F, Krammer F. Immunity. 2020;52(4):583-9.
75. COVID-19 in Colombia endpoints. Are we different, like Europe? Amariles P, Granados J, Ceballos M, Montoya CJ. Research in social & administrative pharmacy : RSAP. 2020. http://dx.doi.org/10.1016/j.sapharm.2020.03.013.
76. Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered Questions. Amgalan A, Othman M. Journal of thrombosis and haemostasis : JTH. 2020.
77. COVID-19 Outbreak and Surgical Practice: Unexpected Fatality in Perioperative Period. Aminian A, Safari S, Razeghian-Jahromi A, Ghorbani M, Delaney CP. Annals of surgery. 2020. http://dx.doi.org/10.1097/SLA.0000000000003925.
78. Viral hemorrhagic fevers in pregnancy: A systematic review and meta-analysis. Amsalu R. American Journal of Tropical Medicine and Hygiene. 2019;101(5):72.
79. Data-based analysis, modelling and forecasting of the COVID-19 outbreak. Anastassopoulou C, Russo L, Tsakris A, Siettos C. PLoS One. 2020;15(3):e0230405. http://dx.doi.org/10.1371/journal.pone.0230405. eCollection 2020.
80. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. The Lancet. 2020;395(10228):931-4.
81. The Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Study: Rationale and Design. Angus DC, Berry S, Lewis RJ, Al-Beidh F, Arabi Y, van Bentum-Puijk W, et al. Annals of the American Thoracic Society. 2020. http://dx.doi.org/10.1513/AnnalsATS.202003-192SD.
82. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. Arabi YM, Asiri AY, Assiri AM, Aziz Jokhdar HA, Alothman A, Balkhy HH, et al. Trials. 2020;21(1):8.
83. Macrolides in critically ill patients with Middle East Respiratory Syndrome. Arabi YM, Deeb AM, Al-Hameed F, Mandourah Y, Almekhlafi GA, Sindi AA, et al. International Journal of Infectious Diseases. 2019;81:184-90.
84. Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study. Arabi YM, Shalhoub S, Mandourah Y, Al-Hameed F, Al-Omari A, Al Qasim E, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019.
85. Hydroxychloroquine for treatment of SARS-CoV-2 infection? Improving our confidence in a model-based approach to dose selection. Arnold SL, Buckner F. Clinical and translational science. 2020. http://dx.doi.org/10.1111/cts.12797.
86. Case Report: A Kidney Transplant Patient with Mild COVID-19. Arpali E, Akyollu B, Yelken B, Tekin S, Turkmen A, Kocak B. Transpl Infect Dis. 2020:e13296-e.
87. Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India. Arvind B, Medigeshi GR, Kapil A, Xess I, Singh U, Lodha R, et al. The Indian journal of medical research. 2020;151(1):65-70.
88. Potential of Heparin and Nafamostat Combination Therapy for COVID-19. Asakura H, Ogawa H. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14858.
89. Insights into the recent 2019 novel coronavirus (Sars-coV-2) in light of past human coronavirus outbreaks. Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA. Pathogens. 2020;9(3).
90. How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know. Asmundson GJG, Taylor S. Journal of Anxiety Disorders. 2020;71.
91. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. Atluri S, Manchikanti L, Hirsch JA. Pain physician. 2020;23(2):E71-e83.
92. COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies. Atri D, Siddiqi HK, Lang J, Nauffal V, Morrow DA, Bohula EA. JACC Basic to translational science. 2020. http://dx.doi.org/10.1016/j.jacbts.2020.04.002.
93. A 3-Year Retrospective Study of the Epidemiology of Acute Respiratory Viral Infections in Pediatric Patients with Cancer Undergoing Chemotherapy. Aydin Köker S, Demiraǧ B, Tahta N, Bayram N, Oymak Y, Karapinar TH, et al. Journal of Pediatric Hematology/Oncology. 2019;41(4):e242-e6.
94. The Middle East Respiratory Syndrome (MERS). Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A. Infectious Disease Clinics of North America. 2019;33(4):891-905.
95. A Chinese Case of COVID-19 Did Not Show Infectivity During the Incubation Period: Based on an Epidemiological Survey. Bae JM. Journal of preventive medicine and public health = Yebang Uihakhoe chi. 2020.
96. MERS-CoV as an emerging respiratory illness: A review of prevention methods. Baharoon S, Memish ZA. Travel Medicine and Infectious Disease. 2019;32.
97. Cas12a-Based On-Site and Rapid Nucleic Acid Detection of African Swine Fever. Bai J, Lin H, Li H, Zhou Y, Liu J, Zhong G, et al. Frontiers in Microbiology. 2019;10.
98. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. Baig AM, Khaleeq A, Ali U, Syeda H. ACS chemical neuroscience. 2020.
99. New Zealand's elimination strategy for the COVID-19 pandemic and what is required to make it work. Baker M, Kvalsvig A, Verrall AJ, Telfar-Barnard L, Wilson N. The New Zealand medical journal. 2020;133(1512):10-4.
100. Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not? Balasubramanian S, Rao NM, Goenka A, Roderick M, Ramanan AV. Indian Pediatr. 2020.
101. How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere. Banna G, Curioni-Fontecedro A, Friedlaender A, Addeo A. ESMO open. 2020;5(2). http://dx.doi.org/10.1136/esmoopen-2020-000765.
102. How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere</i>. Banna G, Curioni-Fontecedro A, Friedlaender A, Addeo A. 2020;5(2).
103. Cardiovascular disease and COVID-19. Bansal M. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020.
104. Circulating exosomes isolated from human lung transplant recipients with respiratory viral infections contain nucleic acids specific to virus and can lead to activation of stress proteins. Bansal S, Bremner R, Smith M, Mohanakumar T. American Journal of Transplantation. 2019;19:482.
105. Circulating Exosomes from Human Lung Transplant Recipients Having Respiratory Viral Infections Contain Nucleic Acids and Activate Signaling Pathways CGAS/STING and RIG-1. Bansal S, Limaye A, Bharat A, Bremner R, Smith M, Omar A, et al. Journal of Heart and Lung Transplantation. 2020;39(4):S113-S4.
106. 2019-nCoV epidemic: address mental health care to empower society. Bao Y, Sun Y, Meng S, Shi J, Lu L. The Lancet. 2020;395(10224):e37-e8.
107. Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration. Baraibar MA, Barbeito AG, Muhoberac BB, Vidal R. The Journal of biological chemistry. 2008;283(46):31679-89. http://dx.doi.org/10.1074/jbc.M805532200. Epub 2008 Aug 28.
108. SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria. Barrasa H, Rello J, Tejada S, Martin A, Balziskueta G, Vinuesa C, et al. Anaesthesia, critical care & pain medicine. 2020. http://dx.doi.org/10.1016/j.accpm.2020.04.001.
109. The Role of YouTube and the Entertainment Industry in Saving Lives by Educating and Mobilizing the Public to Adopt Behaviors for Community Mitigation of COVID-19: A Successive Sampling Design. Basch CE, Basch CH, Hillyer GC, Jaime C. 2020.
110. The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. Bassetti M, Vena A, Giacobbe DR. European Journal of Clinical Investigation. 2020;50(3).
111. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Batawi S, Tarazan N, Al-Raddadi R, Al Qasim E, Sindi A, Al Johni S, et al. Health and Quality of Life Outcomes. 2019;17(1).
112. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch HH, Widmer AF, Neher RA. Swiss medical weekly. 2020;150:w20203.
113. Real estimates of mortality following COVID-19 infection. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. The Lancet Infectious diseases. 2020.
114. Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study. Bayham J, Fenichel EP. The Lancet Public health. 2020. http://dx.doi.org/10.1016/S2468-2667(20)30082-7.
115. Novel Coronavirus disease (COVID-19) in children. Bedir Demirdag T, Tezer H. Turkish journal of medical sciences. 2020. http://dx.doi.org/10.3906/sag-2004-174.
116. Critically ill influenza patients-co-infections and cardiovascular events. Begot E, Prevel R, Camou F, Picard W, Gisbert-Mora C, Boyer A, et al. Annals of Intensive Care. 2019;9.
117. Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus, and Middle East respiratory syndrome coronavirus infections. Behzadi MA, Leyva-Grado VH. Frontiers in Microbiology. 2019;10.
118. Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference. Beigel JH, Nam HH, Adams PL, Krafft A, Ince WL, El-Kamary SS, et al. Antiviral Research. 2019;167:45-67.
119. Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study. Bénézit F, Loubet P, Galtier F, Pronier C, Lenzi N, Lesieur Z, et al. Infection. 2020.
120. New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. Bennardo F, Buffone C, Giudice A. Oral oncology. 2020:104659. http://dx.doi.org/10.1016/j.oraloncology.2020.104659.
121. The global spread of 2019-nCoV: a molecular evolutionary analysis. Benvenuto D, Giovanetti M, Salemi M, Prosperi M, De Flora C, Junior Alcantara LC, et al. Pathog Glob Health. 2020;114(2):64-7.
122. Comparative Analysis of Eleven Healthcare-Associated Outbreaks of Middle East Respiratory Syndrome Coronavirus (Mers-Cov) from 2015 to 2017. Bernard-Stoecklin S, Nikolay B, Assiri A, Bin Saeed AA, Ben Embarek PK, El Bushra H, et al. Scientific reports. 2019;9(1):7385.
123. Clinical presentation, diagnostic findings, and outcome of adult horses with equine coronavirus infection at a veterinary teaching hospital: 33 cases (2012–2018). Berryhill EH, Magdesia KG, Aleman M, Pusterla N. Veterinary Journal. 2019;248:95-100.
124. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use. Bhatnagar T, Murhekar MV, Soneja M, Gupta N, Giri S, Wig N, et al. The Indian journal of medical research. 2020.
125. COVID-19 in patients with HIV: clinical case series. Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, et al. The Lancet HIV. 2020.
126. Focus on Middle East respiratory syndrome coronavirus (MERS-CoV). Bleibtreu A, Bertine M, Bertin C, Houhou-Fidouh N, Visseaux B. Medecine et Maladies Infectieuses. 2019.
127. Diabetes and COVID-19. Bloomgarden ZT. Journal of Diabetes. 2020;12(4):347-8.
128. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, et al. JHEP Reports. 2020;2(3).
129. Coronavirus infections reported by ProMED, February 2000-January 2020. Bonilla-Aldana DK, Holguin-Rivera Y, Cortes-Bonilla I, Cardona-Trujillo MC, Garcia-Barco A, Bedoya-Arias HA, et al. Travel Med Infect Dis. 2020:101575. http://dx.doi.org/10.1016/j.tmaid.2020.101575.
130. Coronavirus infections reported by ProMED, February 2000–January 2020. Bonilla-Aldana DK, Holguin-Rivera Y, Cortes-Bonilla I, Cardona-Trujillo MC, García-Barco A, Bedoya-Arias HA, et al. Travel Medicine and Infectious Disease. 2020.
131. Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and Mortality. Bonow RO, Fonarow GC, O'Gara PT, Yancy CW. JAMA Cardiology. 2020.
132. Primary and Repeated Respiratory Viral Infections among Infants in Rural Nepal. Boonyaratanakornkit J, Englund JA, Magaret AS, Bu Y, Tielsch JM, Khatry SK, et al. Journal of the Pediatric Infectious Diseases Society. 2019;9(1):21-9.
133. Early Respiratory Viral Acquisition after Allogeneic Hematopoietic Cell Transplant (HCT). Boonyaratanakornkit J, Xie H, Waghmare A, Campbell AP, Cheng GS, Davis C, et al. Biology of Blood and Marrow Transplantation. 2019;25(3):S346-S7.
134. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, et al. Journal of clinical medicine. 2020;9(4). http://dx.doi.org/10.3390/jcm9040941.
135. Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella. Bradley BT, Bryan A. Seminars in Diagnostic Pathology. 2019;36(3):152-9.
136. Breast radiotherapy under COVID-19 pandemic resource constraints -- approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States. Braunstein LZ, Gillespie EF, Hong L, Xu A, Bakhoum SF, Cuaron J, et al. Advances in radiation oncology. 2020. http://dx.doi.org/10.1016/j.adro.2020.03.013.
137. Coronavirus pandemic and HIV infection. Brichacek B, Bukrinsky M. Open AIDS Journal. 2020;14(1):10.
138. The emergence of porcine epidemic diarrhoea in Croatia: molecular characterization and serology. Brnić D, Šimić I, Lojkić I, Krešić N, Jungić A, Balić D, et al. BMC veterinary research. 2019;15(1):249.
139. Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence. Brook CE, Boots M, Chandran K, Dobson AP, Drosten C, Graham AL, et al. eLife. 2020;9. http://dx.doi.org/10.7554/eLife.48401.
140. Older people and COVID-19: Isolation, risk and ageism. Brooke J, Jackson D. Journal of clinical nursing. 2020. http://dx.doi.org/10.1111/jocn.15274.
141. CRISPR-Cas12-based detection of SARS-CoV-2. Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, et al. Nat biotechnol. 2020.
142. Studying COVID-19 in light of critical approaches to risk and uncertainty: research pathways, conceptual tools, and some magic from Mary Douglas. Brown P. Health, Risk and Society. 2020;22(1):1-14.
143. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times. Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, et al. Dermatology and therapy. 2020:1-11. http://dx.doi.org/10.1007/s13555-020-00377-9.
144. Epidemiology of COVID-19. Bulut C, Kato Y. Turkish journal of medical sciences. 2020. http://dx.doi.org/10.3906/sag-2004-172.
145. Narrow size distribution nanoparticle production by electrospray processing of ferritin. C JH, Jr., Biswas P. Journal of Aerosol Science. 2008;39(5):432-40.
146. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Caccialanza R, Laviano A, Lobascio F, Montagna E, Bruno R, Ludovisi S, et al. Nutrition (Burbank, Los Angeles County, Calif). 2020:110835. http://dx.doi.org/10.1016/j.nut.2020.110835.
147. Sex difference and smoking predisposition in patients with COVID-19. Cai H. The Lancet Respiratory Medicine. 2020;8(4):e20.
148. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Cai J, Xu J, Lin D, Yang Z, Xu L, Qu Z, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
149. A multi-centered, retrospective, descriptive study on 107 dead patients with COVID-19. cai l, zhang c, Wu M, Zhu X, wu m, zhu y, et al. Journal. 2020(Issue).
150. COVID-19 in a Designated Infectious Diseases Hospital Outside Hubei Province, China. Cai Q, Huang D, Ou P, Yu H, Zhu Z, Xia Z, et al. Allergy. 2020. http://dx.doi.org/10.1111/all.14309.
151. COVID-19 in the perioperative period of lung resection: a brief report from a single thoracic surgery department in Wuhan, China. Cai Y, Hao Z, Gao Y, Ping W, Wang Q, Peng S, et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020. http://dx.doi.org/10.1016/j.jtho.2020.04.003.
152. China coronavirus: Six questions scientists are asking. Callaway E, Cyranoski D. Nature. 2020;577(7792):605-7.
153. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Caly L, Druce J, Roberts J, Bond K, Tran T, Kostecki R, et al. Med j Aust. 2020.
154. Bayesian inference of transmission chains using timing of symptoms, pathogen genomes and contact data. Campbell F, Cori A, Ferguson N, Jombart T. PLoS Computational Biology. 2019;15(3).
155. COVID-19 infection in a paucisymptomatic infant: Raising the index of suspicion in epidemic settings. Canarutto D, Priolo A, Russo G, Pitea M, Vigone MC, Barera G. Pediatric Pulmonology. 2020.
156. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. The New England journal of medicine. 2020.
157. Epidemiological Features of 135 Patients with Coronavirus Disease (COVID-19) in Tianjin, China. Cao C, Li Y, Liu S, Fan H, Hao L. Disaster medicine and public health preparedness. 2020:1-9. http://dx.doi.org/10.1017/dmp.2020.63.
158. Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China. Cao J, Tu WJ, Cheng W, Yu L, Liu YK, Hu X, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa243.
159. P200 family protein IFI204 negatively regulates type I interferon responses by targeting IRF7 in nucleus. Cao L, Ji Y, Zeng L, Liu Q, Zhang Z, Guo S, et al. PLoS Pathogens. 2019;15(10).
160. The psychological impact of the COVID-19 epidemic on college students in China. Cao W, Fang Z, Hou G, Han M, Xu X, Dong J, et al. Psychiatry research. 2020;287:112934. http://dx.doi.org/10.1016/j.psychres.2020.112934.
161. Imaging and Clinical Features of Patients With 2019 Novel Coronavirus SARS-CoV-2: A systematic review and meta-analysis. Cao Y, Liu X, Xiong L, Cai K. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25822.
162. Detection of respiratory viruses in cystic fibrosis: comparison of nasal FLOQ Swabs™ and sputum using the FilmArray® platform. Carter S, Keogan B, O'Reilly P, Coughlan S, Cooke G, De Gascun C, et al. Journal of Cystic Fibrosis. 2019;18:S107.
163. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Chan JF, Zhang AJ, Yuan S, Poon VK, Chan CC, Lee AC, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa325.
164. COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease. Chan KW, Wong VT, Tang SCW. American Journal of Chinese Medicine. 2020.
165. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. Chang D, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, et al. JAMA - Journal of the American Medical Association. 2020;323(11):1092-3.
166. Phase- and epidemic region-adjusted estimation of the number of coronavirus disease 2019 cases in China. Chang R, Wang H, Zhang S, Wang Z, Dong Y, Tsamlag L, et al. Front Med (Online). 2020.
167. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. Channappanavar R, Fehr AR, Zheng J, Wohlford-Lenane C, Abrahante JE, Mack M, et al. Journal of Clinical Investigation. 2019;129(9):3625-39.
168. Evaluation of activation and inflammatory activity of myeloid cells during pathogenic human coronavirus infection. Channappanavar R, Perlman S. Journal. 2020;2099(Issue):195-204.
169. U-Shaped Association Between Baseline Neutrophil Count (bNC) And COVID-19-Related Mortality: A Retrospective Cohort Study in Chinese Patient Diagnosed with COVID-19 Infection (3/27/2020). Chen C, Chen X-L, Wu X-L, Wang K, Zuo P-y, Liu Y, et al. The Lancet Respiratory Medicine. 2020.
170. [Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies]. Chen C, Zhang XR, Ju ZY, He WF. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns. 2020;36:E005. http://dx.doi.org/10.3760/cma.j.cn501120-20200224-00088.
171. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. The Journal of clinical investigation. 2020. http://dx.doi.org/10.1172/JCI137244.
172. Evidence for cross-protection against subsequent febrile respiratory illness episodes from prior infections by different viruses among singapore military recruits 2009-2014. Chen ICM, Loh JP, Chuah CXP, Christine Gao QH, Sun Y, Ng SH, et al. Journal of Infectious Diseases. 2019;219(12):1913-23.
173. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Chen J. Microbes Infect. 2020;22(2):69-71. http://dx.doi.org/10.1016/j.micinf.2020.01.004. Epub 2020 Feb 4.
174. Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses. Chen J. Microbes and Infection. 2020;22(2):69-71.
175. Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment. Chen J, Hu C, Chen L, Tang L, Zhu Y, Xu X, et al. Engineering (Beijing, China). 2020. http://dx.doi.org/10.1016/j.eng.2020.02.006.
176. Clinical progression of patients with COVID-19 in Shanghai, China. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al. The Journal of infection. 2020.
177. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, et al. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43:E005. http://dx.doi.org/10.3760/cma.j.issn.1001-0939.2020.0005.
178. Convalescent plasma as a potential therapy for COVID-19. Chen L, Xiong J, Bao L, Shi Y. The Lancet Infectious Diseases. 2020;20(4):398-400.
179. Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression. chen m, tu c, Tan C, Zheng X, wang x, wu j, et al. medRxiv. 2020:2020.04.06.20054890.
180. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. The Lancet. 2020;395(10223):507-13.
181. A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019. Chen Q, Quan B, Li X, Gao G, Zheng W, Zhang J, et al. J med virol. 2020.
182. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, et al. Chest. 2020. http://dx.doi.org/10.1016/j.chest.2020.04.010.
183. Clinical features of 109 cases of novel coronavirus pneumonia. Chen S, Wu JJ, Li MZ, Xu DZ, Zhu YZ, Wang HC, et al. Chinese Journal of Infectious Diseases. 2020.
184. COVID-19 control in China during mass population movements at New Year. Chen S, Yang J, Yang W, Wang C, Bärnighausen T. The Lancet. 2020;395(10226):764-6.
185. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Bmj. 2020;368:m1091. http://dx.doi.org/10.1136/bmj.m1091.
186. A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Chen TM, Rui J, Wang QP, Zhao ZY, Cui JA, Yin L. Infectious Diseases of Poverty. 2020;9(1).
187. The SARS-CoV-2 Vaccine Pipeline: an Overview. Chen WH, Strych U, Hotez PJ, Bottazzi ME. Current Tropical Medicine Reports. 2020.
188. Dynamic Chest CT Evaluation in Three Cases of 2019 Novel Coronavirus Pneumonia. Chen X, Liu S, Zhang C, Pu G, Sun J, Shen J, et al. Arch Iran Med. 2020;23(4):277-80. http://dx.doi.org/10.34172/aim.2020.11.
189. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. medRxiv. 2020:2020.02.29.20029520.
190. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa449.
191. Distribution of the COVID-19 epidemic and correlation with population emigration from wuhan, China. Chen ZL, Zhang Q, Lu Y, Guo ZM, Zhang X, Zhang WJ, et al. Chinese medical journal. 2020.
192. From SARS-CoV to 2019-nCoV Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends. Chen Z-L, Zhang W-J, Lu Y, Guo C, Guo Z-M, Liao C-H, et al. Chin med j. 2020.
193. Reply to: "Reporting of all cardiac medications and their outcome in COVID-19". Cheng H, Wang Y, Wang G-Q. Journal of medical virology. 2020.
194. Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19. Cheng H, Wang Y, Wang GQ. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25785.
195. [Epidemiological characteristics of novel coronavirus pneumonia in Henan]. Cheng JL, Huang C, Zhang GJ, Liu DW, Li P, Lu CY, et al. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43:E027. http://dx.doi.org/10.3760/cma.j.cn112147-20200222-00148.
196. Preparedness and proactive infection control measures against the emerging novel coronavirus in China. Cheng VCC, Wong SC, To KKW, Ho PL, Yuen KY. Journal of Hospital Infection. 2020;104(3):254-5.
197. Kidney disease is associated with in-hospital death of patients with COVID-19. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney Int. 2020. http://dx.doi.org/10.1016/j.kint.2020.03.005.
198. Innate immune responses and viral-induced neurologic disease. Cheng Y, Skinner DD, Lane TE. Journal of Clinical Medicine. 2019;8(1).
199. Covid-19: A digital epidemic. Chiolero A. The BMJ. 2020;368.
200. Epidemiology and Clinical Features of Coronavirus disease 2019 in Children. Choi SH, Kim HW, Kang JM, Kim DH, Cho EY. Clinical and experimental pediatrics. 2020. http://dx.doi.org/10.3345/cep.2020.00535.
201. Middle East respiratory syndrome: Pathogenesis and therapeutic developments. Choudhry H, Bakhrebah MA, Abdulaal WH, Zamzami MA, Baothman OA, Hassan MA, et al. Future Virology. 2019;14(4):237-46.
202. A citizen's thoughts about COVID-19. Chow R. The Lancet. 2020;395(10231):e65.
203. The COVID-19 pandemic in the USA: what might we expect? Chowell G, Mizumoto K. The Lancet. 2020;395(10230):1093-4.
204. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. Radiology. 2020;295(1):202-7.
205. Oxidation of guanines in the iron-responsive element RNA: similar structures from chemical modification and recent NMR studies. Ciftan SA, Theil EC, Thorp HH. Chemistry & biology. 1998;5(12):679-87. http://dx.doi.org/10.1016/s1074-5521(98)90661-5.
206. Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe. Cinar P, Kubal T, Freifeld A, Mishra A, Shulman L, Bachman J, et al. Journal of the National Comprehensive Cancer Network : JNCCN. 2020:1-6. http://dx.doi.org/10.6004/jnccn.2020.7572.
207. Viruses of Respiratory Tract: an Observational Retrospective Study on Hospitalized Patients in Rome, Italy. Ciotti M, Maurici M, Santoro V, Coppola L, Sarmati L, De Carolis G, et al. Microorganisms. 2020;8(4). http://dx.doi.org/10.3390/microorganisms8040501.
208. Prevalence of pathogens related to bovine respiratory disease before and after transportation in beef steers: Preliminary results. Cirone F, Padalino B, Tullio D, Capozza P, Surdo ML, Lanave G, et al. Animals. 2019;9(12).
209. Photosensitized H2 generation from "one-pot" and "two-pot" assemblies of a zinc-porphyrin/platinum nanoparticle/protein scaffold. Clark ER, Kurtz DM, Jr. Dalton transactions (Cambridge, England : 2003). 2016;45(2):630-8. http://dx.doi.org/10.1039/c5dt03418c.
210. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. Circulation. 2020.
211. Strategies shift as coronavirus pandemic looms: The virus seems unstoppable, but mitigating its speed and impact is possible. Cohen J, Kupferschmidt K. Science. 2020;367(6481):962-3.
212. COVID-19-related mortality by age groups in Europe: A meta-analysis. Cohen JF, Korevaar DA, Matczak S, Brice J, Chalumeau M, Toubiana J. medRxiv. 2020:2020.04.11.20061721.
213. Characterization of mouse serum ferritin. Cohen LA, Morgenstern A, Meyron-Holtz EG. American Journal of Hematology. 2009;84(8):E313-E4.
214. Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia. Colombi D, Bodini FC, Petrini M, Maffi G, Morelli N, Milanese G, et al. Radiology. 2020:201433. http://dx.doi.org/10.1148/radiol.2020201433.
215. Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Colson P, La Scola B, Esteves-Vieira V, Ninove L, Zandotti C, Jimeno MT, et al. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25(8).
216. Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle. Cong Y, Ulasli M, Schepers H, Mauthe M, V’kovski P, Kriegenburg F, et al. Journal of Virology. 2020;94(4).
217. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. Conti P, Gallenga CE, Tete G, Caraffa A, Ronconi G, Younes A, et al. Journal of biological regulators and homeostatic agents. 2020;34(2). http://dx.doi.org/10.23812/Editorial-Conti-2.
218. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies. Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. Journal of biological regulators and homeostatic agents. 2020;34(2).
219. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. Journal of biological regulators and homeostatic agents. 2020;34(2). http://dx.doi.org/10.23812/CONTI-E.
220. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. Conti P, Younes A. Journal of biological regulators and homeostatic agents. 2020.
221. The novel zoonotic COVID-19 pandemic: An expected global health concern. Contini C, Nuzzo MD, Barp N, Bonazza A, de Giorgio R, Tognon M, et al. Journal of Infection in Developing Countries. 2020;14(3):254-64.
222. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Anaesthesia (Lond). 2020.
223. Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis. Coomes EA, Haghbayan H. medRxiv. 2020:2020.03.30.20048058.
224. Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy". Coto-Hernandez R, Fabregas Ruano MT. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14852.
225. Covid-19: Are we getting the communications right? Cowper A. The BMJ. 2020;368.
226. WHO declares COVID-19 a pandemic. Cucinotta D, Vanelli M. Acta Biomedica. 2020;91(1):157-60.
227. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Cui S, Chen S, Li X, Liu S, Wang F. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14830.
228. Treatment of COVID-19: Old tricks for new challenges. Cunningham AC, Goh HP, Koh D. Critical Care. 2020;24(1).
229. Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19". Cure E, Cumhur Cure M. Journal of medical virology. 2020.
230. Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome ;Коронавирусная инфекция (COVID-19) и синдром диссеминированного внутрисосудистого свертывания. D AM, N KG, A MM, O VB, Kh JK, V MT, et al. Obstetrics, Gynecology and Reproduction (AGR - E-Journal) / Акушерство, Гинекология и Репродукция (АГР). 2020.
231. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Danser AHJ, Epstein M, Batlle D. Hypertension (Dallas, Tex : 1979). 2020:HYPERTENSIONAHA12015082.
232. A multicenter consortium to define the epidemiology and outcomes of pediatric solid organ transplant recipients with inpatient respiratory virus infection. Danziger-Isakov L, Steinbach WJ, Paulsen G, Munoz FM, Sweet LR, Green M, et al. Journal of the Pediatric Infectious Diseases Society. 2019;8(3):197-204.
233. Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. Dashraath P, Jing Lin Jeslyn W, Mei Xian Karen L, Li Min L, Sarah L, Biswas A, et al. Am J Obstet Gynecol. 2020. http://dx.doi.org/10.1016/j.ajog.2020.03.021.
234. Thalidomide against coronavirus disease 2019 (Covid-19): A medicine with a thousand faces. Dastan F, Tabarsi P, Marjani M, Moniri A, Hashemian SM, Tavakoli-Ardakani M, et al. Iranian Journal of Pharmaceutical Research. 2020;19(1):1-2.
235. [Coronavirus and COVID-19 : focus on a galopping pandemic]. Davenne E, Giot JB, Huynen P. Rev Med Liege. 2020;75(4):218-25.
236. Aetiology of Canine Infectious Respiratory Disease Complex and Prevalence of its Pathogens in Europe. Day MJ, Carey S, Clercx C, Kohn B, MarsilIo F, Thiry E, et al. Journal of Comparative Pathology. 2020;176:86-108.
237. Weathering the pandemic: How the Caribbean Basin can use viral and environmental patterns to predict, prepare and respond to COVID-19. de Angel Sola DE, Wang L, Vazquez M, Mendez Lazaro PA. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25864.
238. Letalidad del COVID-19: ausencia de patrón epidemiológico. de Figueiredo AM, Codina AD, de Figueiredo DCMM, Gil-García E, Kalache A. Gaceta Sanitaria. 2020.
239. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology. de Leon J, Ruan CJ, Schoretsanitis G, De Las Cuevas C. Psychotherapy and psychosomatics. 2020:1-15. http://dx.doi.org/10.1159/000507638.
240. Identifying Locations with Possible Undetected Imported Severe Acute Respiratory Syndrome Coronavirus 2 Cases by Using Importation Predictions. De Salazar PM, Niehus R, Taylor A, Buckee CO, Flaherty, Lipsitch M. Emerg infect dis. 2020;26(7).
241. Implementation of electronic travel history screening at an urban medical center. de St. Maurice AM, Martinez S, Sweeney S, Genta E, Walton S, Rubin ZA, et al. Open Forum Infectious Diseases. 2019;6:S613-S4.
242. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, et al. Proc Natl Acad Sci U S A. 2020;117(12):6771-6. http://dx.doi.org/10.1073/pnas.1922083117. Epub 2020 Feb 13.
243. Verification of a novel multiplex PCR respiratory virus panel in a us biocontainment unit. Dean CL, Alvey E, Evans C, Hill C, Burd E, Kraft C. American Journal of Clinical Pathology. 2019;152:S7.
244. COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us. Decaro N, Martella V, Saif LJ, Buonavoglia C. Research in Veterinary Science. 2020;131:21-3.
245. The GReek study in the Effects of Colchicine in COvid-19 complications prevention (GRECCO-19 study): rationale and study design. Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, et al. Hell j cardiol. 2020.
246. Serological investigation of MERS-CoV in humans between 2011-2016, Jeddah, Saudi Arabia. Degnah A, Hassan A, Al-amri S, Hindawi S, Azhar E, Hashem A. Journal of Infection and Public Health. 2019;12(1):138.
247. Management-supportive measures for managers of healthcare organization during the COVID-19 epidemic. Dehnavieh R, Kalavani K. Infect Control Hosp Epidemiol. 2020:1. http://dx.doi.org/10.1017/ice.2020.108.
248. Comparing viral respiratory infections between children who do and do not attend child care. DeJonge P, Malosh R, Truscon R, Johnson E, Foote S, Cheng B, et al. Open Forum Infectious Diseases. 2019;6:S599.
249. 2019 Novel Coronavirus - Important Information for Clinicians. Del Rio C, Malani PN. JAMA - Journal of the American Medical Association. 2020;323(11):1039-40.
250. COVID-19 outbreak control, example of the ministry of health of Turkey. Demirbilek Y, Pehlivanturk G, Ozguler ZO, Alp Mese E. Turkish journal of medical sciences. 2020. http://dx.doi.org/10.3906/sag-2004-187.
251. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. Deng SQ, Peng HJ. Journal of Clinical Medicine. 2020;9(2).
252. Coronavirus endoribonuclease activity in porcine epidemic diarrhea virus suppresses type I and type III interferon responses. Deng X, Van Geelen A, Buckley AC, O’Brien A, Pillatzki A, Lager KM, et al. Journal of Virology. 2019;93(8).
253. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L, et al. Chinese medical journal. 2020.
254. Virologic study of acute lower respiratory tract infections in children admitted to the paediatric department of Blida University Hospital, Algeria. Derrar F, Izri K, Kaddache C, Boukari R, Hannoun D. New Microbes and New Infections. 2019;30.
255. Analyzing the epidemiological outbreak of COVID-19: A visual exploratory data analysis approach. Dey SK, Rahman MM, Siddiqi UR, Howlader A. Journal of Medical Virology. 2020.
256. Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. Di Pierro F, Bertuccioli A, Cavecchia I. Minerva gastroenterologica e dietologica. 2020.
257. Obesity and its Implications for COVID-19 Mortality. Dietz W, Santos-Burgoa C. Obesity (Silver Spring, Md). 2020.
258. A mathematical model of the transmission of middle East respiratory syndrome coronavirus in dromedary camels (Camelus dromedarius). Dighe A, Jombart T, van Kerkhove M, Ferguson N. International Journal of Infectious Diseases. 2019;79:1.
259. A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination. Dighe A, Jombart T, Van Kerkhove MD, Ferguson N. Epidemics. 2019;29.
260. SARS-CoV-2: a novel deadly virus in a globalised world. Dilcher M, Werno A, Jennings LC. The New Zealand medical journal. 2020;133(1510):6-11.
261. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. Ding Q, Lu P, Fan Y, Xia Y, Liu M. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25781.
262. The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. Ding Q, Lu P, Fan Y, Xia Y, Liu M. Journal of medical virology. 2020.
263. Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19). Dixon DL, Van Tassell BW, Vecchie A, Bonaventura A, Talasaz A, Kakavand H, et al. Journal of cardiovascular pharmacology. 2020. http://dx.doi.org/10.1097/FJC.0000000000000836.
264. Eleven faces of coronavirus disease 2019. Dong X, Cao Y-Y, Lu X-X, Zhang J-J, Du H, Yan Y-Q, et al. Allergy. 2020.
265. Epidemiological characteristics of confirmed COVID-19 cases in Tianjin. Dong XC, Li JM, Bai JY, Liu ZQ, Zhou PH, Gao L, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(5):638-42.
266. Worldwide reduction in MERS cases and deaths since 2016. Donnelly CA, Malik MR, Elkholy A, Cauchemez S, Van Kerkhove MD. Emerging Infectious Diseases. 2019;25(9):1758-60.
267. Attitudes of Anesthesiology Specialists and Residents Toward Patients Infected with the Novel Coronavirus (COVID-19): A National Survey Study. Dost B, Koksal E, Terzi Ö, Bilgin S, Ustun YB, Arslan HN. Surg infect,(Larchmt). 2020.
268. Considerations for Obstetric Care during the COVID-19 Pandemic. Dotters-Katz SK, Hughes BL. American journal of perinatology. 2020. http://dx.doi.org/10.1055/s-0040-1710051.
269. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, et al. Journal of the American College of Cardiology. 2020.
270. Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al. The European respiratory journal. 2020. http://dx.doi.org/10.1183/13993003.00524-2020.
271. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study. Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Am J Respir Crit Care Med. 2020. http://dx.doi.org/10.1164/rccm.202003-0543OC.
272. Detection of antibodies against SARS-CoV-2 in patients with COVID-19. Du Z, Zhu F, Guo F, Yang B, Wang T. Journal of medical virology. 2020.
273. The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 COVID-19 and Its Research Progress in Forensic Toxicology. Duan YJ, Liu Q, Zhao SQ, Huang F, Ren L, Liu L, et al. Fa yi xue za zhi. 2020;36(2). http://dx.doi.org/10.12116/j.issn.1004-5619.2020.02.001.
274. The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 （COVID-19） and Its Research Progress in Forensic Toxicology. Duan YJ, Liu Q, Zhao SQ, Huang F, Ren L, Liu L, et al. Fa yi xue za zhi. 2020;36(2).
275. CT features of novel coronavirus pneumonia (COVID-19) in children. Duan YN, Zhu YQ, Tang LL, Qin J. Eur Radiol. 2020. http://dx.doi.org/10.1007/s00330-020-06860-3.
276. The 2019 novel Coronavirus (2019-NCoV): Novel virus, old challenges. Duarte R, Furtado I, Sousa L, Carvalho C. Acta Medica Portuguesa. 2020;33(3):155-7.
277. Monitoring trends and differences in COVID-19 case fatality rates using decomposition methods: Contributions of age structure and age-specific fatality. Dudel C, Riffe T, Acosta E, van Raalte AA, Myrskyla M. medRxiv. 2020:2020.03.31.20048397.
278. Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea. Dudley JP, Lee NT. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
279. Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients. Eichenberger EM, Soave R, Zappetti D, Small CB, Shore T, van Besien K, et al. Bone Marrow Transplantation. 2019;54(7):1058-66.
280. From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach. El Zowalaty ME, Järhult JD. One Health. 2020;9.
281. Enzootic patterns of Middle East respiratory syndrome coronavirus in imported African and local Arabian dromedary camels: a prospective genomic study. El-Kafrawy SA, Corman VM, Tolah AM, Al Masaudi SB, Hassan AM, Müller MA, et al. The Lancet Planetary Health. 2019;3(12):e521-e8.
282. MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018. Elkholy AA, Grant R, Assiri A, Elhakim M, Malik MR, Van Kerkhove MD. Journal of Infection and Public Health. 2020;13(3):418-22.
283. Coronavirus Vaccines: Light at the End of the Tunnel. Ella KM, Mohan VK. Indian Pediatr. 2020.
284. Respiratory viral coinfection in a birth cohort of infants in rural Nepal. Emanuels A, Newman KL, Hawes SE, Martin ET, Englund JA, Tielsch J, et al. Open Forum Infectious Diseases. 2019;6:S797-S8.
285. With COVID-19, modeling takes on life and death importance. Enserink M, Kupferschmidt K. Science. 2020;367(6485):1414-5. http://dx.doi.org/10.1126/science.367.6485.1414-b.
286. 2019 Coronavirus pandemic in Turkey and across the world. Er AG, Ünal S. Flora. 2020;25(1):1-8.
287. Clinical features of cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain. Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, Alarcon-De-la-Vega G, Alvarado-Arnez LE, Balderrama-Saavedra MA, et al. Travel Med Infect Dis. 2020:101653. http://dx.doi.org/10.1016/j.tmaid.2020.101653.
288. The role and response of palliative care and hospice services in epidemics and pandemics: a rapid review to inform practice during the COVID-19 pandemic. Etkind SN, Bone AE, Lovell N, Cripps RL, Harding R, Higginson IJ, et al. Journal of pain and symptom management. 2020. http://dx.doi.org/10.1016/j.jpainsymman.2020.03.029.
289. Commentary on Ferguson, et al., "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand". Eubank S, Eckstrand I, Lewis B, Venkatramanan S, Marathe M, Barrett CL. Bulletin of mathematical biology. 2020;82(4):52. http://dx.doi.org/10.1007/s11538-020-00726-x.
290. Understanding COVID-19 new diagnostic guidelines – A message of reassurance from an internal medicine doctor in Shanghai. Evelyne B, Guoting C, Teresa FM. Swiss Medical Weekly. 2020;150(9).
291. Human challenge studies to accelerate coronavirus vaccine licensure. Eyal N, Lipsitch M, Smith PG. The Journal of infectious diseases. 2020. http://dx.doi.org/10.1093/infdis/jiaa152.
292. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Fan J, Wang H, Ye G, Cao X, Xu X, Tan W, et al. Metabolism. 2020.
293. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Fang L, Karakiulakis G, Roth M. The Lancet Respiratory Medicine. 2020;8(4):e21.
294. CT manifestations of two cases of 2019 novel coronavirus (2019-NCoV) pneumonia. Fang Y, Zhang H, Xu Y, Xie J, Pang P, Ji W. Radiology. 2020;295(1):208-9.
295. Covid-19 - Navigating the Uncharted. Fauci AS, Lane HC, Redfield RR. The New England journal of medicine. 2020;382(13):1268-9. http://dx.doi.org/10.1056/NEJMe2002387. Epub 2020 Feb 28.
296. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring. Favaloro EJ, Lippi G. Seminars in thrombosis and hemostasis. 2020.
297. 2019-nCoV epidemic: what about pregnancies? Favre G, Pomar L, Musso D, Baud D. The Lancet. 2020;395(10224):e40.
298. Hiding in plain sight: An approach to treating patients with severe covid-19 infection. Fedson DS, Opal SM, Rordam OM. mBio. 2020;11(2).
299. Effectiveness of zinc supplementation on diarrhea and average daily gain in preweaned dairy calves: A double-blind, blockrandomized, placebo-controlled clinical trial. Feldmann HR, Williams DR, Champagne JD, Lehenbauer TW, Aly SS. PLoS ONE. 2019;14(7).
300. COVID-19 with Different Severity: A Multi-center Study of Clinical Features. Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. Am J Respir Crit Care Med. 2020. http://dx.doi.org/10.1164/rccm.202002-0445OC.
301. COVID-19 in solid organ transplant recipients: a single-center case series from Spain. Fernández-Ruiz M, Andrés A, Loinaz C, Delgado JF, López-Medrano F, San Juan R, et al. Am j transplant. 2020.
302. High incidence of rhinovirus infection in children with community-acquired pneumonia from a city in the Brazilian pre-Amazon region. Ferreira HLDS, Costa KLP, Cariolano MS, Oliveira GS, Felipe KKP, Silva ESA, et al. Journal of Medical Virology. 2019;91(10):1751-8.
303. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Ferretti L, Wymant C, Kendall M, Zhao L, Nurtay A, Abeler-Dorner L, et al. Science. 2020. http://dx.doi.org/10.1126/science.abb6936.
304. A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease. Ferrey AJ, Choi G, Hanna RM, Chang Y, Tantisattamo E, Ivaturi K, et al. Am J Nephrol. 2020:1-6. http://dx.doi.org/10.1159/000507417.
305. Has China faced only a herald wave of SARS-CoV-2? Flahault A. The Lancet. 2020;395(10228):947.
306. Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient. Fontana L, Strasfeld L. Infectious Disease Clinics of North America. 2019;33(2):523-44.
307. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment. Ford N, Vitoria M, Rangaraj A, Norris SL, Calmy A, Doherty M. Journal of the International AIDS Society. 2020;23(4):e25489. http://dx.doi.org/10.1002/jia2.25489.
308. And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan. Froes F. Pulmonology. 2020;26(2):114-5.
309. COVID-19 Infection in a Patient with End-Stage Kidney Disease. Fu D, Yang B, Xu J, Mao Z, Zhou C, Xue C. Nephron. 2020:1-3.
310. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.03.041.
311. Coronavirus: Update Related to the Current Outbreak of COVID-19. Gabutti G, d'Anchera E, Sandri F, Savio M, Stefanati A. Infectious diseases and therapy. 2020. http://dx.doi.org/10.1007/s40121-020-00295-5.
312. Knowledge and practices of dentists regarding MERS-CoV: A cross-sectional survey in Saudi Arabia. Gaffar BO, El Tantawi M, Al-Ansari AA, Al-AnsariAlAgl AS, Farooqi FA, Almas KM. Saudi Medical Journal. 2019;40(7):714-20.
313. Longitudinal active sampling for respiratory viral infections across age groups. Galanti M, Birger R, Ud-Dean M, Filip I, Morita H, Comito D, et al. Influenza and other Respiratory Viruses. 2019;13(3):226-32.
314. Prognostic value of NT-proBNP in patients with severe COVID-19. Gao L, Jiang D, Wen XS, Cheng XC, Sun M, He B, et al. Respiratory research. 2020;21(1):83. http://dx.doi.org/10.1186/s12931-020-01352-w.
315. Advances on presymptomatic or asymptomatic carrier transmission of COVID-19. Gao WJ, Li LM. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41:485-8.
316. Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19. Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25770.
317. Forecasting the Cumulative Number of COVID-19 Deaths in China: a Boltzmann Function-based Modeling Study. Gao Y, Zhang Z, Yao W, Ying Q, Long C, Fu X. Infect Control Hosp Epidemiol. 2020:1-16. http://dx.doi.org/10.1017/ice.2020.101.
318. A case-crossover analysis of the impact of weather on primary cases of Middle East respiratory syndrome. Gardner EG, Kelton D, Poljak Z, Van Kerkhove M, Von Dobschuetz S, Greer AL. BMC Infectious Diseases. 2019;19(1).
319. COVID-19: the medium is the message. Garrett L. The Lancet. 2020;395(10228):942-3.
320. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Gasmi A, Noor S, Tippairote T, Dadar M, Menzel A, Bjorklund G. Clinical immunology (Orlando, Fla). 2020:108409. http://dx.doi.org/10.1016/j.clim.2020.108409.
321. The epidemiology and clinical information about COVID-19. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. European Journal of Clinical Microbiology & Infectious Diseases 2020. 2020.
322. Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19. Geldsetzer P. Journal of medical Internet research. 2020;22(4):e18790. http://dx.doi.org/10.2196/18790.
323. Burden and prevalence of prognostic factors for severe covid-19 disease in Sweden. Gemes K, Talback M, Modig K, Ahlbom A, Berglund A, Feychting M, et al. medRxiv. 2020:2020.04.08.20057919.
324. Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 epidemic in France. Ghanchi A. Disaster medicine and public health preparedness. 2020:1-9. http://dx.doi.org/10.1017/dmp.2020.82.
325. Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020). Ghosal S, Sengupta S, Majumder M, Sinha B. Diabetes & metabolic syndrome. 2020;14(4):311-5. http://dx.doi.org/10.1016/j.dsx.2020.03.017.
326. Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis. Ghosal S, Sinha B, Majumder M, Misra A. Diabetes & metabolic syndrome. 2020;14(4):319-23. http://dx.doi.org/10.1016/j.dsx.2020.03.014.
327. Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy. Giorgi Rossi P, Marino M, Formisano D, Venturelli F, Vicentini M, Grilli R. medRxiv. 2020:2020.04.13.20063545.
328. Novel coronavirus COVID-19: an overview for emergency clinicians. Giwa A, Desai A. Emergency medicine practice. 2020;22(2):1-21.
329. Rigidity of the outer shell predicted by a protein intrinsic disorder model sheds light on the COVID-19 (Wuhan-2019-nCoV) infectivity. Goh GKM, Keith Dunker A, Foster JA, Uversky VN. Biomolecules. 2020;10(2).
330. Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection. Goh KJ, Choong MC, Cheong EH, Kalimuddin S, Duu Wen S, Phua GC, et al. Annals of the Academy of Medicine, Singapore. 2020;49(1):1-9.
331. Are certain drugs associated with enhanced mortality in COVID-19? Goldstein MR, Poland GA, Graeber CW. QJM : monthly journal of the Association of Physicians. 2020.
332. Correlation Analysis Between Disease Severity and Inflammation-related Parameters in Patients with COVID-19 Pneumonia. Gong J, Dong H, Xia SQ, Huang YZ, Wang D, Zhao Y, et al. medRxiv. 2020:2020.02.25.20025643.
333. A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China. Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan L, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa443.
334. Cloud-Based System for Effective Surveillance and Control of COVID-19: Useful Experiences From Hubei, China. Gong M, Li L, Xin S, Yue Y, Wang S, Hong Z. J med internet res. 2020.
335. Videoconferences of Infectious Diseases: An educational tool that transcends borders. A useful tool also for the current COVID-19 pandemic. Gonzales-Zamora JA, Alave J, De Lima-Corvino DF, Fernandez A. Infez Med. 2020;28(2):135-8.
336. Respiratory viral infections and patient outcomes in solid organ transplant recipients. Gonzalez M, Vestal A, Darling N, Papastamelos C, Natarajan M, Kumar P, et al. American Journal of Transplantation. 2019;19:730-1.
337. COVID-19 and finance: Agendas for future research. Goodell JW. Finance Research Letters. 2020.
338. Perspective: cardiovascular disease and the Covid-19 pandemic. Gori T, Lelieveld J, Munzel T. Basic research in cardiology. 2020;115(3):32. http://dx.doi.org/10.1007/s00395-020-0792-4.
339. US Emergency Legal Responses to Novel Coronavirus: Balancing Public Health and Civil Liberties. Gostin LO, Hodge JG. JAMA - Journal of the American Medical Association. 2020;323(12):1131-2.
340. Epidemiological characteristics of COVID-19 in Gansu province. Gou FX, Zhang XS, Yao JX, Yu DS, Wei KF, Zhang H, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41:E032.
341. Immune Predictors of Mortality After Ribonucleic Acid Virus Infection. Graham JB, Swarts JL, Menachery VD, Gralinski LE, Schäfer A, Plante KS, et al. The Journal of infectious diseases. 2020;221(6):882-9.
342. Return of the coronavirus: 2019-nCoV. Gralinski LE, Menachery VD. Viruses. 2020;12(2).
343. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Nutrients. 2020;12(4). http://dx.doi.org/10.3390/nu12040988.
344. Synanthropic rodents as virus reservoirs and transmitters. Gravinatti ML, Barbosa CM, Soares RM, Gregori F. Revista da Sociedade Brasileira de Medicina Tropical. 2020;53.
345. Unknown unknowns - COVID-19 and potential global mortality. Grech V. Early human development. 2020;144:105026. http://dx.doi.org/10.1016/j.earlhumdev.2020.105026.
346. Unknown unknowns – COVID-19 and potential global mortality. Grech V. Early Human Development. 2020;144.
347. Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term? Green MS. The Lancet. 2020;395(10229):1034-5.
348. Full spectrum of COVID-19 severity still being depicted – Authors' reply. Gu X, Cao B, Wang J. The Lancet. 2020;395(10228):948-9.
349. Epidemiological investigation of a family clustering of COVID-19. Guan Q, Liu M, Zhuang YJ, Yuan Y, Wang SS, Li J, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41:629-33.
350. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. The European respiratory journal. 2020. http://dx.doi.org/10.1183/13993003.00547-2020.
351. Epidemiological investigation of feline infectious peritonitis in cats living in Harbin, Northeast China from 2017 to 2019 using a combination of an EvaGreen-based real-time RT-PCR and serum chemistry assays. Guan X, Li H, Han M, Jia S, Feng B, Gao X, et al. Molecular and Cellular Probes. 2020;49.
352. Three Emerging Coronaviruses in Two Decades: The Story of SARS, MERS, and Now COVID-19. Guarner J. American Journal of Clinical Pathology. 2020;153(4):420-1.
353. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, et al. Radiotherapy and Oncology. 2020.
354. COVID-19 and neuromuscular disorders. Guidon AC, Amato AA. Neurology. 2020. http://dx.doi.org/10.1212/WNL.0000000000009566.
355. Characterization and evaluation of the pathogenicity of a natural recombinant transmissible gastroenteritis virus in China. Guo R, Fan B, Chang X, Zhou J, Zhao Y, Shi D, et al. Virology. 2020;545:24-32.
356. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. JAMA Cardiol. 2020. http://dx.doi.org/10.1001/jamacardio.2020.1017.
357. Diabetes is a risk factor for the progression and prognosis of COVID-19. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes/metabolism research and reviews. 2020:e3319.
358. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Gupta R, Ghosh A, Singh AK, Misra A. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(3):211-2.
359. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Gurwitz D. Drug Development Research. 2020.
360. Clinical outcomes among hospital patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Habib AMG, Ali MAE, Zouaoui BR, Taha MAH, Mohammed BS, Saquib N. BMC Infectious Diseases. 2019;19(1).
361. The Novel Coronavirus: A Bird's Eye View. Habibzadeh P, Stoneman EK. The international journal of occupational and environmental medicine. 2020;11(2):65-71.
362. [COVID-19 andcardiovascular diseases]. Haeck G, Ancion A, Marechal P, Oury C, Lancellotti P. Rev Med Liege. 2020;75(4):226-32.
363. COVID-19 et maladies cardiovasculaires. Haeck G, Ancion A, Marechal P, Oury C, Lancellotti P. Rev Med Liege. 2020;75(4):226-32.
364. [Telemedicine in the fight against SARS-COV-2-opportunities and possible applications in otorhinolaryngology : Narrative review]. Hagge D, Knopf A, Hofauer B. Hno. 2020. http://dx.doi.org/10.1007/s00106-020-00864-7.
365. Structural and thermodynamic characterization of metal ion binding in Streptococcus suis Dpr. Haikarainen T, Thanassoulas A, Stavros P, Nounesis G, Haataja S, Papageorgiou AC. Journal of molecular biology. 2011;405(2):448-60. http://dx.doi.org/10.1016/j.jmb.2010.10.058. Epub 2010 Nov 5.
366. National UK programme of community health workers for COVID-19 response. Haines A, de Barros EF, Berlin A, Heymann DL, Harris MJ. The Lancet. 2020;395(10231):1173-5.
367. Centring sexual and reproductive health and justice in the global COVID-19 response. Hall KS, Samari G, Garbers S, Casey SE, Diallo DD, Orcutt M, et al. The Lancet. 2020;395(10231):1175-7.
368. Graft cryopreservation does not impact overall survival allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide for GVHD prophylaxis. Hamadani M, Zhang MJ, Tang XY, Fei M, Brunstein C, Chhabra S, et al. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020. http://dx.doi.org/10.1016/j.bbmt.2020.04.001.
369. Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes. Han C, Duan C, Zhang S, Spiegel B, Shi H, Wang W, et al. Am j gastroenterol. 2020.
370. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. Han H, Xie L, Liu R, Yang J, Liu F, Wu K, et al. Journal of medical virology. 2020.
371. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Clin Chem Lab Med. 2020. http://dx.doi.org/10.1515/cclm-2020-0188.
372. Comparison of Clinical Features between Critically and Non-Critically Ill Patients In SARS and COVID-19: A Systematic Review and Meta-Analysis. Han P-l, Diao K-y, Pang T, Huang S, Yang Z-g. Available at SSRN 3566133. 2020.
373. Coronavirus 2019-nCoV: A brief perspective from the front line. Han Q, Lin Q, Jin S, You L. Journal of Infection. 2020;80(4):373-7.
374. Identification of diverse bat alphacoronaviruses and betacoronaviruses in china provides new insights into the evolution and origin of coronavirus-related diseases. Han Y, Du J, Su H, Zhang J, Zhu G, Zhang S, et al. Frontiers in Microbiology. 2019;10.
375. Application of integrative medicine protocols in treatment of coronavirus disease 2019. Han YY, Zhao MR, Shi Y, Song ZH, Zhou SP, He Y. Chinese Traditional and Herbal Drugs. 2020;51(4):878-82.
376. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System-a Call for Epidemiologic Investigations. Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa329.
377. An evidence-based framework for priority clinical research questions for COVID-19. Harris C, Carson G, Baillie JK, Horby P, Nair H. J Glob Health. 2020;10(1):011001-.
378. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model. Hashem AM, Algaissi A, Agrawal AS, Al-Amri SS, Alhabbab RY, Sohrab SS, et al. Journal of Infectious Diseases. 2019;220(10):1558-67.
379. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon. Haslak F, Yildiz M, Adrovic A, Barut K, Kasapcopur O. Balkan medical journal. 2020. http://dx.doi.org/10.4274/balkanmedj.galenos.2020.2020.4.43.
380. Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): Results from the Egyptian surveillance study 2010-2014. Hatem A, Mohamed S, Abu Elhassan UE, Ismael EAM, Rizk MS, El-Kholy A, et al. Multidisciplinary Respiratory Medicine. 2019;14(1).
381. The clinical course and its correlated immune status in COVID-19 pneumonia. He R, Lu Z, Zhang L, Fan T, Xiong R, Shen X, et al. Journal of Clinical Virology. 2020.
382. Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients. He XW, Lai JS, Cheng J, Wang MW, Liu YJ, Xiao ZC, et al. Zhonghua xin xue guan bing za zhi. 2020;48:E011.
383. Chinese Society of Anesthesiology Expert Consensus on Anesthetic Management of Cardiac Surgical Patients With Suspected or Confirmed Coronavirus Disease 2019. He Y, Wei J, Bian J, Guo K, Lu J, Mei W, et al. J Cardiothorac Vasc Anesth. 2020. http://dx.doi.org/10.1053/j.jvca.2020.03.026.
384. Risks and benefits of bronchoscopy during the first 100 days following allogeneic hematopoietic cell transplantation. Hefazi M, Sakemura R, Kenderian SS, Patnaik MM, Hogan WJ, Litzow M, et al. Blood. 2019;134.
385. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, et al. The Lancet Global Health. 2020;8(4):e488-e96.
386. Comparison of the three-dimensional structures of recombinant human H and horse L ferritins at high resolution. Hempstead PD, Yewdall SJ, Fernie AR, Lawson DM, Artymiuk PJ, Rice DW, et al. Journal of molecular biology. 1997;268(2):424-48. http://dx.doi.org/10.1006/jmbi.1997.0970.
387. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Hendren NS, Drazner MH, Bozkurt B, Cooper LT, Jr. Circulation. 2020. http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047349.
388. COVID-19, ECMO, and lymphopenia: a word of caution. Henry BM. The Lancet Respiratory Medicine. 2020;8(4):e24.
389. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Clinical Chemistry and Laboratory Medicine (CCLM). 2020;1.
390. COVID-19: what is next for public health? Heymann DL, Shindo N. The Lancet. 2020;395(10224):542-5.
391. Commentary: COVID-19 in patients with diabetes. Hill MA, Mantzoros C, Sowers JR. Metabolism: Clinical and Experimental. 2020;107.
392. Efficient inactivation of mers-coronavirus in human apheresis platelets with amotosalen and ultraviolet a light treatment. Hindawi SI, Hashem A, Hassan A, Damanhouri G, Al-Kafrawi S, Azhar E. Vox Sanguinis. 2019;114:133.
393. Respiratory tract infections among French Hajj pilgrims from 2014 to 2017. Hoang VT, Ali-Salem S, Belhouchat K, Meftah M, Sow D, Dao TL, et al. Scientific reports. 2019;9(1):17771.
394. Offline: COVID-19—bewilderment and candour. Horton R. The Lancet. 2020;395(10231):1178.
395. Offline: COVID-19—what countries must do now. Horton R. The Lancet. 2020;395(10230):1100.
396. Engineering a live attenuated porcine epidemic diarrhea virus vaccine candidate via inactivation of the viral 2’-O-methyltransferase and the endocytosis signal of the spike protein. Hou Y, Ke H, Kim J, Yoo D, Su Y, Boley P, et al. Journal of Virology. 2019;93(15).
397. Emerging highly virulent porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and rational design of live attenuated vaccines. Hou Y, Wang Q. International Journal of Molecular Sciences. 2019;20(21).
398. Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan. Hsih WH, Cheng MY, Ho MW, Chou CH, Lin PC, Chi CY, et al. Journal of Microbiology, Immunology and Infection. 2020.
399. Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China. Hu L, Chen S, Fu Y, Gao Z, Long H, Ren H-w, et al. medRxiv. 2020:2020.03.25.20037721.
400. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. The Lancet. 2020;395(10223):497-506.
401. Timely Diagnosis and Treatment Shortens the Time to Resolution of Coronavirus Disease (COVID-19) Pneumonia and Lowers the Highest and Last CT Scores From Sequential Chest CT. Huang G, Gong T, Wang G, Wang J, Guo X, Cai E, et al. AJR American journal of roentgenology. 2020.
402. Prediction of COVID-19 Outbreak in China and Optimal Return Date for University Students Based on Propagation Dynamics. Huang G, Pan Q, Zhao S, Gao Y, Gao X. Journal of Shanghai Jiaotong University (science). 2020;25(2):140-6. http://dx.doi.org/10.1007/s12204-020-2167-2. Epub 2020 Apr 7.
403. COVID-19 in post-transplantation patients- report of two cases. Huang J, Lin H, Wu Y, Fang Y, Kumar R, Chen G, et al. American Journal of Transplantation. 2020.
404. [Dynamic basic reproduction number based evaluation for current prevention and control of COVID-19 outbreak in China]. Huang LL, Shen SP, Yu P, Wei YY. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(4):466-9.
405. Spatial-temporal distribution of COVID-19 in China and its prediction: A data-driven modeling analysis. Huang R, Liu M, Ding Y. J Infect Dev Ctries. 2020;14(3):246-53.
406. Implications for Online Management: Two Cases with COVID-19. Huang S, Xiao Y, Yan L, Deng J, He M, Lu J, et al. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2020.
407. Epidemiology and Clinical Characteristics of COVID-19. Huang X, Wei F, Hu L, Wen L, Chen K. Arch Iran Med. 2020;23(4):268-71.
408. [Coronavirus: from common cold to severe pulmonary failure]. Hufert F, Spiegel M. Monatsschr Kinderheilkd. 2020:1-11. http://dx.doi.org/10.1007/s00112-020-00910-2.
409. Coronaviren: von der banalen Erkältung zum schweren Lungenversagen: Chronologie einer Pandemie. Hufert F, Spiegel M. Monatsschr Kinderheilkd. 2020:1-11.
410. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China. Hui DS, E IA, Madani TA, Ntoumi F, Kock R, Dar O, et al. International Journal of Infectious Diseases. 2020;91:264-6.
411. SARS: clinical features and diagnosis. Hui DS, Wong PC, Wang C. Respirology. 2003;8:S20-4. http://dx.doi.org/10.1046/j.1440-1843.2003.00520.x.
412. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Hui DSC, Zumla A. Infectious Disease Clinics of North America. 2019;33(4):869-89.
413. COVID-19 and Diabetes: Knowledge in Progress. Hussain A, Bhowmik B, Cristina do Vale Moreira N. Diabetes research and clinical practice. 2020:108142. http://dx.doi.org/10.1016/j.diabres.2020.108142.
414. Middle East respiratory syndrome coronavirus (MERS-CoV): threats, gaps and containment strategies. Hussain HY. Journal of Infection and Public Health. 2020;13(3):467.
415. In silico identification of vaccine targets for 2019-nCoV. Hyun-Jung Lee C, Koohy H. F1000Res. 2020;9:145-.
416. Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters. Ioannidis JPA, Axfors C, Contopoulos-Ioannidis DG. medRxiv. 2020:2020.04.05.20054361.
417. Toning down the 2019-nCoV media hype—and restoring hope. Ippolito G, Hui DS, Ntoumi F, Maeurer M, Zumla A. The Lancet Respiratory Medicine. 2020;8(3):230-1.
418. Healthcare Ethics During a Pandemic. Iserson KV. The western journal of emergency medicine. 2020. http://dx.doi.org/10.5811/westjem.2020.4.47549.
419. Virus-associated hemophagocytic syndrome in an international traveler as a differential diagnosis of SARS. Ishii H, Asai S, Suzuki T, Eguchi K, Miyachi H. Internal Medicine. 2005;44(4):342-5.
420. Community-acquired respiratory viruses in transplant patients: Diversity, impact, unmet clinical needs. Ison MG, Hirsch HH. Clinical Microbiology Reviews. 2019;32(4).
421. Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia. Iwasawa T, Sato M, Yamaya T, Sato Y, Uchida Y, Kitamura H, et al. Japanese journal of radiology. 2020. http://dx.doi.org/10.1007/s11604-020-00956-y.
422. A simulation on potential secondary spread of novel coronavirus in an exported country using a stochastic epidemic seir model. Iwata K, Miyakoshi C. Journal of Clinical Medicine. 2020;9(4).
423. Acute respiratory infection in human dipeptidyl peptidase 4-transgenic mice infected with Middle East respiratory syndrome coronavirus. Iwata-Yoshikawa N, Okamura T, Shimizu Y, Kotani O, Sato H, Sekimukai H, et al. Journal of Virology. 2019;93(6).
424. Outcome of Oncology Patients Infected With Coronavirus. Jazieh A-R, Alenazi TH, Alhejazi A, Al Safi F, Al Olayan A. JCO Glob Oncol. 2020;6:471-5.
425. 2019 novel coronavirus disease outbreak and molecular genetic characteristics of severe acute respiratory syndrome-coronavirus-2. Jeong YS. Journal of Bacteriology and Virology. 2020;50(1):1-8.
426. Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic. Jewell NP, Lewnard JA, Jewell BL. Ann intern med. 2020.
427. Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score. Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa414.
428. Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility. Ji HL, Zhao R, Matalon S, Matthay MA. Physiological reviews. 2020. http://dx.doi.org/10.1152/physrev.00013.2020.
429. Lockdown contained the spread of 2019 novel coronavirus disease in Huangshi city, China: Early epidemiological findings. Ji T, Chen HL, Xu J, Wu LN, Li JJ, Chen K, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa390.
430. Potential association between COVID-19 mortality and health-care resource availability. Ji Y, Ma Z, Peppelenbosch MP, Pan Q. The Lancet Global Health. 2020;8(4):e480.
431. First Case of COVID-19 Infection with Fulminant Myocarditis Complication: Case Report and Insights. Jia Hui Zeng * Y-XLJYF-XWW-BWJ-XLL-FWHGYWC-FDY-JL. Preprints 2020.
432. Epidemiological characteristics on the clustering nature of COVID-19 in Qingdao City, 2020: a descriptive analysis. Jia J, Hu X, Yang F, Song X, Dong L, Zhang J, et al. Disaster medicine and public health preparedness. 2020:1-17.
433. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Jia W, Channappanavar R, Zhang C, Li M, Zhou H, Zhang S, et al. Emerging Microbes and Infections. 2019;8(1):760-72.
434. Flavonoids isolated from loquat (Eriobotrya japonica) leaves inhibit oxidative stress and inflammation induced by cigarette smoke in COPD mice: the role of TRPV1 signaling pathways. Jian T, Chen J, Ding X, Lv H, Li J, Wu Y, et al. Food & function. 2020. http://dx.doi.org/10.1039/c9fo02921d.
435. Treatment experience of burn patients combined with inhalation injury during epidemic period of Corona Virus Disease 2019. Jiang NN, Wang DY, Chen L, Xie WG. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns. 2020.
436. Does SARS-CoV-2 has a longer incubation period than SARS and MERS? Jiang X, Rayner S, Luo MH. Journal of Medical Virology. 2020;92(5):476-8.
437. Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity. Jiang Y, Cheng X, Zhao X, Yu Y, Gao M, Zhou S. Vaccine. 2020;38(15):3157-68.
438. Complement receptor c5ar1 inhibition reduces pyroptosis in hdpp4-transgenic mice infected with mers-cov. Jiang Y, Li J, Teng Y, Sun H, Tian G, He L, et al. Viruses. 2019;11(1).
439. Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults. Jiaqiang L, Shibing F, Jing C, Jianglin W, Shunqing, Xu, et al. Cell Press. 2020.
440. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Gut. 2020.
441. Factors related to COVID-19 severity and mortality based on comparison between Henan and Zhejiang: an observational study. Jin Y, Ji W, Liang R, Zhu P, Yang H, Chen S, et al. 2020.
442. Virology, epidemiology, pathogenesis, and control of covid-19. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, et al. Viruses. 2020;12(4).
443. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. Military Medical Research. 2020;7(1).
444. Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020. Johnson HC, Gossner CM, Colzani E, Kinsman J, Alexakis L, Beauté J, et al. Eurosurveillance. 2020;25(9).
445. Redox reactivity of animal apoferritins and apoheteropolymers assembled from recombinant heavy and light human chain ferritins. Johnson JL, Norcross DC, Arosio P, Frankel RB, Watt GD. Biochemistry. 1999;38(13):4089-96. http://dx.doi.org/10.1021/bi982690d.
446. Respiratory viral infections and the risk of rheumatoid arthritis. Joo YB, Lim YH, Kim KJ, Park KS, Park YJ. Arthritis Research and Therapy. 2019;21(1).
447. Covid-19: risk factors for severe disease and death. Jordan RE, Adab P, Cheng KK. Bmj. 2020;368:m1198. http://dx.doi.org/10.1136/bmj.m1198.
448. Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: Inference using exported cases. Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. Journal of Clinical Medicine. 2020;9(2).
449. Headaches Associated with Personal Protective Equipment - A Cross-sectional Study Amongst Frontline Healthcare Workers During COVID-19 (HAPPE Study). Jy Ong J, Bharatendu C, Goh Y, Zy Tang J, Wx Sooi K, Lin Tan Y, et al. Headache. 2020.
450. Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome. Kain T, Lindsay PJ, Adhikari NKJ, Arabi YM, Van Kerkhove MD, Fowler RA. Emerg Infect Dis. 2020;26(6). http://dx.doi.org/10.3201/eid2606.200037.
451. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Kakodkar P, Kaka N, Baig MN. Cureus. 2020;12(4):e7560. http://dx.doi.org/10.7759/cureus.7560.
452. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Kandeel M, Al-Nazawi M. Life sciences. 2020:117627. http://dx.doi.org/10.1016/j.lfs.2020.117627.
453. Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers. Kandeel M, Yamamoto M, Al-Taher A, Watanabe A, Oh-Hashi K, Park BK, et al. Biomolecules & therapeutics. 2020. http://dx.doi.org/10.4062/biomolther.2019.202.
454. Mortality rate of infection with COVID-19 in Korea from the perspective of underlying disease. Kang YJ. Disaster medicine and public health preparedness. 2020:1-6.
455. Do Peri-Transplant Respiratory Viral Infections Increase Incidence of Idiopathic Pneumonia Syndrome or Bronchiolitis Obliterans in Pediatric Pateints? Kapadia M, Perentesis EM, Lane A, Dandoy CE, Davies SM. Biology of Blood and Marrow Transplantation. 2019;25(3):S346.
456. To control the covid-19 outbreak, young, healthy patients should avoid the emergency department. Karan A. The BMJ. 2020;368.
457. Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection? Kattan J, Kattan C, Assi T. Immunotherapy. 2020. http://dx.doi.org/10.2217/imt-2020-0077.
458. Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection? Kattan J, Kattan C, Assi T. 2020.
459. Evaluation of polymorphisms in inflammatory mediator and cellular adhesion genes as risk factors for feline infectious peritonitis. Kedward-Dixon H, Barker EN, Tasker S, Kipar A, Helps CR. Journal of Feline Medicine and Surgery. 2019.
460. Case fatality rate and viral aetiologies of acute respiratory tract infections in HIV positive and negative people in Africa: The VARIAFRICA-HIV systematic review and meta-analysis. Kenmoe S, Bigna JJ, Fatawou Modiyingi A, Ndangang MS, Ngoupo PA, Simo FBN, et al. Journal of Clinical Virology. 2019;117:96-102.
461. Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2. Khafaie MA, Rahim F. Osong public health and research perspectives. 2020;11(2):74-80. http://dx.doi.org/10.24171/j.phrp.2020.11.2.03.
462. Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth. Khan S, Peng L, Siddique R, Nabi G, Nawsherwan, Xue M, et al. Infection Control and Hospital Epidemiology. 2020.
463. SARS-CoV-2: What do we know so far? Khedkar PH, Patzak A. Acta physiologica (Oxford, England). 2020:e13470.
464. The 2019 Novel Coronavirus Outbreak-A Global Threat. Khot WY, Nadkar MY. J Assoc Physicians India. 2020;68(3):67.
465. Risk factors for MERS-CoV seropositivity among animal market and slaughterhouse workers, Abu Dhabi, United Arab Emirates, 2014–2017. Khudhair A, Killerby ME, Al Mulla M, Elkheir KA, Ternanni W, Bandar Z, et al. Emerging Infectious Diseases. 2019;25(5).
466. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Ki M. Epidemiology and health. 2020;42:e2020007.
467. Stability of a 24-meric homopolymer: comparative studies of assembly-defective mutants of Rhodobacter capsulatus bacterioferritin and the native protein. Kilic MA, Spiro S, Moore GR. Protein science : a publication of the Protein Society. 2003;12(8):1663-74. http://dx.doi.org/10.1110/ps.0301903.
468. Middle east respiratory syndrome coronavirus transmission. Killerby ME, Biggs HM, Midgley CM, Gerber SI, Watson JT. Emerging Infectious Diseases. 2020;26(2):191-8.
469. Understanding and Interpretation of Case Fatality Rate of Coronavirus Disease 2019. Kim DH, Choe YJ, Jeong JY. Journal of Korean medical science. 2020;35(12):e137.
470. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. Kim ES, Chin BS, Kang CK, Kim NJ, Kang YM, Choi JP, et al. Journal of Korean medical science. 2020;35(13):e142. http://dx.doi.org/10.3346/jkms.2020.35.e142.
471. Middle East respiratory syndrome-coronavirus infection into established hDDP4-transgenic mice accelerates lung damage via activation of the pro-inflammatory response and pulmonary fibrosis. Kim J, Yang YL, Jeong Y, Jang YS. Journal of microbiology and biotechnology. 2019.
472. Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis. Kim J, Yang YL, Jeong Y, Jang YS. Journal of microbiology and biotechnology. 2020;30(3):427-38. http://dx.doi.org/10.4014/jmb.1910.10055.
473. Pneumonia severity index in viral community acquired pneumonia in adults. Kim MA, Park JS, Lee CW, Choi WI. PLoS ONE. 2019;14(3).
474. Selection and characterization of monoclonal antibodies targeting middle east respiratory syndrome coronavirus through a human synthetic fab phage display library panning. Kim Y, Lee H, Park K, Park S, Lim JH, So MK, et al. Antibodies. 2019;8(3).
475. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM, et al. Cell host & microbe. 2020. http://dx.doi.org/10.1016/j.chom.2020.03.023.
476. High mortality from viral pneumonia in patients with cancer. Kim YJ, Lee ES, Lee YS. Infectious Diseases. 2019;51(7):502-9.
477. Sequential emergence and wide spread of neutralization escape middle east respiratory syndrome coronavirus Mutants, South Korea, 2015. Kim YS, Aigerim A, Park U, Kim Y, Rhee JY, Choi JP, et al. Emerging Infectious Diseases. 2019;25(6):1161-8.
478. Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles. Kim YS, Son A, Kim J, Kwon SB, Kim MH, Kim P, et al. Front Immunol. 2018;9:1093. http://dx.doi.org/10.3389/fimmu.2018.01093. eCollection 2018.
479. Pediatric Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection – UAE. Kindi FA, Nair SC, Hashmey R. Journal of Infection and Public Health. 2020;13(2):372.
480. Prisons and custodial settings are part of a comprehensive response to COVID-19. Kinner SA, Young JT, Snow K, Southalan L, Lopez-Acuña D, Ferreira-Borges C, et al. The Lancet Public Health. 2020;5(4):e188-e9.
481. Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020. Kinross P, Suetens C, Dias JG, Alexakis L, Wijermans A, Colzani E, et al. Eurosurveillance. 2020;25(11).
482. The use of inflammatory markers as a diagnostic and prognostic approach in neonatal calves with septicaemia. Kirbas A, Kandemir FM, Celebi D, Hanedan B, Timurkan MO. Acta veterinaria Hungarica. 2019;67(3):360-76.
483. The fiscal value of human lives lost from coronavirus disease (COVID-19) in China. Kirigia JM, Muthuri RNDK. BMC research notes. 2020;13(1):198.
484. Communicating the risk of death from novel coronavirus disease (COVID-19). Kobayashi T, Jung SM, Linton NM, Kinoshita R, Hayashi K, Miyama T, et al. Journal of Clinical Medicine. 2020;9(2).
485. Crushing the curve, the role of national and international institutions and policy makers in COVID-19 pandemic. Kocak Tufan Z, Kayaaslan B. Turkish journal of medical sciences. 2020. http://dx.doi.org/10.3906/sag-2004-167.
486. Counting Coronavirus Disease 2019 (COVID-19) Cases: Case Definitions, Screened Populations and Testing Techniques Matter. Koh D, Cunningham AC. Ann Acad Med Singapore. 2020;49(3):161-5.
487. How Should the Rehabilitation Community Prepare for 2019-nCoV? Koh GCH, Hoenig H. Archives of physical medicine and rehabilitation. 2020.
488. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action. Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16727.
489. Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus. Kost GJ. Archives of pathology & laboratory medicine. 2020. http://dx.doi.org/10.5858/arpa.2020-0172-RA.
490. Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario. Kozak R, Prost K, Yip L, Williams V, Leis JA, Mubareka S. Journal of Clinical Virology. 2020;126.
491. Geburtshilfliche Anästhesie während der SARS-CoV-2-Pandemie: Übersicht der Handlungsempfehlungen. Kranke P, Weibel S, Sitter M, Meybohm P, Girard T. Anasthesiol Intensivmed Notfallmed Schmerzther. 2020;55(4):266-74.
492. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et al. Cardiovascular research. 2020. http://dx.doi.org/10.1093/cvr/cvaa097.
493. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. Kritas SK, Ronconi G, Caraffa A, Gallenga CE, Ross R, Conti P. Journal of biological regulators and homeostatic agents. 2020;34(1). http://dx.doi.org/10.23812/20-Editorial-Kritas.
494. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. Kruse RL. F1000Research. 2020;9:72.
495. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Chinese medical journal. 2020.
496. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. Kulcsar KA, Coleman CM, Beck SE, Frieman MB. JCI Insight. 2019;4(20).
497. Prediction of the epidemic peak of coronavirus disease in Japan, 2020. Kuniya T. Journal of Clinical Medicine. 2020;9(3).
498. Race to find COVID-19 treatments accelerates. Kupferschmidt K, Cohen J. Science. 2020;367(6485):1412-3.
499. Epidemic Models of Contact Tracing: Systematic Review of Transmission Studies of Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. Kwok KO, Tang A, Wei VWI, Park WH, Yeoh EK, Riley S. Computational and Structural Biotechnology Journal. 2019;17:186-94.
500. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Lagunas-Rangel FA. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25819.
501. Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2. Lai A, Bergna A, Acciarri C, Galli M, Zehender G. Journal of Medical Virology. 2020.
502. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, et al. Journal of Microbiology, Immunology and Infection. 2020.
503. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. International journal of antimicrobial agents. 2020;55(3).
504. Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Lai CC, Wang CY, Wang YH, Hsueh SC, Ko WC, Hsueh PR. International journal of antimicrobial agents. 2020:105946.
505. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Lai CC, Wang CY, Wang YH, Hsueh SC, Ko WC, Hsueh PR. International journal of antimicrobial agents. 2020.
506. Host factors affecting generation of immunity against porcine epidemic diarrhea virus in pregnant and lactating swine and passive protection of neonates. Langel SN, Wang Q, Vlasova AN, Saif LJ. Pathogens. 2020;9(2).
507. Middle east respiratory syndrome coronavirus antibodies in bactrian and hybrid camels from Dubai. Lau SKP, Li KSM, Luk HKH, He Z, Teng JLL, Yuen KY, et al. mSphere. 2020;5(1).
508. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. Annals of internal medicine. 2020.
509. New coronavirus outbreak: Framing questions for pandemic prevention. Layne SP, Hyman JM, Morens DM, Taubenberger JK. Science Translational Medicine. 2020;12(534).
510. SARS-CoV-2 et ORL pédiatrique en contexte de pandémie à SARS-CoV-2 (COVID-19). Leboulanger N, Sagardoy T, Akkari M, Ayari-Khalfallah S, Celerier C, Fayoux P, et al. Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale. 2020.
511. COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL). Leboulanger N, Sagardoy T, Akkari M, Ayari-Khalfallah S, Celerier C, Fayoux P, et al. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2020.
512. Stochastic and spatio-temporal analysis of the Middle East Respiratory Syndrome outbreak in South Korea, 2015. Lee H. Infectious Disease Modelling. 2019;4:227-38.
513. Gastrointestinal and Liver Manifestations in Patients with COVID-19. Lee IC, Huo T-I, Huang Y-H. J Chin Med Assoc. 2020.
514. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients. Lee KH, Yoo SG, Cho Y, Kwon DE, La Y, Han SH, et al. Journal of Microbiology, Immunology and Infection. 2019.
515. Pneumonia associated with 2019 novel coronavirus: Can computed tomographic findings help predict the prognosis of the disease? Lee KS. Korean Journal of Radiology. 2020;21(3):257-8.
516. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic. Lee N-Y, Li C-W, Tsai H-P, Chen P-L, Syue L-S, Li M-C, et al. J microbiol immunol infect. 2020.
517. Causative agents and epidemiology of diarrhea in Korean native calves. Lee SH, Kim HY, Choi EW, Kim D. Journal of veterinary science. 2019;20(6):e64.
518. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, et al. EClinicalMedicine. 2020.
519. A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan, China. Lei Z, Cao H, Jie Y, Huang Z, Guo X, Chen J, et al. Travel Med Infect Dis. 2020:101664. http://dx.doi.org/10.1016/j.tmaid.2020.101664.
520. Genetically engineering a susceptible mouse model for MERS-CoV-induced acute respiratory distress syndrome. Leist SR, Cockrell AS. Journal. 2020;2099(Issue):137-59.
521. Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis. Leist SR, Jensen KL, Baric RS, Sheahan TP. PLoS ONE. 2019;14(7).
522. Silent circulation of coronaviruses in pigs. Leopardi S, Terregino C, Paola DB. Veterinary Record. 2020;186(10):323.
523. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Letko M, Marzi A, Munster V. Nature Microbiology. 2020.
524. Clinical features of deaths in the novel coronavirus epidemic in China. Leung C. Reviews in Medical Virology. 2020.
525. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Leung K, Wu JT, Liu D, Leung GM. Lancet. 2020. http://dx.doi.org/10.1016/S0140-6736(20)30746-7.
526. The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. Levi S, Santambrogio P, Cozzi A, Rovida E, Corsi B, Tamborini E, et al. Journal of molecular biology. 1994;238(5):649-54. http://dx.doi.org/10.1006/jmbi.1994.1325.
527. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Clinical Research in Cardiology. 2020.
528. Circulation and genetic diversity of Feline coronavirus type I and II from clinically healthy and FIP-suspected cats in China. Li C, Liu Q, Kong F, Guo D, Zhai J, Su M, et al. Transboundary and Emerging Diseases. 2019;66(2):763-75.
529. A novel bacterium-like particle vaccine displaying the MERS-CoV receptor-binding domain induces specific mucosal and systemic immune responses in mice. Li E, Chi H, Huang P, Yan F, Zhang Y, Liu C, et al. Viruses. 2019;11(9).
530. Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice. Li E, Yan F, Huang P, Chi H, Xu S, Li G, et al. Viruses. 2020;12(1).
531. SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19). Li H, Xiang X, Ren H, Xu L, Zhao L, Chen X, et al. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.03.035.
532. [Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia]. Li HC, Ma J, Zhang H, Cheng Y, Wang X, Hu ZW, et al. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43:E038. http://dx.doi.org/10.3760/cma.j.cn112147-20200312-00320.
533. AVNP2 protects against cognitive impairments induced by C6 glioma by suppressing tumour associated inflammation in rats. Li J, Liu M, Gao J, Jiang Y, Wu L, Cheong YK, et al. Brain, behavior, and immunity. 2020. http://dx.doi.org/10.1016/j.bbi.2020.02.009.
534. Puzzle of highly pathogenic human coronaviruses (2019-nCoV). Li J, Liu W. Protein Cell. 2020;11(4):235-8.
535. Data Mining and Content Analysis of Chinese Social Media Platform Weibo During Early COVID-19 Outbreak: A Retrospective Observational Infoveillance Study. Li J, Xu Q, Cuomo R, Purushothaman V, Mackey T. 2020.
536. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Li JPO, Lam DSC, Chen Y, Ting DSW. British Journal of Ophthalmology. 2020;104(3):297-8.
537. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection. Li K, Li Z, Wohlford-Lenane C, Meyerholz DK, Channappanavar R, An D, et al. mBio. 2020;11(2). http://dx.doi.org/10.1128/mBio.00554-20.
538. Development of a mouse-adapted MERS coronavirus. Li K, McCray PB. Journal. 2020;2099(Issue):161-71.
539. The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia. Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. Investigative radiology. 2020.
540. Acute lung injury in patients with COVID-19 infection. Li L, Huang Q, Wang DC, Ingbar DH, Wang X. Clinical and Translational Medicine. 2020.
541. Follow-Up Information About the Four Pregnant Patients With Coronavirus Disease (COVID-19) Pneumonia Who Were Still in the Hospital at the End of Our Study. Li L, Liu D, Yang L. AJR Am J Roentgenol. 2020:W1-W2.
542. COVID-19: the need for continuous medical education and training. Li L, Xv Q, Yan J. The Lancet Respiratory Medicine. 2020;8(4):e23.
543. Propagation analysis and prediction of the COVID-19. Li L, Yang Z, Dang Z, Meng C, Huang J, Meng H, et al. Infectious Disease Modelling. 2020;5:282-92.
544. 2019 novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis. Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. Journal of medical virology. 2020.
545. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Li M, Dong Y, Wang H, Guo W, Zhou H, Zhang Z, et al. Nutrition, Metabolism and Cardiovascular Diseases. 2020.
546. Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease. Li M, Lei P, Zeng B, Li Z, Yu P, Fan B, et al. Academic Radiology. 2020.
547. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. The New England journal of medicine. 2020;382(13):1199-207.
548. Regulation of the ER Stress Response by the Ion Channel Activity of the Infectious Bronchitis Coronavirus Envelope Protein Modulates Virion Release, Apoptosis, Viral Fitness, and Pathogenesis. Li S, Yuan L, Dai G, Chen RA, Liu DX, Fung TS. Frontiers in Microbiology. 2020;10.
549. Clinical observation and management of COVID-19 patients. Li T, Lu H, Zhang W. Emerg Microbes Infect. 2020;9(1):687-90.
550. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China. Li X, Guo Z, Li B, Zhang X, Tian R, Wu W, et al. ASAIO journal (American Society for Artificial Internal Organs : 1992). 2020.
551. Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.03.053.
552. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. The Journal of allergy and clinical immunology. 2020. http://dx.doi.org/10.1016/j.jaci.2020.04.006.
553. Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou. Li XQ, Cai WF, Huang LF, Chen C, Liu YF, Zhang ZB, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(5):634-7.
554. [The keypoints in treatment of the critical coronavirus disease 2019 patient]. Li XY, Du B, Wang YS, Kang HYJ, Wang F, Sun B, et al. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43:E026. http://dx.doi.org/10.3760/cma.j.cn112147-20200224-00159.
555. [The keypoints in treatment of the critical coronavirus disease 2019 patient(2)]. Li XY, Du B, Wang YS, Kang HYJ, Wang F, Sun B, et al. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43(4):277-81. http://dx.doi.org/10.3760/cma.j.cn112147-20200224-00159.
556. [Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19)]. Li Y, Hu Y, Zhang X, Yu Y, Li B, Wu J, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49(1).
557. [Surgical treatment for esophageal cancer during the outbreak of COVID-19]. Li Y, Qin JJ, Wang Z, Yu Y, Wen YY, Chen XK, et al. Zhonghua Zhong Liu Za Zhi. 2020;42:E003-E.
558. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. Li Y, Xia L. AJR Am J Roentgenol. 2020:1-7.
559. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Li Y, Zhou W, Yang L, You R. Pharmacological research. 2020.
560. Analysis of TCM in prevention and treatment of post-traumatic stress disorder induced by COVID-19. Li YF, Zhang YG, Niu JT, Si XL, Yan XK. Chinese Traditional and Herbal Drugs. 2020;51(5):1130-8.
561. Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins. Li YH, Hu CY, Wu NP, Yao HP, Li LJ. Engineering (Beijing, China). 2019;5(5):940-7. http://dx.doi.org/10.1016/j.eng.2018.11.035. Epub 2019 Jul 17.
562. Chemotherapy strategy for colorectal cancer under the outbreak of novel coronavirus pneumonia. Li YH, Shen L, Li J. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2020;23:E004.
563. [Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019]. Li YH, Shen L, Li J. Zhonghua Wei Chang Wai Ke Za Zhi. 2020;23(3):217-9.
564. Clinical and Transmission Characteristics of Covid-19 - A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department. Li YK, Peng S, Li LQ, Wang Q, Ping W, Zhang N, et al. Current medical science. 2020. http://dx.doi.org/10.1007/s11596-020-2176-2.
565. Clinical and Transmission Characteristics of Covid-19 — A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department. Li Y-K, Peng S, Li L-Q, Wang Q, Ping W, Zhang N, et al. Current Medical Science. 2020.
566. Emerging lethal infectious bronchitis coronavirus variants with multiorgan tropism. Li YT, Chen TC, Lin SY, Mase M, Murakami S, Horimoto T, et al. Transboundary and Emerging Diseases. 2020;67(2):884-93.
567. From the insight of glucose metabolism disorder: Oxygen therapy and blood glucose monitoring are crucial for quarantined COVID-19 patients. Li Z, Liu G, Wang L, Liang Y, Zhou Q, Wu F, et al. Ecotoxicology and Environmental Safety. 2020;197.
568. Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan. Lian J, Jin X, Hao S, Cai H, Zhang S, Zheng L, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
569. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. The Lancet Oncology. 2020;21(3):335-7.
570. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China. Liang WH, Guan WJ, Li CC, Li YM, Liang HR, Zhao Y, et al. The European respiratory journal. 2020. http://dx.doi.org/10.1183/13993003.00562-2020.
571. Extracorporeal Membrane Oxygenation for Severe Respiratory Failure during Respiratory Epidemics and Pandemics: A Narrative Review. Lim JKB, Qadri SK, Toh TSW, Lin CB, Mok YH, Lee JH. Ann Acad Med Singapore. 2020;49(4):1-34.
572. People experiencing homelessness: Their potential exposure to COVID-19. Lima NNR, de Souza RI, Feitosa PWG, Moreira JLS, da Silva CGL, Neto MLR. Psychiatry research. 2020;288:112945. http://dx.doi.org/10.1016/j.psychres.2020.112945.
573. Hypothesis for potential pathogenesis of SARS-CoV-2 infection--a review of immune changes in patients with viral pneumonia. Lin L, Lu L, Cao W, Li T. Emerging microbes & infections. 2020:1-14.
574. Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia. Lin L, Lu L, Cao W, Li T. Emerging Microbes and Infections. 2020;9(1):727-32.
575. Infection control in non-clinical areas during COVID-19 pandemic. Ling L, Wong WT, Wan WTP, Choi G, Joynt GM. Anaesthesia. 2020. http://dx.doi.org/10.1111/anae.15075.
576. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: A statistical analysis of publicly available case data. Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung SM, et al. Journal of Clinical Medicine. 2020;9(2).
577. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Lippi G, Favaloro EJ. Thromb Haemost. 2020. http://dx.doi.org/10.1055/s-0040-1709650.
578. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Lippi G, Lavie CJ, Sanchis-Gomar F. Progress in cardiovascular diseases. 2020.
579. Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China. Lippi G, Mattiuzzi C, Sanchis-Gomar F, Henry BM. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25860.
580. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Lippi G, Plebani M. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2020.
581. Laboratory abnormalities in patients with COVID-2019 infection. Lippi G, Plebani M. Clinical Chemistry and Laboratory Medicine. 2020.
582. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Lippi G, Plebani M, Henry BM. Clin Chim Acta. 2020;506:145-8. http://dx.doi.org/10.1016/j.cca.2020.03.022.
583. Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. Lippi G, Wong J, Henry BM. Polish archives of internal medicine. 2020. http://dx.doi.org/10.20452/pamw.15272.
584. Estimating case fatality rates of COVID-19. Lipsitch M. The Lancet Infectious diseases. 2020.
585. Non-steroidal anti-inflammatory drugs and covid-19. Little P. The BMJ. 2020;368.
586. Overall reduced lymphocyte subsets worsening disease severity and prognosis in COVID-19 severe cases with diabetes mellitus in Chengdu, China. Liu A. BMC Infectious diseases. 2020.
587. Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression. Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan K, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
588. Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation. Liu H, He X, Wang Y, Zhou S, Zhang D, Zhu J, et al. Hepatology international. 2020. http://dx.doi.org/10.1007/s12072-020-10043-z.
589. A survey on awareness of digestive system injury caused by corona virus disease 2019 in gastroenterologists. Liu H, Wang B, Liu K, Wen L, Wang X, Li Q, et al. Chinese Journal of Digestion. 2020.
590. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. EBioMedicine. 2020.
591. Comprehensive Genomic Characterization Analysis of lncRNAs in Cells With Porcine Delta Coronavirus Infection. Liu J, Wang F, Du L, Li J, Yu T, Jin Y, et al. Frontiers in Microbiology. 2020;10.
592. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. Liu K, Chen Y, Lin R, Han K. Journal of Infection. 2020.
593. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Complementary Therapies in Clinical Practice. 2020.
594. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. Liu L, Wei Q, Lin Q, Fang J, Wang H, Kwok H, et al. JCI insight. 2019;4(4).
595. [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]. Liu M, He P, Liu HG, Wang XJ, Li FJ, Chen S, et al. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43(3):209-14. http://dx.doi.org/10.3760/cma.j.issn.1001-0939.2020.03.014.
596. The Science Underlying COVID-19: Implications for the Cardiovascular System. Liu PP, Blet A, Smyth D, Li H. Circulation. 2020. http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047549.
597. The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019. Liu R, Ma Q, Han H, Su H, Liu F, Wu K, et al. Clinical Chemistry and Laboratory Medicine (CCLM). 2020;1.
598. Traditional Chinese medicine for treatment of COVID-19 based on literature mining of targeting cytokine storm. Liu RP, Ge JD, Zhong Y, Zheng Q, Sun R. Chinese Traditional and Herbal Drugs. 2020.
599. Optimal mean airway pressure during high-frequency oscillatory ventilation in an experimental model of acute respiratory distress syndrome: EIT-based method. Liu S, Zhao Z, Tan L, Wang L, Moller K, Frerichs I, et al. Annals of intensive care. 2020;10(1):31. http://dx.doi.org/10.1186/s13613-020-0647-z.
600. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Liu W, Tao ZW, Lei W, Ming-Li Y, Kui L, Ling Z, et al. Chinese medical journal. 2020.
601. Coronavirus disease 2019 (COVID-19) during pregnancy: A case series. Liu W, Wang Q, Zhang Q, Chen L, Chen J, Zhang B, et al. 2020.
602. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.04.002.
603. Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China. Liu Y, Li J, Feng Y. Critical Care. 2020;24(1).
604. Clinical features and outcomes of 2019 novel coronavirus-infected patients with high plasma BNP levels. liu y, Liu D, Song H, chen C, lv M, pei X, et al. medRxiv. 2020:2020.03.31.20047142.
605. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao S, et al. Platelets. 2020:1-7. http://dx.doi.org/10.1080/09537104.2020.1754383.
606. Analysis on cluster cases of COVID-19 in Tianjin. Liu YF, Li JM, Zhou PH, Liu J, Dong XC, Lyu J, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(5):654-7.
607. [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019]. Liu YJ, Yang YL, Xu Y. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43(4):339-44.
608. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, et al. J med virol. 2020.
609. WHO must prioritise the needs of older people in its response to the covid-19 pandemic. Lloyd-Sherlock PG, Kalache A, McKee M, Derbyshire J, Geffen L, Casas FGO, et al. The BMJ. 2020;368.
610. Laboratory diagnosis of emerging human coronavirus infections–the state of the art. Loeffelholz MJ, Tang YW. Emerging Microbes and Infections. 2020;9(1):747-56.
611. Admission biochemical test associated with the prognosis of COVID-19: a multi-centered retrospective cohort study. Long Q, Song B, Li G, Zhou C-l, Wang Y-m, Cheng X-b, et al. Journal. 2020(Issue).
612. New-onset acute symptomatic seizure and risk factors in Corona Virus Disease 2019: A Retrospective Multicenter Study. Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, et al. Epilepsia. 2020. http://dx.doi.org/10.1111/epi.16524.
613. Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients. Lu S, Lin J, Zhang Z, Xiao L, Jiang Z, Chen J, et al. Journal of medical virology. 2020.
614. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Ludvigsson JF. Acta paediatrica (Oslo, Norway : 1992). 2020.
615. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Ludvigsson JF. Acta paediatrica (Oslo, Norway : 1992). 2020. http://dx.doi.org/10.1111/apa.15270.
616. Aminopeptidase N-null neonatal piglets are protected from transmissible gastroenteritis virus but not porcine epidemic diarrhea virus. Luo L, Wang S, Zhu L, Fan B, Liu T, Wang L, et al. Scientific reports. 2019;9(1):13186.
617. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa FG, Corcione S. Journal of Global Antimicrobial Resistance. 2020;21:22-7.
618. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic. Luzi L, Radaelli MG. Acta diabetologica. 2020. http://dx.doi.org/10.1007/s00592-020-01522-8.
619. Pathogenic Priming Likely Contributes to Serious and Critical Illness and Mortality in COVID-19 via Autoimmunity. Lyons-Weiler J. Journal of translational autoimmunity. 2020:100051. http://dx.doi.org/10.1016/j.jtauto.2020.100051.
620. Surgical treatment strategy for digestive system malignancies during the outbreak of novel coronavirus pneumonia. Ma F, Hu H, Tian Y. Chinese Journal of Oncology. 2020.
621. Clinical Characteristics and Prognosis in Cancer Patients with COVID-19: a Single Center's Retrospective Study. Ma J, Yin J, Qian Y, Wu Y. Journal of Infection.
622. Management and clinical thinking of Coronavirus Disease 2019. Ma K, Chen T, Han MF, Guo W, Ning Q. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2020;28:E002.
623. [The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19]. Ma WX, Ran XW. Sichuan da xue xue bao Yi xue ban = Journal of Sichuan University Medical science edition. 2020;51(2):146-50. http://dx.doi.org/10.12182/20200360606.
624. Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China. Ma Y, Zhao Y, Liu J, He X, Wang B, Fu S, et al. Science of the Total Environment. 2020;724.
625. Feline retrovirus-infected hospitalised cats - Aetiology, coinfections and survival rates. MacHado IC, Carvalho AJ, Gomes JF, Cunha EG, Tavares LM, Almeida VS, et al. Journal of Feline Medicine and Surgery. 2019;21(9):844.
626. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. JAMA Cardiol. 2020. http://dx.doi.org/10.1001/jamacardio.2020.1286.
627. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. Mahase E. BMJ (Clinical research ed). 2020;368:m641.
628. Covid-19: death rate is 0.66% and increases with age, study estimates. Mahase E. BMJ (Clinical research ed). 2020;369:m1327.
629. Covid-19: Patients who are improving could have treatment withdrawn if others could benefit more. Mahase E. BMJ. 2020.
630. RARE CASE OF MORTALITY FROM NON-CIRRHOTIC HYPERAMMONEMIA. Maher D, Chapman K. Chest. 2019;156(4):A2125.
631. Feline Infectious Peritonitis as a Systemic Inflammatory Disease: Contribution of Liver and Heart to the Pathogenesis. Malbon AJ, Fonfara S, Meli ML, Hahn S, Egberink H, Kipar A. Viruses. 2019;11(12). http://dx.doi.org/10.3390/v11121144.
632. Inflammatory Mediators in the Mesenteric Lymph Nodes, Site of a Possible Intermediate Phase in the Immune Response to Feline Coronavirus and the Pathogenesis of Feline Infectious Peritonitis? Malbon AJ, Meli ML, Barker EN, Davidson AD, Tasker S, Kipar A. Journal of Comparative Pathology. 2019;166:69-86.
633. Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. Malik YS, Sircar S, Bhat S, Sharun K, Dhama K, Dadar M, et al. The veterinary quarterly. 2020;40(1):68-76. http://dx.doi.org/10.1080/01652176.2020.1727993.
634. Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments. Malik YS, Sircar S, Bhat S, Sharun K, Dhama K, Dadar M, et al. Veterinary Quarterly. 2020;40(1):68-76.
635. Disease features of equine coronavirus and enteric salmonellosis are similar in horses. Manship AJ, Blikslager AT, Elfenbein JR. Journal of Veterinary Internal Medicine. 2019;33(2):912-7.
636. 2019-Novel Coronavirus (2019-NCOV): Estimating the case fatality rate – A word of caution. Manuel B, Richard K, Sarah TS, Hirsch Hans H, Widmer Andreas F, Neher Richard A. Swiss Medical Weekly. 2020;150(5).
637. Guide to the Forensic Pathology Practice on Death Cases Related to Corona Virus Disease 2019 COVID-19 Trial Draft. Mao DM, Zhou N, Zheng D, Le JC, Zhao QH, Luo B, et al. Fa yi xue za zhi. 2020;36(1):6-5. http://dx.doi.org/10.12116/j.issn.1004-5619.2020.01.003.
638. Guide to the Forensic Pathology Practice on Death Cases Related to Corona Virus Disease 2019 （ COVID-19） （Trial Draft）. Mao DM, Zhou N, Zheng D, Le JC, Zhao QH, Luo B, et al. Fa yi xue za zhi. 2020;36(1):6-5.
639. COVID-19 epidemic in Switzerland: On the importance of testing, contact tracing and isolation. Marcel S, Christian AL, Richard N, Silvia S, Emma H, Jacques F, et al. Swiss Medical Weekly. 2020;150(11).
640. Consideration of the respiratory support strategy of severe acute respiratory failure caused by SARS-CoV-2 infection in children. Marraro GA, Spada C. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. 2020;22(3):183-94.
641. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Martinez MA. Antimicrobial agents and chemotherapy. 2020.
642. Primary care management of the coronavirus (COVID-19). Mash B. South African family practice : official journal of the South African Academy of Family Practice/Primary Care. 2020;62(1):e1-e4. http://dx.doi.org/10.4102/safp.v62i1.5115.
643. Blockchain and artificial intelligence technology for novel coronavirus disease-19 self-testing. Mashamba-Thompson TP, Crayton ED. Diagnostics. 2020;10(4).
644. Crystallization and preliminary X-ray characterization of a ferritin from the hyperthermophilic archaeon and anaerobe Pyrococcus furiosus. Matias PM, Tatur J, Carrondo MA, Hagen WR. Acta crystallographica Section F, Structural biology and crystallization communications. 2005;61:503-6. http://dx.doi.org/10.1107/S1744309105011516. Epub 2005 Apr 22.
645. Should we expect neurological symptoms in the SARS-CoV-2 epidemic? Matías-Guiu J, Gomez-Pinedo U, Montero-Escribano P, Gomez-Iglesias P, Porta-Etessam J, Matias-Guiu JA. Neurología (English Edition). 2020.
646. ¿Es esperable que haya cuadros neurológicos por la pandemia de SARS2-CoV? Matías-Guiu J, Gomez-Pinedo U, Montero-Escribano P, Gomez-Iglesias P, Porta-Etessam J, Matias-Guiu JA. Neurología. 2020.
647. The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis. Matsushita K, Ding N, Kou M, Hu X, Chen M, Gao Y, et al. medRxiv. 2020:2020.04.05.20054155.
648. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Mattiuzzi C, Lippi G. Annals of Translational Medicine. 2020;8(3).
649. Geriatric Care during Public Health Emergencies: Lessons Learned from Novel Corona Virus Disease (COVID-19) Pandemic. Mazumder H, Hossain MM, Das A. Journal of gerontological social work. 2020:1-2.
650. Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection. McCullough PA, Eidt J, Rangaswami J, Lerma E, Tumlin J, Wheelan K, et al. Reviews in cardiovascular medicine. 2020;21(1):1-7. http://dx.doi.org/10.31083/j.rcm.2020.01.42.
651. Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome. McGonagle D, Sharif K, O'Regan A, Bridgewood C. Autoimmun Rev. 2020:102537. http://dx.doi.org/10.1016/j.autrev.2020.102537.
652. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. McGonagle D, Sharif K, O'Regan A, Bridgewood C. Autoimmunity Reviews. 2020.
653. Corticosteroid Guidance for Pregnancy during COVID-19 Pandemic. McIntosh JJ. American journal of perinatology. 2020. http://dx.doi.org/10.1055/s-0040-1709684.
654. Prevalence and mutation analysis of the spike protein in feline enteric coronavirus and feline infectious peritonitis detected in household and shelter cats in western Canada. McKay LA, Meachem M, Snead E, Brannen T, Mutlow N, Ruelle L, et al. Canadian Journal of Veterinary Research. 2020;84(1):18-23.
655. COVID-19 in a Long-Term Care Facility - King County, Washington, February 27-March 9, 2020. McMichael TM, Clark S, Pogosjans S, Kay M, Lewis J, Baer A, et al. MMWR Morbidity and mortality weekly report. 2020;69(12):339-42. http://dx.doi.org/10.15585/mmwr.mm6912e1.
656. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington. McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. The New England journal of medicine. 2020. http://dx.doi.org/10.1056/NEJMoa2005412.
657. 314 Identifying Acute HIV Infection in the Emergency Department. McWilliams K, Palakurty SH, Hazlett A, Henderson H, Wilson J. Annals of Emergency Medicine. 2019;74(4):S123.
658. COVID-19: consider cytokine storm syndromes and immunosuppression. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. The Lancet. 2020.
659. Recommendations CCAFU on the management of cancers of the urogenital system during an epidemic with Coronavirus COVID-19. Mejean A, Rouprêt M, Rozet F, Bensalah K, Murez T, Game X, et al. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2020.
660. Recommandations CCAFU sur la prise en charge des cancers de l’appareil urogénital en période d’épidémie au Coronavirus COVID-19. Mejean A, Rouprêt M, Rozet F, Bensalah K, Murez T, Game X, et al. Progrès en Urologie. 2020.
661. Recommandations CCAFU sur la prise en charge des cancers de l'appareil urogénital en période d'épidémie au Coronavirus COVID-19. Méjean A, Rouprêt M, Rozet F, Bensalah K, Murez T, Game X, et al. Prog urol (Paris). 2020.
662. Recommendations CCAFU on the management of cancers of the urogenital system during an epidemic with Coronavirus COVID-19. TT - Recommandations CCAFU sur la prise en charge des cancers de lappareil urogenital en periode depidemie au Coronavirus COVID-19. Mejean A, Roupret M, Rozet F, Bensalah K, Murez T, Game X, et al. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2020.
663. Middle East respiratory syndrome. Memish ZA, Perlman S, Van Kerkhove MD, Zumla A. The Lancet. 2020;395(10229):1063-77.
664. Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience. Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, et al. Anesthesiology. 2020.
665. Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience. Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, et al. Anesthesiology. 2020.
666. Novel coronavirus 2019-nCoV: Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Meo SA, Alhowikan AM, Khlaiwi TAL, Meo IM, Halepoto DM, Iqbal M, et al. European Review for Medical and Pharmacological Sciences. 2020;24(4):2012-9.
667. Biological and Epidemiological Trends in the Prevalence and Mortality due to Outbreaks of Novel Coronavirus COVID-19. Meo SA, Al-Khlaiwi T, Usmani AM, Meo AS, Klonoff DC, Hoang TD. Journal of King Saud University Science. 2020. http://dx.doi.org/10.1016/j.jksus.2020.04.004.
668. Mesenchymal stem cells and management of COVID-19 pneumonia. Metcalfe SM. Medicine in Drug Discovery. 2020;5.
669. Histopathologic evaluation and scoring of viral lung infection. Meyerholz DK, Beck AP. Journal. 2020;2099(Issue):205-20.
670. Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients. Mi B, Chen L, Xiong Y, Xue H, Zhou W, Liu G. J Bone Joint Surg Am. 2020. http://dx.doi.org/10.2106/JBJS.20.00390.
671. Reporting of all cardiac medications and their outcome in COVID - 19. Mishra AK, Sahu KK, Lal A. Journal of medical virology. 2020.
672. Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020. Mizumoto K, Chowell G. Emerging infectious diseases. 2020;26(6).
673. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
674. Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1.2017 to 17.1.2018: A cross-sectional study. Mobaraki K, Ahmadzadeh J. BMC Infectious Diseases. 2019;19(1).
675. Standard Expected Years of Life Lost as a Neglected Index for Calculating the Burden of Premature Mortality due to Middle East Respiratory Syndrome. Mobaraki K, Salamatbakhsh M, Ahmadzadeh J. Health security. 2019;17(5):407-9.
676. Following the evidence, from coronavirus to terrorism response. Moberly T. The BMJ. 2020;368.
677. The Exponentially Increasing Rate of Patients Infected with COVID-19 in Iran. Moftakhar L, Seif M. Arch Iran Med. 2020;23(4):235-8.
678. The Causes of Canine Myocarditis and Myocardial Fibrosis Are Elusive by Targeted Molecular Testing: Retrospective Analysis and Literature Review. Molesan A, Goodman L, Ford J, Lovering SJ, Kelly K. Veterinary Pathology. 2019;56(5):761-77.
679. A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Momattin H, Al-Ali AY, Al-Tawfiq JA. Travel Medicine and Infectious Disease. 2019;30:9-18.
680. Burden of respiratory virus infections in solid-organ transplant recipients: A nationwide multi-season cohort study. Mombelli M, Neofytos D, Aubert J, Benden C, Berger C, Boggian K, et al. American Journal of Transplantation. 2019;19:730.
681. Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? Monteleone G, Ardizzone S. Journal of Crohn's & colitis. 2020. http://dx.doi.org/10.1093/ecco-jcc/jjaa061.
682. Porcine hemagglutinating encephalomyelitis virus: A review. Mora-Díaz JC, Piñeyro PE, Houston E, Zimmerman J, Giménez-Lirola LG. Frontiers in Veterinary Science. 2019;6.
683. COVID-19 virus and children: What do we know? Morand A, Fabre A, Minodier P, Boutin A, Vanel N, Bosdure E, et al. Archives de Pediatrie. 2020;27(3):117-8.
684. COVID19 Prevention & Care; A Cancer Specific Guideline. Motlagh A, Yamrali M, Azghandi S, Azadeh P, Vaezi M, Ashrafi F, et al. Arch Iran Med. 2020;23(4):255-64.
685. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis. Mourya DT, Sapkal G, Yadav PD, Belani SKM, Shete A, Gupta N. The Indian journal of medical research. 2020. http://dx.doi.org/10.4103/ijmr.IJMR_763_20.
686. Abnormal iron homeostasis and neurodegeneration. Muhoberac BB, Vidal R. Frontiers in aging neuroscience. 2013;5:32. http://dx.doi.org/10.3389/fnagi.2013.00032. eCollection 2013.
687. COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus. Muniyappa R, Gubbi S. American journal of physiology Endocrinology and metabolism. 2020. http://dx.doi.org/10.1152/ajpendo.00124.2020.
688. A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. The New England journal of medicine. 2020;382(8):692-4.
689. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now? Musa S. Arab Journal of Gastroenterology. 2020.
690. Global outbreak of COVID-19: A new challenge? Musa TH, Ahmad T, Khan M, Haroon, Wei P. Journal of Infection in Developing Countries. 2020;14(3):244-5.
691. Multiple viral etiologies in patients with influenza-like illness and severe acute respiratory infection in Qatar, 2013–2016. Nadeem S, Romaihi HA, Ganesan N, Elberdiny A. Journal of Infection and Public Health. 2020;13(3):466.
692. The role of afferent pulmonary innervation in poor prognosis of acute respiratory distress syndrome in COVID-19 patients and proposed use of resiniferatoxin (RTX) to improve patient outcomes in advanced disease state: A review. Nahama A, Ramachandran R, Cisternas AF, Ji H. Medicine in drug discovery. 2020:100033. http://dx.doi.org/10.1016/j.medidd.2020.100033.
693. African green monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Nalca A, Totura A, Livingston V, Frick O, Dyer D. International Journal of Infectious Diseases. 2019;79:99-100.
694. Respiratory support for patients with COVID-19 infection. Ñamendys-Silva SA. The Lancet Respiratory Medicine. 2020;8(4):e18.
695. Etiology of acute viral respiratory infections common in Pakistan: A review. Naz R, Gul A, Javed U, Urooj A, Amin S, Fatima Z. Reviews in Medical Virology. 2019;29(2).
696. Molecular characteristics of a novel recombinant of porcine epidemic diarrhea virus. Nefedeva M, Titov I, Malogolovkin A. Archives of virology. 2019;164(4):1199-204.
697. The battle against covid-19: Where do we stand now? Negahdaripour M. Iranian Journal of Medical Sciences. 2020;45(2):81-2.
698. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. Neher RA, Dyrdak R, Druelle V, Hodcroft EB, Albert J. Swiss medical weekly. 2020;150:w20224.
699. Coronaviruses in animals and humans. Ng LFP, Hiscox JA. The BMJ. 2020;368.
700. Covid-19 fatality is likely overestimated. Niforatos JD, Melnick ER, Faust JS. The BMJ. 2020;368.
701. The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights. Nishiura H, Kobayashi T, Yang Y, Hayashi K, Miyama T, Kinoshita R, et al. Journal of clinical medicine. 2020;9(2). http://dx.doi.org/10.3390/jcm9020419.
702. The rate of underascertainment of novel coronavirus (2019‐ncov) infection: Estimation using japanese passengers data on evacuation flights. Nishiura H, Kobayashi T, Yang Y, Hayashi K, Miyama T, Kinoshita R, et al. Journal of Clinical Medicine. 2020;9(2).
703. Serial interval of novel coronavirus (COVID-19) infections. Nishiura H, Linton NM, Akhmetzhanov AR. International Journal of Infectious Diseases. 2020;93:284-6.
704. UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments. Noad RJ, Simpson K, Fooks AR, Hewson R, Gilbert SC, Stevens MP, et al. Vaccine. 2019;37(43):6241-7.
705. Mucoviscidosis: fisiopatología, genética, aspectos clínicos y terapéuticos. Noël S, Sermet-Gaudelus I. EMC - Pediatría. 2020.
706. Public awareness of coronavirus in Al-Jouf region, Saudi Arabia. Nooh HZ, Alshammary RH, Alenezy JM, Alrowaili NH, Alsharari AJ, Alenzi NM, et al. Journal of Public Health (Germany). 2020.
707. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, et al. The Cochrane database of systematic reviews. 2020;4:Cd013574. http://dx.doi.org/10.1002/14651858.CD013574.
708. Plagues and adaptation: Lessons from the Felidae models for SARS and AIDS. O'Brien SJ, Troyer JL, Roelke M, Marker L, Pecon-Slattery J. Biological conservation. 2006;131(2):255-67. http://dx.doi.org/10.1016/j.biocon.2006.05.001. Epub 2006 Jun 6.
709. Role of human bocavirus respiratory tract infection in hematopoietic cell transplant recipients. Ogimi C, Martin ET, Xie H, Campbell AP, Waghmare A, Kuypers J, et al. Open Forum Infectious Diseases. 2019;6:S645.
710. Sensitive and specific detection of low-level antibody responses in mild Middle East respiratory syndrome coronavirus infections. Okba NMA, Stalin Raj V, Widjaja I, GeurtsvanKessel CH, De Bruin E, Chandler FD, et al. Emerging Infectious Diseases. 2019;25(10):1868-77.
711. Regulation and trust: COVID-19 mortality in 25 European countries. Oksanen A, Kaakinen M, Latikka R, Savolainen I, Savela N, Koivula A. JMIR public health and surveillance. 2020. http://dx.doi.org/10.2196/19218.
712. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? Olds JL, Kabbani N. The FEBS journal. 2020.
713. Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: How Close Are We? Omrani AS, Memish ZA. Current treatment options in infectious diseases. 2015;7(3):202-16. http://dx.doi.org/10.1007/s40506-015-0048-2. Epub 2015 Jun 12.
714. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. Onder G, Rezza G, Brusaferro S. JAMA - Journal of the American Medical Association. 2020.
715. Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target. Ortega JT, Serrano ML, Pujol FH, Rangel HR. EXCLI Journal. 2020;19:400-9.
716. Hepatitis e virus: Viral evasion through OAS/RNase L inactivation. Ortega O, Laurence B, Coutard B, Canard B, Rabah N. Virologie. 2019;23(2):68.
717. Mapping the environmental suitability for middle eastern respiratory syndrome coronavirus. Osborne JC, Ramshaw RE, Letourneau ID, Shirude S, Hay SI, Pigott DM. American Journal of Tropical Medicine and Hygiene. 2019;101(5):69.
718. COVID-19, diabetes mellitus and ACE2: The conundrum. Pal R, Bhansali A. Diabetes Research and Clinical Practice. 2020;162.
719. COVID-19, a worldwide public health emergency. Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. Revista Clinica Espanola. 2020.
720. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Radiology. 2020:200370-.
721. [Analysis on pattern of prescriptions and syndromes of traditional Chinese medicine for prevention and treatment of COVID-19]. Pang W-T, Jin X-Y, Pang B, Yang F-W, Wang H, Liu C-X, et al. Zhongguo Zhong Yao Za Zhi. 2020;45(6):1242-7.
722. Initial evidence of higher morbidity and mortality due to SARS-CoV-2 in regions with lower air quality. Pansini R, Fornacca D. medRxiv. 2020:2020.04.04.20053595.
723. Case Report of Transmissible Gastroenteritis Coronavirus Infection Associated with Small Intestine and Brain Lesions in Piglets. Papatsiros VG, Stylianaki I, Papakonstantinou G, Papaioannou N, Christodoulopoulos G. Viral Immunology. 2019;32(1):63-7.
724. Optimizing provision of extracorporeal life support during the COVID-19 pande.mic: Practical considerations for Canadian jurisdictions. Parhar KKS, Lequier L, Blackwood J, Zuege DJ, Singh G. CMAJ. 2020;192(14):E372-E4.
725. Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients: A 2-year prospective cohort study. Park HC, Lee SH, Kim J, Kim DH, Cho A, Jeon HJ, et al. Medicine (United States). 2020;99(3).
726. First Pediatric Case of Coronavirus Disease 2019 in Korea. Park JY, Han MS, Park KU, Kim JY, Choi EH. Journal of Korean medical science. 2020;35(11):e124.
727. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. Park M, Cook AR, Lim JT, Sun Y, Dickens BL. Journal of clinical medicine. 2020;9(4). http://dx.doi.org/10.3390/jcm9040967.
728. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Park SE. Clinical and experimental pediatrics. 2020. http://dx.doi.org/10.3345/cep.2020.00493.
729. Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers. Park SY, Lee JS, Son JS, Ko JH, Peck KR, Jung Y, et al. Journal of Hospital Infection. 2019;101(1):42-6.
730. Risk factors for mortality of adult inpatients with Coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of retrospective studies. Parohan M, Yaghoubi S, Seraj A, Javanbakht MH, Sarraf P, Djalali M. medRxiv. 2020:2020.04.09.20056291.
731. Respiratory viruses infections are a significant clinical problem in haematological patients with underestimated adverse outcome: A single institution 9-years experience. Passi A, Pagani C, Gramegna D, Daffini R, Pollara CP, Signorini L, et al. Haematologica. 2019;104:29-30.
732. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. Patel A, Jernigan DB. MMWR Morbidity and mortality weekly report. 2020;69(5):140-6.
733. A meta-analysis of 2019 novel corona virus patient clinical characteristics and comorbidities. Paudel. 2020.
734. Coronavirus Infections-More Than Just the Common Cold. Paules CI, Marston HD, Fauci AS. JAMA - Journal of the American Medical Association. 2020;323(8):707-8.
735. SARS-CoV-2: A Storm is Raging. Pedersen SF, Ho YC. The Journal of clinical investigation. 2020. http://dx.doi.org/10.1172/JCI137647.
736. Genetic modifiers in HFE-hemochromatosis: Analysis of 355 TAG SNPs in an Italian population of C282Y homozygotes. Pelucchi S, Mariani R, Calza S, Bertola F, Fracanzani AL, Busti F, et al. American Journal of Hematology. 2011;86(9):E45-E6.
737. Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis. Peng S, Huang L, Zhao B, Zhou S, Braithwaite I, Zhang N, et al. The Journal of Thoracic and Cardiovascular Surgery. 2020.
738. How to conduct clinical research on anesthesiology during epidemic of the novel coronavirus pneumonia: recommendations from the epidemiological perspective. Peng X, Li N. Chinese Journal of Anesthesiology. 2020.
739. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Peng YD, Meng K, Guan HQ, Leng L, Zhu RR, Wang BY, et al. Zhonghua xin xue guan bing za zhi. 2020;48:E004.
740. Post-Discharge Cardiac Care in the Era of Coronavirus 2019: How Should We Prepare? Percy E, Luc JGY, Vervoort D, Hirji S, Ruel M, Coutinho T. Can j cardiol. 2020.
741. Concerted iron and oxygen detoxification at the tri-nuclear Fe site of bacterial ferritin from Desulfovibrio vulgaris Hildenborough. Pereira AS, Folgosa F, Guilherme M, Duarte AG, Timoteo CG, Tavares P, et al. Journal of Biological Inorganic Chemistry. 2009;14:S33.
742. Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor. Perera KD, Rathnayake A, Liu H, Pedersen NC, Groutas WC, Chang KO, et al. Veterinary Microbiology. 2019;237.
743. Another decade, another coronavirus. Perlman S. New England Journal of Medicine. 2020;382(8):760-2.
744. SARS-CoV-2 Epidemiology and Control, Different Scenarios for Turkey. Petersen E. Turkish journal of medical sciences. 2020. http://dx.doi.org/10.3906/sag-2003-260.
745. Forecasting the novel coronavirus COVID-19. Petropoulos F, Makridakis S. PLoS ONE. 2020;15(3).
746. COVID-19, SARS and MERS: are they closely related? Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.cmi.2020.03.026.
747. [SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF]. Peyronnet V, Sibiude J, Deruelle P, Huissoud C, Lescure X, Lucet JC, et al. Gynecologie, obstetrique, fertilite & senologie. 2020. http://dx.doi.org/10.1016/j.gofs.2020.03.014.
748. Bat research networks and viral surveillance: Gaps and opportunities in western Asia. Phelps KL, Hamel L, Alhmoud N, Ali S, Bilgin R, Sidamonidze K, et al. Viruses. 2019;11(3).
749. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. The Lancet Respiratory medicine. 2020. http://dx.doi.org/10.1016/S2213-2600(20)30161-2.
750. The New Coronavirus, the Current King of China. Plotkin SA. Journal of the Pediatric Infectious Diseases Society. 2019;9(1):1-2.
751. Another coronavirus, another epidemic, another warning. Poland GA. Vaccine. 2020;38(10):v-vi.
752. Covid-19: Why is the UK government ignoring WHO's advice? Pollock AM, Roderick P, Cheng KK, Pankhania B. The BMJ. 2020;368.
753. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Journal of Infection in Developing Countries. 2020;14(2):125-8.
754. Is low sodium intake a risk factor for severe and fatal COVID-19 infection? Post A, Dullaart RPF, Bakker SJL. European journal of internal medicine. 2020. http://dx.doi.org/10.1016/j.ejim.2020.04.003.
755. A geroscience perspective on COVID-19 mortality. Promislow DEL. The journals of gerontology Series A, Biological sciences and medical sciences. 2020. http://dx.doi.org/10.1093/gerona/glaa094.
756. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Prompetchara E, Ketloy C, Palaga T. Asian Pac J Allergy Immunol. 2020;38(1):1-9.
757. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Pung R, Chiew CJ, Young BE, Chin S, Chen MIC, Clapham HE, et al. The Lancet. 2020;395(10229):1039-46.
758. An Invited Commentary on “World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)”: Emergency or new reality? Purcell LN, Charles AG. International Journal of Surgery. 2020;76:111.
759. Frequency of molecular detection of equine coronavirus in faeces and nasal secretions in 277 horses with acute onset of fever. Pusterla N, James K, Mapes S, Bain F. Veterinary Record. 2019;184(12):385.
760. Safe Delivery for COVID-19 Infected Pregnancies. Qi H, Luo X, Zheng Y, Zhang H, Li J, Zou L, et al. BJOG : an international journal of obstetrics and gynaecology. 2020.
761. Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series. Qian GQ, Yang NB, Ding F, Ma AHY, Wang ZY, Shen YF, et al. QJM : monthly journal of the Association of Physicians. 2020.
762. Transmissible Gastroenteritis Virus Infection Up-Regulates FcRn Expression via Nucleocapsid Protein and Secretion of TGF-beta in Porcine Intestinal Epithelial Cells. Qian S, Gao Z, Cao R, Yang K, Cui Y, Li S, et al. Front Microbiol. 2019;10:3085. http://dx.doi.org/10.3389/fmicb.2019.03085. eCollection 2019.
763. Transmissible Gastroenteritis Virus Infection Up-Regulates FcRn Expression via Nucleocapsid Protein and Secretion of TGF-β in Porcine Intestinal Epithelial Cells. Qian S, Gao Z, Cao R, Yang K, Cui Y, Li S, et al. Frontiers in Microbiology. 2020;10.
764. What are the risks of COVID-19 infection in pregnant women? Qiao J. The Lancet. 2020;395(10226):760-2.
765. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Lancet Infect Dis. 2020. http://dx.doi.org/10.1016/S1473-3099(20)30198-5.
766. Epidemiological analysis on a family cluster of COVID-19. Qiu YY, Wang SQ, Wang XL, Lu WX, Qiao D, Li JB, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(4):506-9.
767. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. Qu R, Ling Y, Zhang YHZ, Wei LY, Chen X, Li XM, et al. Journal of Medical Virology. 2020.
768. Sars-cov-2 and coronavirus disease 2019: What we know so far. Rabi FA, Al Zoubi MS, Al-Nasser AD, Kasasbeh GA, Salameh DM. Pathogens. 2020;9(3).
769. Risk Factors for Fatal Middle East Respiratory Syndrome Coronavirus Infections in Saudi Arabia: Analysis of the WHO Line List, 2013-2018. Rahman A, Sarkar A. American journal of public health. 2019;109(9):1288-93.
770. The many estimates of the COVID-19 case fatality rate. Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek SC. The Lancet Infectious diseases. 2020.
771. Middle east respiratory syndrome coronavirus (MERS-COV): A review. Ramadan N, Shaib H. GERMS. 2019;9(1):35-42.
772. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. The Lancet Respiratory medicine. 2020.
773. Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care During the COVID-19 Pandemic. Ramos KJ, Pilewski JM, Faro A, Marshall BC. Am j respir crit care med. 2020.
774. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Cell stress. 2020;4(4):66-75. http://dx.doi.org/10.15698/cst2020.04.216.
775. Coronavirus Disease 2019 (COVID-19) and Pregnancy: Responding to a Rapidly Evolving Situation. Rasmussen SA, Jamieson DJ. Obstetrics and gynecology. 2020.
776. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. American Journal of Obstetrics and Gynecology. 2020.
777. Reflexiones derivadas de la pandemia COVID-19. Raurell-Torredà M, Martínez-Estalella G, Frade-Mera MJ, Carrasco Rodríguez-Rey LF, Romero de San Pío E. Enferm intensiva (Ed impr). 2020.
778. Coronavirus disease 2019 (covid-19): A guide for UK GPS. Razai MS, Doerholt K, Ladhani S, Oakeshott P. The BMJ. 2020;368.
779. The SARS-CoV-2, a new pandemic zoonosis that threatens the world. Reina J. Vacunas. 2020.
780. Pathogenicity of a QX-like avian infectious bronchitis virus isolated in China. Ren G, Liu F, Huang M, Li L, Shang H, Liang M, et al. Poultry science. 2019.
781. [Study on treatment of "cytokine storm" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway]. Ren Y, Yao MC, Huo XQ, Gu Y, Zhu WX, Qiao YJ, et al. Zhongguo Zhong Yao Za Zhi. 2020;45(6):1225-31. http://dx.doi.org/10.19540/j.cnki.cjcmm.20200224.405.
782. Authors' response: Plenty of coronaviruses but no SARS-CoV-2. Reusken CB, Haagmans B, Meijer A, Corman VM, Papa A, Charrel R, et al. Eurosurveillance. 2020;25(8).
783. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Rismanbaf A, Zarei S. Archives of Academic Emergency Medicine. 2020;8(1).
784. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? Ritchie AI, Singanayagam A. The Lancet. 2020.
785. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. Rocklöv J, Sjödin H, Wilder-Smith A. Journal of travel medicine. 2020.
786. An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement. Rodrigues JCL, Hare SS, Edey A, Devaraj A, Jacob J, Johnstone A, et al. Clinical Radiology. 2020.
787. Genomic Epidemiology and its importance in the study of the COVID-19 pandemic. Rodriguez-Morales AJ, Balbin-Ramon GJ, Rabaan AA, Sah R, Dhama K, Paniz-Mondolfi A, et al. Infez Med. 2020;28(2):139-42.
788. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Travel medicine and infectious disease. 2020:101623.
789. All Feet On Deck-The Role of Podiatry During the COVID-19 Pandemic: Preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes. Rogers LC, Lavery LA, Joseph WS, Armstrong DG. Journal of the American Podiatric Medical Association. 2020.
790. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care. Ronco C, Navalesi P, Vincent JL. The Lancet Respiratory Medicine. 2020;8(3):240-1.
791. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. Roncon L, Zuin M, Rigatelli G, Zuliani G. Journal of Clinical Virology. 2020.
792. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Rothan HA, Byrareddy SN. Journal of Autoimmunity. 2020.
793. SARS-CoV-2: fear versus data. Roussel Y, Giraud-Gatineau A, Jimeno MT, Rolain JM, Zandotti C, Colson P, et al. International journal of antimicrobial agents. 2020:105947.
794. One proline deletion in the fusion peptide of neurotropic mouse hepatitis virus (MHV) restricts retrograde axonal transport and neurodegeneration. Rout SS, Singh M, Shindler KS, Das Sarma J. The Journal of biological chemistry. 2020. http://dx.doi.org/10.1074/jbc.RA119.011918.
795. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Ruan Q, Yang K, Wang W, Jiang L, Song J. Intensive Care Medicine. 2020.
796. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Ruan Q, Yang K, Wang W, Jiang L, Song J. Intensive Care Med. 2020. http://dx.doi.org/10.1007/s00134-020-06028-z.
797. The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society. Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, et al. Radiology. 2020:201365. http://dx.doi.org/10.1148/radiol.2020201365.
798. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation. Rubino S, Kelvin N, Bermejo-Martin JF, Kelvin DJ. Journal of Infection in Developing Countries. 2020;14(3):265-7.
799. COVID-19 Related School Closings and Risk of Weight Gain Among Children. Rundle AG, Park Y, Herbstman JB, Kinsey EW, Wang YC. Obesity (Silver Spring, Md). 2020. http://dx.doi.org/10.1002/oby.22813.
800. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Runfeng L, Yunlong H, Jicheng H, Weiqi P, Qinhai M, Yongxia S, et al. Pharmacological research. 2020:104761. http://dx.doi.org/10.1016/j.phrs.2020.104761.
801. The Utah Model: mental bandwidth and strategic risk generation in COVID-19 airway management. Runnels S, Ferranti D, Davis AN, Pollard J. Anaesthesia. 2020. http://dx.doi.org/10.1111/anae.15086.
802. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, et al. Ecancermedicalscience. 2020;14:1022. http://dx.doi.org/10.3332/ecancer.2020.1022. eCollection 2020.
803. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Russell CD, Millar JE, Baillie JK. The Lancet. 2020;395(10223):473-5.
804. The Canadian 2014 porcine epidemic diarrhoea virus outbreak: Important risk factors that were not considered in the epidemiological investigation could change the conclusions. Russell LE, Polo J, Meeker D. Transboundary and Emerging Diseases. 2020.
805. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Russell TW, Hellewell J, Jarvis CI, Zandvoort K, Abbott S, Ratnayake R, et al. Eurosurveillance. 2020;25(12).
806. Immune-epidemiological parameters of the novel coronavirus - a perspective. Saghazadeh A, Rezaei N. Expert review of clinical immunology. 2020.
807. Immune-epidemiological parameters of the novel coronavirus–a perspective. Saghazadeh A, Rezaei N. Expert Review of Clinical Immunology. 2020.
808. COVID-19 in Europe: the Italian lesson. Saglietto A, D'Ascenzo F, Zoccai GB, De Ferrari GM. The Lancet. 2020;395(10230):1110-1.
809. COVID-2019: update on epidemiology, disease spread and management. Sahu KK, Mishra AK, Lal A. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 2020;90(1). http://dx.doi.org/10.4081/monaldi.2020.1292.
810. Upheaval in cancer care during the COVID-19 outbreak. Salako O, Okunade K, Allsop M, Habeebu M, Toye M, Oluyede G, et al. Ecancermedicalscience. 2020;14:ed97. http://dx.doi.org/10.3332/ecancer.2020.ed97. eCollection 2020.
811. The global burden of premature mortality due to the Middle East respiratory syndrome (MERS) using standard expected years of life lost, 2012 to 2019. Salamatbakhsh M, Mobaraki K, Sadeghimohammadi S, Ahmadzadeh J. BMC public health. 2019;19(1):1523.
812. Citrate plasma quality as an essential part of clinical laboratory hemostasis testing. Samoylenko V, Andreeva A, Goncharova I, Amosova A, Kutueva E. Clinical Chemistry and Laboratory Medicine. 2019;57(4):eA16.
813. Minimum determinants of transmissible gastroenteritis virus enteric tropism are located in the n-terminus of spike protein. Sanchez CM, Pascual-Iglesias A, Sola I, Zuñiga S, Enjuanes L. Pathogens. 2020;9(1).
814. Effects of modifications near the 2-, 3- and 4-fold symmetry axes on human ferritin renaturation. Santambrogio P, Pinto P, Levi S, Cozzi A, Rovida E, Albertini A, et al. The Biochemical journal. 1997;322:461-8. http://dx.doi.org/10.1042/bj3220461.
815. Guidance On Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society. Sapp JL, Alqarawi W, MacIntyre CJ, Tadros R, Steinberg C, Roberts JD, et al. The Canadian journal of cardiology. 2020. http://dx.doi.org/10.1016/j.cjca.2020.04.003.
816. A realistic two-strain model for MERS-CoV infection uncovers the high risk for epidemic propagation. Sardar T, Ghosh I, Rodó X, Chattopadhyay J. PLoS Neglected Tropical Diseases. 2020;14(2).
817. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Sargiacomo C, Sotgia F, Lisanti MP. Aging. 2020.
818. Investigating the cases of novel coronavirus disease (COVID-19) in China using dynamic statistical techniques. Sarkodie SA, Owusu PA. Heliyon. 2020;6(4):e03747. http://dx.doi.org/10.1016/j.heliyon.2020.e03747. Epub 2020 Apr 4.
819. Electrostatic Repulsion during Ferritin Assembly and Its Screening by Ions. Sato D, Takebe S, Kurobe A, Ohtomo H, Fujiwara K, Ikeguchi M. Biochemistry. 2016;55(3):482-8. http://dx.doi.org/10.1021/acs.biochem.5b01197. Epub 2016 Jan 8.
820. Infectious complications following venetoclax-proteasome inhibitor based regimens in relapsed myeloma: A single center retrospective analysis. Sauter CT, Bernabei LL, Waxman A, Cohen AD, Garfall AL, Vogl DT, et al. Blood. 2019;134.
821. Seroprevalence of Middle East Respiratory Syndrome Corona Virus in dromedaries and their traders in upper Egypt. Sayed ASM, Malek SS, Abushahba MFN. Journal of Infection in Developing Countries. 2020;14(2):191-8.
822. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic]. Schmeiser T, Broll M, Dormann A, Frabel C, Hermann W, Hudowenz O, et al. Zeitschrift fur Rheumatologie. 2020. http://dx.doi.org/10.1007/s00393-020-00800-8.
823. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Schwartz DA, Graham AL. Viruses. 2020;12(2). http://dx.doi.org/10.3390/v12020194.
824. Potential maternal and infant outcomes from coronavirus 2019-NCOV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. Schwartz DA, Graham AL. Viruses. 2020;12(2).
825. Fulminant Tritrichomonas foetus ‘feline genotype’ infection in a 3-month old kitten associated with viral co-infection. Setyo L, Donahoe SL, Šlapeta J. Veterinary Parasitology. 2019;267:17-20.
826. Guide to Understanding the 2019 Novel Coronavirus. Shah A, Kashyap R, Tosh P, Sampathkumar P, O'Horo JC. Mayo Clinic Proceedings. 2020;95(4):646-52.
827. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement. Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, et al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2020. http://dx.doi.org/10.1002/ccd.28910.
828. A commentary on “World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)”. Shah SGS, Farrow A. International Journal of Surgery. 2020;76:128-9.
829. COVID-19 And Older Adults: What We Know. Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, et al. Journal of the American Geriatrics Society. 2020. http://dx.doi.org/10.1111/jgs.16472.
830. Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis. Shamshirian A, Heydari K, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Hessami A. medRxiv. 2020:2020.04.12.20062869.
831. On the use of corticosteroids for 2019-nCoV pneumonia. Shang L, Zhao J, Hu Y, Du R, Cao B. The Lancet. 2020;395(10225):683-4.
832. Emergence of novel coronavirus 2019-nCoV: Need for rapid vaccine and biologics development. Shanmugaraj B, Malla A, Phoolcharoen W. Pathogens. 2020;9(2).
833. Caring for patients with pain during the COVID-19 pandemic: Consensus recommendations from an international expert panel. Shanthanna H, Strand NH, Provenzano DA, Lobo CA, Eldabe S, Bhatia A, et al. Anaesthesia. 2020. http://dx.doi.org/10.1111/anae.15076.
834. Novel Insights of Illness Evolution And Mortality Risk Profiles for the Non-Survivors with COVID-19. Shao L, Li X, Zhou Y, Yu Y, Liu Y, Liu M, et al. Available at SSRN 3559596. 2020.
835. Guillain–Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report. Sharma K, Tengsupakul S, Sanchez O, Phaltas R, Maertens P. SAGE Open Medical Case Reports. 2019;7.
836. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. She J, Jiang J, Ye L, Hu L, Bai C, Song Y. Clinical and Translational Medicine. 2020;9(1).
837. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, et al. Nature Communications. 2020;11(1).
838. Neurologists and Covid-19: A note on courage in a time of uncertainty. Shellhaas RA. Neurology. 2020.
839. Novel coronavirus infection in children outside of Wuhan, China. Shen Q, Guo W, Guo T, Li J, He W, Ni S, et al. Pediatr Pulmonol. 2020. http://dx.doi.org/10.1002/ppul.24762.
840. Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future. Shetty R, Ghosh A, Honavar SG, Khamar P, Sethu S. Indian journal of ophthalmology. 2020.
841. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. The Lancet Infectious Diseases. 2020;20(4):425-34.
842. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019: a retrospective cross-sectional study. Shi Q-K, Sun J-K, Zhang W-H, Zou L, Liu Y, Li J-J, et al. Journal. 2020(Issue).
843. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. JAMA cardiology. 2020.
844. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Critical care (London, England). 2020;24(1):108.
845. Clinical Manifestation of Severe Cases with COVID-19. Shi Y-f, Shi X-h, Li S-w, Wang Y-h, Hu J-j, Ba J-h, et al. Journal of Sun Yat-sen University(Medical Sciences). 2020.
846. Transmission potential and severity of COVID-19 in South Korea. Shim E, Tariq A, Choi W, Lee Y, Chowell G. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
847. Immune Responses to Middle East Respiratory Syndrome Coronavirus during the Acute and Convalescent Phases of Human Infection. Shin HS, Kim Y, Kim G, Lee JY, Jeong I, Joh JS, et al. Clinical Infectious Diseases. 2019;68(6):984-92.
848. Predicting the mortality due to Covid-19 by the next month for Italy, Iran and South Korea; A simulation study. Shojaee S, Pourhoseingholi MA, Ashtari S, Vahedian-Azimi A, Asadzadeh-Aghdaei H, Zali MR. Gastroenterology and Hepatology from Bed to Bench. 2020;13(2):177-9.
849. Pandemic March: COVID-19's first wave circumnavigates the globe. Shultz JM, Perlin A, Saltzman RG, Espinel Z, Galea S. Disaster medicine and public health preparedness. 2020:1-13. http://dx.doi.org/10.1017/dmp.2020.103.
850. On the possibility of interrupting the coronavirus (COVID-19) epidemic based on the best available scientific evidence. Silva AAMD. Revista brasileira de epidemiologia = Brazilian journal of epidemiology. 2020;23:e200021.
851. Rehabilitation following critical illness in people with COVID-19 infection. Simpson R, Robinson L. Am j phys med rehabilit. 2020.
852. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Singh AK, Gupta R, Misra A. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):283-7.
853. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Singh AK, Singh A, Shaikh A, Singh R, Misra A. Diabetes & metabolic syndrome. 2020;14(3):241-6. http://dx.doi.org/10.1016/j.dsx.2020.03.011.
854. A Minimally Replicative Vaccine Protects Vaccinated Piglets Against Challenge With the Porcine Epidemic Diarrhea Virus. Singh G, Singh P, Pillatzki A, Nelson E, Webb B, Dillberger-Lawson S, et al. Frontiers in Veterinary Science. 2019;6.
855. A Review of Coronavirus Disease-2019 (COVID-19). Singhal T. Indian Journal of Pediatrics. 2020;87(4):281-6.
856. Could COVID-19 represents a negative prognostic factor in patients with stroke? Siniscalchi A, Gallelli L. Infection Control & Hospital Epidemiology. 2020.
857. Epidemiology and Clinical Features of COVID-19: A Review of Current Literature. Siordia JA. Journal of Clinical Virology. 2020.
858. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. International Journal of Surgery. 2020.
859. COVID-19 checklist: Mask, gloves, and video chatting with grandpa. Solomon HV. Psychiatry Research. 2020;288.
860. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? Sommerstein R, Kochen MM, Messerli FH, Grani C. Journal of the American Heart Association. 2020;9(7):e016509. http://dx.doi.org/10.1161/JAHA.120.016509. Epub 2020 Apr 1.
861. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Radiology. 2020;295(1):210-7.
862. Analyses of the clinical features and contributing factors in 13 fatal cases of Coronavirus Disease 2019. Song Q, Liu H, Hu Z, Mao C, Xu R, Zhang F, et al. 2020.
863. Study on assessing early epidemiological parameters of coronavirus disease epidemic in China. Song QQ, Zhao H, Fang LQ, Liu W, Zheng C, Zhang Y. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(4):461-5.
864. From SARS to MERS, thrusting coronaviruses into the spotlight. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. Viruses. 2019;11(1).
865. Imported cases of 2019-novel coronavirus (2019-nCoV) infections in Thailand: Mathematical modelling of the outbreak. Sookaromdee P, Wiwanitkit V. Asian Pacific Journal of Tropical Medicine. 2020;13(3):139-40.
866. Impact of new coronavirus epidemics on HIV-infected patients. Soriano V, Barreiro P. AIDS Reviews. 2020;22(1):57-8.
867. Prevalence and characteristics of acute respiratory virus infections in pediatric cancer patients. Soudani N, Caniza MA, Assaf-Casals A, Shaker R, Lteif M, Su Y, et al. Journal of Medical Virology. 2019;91(7):1191-201.
868. COVID-19, ACE2 and the Cardiovascular Consequences. South AM, Diz D, Chappell MC. American journal of physiology Heart and circulatory physiology. 2020.
869. [Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic]. Specialized Committee Of Neurogenetics Neurophysician Branch Of Chinese Medical Doctor A, Jiang H, Tang B. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics. 2020;37(4):359-66. http://dx.doi.org/10.3760/cma.j.issn.1003-9406.2020.04.001.
870. Prediction models for diagnosis and prognosis in Covid-19. Sperrin M, Grant SW, Peek N. BMJ. 2020.
871. Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple. Spezzani V, Piunno A, Iselin HU. Swiss medical weekly. 2020;150:w20246. http://dx.doi.org/10.4414/smw.2020.20246. eCollection 2020 Apr 6.
872. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Spiteri G, Fielding J, Diercke M, Campese C, Enouf V, Gaymard A, et al. Eurosurveillance. 2020;25(9).
873. Covid-19 and Post Intensive Care Syndrome: A Call for Action. Stam HJ, Stucki G, Bickenbach J. J Rehabil Med. 2020;52(4):jrm00044. http://dx.doi.org/10.2340/16501977-2677.
874. Epidemiology and clinical impact of viral, atypical, and fungal respiratory pathogens in symptomatic immunocompromised patients: a two-center study using a multi-parameter customized respiratory Taqman® array card. Steensels D, Reynders M, Descheemaeker P, Curran MD, Hites M, Etienne I, et al. European Journal of Clinical Microbiology and Infectious Diseases. 2019;38(8):1507-14.
875. The 2019 coronavirus: Learning curves, lessons, and the weakest link. Stein RA. International Journal of Clinical Practice. 2020;74(4).
876. Calculated decisions: COVID-19 calculators during extreme resource-limited situations. Steinberg E, Balakrishna A, Habboushe J, Shawl A, Lee J. Emergency medicine practice. 2020;22(4):Cd1-cd5.
877. Time-course of upper respiratory tract viral infection and COPD exacerbation. Stolz D, Papakonstantinou E, Grize L, Schilter D, Strobel W, Louis R, et al. European Respiratory Journal. 2019;54(4).
878. Iran confronts coronavirus amid a ‘battle between science and conspiracy theories’. Stone R. Science. 2020.
879. The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19. Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, et al. Emerging microbes & infections. 2020;9(1):707-13.
880. The different clinical characteristics of corona virus disease cases between children and their families in China–the character of children with COVID-19. Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, et al. Emerging Microbes and Infections. 2020;9(1):707-13.
881. Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan. Su YJ, Lai YC. Travel medicine and infectious disease. 2020:101625.
882. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study. Sun D, Li H, Lu XX, Xiao H, Ren J, Zhang FR, et al. World journal of pediatrics : WJP. 2020. http://dx.doi.org/10.1007/s12519-020-00354-4.
883. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. Sun K, Chen J, Viboud C. The Lancet Digital Health. 2020;2(4):e201-e8.
884. [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]. Sun ML, Yang JM, Sun YP, Su GH. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43(3):219-22. http://dx.doi.org/10.3760/cma.j.issn.1001-0939.2020.03.016.
885. Clinical characteristics of 50 466 hospitalized patients with 2019-nCoV infection. Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Journal of Medical Virology. 2020.
886. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Sun Q, Qiu H, Huang M, Yang Y. Annals of Intensive Care. 2020;10(1).
887. Mediastinal Emphysema, Giant Bulla, and Pneumothorax Developed during the Course of COVID-19 Pneumonia. Sun R, Liu H, Wang X. Korean j radiol. 2020.
888. [Hematological changes and related gene mutation of post-severe acute respiratory syndrome patients with osteonecrosis]. Sun W, Li ZR, Shi ZC, Zhang NF, Han CW, Cong X, et al. Zhonghua yi xue za zhi. 2006;86(7):442-5.
889. Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population. Sun W, Li ZR, Shi ZC, Zhang NF, Zhang YC. Int Orthop. 2006;30(3):143-6. http://dx.doi.org/10.1007/s00264-005-0067-6. Epub 2006 Mar 18.
890. Potential factors influencing repeated SARS outbreaks in China. Sun Z, Thilakavathy K, Kumar SS, He G, Liu SV. International Journal of Environmental Research and Public Health. 2020;17(5).
891. Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings. Sundaram M, Ravikumar N, Bansal A, Nallasamy K, Basavaraja GV, Lodha R, et al. Indian Pediatr. 2020.
892. Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non-COVID-19 Sepsis but Carry a Moderately Increased Risk of Death. Sunden-Cullberg J. Hypertension (Dallas, Tex : 1979). 2020:Hypertensionaha12015178. http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.15178.
893. High-frequency oscillatory ventilation in treating severe pediatric ards caused by pneumocystis jiroveci pneumonia and multiple viral infections. Sung TH, Lo YC, Tang YH, Chen WY, Tsao PC, Lee YS, et al. Pediatric Pulmonology. 2019;54:S133-S4.
894. Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons from Previous Epidemics. Swerdlow DL, Finelli L. JAMA - Journal of the American Medical Association. 2020;323(12):1129-30.
895. PULSED METHYLPREDNISOLONE USAGE IN ARDS DUE TO VIRAL PNEUMONIA. Szeto CH. Chest. 2019;155(4):126A.
896. Severe course of COVID-19 in a middle-aged man without risk factors. Szymanek-Pasternak A, Serafinska S, Kucharska M, Szymanski W, Simon K. Pol Arch Med Wew (Online). 2020.
897. Efficacy of Mass Quarantine as Leverage of Health System Governance During COVID-19 Outbreak: A Mini Policy Review. Taghrir MH, Akbarialiabad H, Ahmadi Marzaleh M. Arch Iran Med. 2020;23(4):265-7.
898. Significant role of electrostatic interactions for stabilization of protein assemblies. Takahashi T. Advances in biophysics. 1997;34:41-54. http://dx.doi.org/10.1016/s0065-227x(97)89630-x.
899. SARS-CoV-2, the medical profession, ventilator beds, and mortality predictions: personal reflections of an Australian clinician. Talley NJ. The Medical journal of Australia. 2020. http://dx.doi.org/10.5694/mja2.50579.
900. C‐reactive protein correlates with CT findings and predicts severe COVID‐19 early. Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. Journal of Medical Virology. 2020.
901. C-reactive protein correlates with CT findings and predicts severe COVID-19 early. Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25871.
902. [Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection]. Tan FR, Qiu YL, Xu Z. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43(4):337-9.
903. Epidemic and genetic characterization of porcine epidemic diarrhea virus strains circulating in the regions around Hunan, China, during 2017-2018. Tan L, Li Y, He J, Hu Y, Cai X, Liu W, et al. Arch Virol. 2020;165(4):877-89. http://dx.doi.org/10.1007/s00705-020-04532-7. Epub 2020 Feb 13.
904. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ, et al. Signal Transduction and Targeted Therapy. 2020;5(1).
905. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Tan W, Aboulhosn J. International Journal of Cardiology. 2020.
906. Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China. Tan Y-p, Tan B-y, Pan J, Wu J, Zeng S-z, Wei H-y. Journal of Clinical Virology. 2020:104353.
907. Cerebral venous thrombosis due to nontyphoidal Salmonella bacteremia. Taneda K, Adachi T, Watanabe Y, Hanajima R. Internal Medicine. 2019;58(13):1943-6.
908. The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China. Tang B, Xia F, Tang S, Bragazzi NL, Li Q, Sun X, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
909. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China. Tang JW, Tambyah PA, Hui DSC. Journal of Infection. 2020;80(3):350-71.
910. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14817.
911. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Tang N, Li D, Wang X, Sun Z. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14768.
912. [Prediction modeling with data fusion and prevention strategy analysis for the COVID-19 outbreak]. Tang SY, Xiao YN, Peng ZH, Shen HB. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(4):480-4.
913. Comparison of Hospitalized Patients with Acute Respiratory Distress Syndrome Caused by COVID-19 and H1N1. Tang X, Du R, Wang R, Cao T, Guan L, Yang C, et al. Chest. 2020. http://dx.doi.org/10.1016/j.chest.2020.03.032.
914. Covid-19: How doctors and healthcare systems are tackling coronavirus worldwide. Tanne JH, Hayasaki E, Zastrow M, Pulla P, Smith P, Rada AG. The BMJ. 2020;368.
915. Bibliometric analysis of PubMed literature on Coronavirus Disease 2019. Tao L, Ni Q, Liu J, Liu M. Chinese Journal of Medical Science Research Management. 2020.
916. Convalescent plasma: A possible treatment of COVID-19 in India. Teixeira da Silva JA. Medical journal, Armed Forces India. 2020. http://dx.doi.org/10.1016/j.mjafi.2020.04.006.
917. Hematological findings and complications of COVID-19. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Am J Hematol. 2020. http://dx.doi.org/10.1002/ajh.25829.
918. Respiratory viruses in adults with cystic fibrosis during stable and exacerbations. Terranova L, Gramegna A, Oriano M, Pappalettera M, Contarini M, Colombo A, et al. European Respiratory Journal. 2019;54.
919. The versatile heparin in COVID-19. Thachil J. Journal of thrombosis and haemostasis : JTH. 2020.
920. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. Journal of Thrombosis and Haemostasis. 2020.
921. Emerging understandings of 2019-nCoV. The L. The Lancet. 2020;395(10221):311.
922. COVID-19: learning from experience. The L. The Lancet. 2020;395(10229):1011.
923. The gendered dimensions of COVID-19. The L. The Lancet. 2020;395(10231):1168.
924. Palliative care and the COVID-19 pandemic. The L. The Lancet. 2020;395(10231):1168.
925. COVID-19: global consequences for oncology. The Lancet O. The Lancet Oncology. 2020;21(4):467.
926. Solving Biology's Iron Chemistry Problem with Ferritin Protein Nanocages. Theil EC, Tosha T, Behera RK. Accounts of chemical research. 2016;49(5):784-91. http://dx.doi.org/10.1021/ar500469e. Epub 2016 May 2.
927. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, et al. Nat Med. 2020;26(4):453-5.
928. COVID-19: social distancing, ACE 2 receptors, protease inhibitors and beyond? Thomson G. International journal of clinical practice. 2020:e13503.
929. Characteristics of COVID-19 infection in Beijing. Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Journal of Infection. 2020.
930. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how. Tiberghien P, de Lambalerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y. Vox Sang. 2020. http://dx.doi.org/10.1111/vox.12926.
931. Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up. Tobias A. The Science of the total environment. 2020;725:138539. http://dx.doi.org/10.1016/j.scitotenv.2020.138539.
932. High prevalence of viral infections among hospitalized pneumonia patients in equatorial Sarawak, Malaysia. Toh TH, Hii KC, Fieldhouse JK, Ting J, Berita A, Nguyen TT, et al. Open Forum Infectious Diseases. 2019;6(3).
933. Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19). Tolksdorf K, Buda S, Schuler E, Wieler LH, Haas W. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25(11).
934. Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds. Ton AT, Gentile F, Hsing M, Ban F, Cherkasov A. Molecular informatics. 2020.
935. Broad-spectrum coronavirus antiviral drug discovery. Totura AL, Bavari S. Expert Opinion on Drug Discovery. 2019;14(4):397-412.
936. SARS-COV-2 and infectivity. Tresoldi I, Sangiuolo CF, Manzari V, Modesti A. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25831.
937. COVID-19 y enfermedad cardiovascular. Triana JFF, Márquez DAS, Silva JSC, Castro CCA, Sandoval AFB. Revista Colombiana de Cardiología. 2020.
938. Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? Trifirò G, Crisafulli S, Andò G, Racagni G, Drago F. Drug Safety. 2020.
939. Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses. Trivedi SU, Miao C, Sanchez JE, Caidi H, Tamin A, Haynes L, et al. Scientific reports. 2019;9(1):1390.
940. COVID-19: a potential public health problem for homeless populations. Tsai J, Wilson M. The Lancet Public Health. 2020;5(4):e186-e7.
941. Establishment of a clinical nomogram model to predict the progress to severe COVID-19. Tu C, Wang G, Tan C, Chen M, Peng H, Wang Y, et al. 2020.
942. Two clinical cases of Novel coronavirus pneumonia (NCP) in renal transplant recipients. Tu Y, Wu X, Liu F, Wang J, Luo Y, Cai Z, et al. Chinese Journal of Organ Transplantation. 2020.
943. Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic. Tuech JJ, Gangloff A, Di Fiore F, Michel P, Brigand C, Slim K, et al. Journal of visceral surgery. 2020. http://dx.doi.org/10.1016/j.jviscsurg.2020.03.008.
944. Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada. Tuite AR, Fisman DN, Greer AL. CMAJ. 2020.
945. COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN. Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, et al. Journal of pediatric gastroenterology and nutrition. 2020.
946. Launch and global reach of an online COVID-19 course in multiple languages on OpenWHO in the first quarter of 2020. Utunen H, Ndiaye N, Piroux C, George R, Attias M, Gamhewage G. 2020.
947. Artificial Intelligence (AI) applications for COVID-19 pandemic. Vaishya R, Javaid M, Khan IH, Haleem A. Diabetes & metabolic syndrome. 2020;14(4):337-9. http://dx.doi.org/10.1016/j.dsx.2020.04.012.
948. The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease. Van Rijn AL, Van Boheemen S, Sidorov I, Carbo EC, Pappas N, Mei H, et al. PLoS ONE. 2019;14(10).
949. Conformational changes and in vitro core-formation modifications induced by site-directed mutagenesis of the specific N-terminus of pea seed ferritin. van Wuytswinkel O, Briat JF. The Biochemical journal. 1995;305:959-65. http://dx.doi.org/10.1042/bj3050959.
950. Purification and characterization of recombinant pea-seed ferritins expressed in Escherichia coli: influence of N-terminus deletions on protein solubility and core formation in vitro. Van Wuytswinkel O, Savino G, Briat JF. The Biochemical journal. 1995;305:253-61. http://dx.doi.org/10.1042/bj3050253.
951. Iron homeostasis alteration in transgenic tobacco overexpressing ferritin. Van Wuytswinkel O, Vansuyt G, Grignon N, Fourcroy P, Briat JF. The Plant journal : for cell and molecular biology. 1999;17(1):93-7. http://dx.doi.org/10.1046/j.1365-313x.1999.00349.x.
952. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Vankadari N, Wilce JA. Emerging Microbes and Infections. 2020;9(1):601-4.
953. Cleveland Clinic Akron General Urology Residency Program's COVID-19 Experience. Vargo E, Ali M, Henry F, Kmetz D, Krishnan J, Bologna R. Urology. 2020. http://dx.doi.org/10.1016/j.urology.2020.04.001.
954. The COVID-19 epidemic. Velavan TP, Meyer CG. Tropical Medicine and International Health. 2020;25(3):278-80.
955. COVID-19: A promising cure for the global panic. Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. Science of the Total Environment. 2020;725.
956. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Lancet Infect Dis. 2020. http://dx.doi.org/10.1016/S1473-3099(20)30243-7.
957. Covid-19: A puzzle with many missing pieces. Vetter P, Eckerle I, Kaiser L. The BMJ. 2020;368.
958. Prevalence of enteric pathogens in diarrheic and non-diarrheic samples from pig farms with neonatal diarrhea in the North East of Spain. Vidal A, Martín-Valls GE, Tello M, Mateu E, Martín M, Darwich L. Veterinary Microbiology. 2019;237.
959. Commentary: COVID-19 and diabetes. Villabona CV. Diabetes Research and Clinical Practice. 2020;162.
960. COVID19 and acute coagulopathy in pregnancy. Vlachodimitropoulou Koumoutsea E, Vivanti AJ, Shehata N, Benachi A, Le Gouez A, Desconclois C, et al. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14856.
961. Epidemiology and clinical manifestations of acute viral respiratory infections in pediatric patients in Ukraine. Volosovets O, Kryvopustov S, Khomenko V, Iemets O, Umanets T. Archives of Disease in Childhood. 2019;104:A371.
962. When will the battle against novel coronavirus end in Wuhan: A SEIR modeling analysis. Wan K, Chen J, Lu C, Dong L, Wu Z, Zhang L. J Glob Health. 2020;10(1):011002. http://dx.doi.org/10.7189/jogh.10.011002.
963. Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing. Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25783.
964. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Wan Y, Shang J, Graham R, Baric RS, Li F. J virol. 2020;94(7).
965. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Wang C, Pan R, Wan X, Tan Y, Xu L, McIntyre RS, et al. Brain, behavior, and immunity. 2020. http://dx.doi.org/10.1016/j.bbi.2020.04.028.
966. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. JAMA - Journal of the American Medical Association. 2020;323(11):1061-9.
967. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China. Wang D, Ju XL, Xie F, Lu Y, Li FY, Huang HH, et al. Zhonghua er ke za zhi = Chinese journal of pediatrics. 2020;58(4):E011.
968. What to do next to control the 2019-nCoV epidemic? Wang FS, Zhang C. The Lancet. 2020;395(10222):391-3.
969. Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China. Wang H, Wang Z, Dong Y, Chang R, Xu C, Yu X, et al. Cell Discovery. 2020;6(1).
970. Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series. Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14828.
971. Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures. Wang J, Wang BJ, Yang JC, Wang MY, Chen C, Luo GX, et al. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns. 2020;36:E006.
972. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area. Wang K, Kang S, Tian R, Zhang X, Zhang X, Wang Y. Clinical radiology. 2020;75(5):341-7. http://dx.doi.org/10.1016/j.crad.2020.03.004. Epub 2020 Mar 23.
973. Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.03.019.
974. [Prognostic value of myocardial injury in patients with COVID-19]. Wang L, He WB, Yu XM, Liu HF, Zhou WJ, Jiang H. Zhonghua Yan Ke Za Zhi. 2020;56:E009. http://dx.doi.org/10.3760/cma.j.cn112148-20200313-00202.
975. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Wang L, Li X, Chen H, Yan S, Li D, Li Y, et al. American journal of nephrology. 2020:1-6.
976. Engineering a novel antibody-peptide bispecific fusion protein against MERS-COV. Wang L, Xu J, Kong Y, Liang R, Li W, Li J, et al. Antibodies. 2019;8(4).
977. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses. Wang N, Shang J, Jiang S, Du L. Frontiers in Microbiology. 2020;11.
978. A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility. Wang Q, Qiu Y, Li J-Y, Zhou Z-J, Liao C-H, Ge X-Y. 2020.
979. Comorbidities and multi-organ injuries in the treatment of COVID-19. Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, et al. The Lancet. 2020;395(10228):e52.
980. Expert recommendations for diabetes with or without COVID-19 management in communities. Wang W, Shan Z, Wang G, Gu W, Zhang Y, Lu J, et al. Chinese Journal of Endocrinology and Metabolism. 2020.
981. Analysis of Risk Factors for the Thromboembolic Events from 88 Patients with COVID-19 Pneumonia in Wuhan, China: A Retrospective Report. Wang W, Sun Q, Bao Y, Liang M, Meng Q, Chen H, et al. 2020.
982. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Wang W, Tang J, Wei F. Journal of Medical Virology. 2020;92(4):441-7.
983. [From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment]. Wang X, Ding YQ. Zhonghua bing li xue za zhi = Chinese journal of pathology. 2020;49:E012. http://dx.doi.org/10.3760/cma.j.cn112151-20200318-00220.
984. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.cmi.2020.03.032.
985. Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen. Wang XF, Yuan J, Zheng YJ, Chen J, Bao YM, Wang YR, et al. Zhonghua er ke za zhi = Chinese journal of pediatrics. 2020;58:E008.
986. [Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen]. Wang XF, Yuan J, Zheng YJ, Chen J, Bao YM, Wang YR, et al. Zhonghua Er Ke Za Zhi. 2020;58:E008. http://dx.doi.org/10.3760/cma.j.issn.0578-1310.2020.0008.
987. Epidemiological and clinical characteristics analysis of 30 childhood cases with 2019 novel coronavirus infection in Shenzhen. Wang Y, Wang X, Yang Y, Liu Y, Liu L. Chinese Journal of Infectious Diseases. 2020.
988. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. Wang Y, Wang Y, Chen Y, Qin Q. Journal of medical virology. 2020.
989. Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19. Wang YX, Ma JR, Wang SQ, Zeng YQ, Zhou CY, Ru YH, et al. Eur Rev Med Pharmacol Sci. 2020;24(6):3360-84.
990. Elevated serum IgM levels indicate poor outcome in patients with coronavirus disease 2019 pneumonia: A retrospective case-control study. Wang Z, Li H, Li J, Yang C, Guo X, Hu Z, et al. medRxiv. 2020:2020.03.22.20041285.
991. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
992. Coronavirus: global solutions to prevent a pandemic. Watts CH, Vallance P, Whitty CJM. Nature. 2020;578(7795):363.
993. New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility. Weber DJ, Sickbert-Bennett EE, Kanamori H, Rutala WA. American Journal of Infection Control. 2019;47:A29-A38.
994. Clinical course and mortality risk of severe COVID-19. Weiss P, Murdoch DR. The Lancet. 2020;395(10229):1014-5.
995. COVID-19: the gendered impacts of the outbreak. Wenham C, Smith J, Morgan R. The Lancet. 2020;395(10227):846-8.
996. Middle East respiratory syndrome: making the case for surveillance of transboundary coronaviruses in the Middle East. Wernery U, Woo PCY. Revue scientifique et technique (International Office of Epizootics). 2019;38(1):61-9.
997. COVID-19: Knowns, Unknowns, and Questions. Weston S, Frieman MB. mSphere. 2020;5(2).
998. A yeast suppressor screen used to identify mammalian SIRT1 as a proviral factor for middle east respiratory syndrome coronavirus replication. Weston S, Matthews KL, Lent R, Vlk A, Haupt R, Kingsbury T, et al. Journal of Virology. 2019;93(16).
999. Clinical presentation and outcomes of long-term care residents with coronavirus respiratory infection: A retrospective cohort study. Williams VR, Pajak D, Salt N, Leis JA. Open Forum Infectious Diseases. 2019;6:S846.
1000. A comparative analysis of factors influencing two outbreaks of middle eastern respiratory syndrome (MERS) in Saudi Arabia and South Korea. Willman M, Kobasa D, Kindrachuk J. Viruses. 2019;11(12).
1001. Travellers give wings to novel coronavirus (2019-nCoV). Wilson ME, Chen LH. Journal of travel medicine. 2020;27(2).
1002. Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality. Wilson N, Kvalsvig A, Barnard LT, Baker MG. Emerging infectious diseases. 2020;26(6).
1003. PRESCIENT: platform for the rapid evaluation of antibody success using integrated microfluidics enabled technology. Wippold JA, Wang H, Tingling J, Leibowitz JL, de Figueiredo P, Han A. Lab on a chip. 2020.
1004. Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients. Wong HYF, Lam HYS, Fong AH-T, Leung ST, Chin TW-Y, Lo CSY, et al. Radiology. 2019:201160-.
1005. Severe acute respiratory syndrome in a doctor working at the Prince of Wales Hospital. Wong RS. Hong Kong medical journal = Xianggang yi xue za zhi. 2003;9(3):202-5.
1006. Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology. Wood DA, Sathananthan J, Gin K, Mansour S, Ly HQ, Quraishi AU, et al. The Canadian journal of cardiology. 2020. http://dx.doi.org/10.1016/j.cjca.2020.03.027.
1007. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. JAMA Intern Med. 2020. http://dx.doi.org/10.1001/jamainternmed.2020.0994.
1008. Heart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19). Wu C, Hu X, Song J, Du C, Xu J, Yang D, et al. medRxiv. 2020:2020.02.26.20028589.
1009. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. Wu D, Yang XO. Journal of Microbiology, Immunology and Infection. 2020.
1010. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19). Wu J, Li W, Shi X, Chen Z, Jiang B, Liu J, et al. Journal of internal medicine. 2020. http://dx.doi.org/10.1111/joim.13063.
1011. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, et al. Nature Medicine. 2020.
1012. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Wu JT, Leung K, Leung GM. The Lancet. 2020;395(10225):689-97.
1013. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, et al. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25(3).
1014. Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin. Wu WS, Li YG, Wei ZF, Zhou PH, Lyu LK, Zhang GP, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(4):489-93.
1015. SARS in Hong Kong. Wu YP, Wei R, de Groot PG. The New England journal of medicine. 2003;349(7):708-9. http://dx.doi.org/10.1056/NEJMc031468.
1016. SARS in Hong Kong [2]. Wu YP, Wei R, De Groot PG. New England Journal of Medicine. 2003;349(7):708-9.
1017. COVID-19 - what should anaethesiologists and intensivists know about it? Wujtewicz M, Dylczyk-Sommer A, Aszkielowicz A, Zdanowski S, Piwowarczyk S, Owczuk R. Anaesthesiology intensive therapy. 2020;52(1):34-41. http://dx.doi.org/10.5114/ait.2020.93756.
1018. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. Wynants L, Van Calster B, Bonten MMJ, Collins GS, Debray TPA, De Vos M, et al. Bmj. 2020;369:m1328. http://dx.doi.org/10.1136/bmj.m1328.
1019. Risk of COVID-19 for cancer patients. Xia Y, Jin R, Zhao J, Li W, Shen H. The Lancet Oncology.
1020. Risk of COVID-19 for patients with cancer. Xia Y, Jin R, Zhao J, Li W, Shen H. The Lancet Oncology. 2020;21(4):e180.
1021. Tribute to health workers in China: A group of respectable population during the outbreak of the COVID-19. Xiang YT, Jin Y, Wang Y, Zhang Q, Zhang L, Cheung T. Int J Biol Sci. 2020;16(10):1739-40. http://dx.doi.org/10.7150/ijbs.45135. eCollection 2020.
1022. COVID-19 discharged patients in Hunan, China: correlation between early features and prognosis. Xiao E, cai y, liu j, Yang H, Chen T, Yu Q, et al. Journal. 2020(Issue).
1023. Investigation of an epidemic cluster caused by COVID⁃19 cases in incubation period in Shanghai. Xiao WJ, Gao Q, Jin K, Gong XH, Han RB, Jiang CY, et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41:E033.
1024. Association between ambient temperature and COVID-19 infection in 122 cities from China. Xie J, Zhu Y. Science of the Total Environment. 2020;724.
1025. Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV. Xie M, Chen Q. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.03.071.
1026. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. Xie Y, Cao S, Li Q, Chen E, Dong H, Zhang W, et al. Journal of Infection.
1027. Pay attention to SARS-CoV-2 infection in children. Xie Z. Pediatric Investigation. 2020;4(1):1-4.
1028. Construction and evaluation of a novel diagnosis process for 2019-Corona Virus Disease. Xiong Z, Fu L, Zhou H, Liu JK, Wang AM, Huang Y, et al. Zhonghua yi xue za zhi. 2020;100:E019.
1029. Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, et al. Viruses. 2020;12(2).
1030. Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, et al. Zhejiang da xue xue bao Yi xue ban = Journal of Zhejiang University Medical sciences. 2020;49(1):0.
1031. Clinical analysis of 23 cases of 2019 novel coronavirus infection in Xinyang City, Henan Province. Xu M, Li M, Zhan W, Han T, Liu L, Zhang G, et al. Chinese Critical Care Medicine. 2020.
1032. Unveiling the Origin and Transmission of 2019-nCoV. Xu Y. Trends in Microbiology. 2020;28(4):239-40.
1033. Clinical management of lung cancer patients during the outbreak of 2019 novel coronavirus disease (Covid-19). Xu Y, Liu H, Hu K, Wang M. Chinese Journal of Lung Cancer. 2020;23(3):136-41.
1034. Full spectrum of COVID-19 severity still being depicted. Xu Z, Li S, Tian S, Li H, Kong LQ. The Lancet. 2020;395(10228):947-8.
1035. Attenuation and characterization of porcine enteric alphacoronavirus strain GDS04 via serial cell passage. Xu Z, Lin Y, Zou C, Peng P, Wu Y, Wei Y, et al. Veterinary Microbiology. 2019;239.
1036. Isolation and characterization of a highly pathogenic strain of Porcine enteric alphacoronavirus causing watery diarrhoea and high mortality in newborn piglets. Xu Z, Zhang Y, Gong L, Huang L, Lin Y, Qin J, et al. Transboundary and Emerging Diseases. 2019;66(1):119-30.
1037. Full-genome sequences of the first two SARS-CoV-2 viruses from India. Yadav PD, Potdar VA, Choudhary ML, Nyayanit DA, Agrawal M, Jadhav SM, et al. Indian journal of medical research. 2020.
1038. Crimean-Congo Hemorrhagic Fever: Current Scenario in India. Yadav PD, Raut CG, Patil DY, T DM, Mourya DT. Proceedings of the National Academy of Sciences, India Section B. 2014;84(1):9-18. http://dx.doi.org/10.1007/s40011-013-0197-3. Epub 2013 Jun 26.
1039. Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly. YajunYuan, Wang N, Ou X. Journal of medical virology. 2020.
1040. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K, et al. Respiratory investigation. 2020. http://dx.doi.org/10.1016/j.resinv.2019.12.005.
1041. Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019. Yan CX, Li J, Shen X, Luo L, Li Y, Li MY. Sichuan da xue xue bao Yi xue ban = Journal of Sichuan University Medical science edition. 2020;51(2):139-45.
1042. The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. Yan Y, Shin WI, Pang YX, Meng Y, Lai J, You C, et al. International journal of environmental research and public health. 2020;17(7).
1043. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Yang A-P, Liu J-P, Tao W-Q, Li H-M. Int Immunopharmacol. 2020.
1044. Analysis on the epidemic factors for the Corona Virus Disease. Yang HY, Duan GC. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2020;54:E021.
1045. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. International Journal of Infectious Diseases. 2020.
1046. Patients with respiratory symptoms are at greater risk of COVID-19 transmission. Yang R, Gui X, Xiong Y. Respiratory Medicine. 2020;165.
1047. Early estimation of the case fatality rate of COVID-19 in mainland China: A data-driven analysis. Yang S, Cao P, Du P, Wu Z, Zhuang Z, Yang L, et al. Annals of Translational Medicine. 2020;8(4).
1048. Clinical Characteristics of COVID-19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records. Yang S, Zhang Y, Cai J, Wang Z. The oncologist. 2020.
1049. Thrombocytopenia and Its Association with Mortality in Patients with COVID-19. Yang X, Yang Q, Wang Y, Wu Y, Xu J, Yu Y, et al. Journal of thrombosis and haemostasis : JTH. 2020. http://dx.doi.org/10.1111/jth.14848.
1050. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. The Lancet Respiratory Medicine. 2020.
1051. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Yang Y, Peng F, Wang R, Guan K, Jiang T, Xu G, et al. Journal of Autoimmunity. 2020.
1052. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. Yang Y, Shen C, Li J, Yuan J, Yang M, Wang F, et al. medRxiv. 2020:2020.03.02.20029975.
1053. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. Yang Z, Liu J, Zhou Y, Zhao X, Zhao Q, Liu J. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.03.062.
1054. [Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region]. Yao N, Wang SN, Lian JQ, Sun YT, Zhang GF, Kang WZ, et al. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2020;28:E003. http://dx.doi.org/10.3760/cma.j.cn501113-20200226-00070.
1055. [The Effects and Management of Viral Pneumonia on Lung Cancer Patients]. Yao Y, Lu M, Liu Y, Cao B. Zhongguo fei ai za zhi = Chinese journal of lung cancer. 2020.
1056. Peer-to-Peer Contact Tracing: Development of a Privacy-Preserving Smartphone App. Yasaka TM, Lehrich BM, Sahyouni R. JMIR mHealth and uHealth. 2020;8(4):e18936. http://dx.doi.org/10.2196/18936.
1057. Epidemiological analysis of COVID-19 and practical experience from China. Ye Q, Wang B, Mao J, Fu J, Shang S, Shu Q, et al. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.25813.
1058. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Ye Z, Zhang Y, Wang Y, Huang Z, Song B. European radiology. 2020.
1059. Molecular epidemiology of respiratory viruses among Malaysian Young children with a confirmed respiratory infection during 2014-2015. Yew SM, Tan KL, Yeo SK, Ng KP, Kuan CS. Journal of thoracic disease. 2019;11(11):4626-33. http://dx.doi.org/10.21037/jtd.2019.10.69.
1060. Molecular epidemiology of respiratory viruses among Malaysian Young children with a confirmed respiratory infection during 2014–2015. Yew SM, Tan KL, Yeo SK, Ng KP, Kuan CS. Journal of Thoracic Disease. 2019;11(11):4626-33.
1061. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. Int J Biol Sci. 2020;16(10):1753-66. http://dx.doi.org/10.7150/ijbs.45134. eCollection 2020.
1062. COVID-19 information propagation dynamics in the Chinese Sina-microblog. Yin FL, Lv JH, Zhang XJ, Xia XY, Wu JH. Math Biosci Eng. 2020;17(3):2676-92.
1063. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. Yin S, Huang M, Li D, Tang N. J Thromb Thrombolysis. 2020. http://dx.doi.org/10.1007/s11239-020-02105-8.
1064. Management highlights for patients with orthopedic trauma during the epidemic of Corona Virus Disease 2019. Yin Y, Hou Z, Zhu Y, Yang S, Chen W, Wang X, et al. Chinese Journal of Orthopaedic Trauma. 2020.
1065. Differences of viral panel positive versus negative by real-time PCR in COPD exacerbated patients. Yormaz B, Findik D, Süerdem M. Tuberkuloz ve Toraks. 2019;67(2):124-30.
1066. Epidemiologic Features and Clinical Course of Patients Infected with SARS-CoV-2 in Singapore. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, et al. JAMA - Journal of the American Medical Association. 2020.
1067. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. Yu B, Li X, Chen J, Ouyang M, Zhang H, Zhao X, et al. Journal. 2020(Issue).
1068. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. Yu P, Zhu J, Zhang Z, Han Y, Huang L. The Journal of infectious diseases. 2020.
1069. Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19. Yu S, Wang J, Shen H. Ann Palliat Med. 2020;9(2):437-46.
1070. PCR Assays Turned Positive in 25 Discharged COVID-19 Patients. Yuan J, Kou S, Liang Y, Zeng J, Pan Y, Liu L. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa398.
1071. Monitoring Transmissibility and Mortality of COVID-19 in Europe. Yuan J, Li M, Lv G, Lu ZK. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.
1072. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Yuan J, Zou R, Zeng L, Kou S, Lan J, Li X, et al. Inflammation research : official journal of the European Histamine Research Society [et al]. 2020. http://dx.doi.org/10.1007/s00011-020-01342-0.
1073. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. Yuan M, Yin W, Tao Z, Tan W, Hu Y. PLoS ONE. 2020;15(3).
1074. UBXN1 interacts with the S1 protein of transmissible gastroenteritis coronavirus and plays a role in viral replication. Yuan P, Huang S, Yang Z, Xie L, Wang K, Yang Y, et al. Veterinary Research. 2019;50(1).
1075. Comparison of the Indicators of Psychological Stress in the Population of Hubei Province and Non-Endemic Provinces in China During Two Weeks During the Coronavirus Disease 2019 (COVID-19) Outbreak in February 2020. Yuan S, Liao Z, Huang H, Jiang B, Zhang X, Wang Y, et al. Medical science monitor : international medical journal of experimental and clinical research. 2020;26:e923767. http://dx.doi.org/10.12659/MSM.923767.
1076. SARS-CoV-2 and COVID-19: The most important research questions. Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. Cell and Bioscience. 2020;10(1).
1077. A Model for COVID-19 Prediction in Iran Based on China Parameters. Zareie B, Roshani A, Mansournia MA, Rasouli MA, Moradi G. Arch Iran Med. 2020;23(4):244-8. http://dx.doi.org/10.34172/aim.2020.05.
1078. Intubation and mechanical ventilation of patients with COVID-19: what should we tell them? Zareifopoulos N, Lagadinou M, Karela A, Karantzogiannis G, Velissaris D. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 2020;90(1). http://dx.doi.org/10.4081/monaldi.2020.1296.
1079. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. Zeng Y, Cai Z, Xianyu Y, Yang BX, Song T, Yan Q. Critical care (London, England). 2020.
1080. The epidemiology, diagnosis and treatment of COVID-19. Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. International journal of antimicrobial agents. 2020.
1081. Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report. Zhan WQ, Li MD, Xu M, Lu YB. Eur Rev Med Pharmacol Sci. 2020;24(6):3385-9. http://dx.doi.org/10.26355/eurrev_202003_20705.
1082. Controversial treatments: an updated understanding of the Coronavirus Disease 2019. Zhang C, Huang S, Zheng F, Dai Y. Journal of medical virology. 2020.
1083. Liver injury in COVID-19: management and challenges. Zhang C, Shi L, Wang FS. The Lancet Gastroenterology and Hepatology. 2020;5(5):428-30.
1084. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. International journal of antimicrobial agents. 2020:105954.
1085. Single chain fragment variable (scFv) antibodies targeting the spike protein of porcine epidemic diarrhea virus provide protection against viral infection in piglets. Zhang F, Chen Y, Ke Y, Zhang L, Zhang B, Yang L, et al. Viruses. 2019;11(1).
1086. The potential risk of kidney vulnerable to novel coronavirus 2019 infection. Zhang F, Liang Y. American journal of physiology Renal physiology. 2020.
1087. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Journal of Clinical Virology. 2020:104364.
1088. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Respiratory research. 2020;21(1):74. http://dx.doi.org/10.1186/s12931-020-01338-8.
1089. Twin girls infected with SARS-CoV-2. Zhang GX, Zhang AM, Huang L, Cheng LY, Liu ZX, Peng XL, et al. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. 2020;22(3):221-5.
1090. Early lessons from the frontline of the 2019-nCoV outbreak. Zhang H. The Lancet. 2020;395(10225):687.
1091. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, et al. The Lancet Infectious Diseases. 2020.
1092. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China. Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020. http://dx.doi.org/10.1016/j.cmi.2020.04.012.
1093. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Allergy. 2020. http://dx.doi.org/10.1111/all.14238.
1094. [Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province]. Zhang L, Jiang Y, Wei M, Cheng BH, Zhou XC, Li J, et al. Zhonghua Fu Chan Ke Za Zhi. 2020;55:E009-E.
1095. Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series. Zhang L, Li J, Zhou M, Chen Z. Journal of anesthesia. 2020. http://dx.doi.org/10.1007/s00540-020-02778-8.
1096. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Annals of oncology : official journal of the European Society for Medical Oncology. 2020. http://dx.doi.org/10.1016/j.annonc.2020.03.296.
1097. Respiratory viruses identified in western Canadian beef cattle by metagenomic sequencing and their association with bovine respiratory disease. Zhang M, Hill JE, Fernando C, Alexander TW, Timsit E, van der Meer F, et al. Transboundary and Emerging Diseases. 2019;66(3):1379-86.
1098. Genetic manipulation of porcine deltacoronavirus reveals insights into NS6 and NS7 functions: a novel strategy for vaccine design. Zhang M, Li W, Zhou P, Liu D, Luo R, Jongkaewwattana A, et al. Emerging Microbes and Infections. 2020;9(1):20-31.
1099. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19. Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Circ Res. 2020. http://dx.doi.org/10.1161/CIRCRESAHA.120.317134.
1100. CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city. Zhang R, Ouyang H, Fu L, Wang S, Han J, Huang K, et al. European radiology. 2020.
1101. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China. Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. Clinical immunology (Orlando, Fla). 2020;214:108393. http://dx.doi.org/10.1016/j.clim.2020.108393.
1102. Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. Zhang X, Cai H, Hu J, Lian J, Gu J, Zhang S, et al. Int j infect dis. 2020.
1103. Evaluation of a multiplex PCR assay for detection of respiratory viruses and Mycoplasma pneumoniae in oropharyngeal swab samples from outpatients. Zhang Y, Cao L, Xu Z, Zhu P, Huang B, Li K, et al. Journal of Clinical Laboratory Analysis. 2020;34(1).
1104. [Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia]. Zhang Y, Cao W, Xiao M, Li YJ, Yang Y, Zhao J, et al. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2020;41:E006. http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.0006.
1105. A Novel Coronavirus (COVID-19) Outbreak: A Call for Action. Zhang Y, Xu J, Li H, Cao B. Chest. 2020;157(4):e99-e101.
1106. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver international : official journal of the International Association for the Study of the Liver. 2020. http://dx.doi.org/10.1111/liv.14455.
1107. Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources. Zhang Z, Yao W, Wang Y, Long C, Fu X. The Journal of infection. 2020.
1108. COVID-19 indirect contact transmission through the oral mucosa must not be ignored. Zhang Z, Zhang L, Wang Y. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2020. http://dx.doi.org/10.1111/jop.13019.
1109. Prediction of fatal adverse prognosis in patients with fever-related diseases based on machine learning: A retrospective study. Zhao C-H, Wu H-T, Che H-B, Song Y-N, Zhao Y-Z, Li K-Y, et al. Chinese Medical Journal. 2020.
1110. COVID-19 drives new threat to bats in China. Zhao H. Science. 2020;367(6485):1436.
1111. CT scans of patients with 2019 novel coronavirus (covid-19) pneumonia. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Theranostics. 2020;10(10):4606-13.
1112. S gene and 5a accessory gene are responsible for the attenuation of virulent infectious bronchitis coronavirus. Zhao Y, Cheng J, Yan S, Jia W, Zhang K, Zhang G. Virology. 2019;533:12-20.
1113. Challenges for Obstetricians and the Countermeasures of COVID-19 Epidemic. Zhao Y, Zou L, Dong M-H, Liu X-X, Liu Y-L, Zhu J-W, et al. Maternal-Fetal Medicine. 2020.
1114. Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic. Zhao Z, Bai H, Duan J, Wang J. Thoracic cancer. 2020. http://dx.doi.org/10.1111/1759-7714.13424.
1115. A capillary electrophoresis method for studying apo, holo, recombinant, and subunit dissociated ferritins. Zhao Z, Malik A, Lee ML, Watt GD. Analytical biochemistry. 1994;218(1):47-54. http://dx.doi.org/10.1006/abio.1994.1139.
1116. Clinical features and risk factors for the severity of inpatients with COVID-19: a retrospective cohort study. Zheng A. Lancet.
1117. Risk-adapted Treatment Strategy For COVID-19 Patients. Zheng C, Wang J, Guo H, Lu Z, Ma Y, Zhu Y, et al. International Journal of Infectious Diseases. 2020.
1118. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Zheng F, Tang W, Li H, Huang YX, Xie YL, Zhou ZG. European Review for Medical and Pharmacological Sciences. 2020.
1119. Epidemiological Characteristics and Clinical Features of 32 Critical and 67 Noncritical Cases of COVID-19 in Chengdu. Zheng Y, Xu H, Yang M, Zeng Y, Chen H, Liu R, et al. Journal of Clinical Virology. 2020:104366.
1120. Clinical characteristics and immunosuppressants management of coronavirus disease 2019 in solid organ transplant recipients. Zhong Z, Zhang Q, Xia H, Wang A, Liang W, Zhou W, et al. American Journal of Transplantation. 2020.
1121. Utility of Ferritin, Procalcitonin, and C-reactive Protein in Severe Patients with 2019 Novel Coronavirus Disease. Zhou B, She J, Wang Y, Ma X. Journal. 2020(Issue).
1122. Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report. Zhou B, She J, Wang Y, Ma X. Journal of Thrombosis and Thrombolysis. 2020.
1123. Disease severity and clinical outcomes of community acquired pneumonia caused by non-influenza respiratory viruses: A multicenter prospective registry study from CAP-China network. Zhou F, Wang Y, Liu Y, Liu X, Gu L, Zhang X, et al. American Journal of Respiratory and Critical Care Medicine. 2019;199(9).
1124. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: A multicentre prospective registry study from the CAP-China Network. Zhou F, Wang Y, Liu Y, Liu X, Gu L, Zhang X, et al. European Respiratory Journal. 2019;54(2).
1125. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Lancet. 2020;395(10229):1054-62. http://dx.doi.org/10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
1126. Retrospective detection and phylogenetic analysis of swine acute diarrhoea syndrome coronavirus in pigs in southern China. Zhou L, Sun Y, Lan T, Wu R, Chen J, Wu Z, et al. Transboundary and Emerging Diseases. 2019;66(2):687-95.
1127. Coronavirus disease 2019 (COVID-19): a clinical update. Zhou M, Zhang X, Qu J. Frontiers of medicine. 2020.
1128. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Nature. 2020;579(7798):270-3.
1129. Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV. Zhou T, Liu Q, Yang Z, Liao J, Yang K, Bai W, et al. J Evid Based Med. 2020;13(1):3-7.
1130. Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak. Zhou WK, Wang AL, Xia F, Xiao YN, Tang SY. Math Biosci Eng. 2020;17(3):2693-707. http://dx.doi.org/10.3934/mbe.2020147.
1131. Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain. Zhou Y, Yang Y, Huang J, Jiang S, Du L. Viruses. 2019;11(1).
1132. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Zhou Y, Zhang Z, Tian J, Xiong S. Annals of palliative medicine. 2020.
1133. Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial. Zhou YH, Qin YY, Lu YQ, Sun F, Yang S, Harypursat V, et al. Chinese medical journal. 2020.
1134. A study of human coronavirus infections in children with community-acquired pneumonia from 2015 to 2016 in Zhejiang, China. Zhou YL, Zhang YY, Chen ZM. Pediatric Pulmonology. 2019;54:S89-S90.
1135. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Zhu L, Gong N, Liu B, Lu X, Chen D, Chen S, et al. European Urology. 2020.
1136. Dose-Response Association between Risk Factors and Incidence of COVID-19 in 325 Hospitalized Patients: A Multicenter Retrospective Cohort Study. Zhu Q, Zhao S, Lai X, Zhao J, Guo D, Gan L, et al. 2020.
1137. A Comparative Study of Chest Computed Tomography Features in Young and Older Adults With Corona Virus Disease (COVID-19). Zhu T, Wang Y, Zhou S, Zhang N, Xia L. Journal of thoracic imaging. 2020.
1138. As We Went to Press: COVID-19 Continues to Spread A Comparative Study of Chest Computed Tomography Features in Young and Older Adults With Corona Virus Disease (COVID-19). Zhu T, Wang Y, Zhou S, Zhang N, Xia L. AJN The American Journal of Nursing. 2020.
1139. [The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease]. Zhu WJ, Wang J, He XH, Qin Y, Yang S, Hu XS, et al. Zhonghua Zhong Liu Za Zhi. 2020;42:E008-E.
1140. On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak. Zhu Y, Chen YQ. Statistics in Biosciences. 2020.
1141. [WITHDRAWN: Potential false-positive rate among the 'asymptomatic infected individuals' in close contacts of COVID-19 patients]. Zhuang GH, Shen MW, Zeng LX, Mi BB, Chen FY, Liu WJ, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(4):485-8.
1142. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Radiology. 2020:200490.
1143. Chest CT--The gatekeeper to COVID-19. Zu Z-y, Zhang L-j. Journal of Medical Postgraduates. 2020.
1144. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A, Roncon L. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.03.059.
1145. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. The Lancet. 2020;395(10224):e35-e6.
1146. Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020. Zwald ML, Lin W, Sondermeyer Cooksey GL, Weiss C, Suarez A, Fischer M, et al. MMWR Morbidity and mortality weekly report. 2020;69(14):419-21. http://dx.doi.org/10.15585/mmwr.mm6914e3.